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ABSTRACT 
This thesis explores the role of psychological factors in predicting quality of life in patients 
diagnosed and undergoing treatment for head and neck cancer (HNC). A self-regulatory framework 
was used as reference for guiding the selection of psychological factors related to adaptation and 
outcome. The main aim of the thesis was to investigate the effects of illness and treatment beliefs 
on both standardised health related quality of life (HR-QoL) and individualised quality of life 
(QoL). 
The literature review is presented in two parts. The first part provides an overview and critical 
appraisal of the literature evaluating the impact of HNC and its treatment on HR-QoL. The second 
part consists of a systematic review assessing psychosocial and behavioural factors associated with 
HR-QoL in HNC. An additional chapter provides a critical overview of the wider literature 
reporting psychological factors found to be associated with QoL in cancer in general. 
The empirical content of the thesis begins with the results of a qualitative pilot study examining, 
firstly, the types of expectations patients had prior to treatment and the extent to which patients 
considered that these expectations had been met post treatment, and secondly, the role of 
information on the development of expectations. 
A prospective questionnaire based study with a sample of eighty-two HNC patients provided data 
for testing the main hypotheses. Patients completed questionnaires assessing illness and treatment 
beliefs, mood, coping, optimism and individualised and standardised QoL at three time points. 
Results based on pre-treatment data indicated that patient's perceptions of their illness and 
treatment, and style of coping were shown to be determinants of HR-QoL but not individualised 
QoL. 
Finally, a cross-sectional questionnaire based study assessing long-term adaptation was conducted 
using patients with cancer of the head region, two additional patient samples (patients with cancer 
of the glottis/ larynx and surgical patients with benign salivary gland conditions) and a matched 
non-patient sample, for comparisons. The main aim was to assess factors that were associated with 
long term subjective-well being (i. e. cognitive and emotional adaptation) after treatment. 
Results demonstrated that time since treatment had no effect on adaptation in any of the clinical 
samples. HR-QoL and optimism was found to explain 70% of variation in emotional adaptation 
(depression scores) in patients with cancer of the head region. Approximately 50% of the variance 
in cognitive adaptation could be explained by optimism, HR-QoL and treatment type. 
The limitations and implications of the studies and literature are discussed. 
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'How am I? Who knows? Nine months or so after the operation I'm back on an almost entirey liquid 
diet - the radiotherapy put paid to any solids I was managing .... I'm also in pain for much of the time. I 
have to sleep upright because with my salivaglandsgone I still have mucus problems I have no real sense 
of taste and retain a propensity for long coughing jags that keep me out of the cinemas and the theatre. I 
have a voice, of sorts, and although it is one which causes strangers TO. SPEAK TO. ME. LIKE. T- 
H-I-S. as if I were a mentally retarded deaf mute it means I can join in conversations " 
(Diamond, 1998) 
1.1 HEAD AND NECK CANCER (HNC) 
1.1.1 Definition 
`Cancer' is another term for malignant neoplasm. The pathology of malignant neoplasms of the 
head and neck can be subdivided into `squamous cell', `basal cell', `salivary', `thyroid', 
`odontogenic and bone/cartilage tumours' and `others'. Most cancers of the head and neck are 
squamous cell carcinomas (SCC) arising in the mucous membranes of the mouth, pharynx and 
larynx and are considered alcohol and tobacco related. 
Most international databases employ the World Health Organisation's (WHO) International 
Classification of Diseases coding system, and most data currently available are expressed in the 
9th or 10th revisions (ICD-9 or 10). The term `head and neck cancer' usually refers to the 
following sites and codes (ICD-10): Malignant neoplasms of the lip (COO); base of tongue 
(C01); other and unspecified parts of the tongue (CO2); gum (CO3); floor of mouth (C04); 
palate (C05); other and unspecified parts of the mouth (C06); parotid gland (C07); other and 
unspecified major salivary glands (C08); tonsil (C09); oropharynx (C10); nasopharynx (C11); 
pyriform sinus (C12); hypopharynx (C13); other and ill defined sites of the lip, oral cavity and 
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pharynx (C14); nasal cavity and middle ear (C30); accessory sinuses (C31) and larynx (C32). 
Tumours of the skin (unless SCC), eye and brain are normally excluded from the term `head 
and neck cancer'. It is important to recognise these site subdivisions as they have distinct 
management and treatment protocols and differing physical morbidities associated with their 
diagnosis and treatment. 
1.1.2 Epidemiology of head and neck cancer 
The incidence of cancer of the mouth and pharynx ranks sixth of all cancers in the world and 
ranks third in developing countries (Parkin, Whelan, Ferlay, Raymond, & Young, 1997). Striking 
differences in incidence rates exist between different geographical (and therefore cultural, 
ethnic and socio-economic) regions. In developed countries, the number of cases with cancer 
of the mouth or pharynx is higher than that of cervical cancer. Cancer of the mouth, pharynx 
and larynx (ICD-10: COO-C14 & C32) is the fifth most common anatomical site for cancer in 
the world, with half a million incident cases of oral and pharyngeal plus laryngeal cancer cases 
in 1990 (Ferlay, Parkin, & Pisani, 1998; Parkin, Pisani, & Ferlay, 1999). H&N cancer is 
responsible for 12% of male and 7% of female cancers in the developing world and 7% and 
2% respectively, in developed countries (Sankaranarayanan, Masuyer, Swaminathan, Ferlay, & 
Whelan, 1998). In the United Kingdom, considerably higher incidence rates are reported in 
Scotland and Northern Ireland (NI) than in England and Wales for both sexes, although the 
difference is greatest for men. The male European age standardised rates for oral cancer 
(ICD10 C00-C14, excluding C07/08 & C11) were approximately 13 per 100,000 population in 
Scotland and NI (4.5 for women) compared to approximately 7 per 100,000 (3.0 for women) in 
England and Wales (CRC, 2000). Altogether, the figures for H&N cancer represent a 
substantial disease burden, with high mortality rates of 54% overall: death to registration ratios 
range from 0.47 to 0.65 according to site (Johnson, 2002). 
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1.1.3 Aetiological factors 
Carcinogenesis in the head and neck is multi-factorial and exhibits considerable inter-individual 
variation. Excessive alcohol intake and a long history of tobacco use in its many forms, are 
considered to be the principle risk factors. The risk is strongly enhanced by the synergistic 
action of tobacco and alcohol together. If the risk for an abstinent individual is 1, the relative 
risks are approximately 5,18 and 40 for light drinkers or heavy smokers, light smokers and 
heavy drinkers, and heavy smokers and heavy drinkers respectively (Rothman & Keller, 1972). 
This reflects the fact that 90% of patients have a long history of tobacco smoking and alcohol 
intake. Continued tobacco consumption following treatment for HNC is also recognised to 
increase the risk of recurrence (Benninger, Gillen, Thieme, Jacobson, & Dragovich, 1994; 
Rothman et al., 1972; Silverman, Gorsky, & Greenspan, 1983; Stevens, Gardner, Parkin, & 
Johnson, 1983) or secondary HNC (Moore, 1971; Wynder, Dodo, Bloch, Gantt, & Moore, 
1969) and to reduce disease-specific survival (Browman et al., 1993b; Stevens et al., 1983). 
Betel-quid chewing with or without the inclusion of tobacco products has also been identified 
as a major risk factor for oral cancers in Asian populations. In recent years, there has been an 
enormous increase and availability of betel products for sale in the UK, both as separate 
ingredients or pre-packaged (Williams, 1995). This has encouraged the perpetuation of these 
highly carcinogenic practices. Other aetiological factors are thought to include exposure to 
viruses, such as the human papilloma virus (HPV16 & 18) (Gillison & Shah, 2001; Mineta et 
al., 1998; Wilczynski, Lin, Xie, & Paz, 1998) and Epstein-Barr Virus (EBV) (D'Costa, Saranath, 
Sanghvi, & Mehta, 1998; Kobayashi et al., 1999) although these conclusions are still plagued 
with controversy. 
1.1.4 Prognosis 
The five year relative survival rate reported by the Surveillance, Epidemiology and End Results 
(SEER) program of the National Cancer Institute of USA, for oral cavity and and pharyngeal 
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cancers (1986-1991) was 52.1%; cancer of the larynx was 65.7%, and there has been little 
difference in survival rates over the last few decades (Carvalho, Nishimoto, Califano, & 
Kowalski, 2005). For localised lip, salivary gland, paranasal sinus and laryngeal cancers, five year 
survival exceeded 80%; ranging between 65-79% for localised tongue, mouth and 
nasopharyngeal cancers. However, five-year survival rates were less than 50% for localised 
cancers in other H&N sites. The five year relative survival rates reported from 11 countries in 
the European Cancer Registry based Study of Survival and Care of Cancer Patients 
(EUROCARE) were as follows: tongue: 39%; oral cavity: 46%; oropharynx: 33%; 
nasopharynx: 38%; hypopharynx: 19% and larynx: 54% (Berrino, Esteve, & Coleman, 1995). In 
developing countries, five-year relative survival for the majority of subsites (excluding lip) tends 
to be less than 35%. 
Clinical extent of disease seems to be the most important prognostic factor affecting outcome 
of treatment. Outcome results for moderately advanced H&N tumours are poor regardless of 
treatment. Advances in treatment (e. g. adjuvant chemotherapy, modified radiotherapy 
regimens, as discussed below) have not improved long term survival in the case of advanced 
HNC (Sankaranarayanan et al., 1998). 
1.1.5 Treatment /management strategies 
Treating HNC patients for cure involves either surgery, radiotherapy and/or chemotherapy in 
varying combinations. Each treatment has its on toxicities and adverse late effects which are 
often intensified when used in combination. Small primary tumours can be eradicated by either 
surgery or radiotherapy. In cases involving less accessible lesions (e. g. the vocal cords, tonsil 
and hypopharynx), radical radiotherapy can enable good function and cosmesis to be retained 
and this is generally the treatment of choice. Salvage surgery may be required in those patients 
with residual or recurrent disease after radiotherapy (Bloom, 1987). 
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The high doses of radiotherapy required to gain locoregional control of HNC are associated 
with an increased risk to normal tissue. Acute skin and mucosal reactions are common during 
irradiation and generally subside after treatment. Late irradiation-induced changes can lead to 
fibrosis and may lead to permanent and serious problems with regard to function, comfort and 
cosmesis. The most frequent effects following treatment with radiotherapy are due to the 
reduction of saliva following direct or incidental irradiation of the salivary glands. The resulting 
mouth dryness (Xerostomia) may lead to rapid and severe widespread dental caries (Bloom, 
1987), difficulties eating with a decreased or lack of taste and smell, or problems speaking. 
Brachytherapy (external local dose of radiotherapy, usually as an interstitial iradium implant) 
has become an optional treatment, especially in the oral cavity and pharynx. This reduces the 
area of tissue affected by side-effects, but due to the high levels of radiation, may increase the 
side-effects in the smaller area (Hammerlid, Mercke, Sullivan, & Westin, 1997b). New 
computer based techniques allow the radiant beam to be adapted to the tumour but the more 
concentrated dose, especially with concomitant chemotherapy, results in scarring and reduced 
function. 
During the last twenty years, the advances in intra-oral soft tissue reconstruction by 
revascularised tissue transfer (e. g. from pectoral or forearm donor sites) have lead to more 
extensive tumour ablation in patients, as even large defects can be repaired in one step 
procedures. Due to this, current techniques give improved cosmetic results to previous, but still 
poor functional effects, frequently leading to problems eating, drinking, speaking or even 
breathing. 
In advanced cancers, chemotherapy is being used more frequently in combination with 
radiotherapy with the goal of organ preservation in the `neoadjuvant setting' (chemotherapy as 
a substitute for surgery in treatment of advanced resectable HNC). Loss of many vital 
functions (such as those highlighted above) can result (Ganz, 1990). 
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A critical prognostic factor in HNC is spread of disease to regional lymph nodes (Schuller, 
McGuirt, McCabe, & Young, 1980). The traditional gold standard for regional disease control 
has been radical resection of all lymph bearing tissues in the neck. This included removal of the 
spinal accessory nerve (SAN), which leads to patients suffering from `shoulder syndrome'. This 
syndrome was characterised by a shoulder droop, weak abduction, restricted movement and a 
dull ache with pain localised to the shoulder. More conservative modifications to this classic 
dissection have meant sparing the SAN whilst still controlling disease and decreasing the 
associated morbidity. Despite this, neck dissection is still responsible for permanent and 
significant change in shoulder function as well as increased postoperative pain. 
1.1.6 A brief overview of psychological sequelae of HNC and treatment 
The diagnosis of cancer is frightening for patients and their families. Cancer of the H&N not 
only poses a threat to life but, in patients who survive, self-image and confidence is challenged 
through the consequences of the disease itself and the results of treatment. 
There is ample evidence that psychological distress is common in HNC patients (Hutton & 
Williams, 2001). Given the visible deformities caused by the cancer and treatment, studies have 
been conducted to identify the psychosocial impact. Results have been conflicting. Anxiety has 
been reported as a frequent general symptom in HNC patients (De Boer, McCormick, Pruyn, 
Ryckman, & van den Borne, 1999) although the experience of stress associated with HNC has 
been found to be greatest at diagnosis decreasing as the patient progresses through treatment 
(Manuel, Roth, Keefe, & Brantley, 1987). Reports of the prevalence of depression in these 
patients are also inconsistent. However, anxiety and depression have been associated with 
poor function (Hassanein, Musgrove, & Bradbury, 2001). Due to the cancer and treatment, 
many patients must discontinue their usual activities or jobs and as a result often become 
socially isolated. Areas of life that are affected the most by HNC include; communication, 
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functioning in the family and social and interpersonal relationships (De Boer et al., 1999). The 
extent of disruption to sexual functioning has not been investigated fully, although it has been 
suggested that patients with extensive disfigurement report significantly greater reduction in 
sexuality than patients with minor disfigurement (Gamba et al., 1992). 
In the last few decades, interest in the issues, which impact on an individual's life the most, has 
increased. The term quality of life (QoL) although widely used, is problematic to define, 
however, many instruments for measuring this concept exist. Measurement of QoL usually 
refers to health-related quality of life (HR-QoL) and typically includes enquiry into patient 
perceptions of; physical function, symptoms, performance and emotional aspects. 
Psychological distress or functioning is rarely included within HR-QoL measurement. 
1.1.7 The context of the thesis 
Head and neck cancer remains a highly physically and psychologically traumatic disease. The 
basic functions of seeing, swallowing, hearing, smelling, and ultimately of communication 
depend on each element working together in harmony. The function and appearance of the 
head and face are critical to an individual's self-image. Although disfigurement and body-image 
concerns are recognised as critical factors in psychosocial rehabilitation and adjustment after 
HNC (Clarke, 2001; Dropkin, 1998a; Dropkin, 1999; Lansdown, Rumsey, Bradbury, Carr, & 
Partridge, 1997), these aspects have not been included in this thesis for a number of reasons. 
Firstly, the literature detailing the effects of disfigurement in HNC patients is extensive and it 
would not have been possible to do justice to this specific area by incorporating facets within 
the current focus of the PhD. In addition, not all patients have to cope with outward 
disfigurement despite facing functional difficulties, and thirdly, coping with an altered 
appearance is one factor that could influence adaptation. However, the underlying belief system 
that patients had developed in response to their illness as a whole and their associations with 
outcome (adaptation) were of primary interest, rather than focusing on one very specific factor. 
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Despite recent developments in reconstructive techniques and more sophisticated treatment 
regimes involving specialist multidisciplinary teams, the survival rate in advanced disease has 
remained at approximately 50%. Continuing efforts such as conservation and reconstruction 
procedures, speech therapy and prostheses have been directed towards lessening the impact of 
the disease and its treatment in terms of disability and functioning. Comprehensive assessment 
of the impact of head and neck cancer once clinical outcomes such as survival and disease 
progression have been established, go beyond level of functioning, to include patient wellbeing. 
The interest in HR-QoL has increased in recent years and much published data exists 
examining QoL issues in HNC patients. Although exciting developments continue in the area 
of longitudinal research that report changes in HR-QoL over time, there is a paucity of 
research examining the patient's subjective judgement of their own QoL in terms of the 
priorities they have throughout their cancer journey. 
Variation in QoL (both between patients and over time) may be due either to differences in 
functional status (physical disability) or may reflect the underlying belief system the patient has 
about their illness and treatment, for example, in terms of the likely causes of the disease, its 
time scale, whether the illness is likely to be chronic, acute or cyclical, its controllability and the 
perceived consequences. By examining these beliefs, adaptational processes may be revealed, 
for example cognitive `shifts' in which a patient's internal standards change over time and with 
experience. 
The primary value of understanding individual variation in QoL is to attempt to minimise the 
impact and intrusion of HNC to a patient's life. By understanding the relationship between 
outcomes such as QoL, and potentially modifiable psychological factors, such illness 
perceptions, patients long-term QoL can perhaps be enhanced by designing appropriate 
interventions based on theoretical underpinnings. 
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1.1.8 Outline of Chapters 2 and 3: Literature reviews 
The literature reviews are presented in chapters 2 and 3, which were conducted in order to 
identify gaps in the literature and to provide a basis for formulating specific research questions 
and hypotheses for the thesis. The first of the literature reviews (chapter 2, part 1) seeks to 
critically examine the evidence for the impact of head and neck cancer and treatment on 
outcomes such as HR-QoL and depressive symptoms, and the evidence for socio- 
demographic, clinical and treatment related factors predictive of HR-QoL in this patient 
group. 
Part two of chapter 2 consists of a systematic review, which was undertaken to assess whether 
there were any psycho-social or behavioural factors that are associated with HR-QoL in HNC 
and the extent to which depressive symptoms and HR-QoL are related. 
Chapter 3 introduces the theoretical context to the thesis, in terms of Leventhal's self- 
regulatory model (SRM), which has not been widely applied in the field of HNC previously. 
This provides a critical overview of the literature evaluating the role of psychological 
components of the SRM on outcomes such as quality of life and psychological well-being, in a 
wide variety of illness groups. The role of expectations on perceptions of outcome is also 
considered. Chapter 3 also contains a brief overview of the concept of `response-shift' in the 
context of QoL research, and the current approaches to measuring QoL in terms of conceptual 
and methodological issues in addition to the clinical implications. 
Implications of the literature reviews for the thesis are thus presented afterwards followed by 
the main aims and key objectives of the current research. 
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CHAPTER 2. 
THE HEALTH RELATED QUALITY OF LIFE (HR-QOL) OF PATIENTS 
DIAGNOSED WITH HEAD AND NECK CANCER (HNC) 
The following chapter has been divided into two parts. The first part of chapter 2 seeks to 
provide an overview and critical appraisal of the literature assessing the impact of HNC and its 
treatment on HR-QoL and considers the socio-demographic and clinical factors associated 
with HR-QoL. The second part of chapter 2, consists of a systematic review examining the 
extent to which psycho-social and behavioural factors are related to HR-QoL in this patient 
group. 
2.1 PART 1: CRITICAL REVIEW OF THE LITERATURE 
Research question: To what extent does HNC and its treatment impact on HR-QoL? 
2.1.1 SEARCH TECHNIQUES AND TERMS 
2.1.1.1 Databases 
The following databases were searched: Medline 1982-present; CancerLit 1985-2002; Embase 
1980-Present; Psychlnfo 1984-present; the Institute for Scientific Information (ISI) databases 
of SCI-expanded and Social Sciences Citation Index (SciSearch) and the International 
Bibliography of the Social Sciences (IBSS) via the Bath Information and Dissemination Service 
(BIDS). References in articles were also used as a literature source in addition to hand 
searching of relevant journals. 
2.1.1.2 Search terms 
Search terms of. head and neck, cancer, carcinoma, malignant neoplasm, head and neck cancer, 
head, neck, oral, mouth, oral cancer, quality of life, QoL, HR-QoL, health states, assessment, 
were combined variously to search the databases. The term `head and neck cancer' was also 
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exploded to include the following subject index terms: head and neck-neoplasms, 
hypopharyngeal-neoplasms, laryngeal-neoplasms, oropharyngeal-neoplasms, carcinoma, 
pharyngeal-neoplasms, tongue-neoplasms, tonsillar-neoplasms, esophageal-neoplasms, mouth- 
neoplasms, oral cavity-neoplasms, salivary gland-neoplasms, tracheal-neoplasms, 
submandibular gland-neoplasms, otorhinolaryngolic neoplasms, squamous cell carcinoma. 
2.1.1.3 Limitations 
The search was limited by including only literature published in the English language between 
the years 1980 to present and only involving human subjects. 
2.1.2 RESULTS 
The search yielded 479 articles, including 10 general reviews and a number of editorials. The 
reviews are listed in Table 2.1 and excluded from subsequent tables. The majority of the 
articles did not address quality of life issues. Articles were also discarded if they were abstracts, 
editorials, letters, and commentaries or did not report primary data. A total of 177 articles were 
deemed suitable for inclusion, however, due to this overwhelming volume of published 
material it is beyond the scope of this review to include details of every one of these studies. As 
reviews exist examining data published up to 1999, the present review will mainly concentrate 
on the literature post 1999 (2000 - present) but incorporating an overview of literature 
reviewed previously. From the literature search detailed above and hand searching relevant 
articles, over 50 original articles (published 2000 - present) were found. 
The results section next provides a brief overview of the definition of quality of life (section 
2.1.2.1) and a critical appraisal of HR-QoL instruments, including HNC specific measures 
(section 2.1.2.2). Section 2.1.3 presents the results ofthe literature search on the impact of 
HNC and treatment on QoL, considering both short term (<12 months after treatment) and 
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longer-term impacts (> 12 months). Section 2.1.1.4 discusses the limitations of the research 
presented and leads onto the main conclusions derived from the literature (section 2.1.5). 
2.1.2.1 Definitions of 'quality of life' 
There is wide variation in what is meant by `quality of life' (QoL). The World Health 
Organisation has defined a high QoL as a `state of complete physical, mental and social well- 
being and not merely the absence of disease or infirmity. ' Using the WHO's definition, global 
QoL could feasibly include a patient's psychological and emotional status and perceptions of 
satisfaction found in work, home life, religion, family, education or income. Assessing global 
QoL generally provides a broader picture of the impact of disease on an individual's life. In 
clinical practice, however, QoL generally refers to health-related quality-of-life (HR-QoL) 
which seeks to examine aspects of QoL thought to be impacted by a health or medical 
concern. Assessment of HR-QoL typically includes physical, psychological and social domains. 
Each domain may include measures that assess the patient's perception of symptoms, ability to 
function and disability (Troxel, Fairclough, Curran, & Hahn, 1998), therefore, measures of 
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2.1.2.2 HR-QoL measures 
As it is accepted that `HR-QoL' is a broad, multi-dimensional concept, a number of 
questionnaires have been developed that reflect this complex conceptual framework. There are 
three main categories of questionnaire that are commonly applied to assess the HR-QoL of 
HNC patients, performance questionnaires aside: global HR-QoL, general cancer HR-QoL and 
HNC specific HR-QoL. Global or generic questionnaires can be applied to patients with any 
disease or a `normal' population and assess physical, psychological and social functioning (e. g. 
Short form Health Survey (SF-12), (Ware, Kosinski, & Keller, 1996); General Health 
Questionnaire (GHQ), (Goldberg & Williams, 1988). General cancer questionnaires focus on 
common symptoms and side-effects of cancer treatments (e. g. The European Organisation for 
Research and Treatment of Cancer (EORTC) core questionnaire, (Aaronson et al., 1993); The 
Functional Assessment of Cancer Therapy Scale (FACT-G), (Cella et al., 1993); Functional 
Living Index-Cancer Scale (FLIC) (Schipper, Clinch, McMurray, & Levitt, 1984). HNC specific 
HR-QoL questionnaires are intended to assess the specific impact of HNC and its treatment 
on an individual's HR-QoL in terms of oral function, which includes aspects of 
communication, swallowing, chewing, nutrition and cosmesis. 
2.1.2.2.1 HNC specific HR-QoL measures 
Eight disease specific HR-QoL instruments have been published for patients with HNC, with 
varying strengths and weaknesses. Reliability and validity studies using these instruments are 
still ongoing. The European Organisation for Research into Treatment of CancerQuality of life 
Questionnaire for Head and Neck Cancer (EORTC QLQ-C30/H&N35), (Bjordal et al., 1994), is a 
patient based, self-administered and multidimensional core and specific HR-QoL instrument 
developed across many cultural and language groups. The H&N module (H&N35) consists of 
35 items from seven domains: pain, swallowing, senses, speech, social eating, social contact and 
sexuality, in addition to 11 single items (e. g. problems with teeth and mouth, sticky saliva, 
weight and painkillers). This extensive questionnaire demonstrated reliability, validity and 
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internal consistency in a trial of 500 patients (Bjordal et al., 1999), however, the social eating 
and speech domains did not show adequate reliability. Responsiveness to change over time was 
seen in most domains, except for domains of social contact and single items assessing dry 
mouth, mouth opening, sticky saliva and feeling ill. 
The FunctionalAssessment of Cancer Therapy- Head and Neck (FACT-HNS), (List et al., 1996a), is 
also a self-administered, multi-item instrument consisting of 27 items from four domains - 
physical, social/family, emotional and functional, plus an 11 item H&N subscale. Item 
generation was based on 15 HNC patients and 5 `experts'. Item importance was determined by 
clinicians. Reliability and concurrent validity were found to be acceptable in this short 
questionnaire (D'Antonio, Zimmerman, Cella, & Long, 1996; List et al., 1996a) and 
responsiveness to change was also demonstrated (D'Antonio et al., 1996). 
The Head and Neck Radiotherapy Questionnaire (HNRQ), (Browman et al., 1993a) was developed 
as an evaluative instrument to measure radiation induced acute morbidity and HR-QoL in 
patients with stage III or IV HNC. The interviewer administered scale consists of 22 items 
from six domains - skin, throat, oral stomatitis, digestion, energy and psychosocial. An 
unspecified number of oncologists, nurses and patients generated the items and reduction was 
judged by health care workers. Content and face validity are lacking and according to Ringash 
& Bezjak, (2001) it is questionable whether this instrument reflects the multiple dimensions of 
HR-QoL experienced over time. 
The Quality of Life Instrument for Head and Neck Cancer (QL-H&N), (Morton & Witterick, 1995) is 
a short self-administered questionnaire with physical, social and psychological domains. The 
psychometric properties of this instrument are difficult to establish since the entire version has 
not been published. 
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The Quality of Life Questionnairr forAdvanced Head and Neck Cancer (QLQ), (Rathmell, Ash, 
Howes, & Nicholls, 1991) is intended to discriminate between patients who undergo radiation 
treatment alone and those who have both surgery and radiotherapy. 19 items cover four 
domains of physical, functional/mood, psychological and attitude to treatment. No reliability 
data and minimal validity has been established for this instrument. Similarly, the Quality of Life - 
Radiation Therapy Instrument Head and Neck Module (QOL-RTI/H&N), (Trotti et al., 1998) is also 
intended to evaluate HR-QoL in patients undergoing radiotherapy. The self-administered 
questionnaire contains 25 items from four domains - functional, emotional, family/socio- 
economic and general, plus 14 items in the H&N module. Patients were not involved with item 
generation. Good internal consistency and test-rest reliability have been established (Trotti et 
al, 1998), although this instrument has yet to be tested with a sample larger than 34 patients. 
The University of Michigan Head and Neck Quality of Life (HNQOL), (Terrell et al., 1997) is an 
interviewer administered questionnaire consisting of 21 items from four domains - pain, 
emotion, communication and eating. Patients and health care workers generated the items. 
Face and content validity have been found to be moderate (Ringash & Bezjak, 2001) although 
the authors of the instrument advise that it is used in conjunction with a general HR-QoL 
instrument. Test-retest reliability and internal consistency were reported to be high (Terrell et 
al, 1997). Construct and convergent validity were also adequate. The newer 20-item version has 
yet to be tested for reliability and validity. 
The University of Washington Quality of Ilfe0Questionnaire (UW-QOL), (Hassan & Weymuller, Jr., 
1993) is intended to discriminate between a variety of HNC sites and stages. However, it is 
primarily relevant to surgery patients. The self-administered questionnaire consists of 12 items: 
9 disease-specific items (pain, chewing, swallowing, speech, shoulder disability, appearance, 
activity, recreation and employment) in addition to 3 items measuring, global HR-QoL, change 
in HR-QoL since diagnosis and overall QoL. It is not known whether patients were involved 
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with the item generation. Test-retest reliability is reported as very high with an acceptable 
internal consistency (Hassan & Weymuller, 1993). Responsiveness to change has also been 
reported (Deleyiannis, Weymuller, & Coltrera, 1997). 
For a more detailed description and discussion of the psychometric properties of HNC specific 
HR-QoL measurement instruments, refer to Table 2.1, which includes three particularly useful 
and well-written reviews (Gotay & Moore, 1992; Rogers et al, 1999; Ringash & Bezjak, 2001). 
2.1.3 THE IMPACT OF HNC AND TREATMENT ON HR-QOL 
2.1.3.1 Study Design 
In clinical research, HR-QoL is recognised as an important endpoint, as changes in treatment 
policy are aimed not only at maximising chances of survival, but also maintaining QoL (and 
possibly improving it) during treatment and long-term. Three basic types of study have been 
employed in HNC HR-QoL research: cross-sectional, prospective and case-control. Cross- 
sectional studies provide a snapshot evaluation from a specific time period but may have 
reduced sensitivity due to patient under-reporting (Breetvelt & van Dam, 1991). More 
importantly, without pre-treatment data, specific HR-QoL cannot be directly attributed to the 
effects of disease and treatment. Longitudinal (prospective) studies allow for the analyses of the 
impact of treatment, although selection bias is created due to loss of patients over the study 
period because of recurrent illness and death. Case-control studies allow for a comparison 
between the HR-QoL of the sample under study and another population, for example, another 
clinical sample or normative data. 
In the past, the majority of published studies in this field were cross-sectional in design, but in 
the last few years the majority are now prospective. However, there have been very few studies 
published that have used control groups or randomised treatment groups. A considerable 
number of studies have been conducted on patients with oral or laryngeal cancer alone, and 
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care has to be taken when comparing heterogenous cohorts of patients with respect to 
differing cancer sites and hence differing associated problems. 
2.1.3.2 Short-term impact on HR-QoL (: 512 months post-treatment) 
2.1.3.2.1 Prospective studies 
Unsurprisingly, the majority of studies have found a temporary deterioration in HR-QoL in the 
first three months after treatment (de Graeff et al., 1999a; Deleyiannis et al., 1997; Hammerlid 
et al., 1997b; Hammerlid et al., 1997a; Hammerlid, Mercke, Sullivan, & Westin, 1998; 
Hammerlid et al., 2001a; Kohda et al., 2005; List et al., 1999; Lloyd, Devesa-Martinez, Howard, 
& Lund, 2003; Rogers, Lowe, Brown, & Vaughan, 1998; Rogers, Humphris, Lowe, Brown, & 
Vaughan, 1998; Rogers, Lowe, & Humphris, 2000), particularly in domains of physical and role 
functioning, probably caused by treatment itself. However, in the 12 months following 
treatment, the results are less consistent. In a study of 105 HNC patients by Gritz et al, (Gritz 
et al., 1999) despite improvements in some physical functioning domains one month into 
recovery from treatment, patients still reported a decline from 1 month to 12 months in the 
domain of marital and sexual functioning and no significant improvement in other HR-QoL 
domains (Cancer Rehabilitation Evaluation System- Short Form (CARES-SF)). These results 
highlight that, even with functional improvement, HR-QoL is impacted in other ways and for a 
significant time period after treatment. However, baseline (pre-treatment) levels of HR-QoL 
were not presented and it is unknown whether there were any significant differences between 
baseline HR-QoL and scores at 1 and 12 months. Functional status reflecting normal activity 
(as measured by the Karnofsky Performance Scale) was reached within 12 months (Gritz et al, 
1999). The findings of this particular study contrast with several prior reports that indicate a 
gradual improvement in HR-QoL within the same time frame, in primary radiotherapy patients 
(De Boer et al., 1995; Moore, Parsons, & Mendenhall, 1996) and with surgically treated patients 
(De Boer et al., 1995; List et al., 1996b). 
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Paradoxically, despite the initial decline in physical aspects of HR-QoL, pain, mood and anxiety 
scores (UW-QoL) have been shown to significantly improve with surgical patients, at all post- 
operative time points (up to 12 months) compared to pre-operative scores (Lloyd et al., 2003) 
and similarly, with emotional functioning (EORTC QLQ-C30 & HN35) (Bjordal et al., 2001; 
Schliephake &Jamil, 2002). However, in one study of 20 patients treated with radiotherapy 
(Epstein, Robertson, Emerton, Phillips, & Stevenson-Moore, 2001), emotional functioning 
scores initially declined after treatment (as with all aspects of HR-QoL) but showed a gradual 
increase at 6 months in line with the other domains (EORTC QLQ-C30). None of these 
studies reported multivariate analyses. 
2.1.3.3 Long-term impact on HR-QoL (>12 months post-treatment) 
2.1.3.3.1 Prospective studies 
Until relatively recently, no prospective studies had been published with a follow-up of more 
than 1 year. However, several studies have now been reported with follow-up data of 2 and 3 
years. For example, de Graeff et al (2000b) conducted a three-year prospective study of 107 
patients with mixed site HNC treated with surgery and/or radiotherapy. It was found that the 
majority of HR-QoL domains, (as measured by the EORTC QLQ-C30+H&N35), had 
returned to pre-treatment levels after 12 months with little change afterwards. However, at 36 
months, domains of. physical functioning, taste/smell, dry mouth and sticky saliva were still 
significantly worse compared with baseline. The authors conclude that the magnitude of these 
differences was indicative of minor/moderate clinically relevant changes. Despite the longer- 
term deterioration of several physical symptoms and functioning scales, a gradual improvement 
of emotional functioning and depression (as measured with the CES-D) was reported. 
A similar pattern was also reported in a2 year longitudinal study of 201 HNC patients 
(Morton, 2003). Overall QoL (as measured by a modified 10 item version of the Life 
Satisfaction scale (Morton et al., 1995; Warr, Cook, & Wall, 1979)) improved significantly from 
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time of diagnosis to 24 months (p=0.005), although there was no significant difference 
between 12 and 24 months. Psychological distress (GHQ-12) was significantly increased at 3 
months but returned to at least pre-treatment levels by 12 and 24 months. However, all 201 
patients at baseline were included in these analyses when only 91 had completed questionnaires 
at 2 years. An analysis of these 91 patients demonstrated that only global QoL (life-satisfaction) 
was significantly better at 2 years (p=0.006) and psychological distress was not. Amongst 
patients with cancer of the supraglottis and glottis, there was more difficulty speaking 
(p50.005) at 2 years post-diagnosis but not amongst patients with oral/oropharyngeal cancer. 
Many other mean scores of single item measures of somatic and physical dysfunction were 
found to increase over the 24 months follow-up. 
2.1.3.3.2 Cross-sectional studies 
Cross-sectional studies have allowed the exploration of HR-QoL over longer time periods 
since treatment. Patients treated with primary surgery are considered to have a poor physical 
and psychological out-come as a result of mutilating surgery, however, advances in 
microvascular free tissue transfer has reduced the extent of physical deformity but with little 
improvement in function (Vaughan, Bainton, & Martin, 1992). Rogers et al (1999) conducted a 
cross-sectional study comparing 38 patients (out of an original cohort of 220 patients) treated 
5-10 years after primary surgery for oral and oro-pharyngeal cancer, with 25 patients treated a 
year previously (Rogers, Hannah, Lowe, & Magennis, 1999). The results at one year were 
similar to longer-term (5-10 year) survivors, suggesting that most of the longer term gain is 
achievable within one year. Indeed, UW-QoL scores in the longer-term group were better than 
at one year in all domains except shoulder function. This may have been due to the tendency 
towards radical neck dissection as compared to the function preserving neck dissections 
favoured now (see section 2.1.3.5.1.3). Despite the overall good level of functioning, it was 
found that a significant number of patients continued to experience severe problems, 
particularly in domains of: disfigurement, emotional and cognitive functions and chewing 
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related functions (e. g. dry mouth, sticky saliva and trouble eating). Half of the longer-term 
survivors reported the use of painkillers in the last week. However it is not known whether this 
was specifically related to head and neck pain or not. Other cross-sectional studies providing 
long term data since 1999 have also shown similar results, whereby specific symptoms of the 
head and neck area (i. e. problems with speech and eating) are more likely to affect HR-QoL at 
2-10 years post-treatment (Klug et al., 2002), and not surprisingly, are significantly worse than 
in non-cancer controls (Fang et al., 2002). 
Several other survivor studies have demonstrated the long-term emotional effects of cancer 
and treatment. A European radiation therapy trial conducted between 1979 and 1984 randomly 
assigned 845 HNC patients into two radiotherapy schedules. The trial demonstrated no 
difference in survival or late effects between the study arms. However, 7-11 years later, a cross- 
sectional study of the HR-QoL of more than 200 of the trial survivors showed that emotional 
and social function were both adversely affected long-term if surgery was conducted as part of 
treatment (Bjordal, Kaasa, & Mastekaasa, 1994). Long-term psychological distress (using the 
General Health Questionnaire (Goldberg et al., 1988)) was also reported in 30% of the same 
cohort (Bjordal & Kaasa, 1995). This distress was found to be more pronounced in those with 
impaired cognitive function, impaired social function and pain. Pourel et al (2002) reported 
similar results in a study of 113 patients at 2 to 9 years post-treatment (Pourel et al., 2002). 
Compared with the general population, the three scores indicating the most impaired HR-QoL 
(EORTC-QLQ-C30) were emotional and social functioning and fatigue. In addition, the 
physical functioning, role functioning and pain scores did not significantly differ from the 
general population. 
One cross-sectional study compared the results from HNC patients 2 and 3 years post- 
diagnosis with general population norms (Hammerlid & Taft, 2001c). Hammerlid & Taft 
(2001) used the Swedish version of the SF-36 Health Survey (Sullivan & Karlsson, 1995) and 
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the EORTC QLQ-C30 & H&N35, to examine how long term survivors of HNC 3 years after 
diagnosis (n=151) compared with age and gender matched or adjusted norms of Swedish and 
Norwegian populations (Hammerlid, Mercke, Sullivan, & Westin, 1996; Hjermstad & Fayers, 
1998b; Hjermstad & Fayers, 1998a; Sullivan & Karlsson, 1994). Comparison of the SF-36 
demonstrated that only the role-physical functioning domain was significantly worse in the 
HNC patients compared to the population sample (p=0.008), although clinically worse for 
domains of role physical functioning and role-emotional functioning. A gender difference was 
noticed, whereby female HNC patients (n=42) scored the same or better than the female 
reference group on all 8 SF-36 domains. However, for males, an opposite pattern was found 
whereby the population sample scored better than the HNC patients (n=93) on 7 of the 8 
domains. A comparison of the EORTC QLQ-HN35 showed that HNC patients scored 
significantly worse compared to the population on all scales and single items except for 
coughing and feeling ill. An analysis of the EORTC QLQ-C30 by gender, again showed that 
female cancer patients scored better on 13 of the 15 scales and single items compared to the 
normative population but males only scored better on 7 of the 15 scales. 
The results of this study indicate that the general health status of long-term survivors is 
comparable or even better than age and gender matched normative populations. However, 
despite this, patients still report significant problems with more specific functions such as, 
social eating, pain and swallowing 3 years after diagnosis. This highlights the importance of 
measuring HR-QoL with specific as well as generic questionnaires in order to elicit a more 
accurate picture of long standing problems. However, these results also illustrate that despite 
still having specific limitations, patients show functional adaptation both physically and 
emotionally over time. 
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Although these cross-sectional studies cannot provide any pre-treatment comparison data to 
test for causal relationships, they suggest that the emotional and social consequences of HNC 
to survivors remain even after a substantial time has elapsed since treatment. 
2.1.3.4 Patient's priorities regarding treatment outcomes and QoL 
Despite the surfeit of publications measuring HR-QoL within this patient group, little has been 
published regarding patient priorities in terms of treatment outcomes or QoL. The crude 
effects of different treatment regimens on patients functioning is well recognised, therefore, 
patients can be more adequately informed as to the likely effects of treatment. Not much is 
known, however, as to how patients make treatment decisions when faced with the 
probabilities of survival versus likelihood of serious morbidity. 
In an early innovative `trade-off' study involving healthy participants (McNeil, Weichselbaum, 
& Pauker, 1981), it was found that people were willing to `trade-off years of life in order to 
retain normal vocal function, after being educated about the effects of having a laryngectomy. 
However, none were willing to trade off more than 5 years survival. Although, this study was 
influential in suggesting that for some people quality of life was preferable to quantity of life, it 
is questionable whether one can extrapolate healthy patients priorities, using a standard gamble 
technique, to the priorities one would actually have when faced with laryngeal cancer. 
More recently, a few studies have sought to examine patients' preferences among treatment 
effects. Sharp et al (1999) designed a new instrument to allow patients to prioritise 12 
treatment effects and tested it on a cross-sectional sample of 19 patients pre- and post 
treatment (Sharp et al., 1999). The instrument revealed considerable variability in how patients 
prioritise treatment effects leading the authors to conclude that some patients may adjust to 
certain disabilities over time, despite the study being based on a cross-sectional sample of pre- 
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and post-treatment patients. The variation evidenced may have been due to different treatment 
effects being experienced at different stages of recovery. 
List et al (2000), examined newly diagnosed, advanced stage HNC patients' pre-treatment 
preferences of a series of possible late stage effects of treatment (List et al., 2000). Results 
indicated that at this time point, survival was top priority amongst patients. This data is 
consistent with newly diagnosed patients' willingness to accept highly toxic treatment with risk 
of chronic dysfunction for any chance of benefit (Slevin, Stubbs, & Plant, 1990). Studies of 
HR-QoL outcome typically focus on speech, swallowing and other functions that are affected 
but the results of list et al., (2000) demonstrate that items relating to energy levels and normal 
activities were more frequently ranked in the top three considerations than items of 
appearance, chewing and being understood, irrespective of treatment. However, being newly 
diagnosed, patients had not yet experienced the morbidity in question and patient priorities 
may well change over time and with experience. With respect to HR-QoL and performance 
status, patients tended to place higher priorities on areas that they were experiencing difficulties 
with. 
In the only study to report patients' importance ratings of HR-QoL longitudinally, Rogers et 
al., (2002) found that both pre- (n=48) and post-treatment (n=35) there was little correlation 
between importance rating and actual HR-QoL domain score (Rogers, Laher, Overend, & 
Lowe, 2002), thus indicating that patients do not necessarily rate their current functional 
limitation as being most important. This finding is supported by Deleyiannis et al., (1999), who 
reported that following laryngectomy the severity of functional disability did not correlate with 
its importance (Deleyiannis, Weymuller, Jr., Coltrera, & Futran, 1999). At all time points 
(baseline, 6 and 12 months), patients tended to rate speech, chewing and swallowing as more 
important than other HR-QoL domains (as measured by the UW-QoL). No studies have been 
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found that have attempted to explore head and neck cancer patients' priorities or ratings 
outside of functional or standard HR-QoL domains. 
Further prospective studies may help to identify whether particular functional problems 
associated with treatment are more amenable to adaptation than others and to what extent and 
why priorities change over time. 
2.1.3.5 Factors associated with or predictive of HR-QoL 
Numerous descriptive studies of HR-QoL in HNC patients have been published previously, 
recently, emphasis has been on the relationship between patient demographic factors, specific 
disease or treatment related variables, and HR-QoL. 
2.1.3.5.1 Disease or treatment related factors 
2.1.3.5.1.1 Cancer site and stage 
Cancer site and stage are often interrelated, with patients with carcinoma of the hypopharynx, 
nasopharynx and oropharynx more likely to present with advanced stage of disease (Jones & 
Stell, 1991; Vernham & Crowther, 1994). Advanced disease in HNC has been reported as 
associated with poorer pre-treatment HR-QoL (Hammerlid et al., 2001a) and a worse initial 
post-treatment decline in HR-QoL (Bjordal et al., 2001; Weymuller et al., 2000) with no return 
to baseline HR-QoL after 24 months (Weymuller et al., 2000). Similarly, a cross-sectional study 
of 60 patients with oropharyngeal cancer (Allal, Nicoucar, Mach, & Dulguerov, 2003) found 
that tumour size was important when examining the effects of treatment. In patients with 
smaller tumours (T1-T2), there was no significant difference in HR-QoL between RT and 
surgical/RT treatment groups, whereas with larger tumour sizes (T3-T4) patients having 
undergone surgery/RT had significantly worse HR-QoL. In addition, the time since treatment 
for the surgical patients was much longer (median: 78 months, range: 16-200 months) than that 
of the RT group (median: 27 months, range: 12-82 months). However, no multivariate analyses 
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were conducted on these data and it was not known whether stage corresponded with tumour 
size in these patients as nodal involvement was not reported. Other studies also provide 
support for the finding that patients with later stage tumours score significantly worse on HR- 
QoL than those with smaller tumours (Rogers et al., 2000; Hammerlid et al., 2001 a; Rogers, 
Lowe, Fisher, Brown, & Vaughan, 2002). However, similar to Allal et al. (2003), significant 
treatment effects are also reported and not controlled for. In contrast, the results from a cross- 
sectional study of 135 HNC patients showed that stage at presentation did not differentiate 
HR-QoL at three years after treatment (Hammerlid et al., 2001c). It is worth noting that the 
level of tumour staging used in studies may differ, with respect to whether details of nodal 
involvement is known, which may influence the treatment and therefore potentially HR-QoL. 
Indeed, results from a longitudinal study of 91 HNC patients (Morton, 2003), found that nodal 
status (N-status) was significantly associated with a single-item measure of overall QoL (Warr 
et al., 1979) and several single HR-QoL items such as head and neck pain and difficulty 
swallowing, whereas tumour size (T-stage) was not. T-stage, however, was positively correlated 
with a measure of psychiatric distress (GHQ). The inconsistency in the literature regarding the 
role of cancer stage or tumour size is further confounded by the results from a 3-year 
prospective study (de Graeff et al., 2000a). In a multivariate analyses of 107 HNC patients, 
subgroup (oral/oropharynx vs. larynx), stage of cancer and treatment were found to have 
significant effects on HR-QoL, particularly head and neck symptoms (EORTC H&N35). It 
was noted that these clinical factors were associated with physical symptoms but not with any 
psycho-social functioning or depressive symptoms (CES-D). 
The differences in HR-QoL due to tumour site are well reported in the literature with different 
tumour sites affecting different aspects of HR-QoL (Hammerlid et al., 2001a). Patients with 
pharyngeal cancer tend to have the most functional problems, followed by oral cancer then 
laryngeal cancer (Bjordal et al., 2001; Hammerlid et al., 2001a). This is in line with the tendency 
for these cancers to be diagnosed at different stages. At 1 year post-treatment, patients with 
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pharyngeal cancer reported clinically worse scores compared with patients with laryngeal or 
oral cancer on many HR-QoL domains, most of which related to swallowing and nutrition 
(Bjordal et al., 2001). 
2.1.3.5.1.2 Treatment modality 
Choice of treatment is often dependent on the site and stage of disease, therefore, it is often 
not possible to disentangle treatment effects from disease related effects. Studies have shown 
that there are specific consequences to HR-QoL as a result of different types of treatment. 
2.1.3.5.1.2.1 Radiotherapy 
Radiotherapy (RI) patients mainly report xerostomia (dry mouth) and related difficulties, 
namely problems with chewing and swallowing food, recurrent infections, mucositis, increased 
incidence of dental caries and sometimes problems with speech (Ackerstaff et al., 2002; Epstein 
et al., 1999; Tschudi, Stoeckli, & Schmid, 2003). The majority of RT patients note a decrease in 
the amount of saliva or a change in its consistency. Studies have shown that long-term 
xerostomia has a more detrimental effect on QoL than voice function, which is often 
considered worse (Stoeckli, Guidicelli, Schneider, Huber, & Schmid, 2001). Recently, the 
severity of xerostomia after radiotherapy has been reduced by using 3-D treatment planning (3- 
DTP) and intensity -modulated radiotherapy (IMRT). The goal of this has been to spare the 
major salivary glands while delivering the fully prescribed doses to the target (Eisbruch et at, 
1999; Eisbruch et at, 2001). Several papers have examined the salivary function and HR-QoL 
of patients receiving parotid sparing RT (Henson, Inglehart, Eisbruch, & Ship, 2001; Lin et at, 
2003). 
Henson et al. (2001) and Lin et al. (2003) both conducted prospective, 12 month longitudinal 
studies examining whether the preservation of saliva post RT to the neck region resulted in 
better xerostomia-related QoL. Results were similar between the 20 HNC patients recruited in 
Qýý, tu. 
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the Henson et al. (2001) study and the 36 HNC patients recruited in the Lin et al. (2003) study. 
Key findings were the strong relationships demonstrated between all HNQOL domains and 
patient reported xerostomia, and the effect of time on xerostomia-related QoL. The findings 
suggest that despite parotid sparing RT, salivary flow rates and HR-QoL decrease at the 
completion of RT but both improve over the following 12 months. 
2.1.3.5.1.2.2 Radiotherapy versus Surgery 
Many of the major functional deficits commonly resulting from surgery have been alleviated by 
microsurgical reconstructive techniques (Vaughan et al., 1992). However, patients still face a 
certain amount of morbidity following surgery. Some of the issues more pertinent to surgical 
treatment are; difficulties with appearance (Dropkin, 1997), speech (Pauloski, Logemann, 
Colangelo, & et al, 1998), swallowing (Logemann, Pauloski, Rademaker, & Colangelo, 1997), 
chewing (Curtis, Plesh, Miller, & et al, 1997), oral rehabilitation (Rogers, McNally, Mahmood, 
Chan, & Humphris, 1999), nutrition (Beeken & Calman, 1994) and shoulder function (Kuntz & 
Weymuller, Jr., 1999). 
Compared to surgery with or without post-operative RT, it has been suggested that non- 
surgical treatments are associated with superior functional outcomes in oral cancer (Campbell, 
Marbella, & Layde, 2000; Harrison, Zelefsky, Armstrong, Carper, & Gaynor, 1994). A recent 
cross-sectional study of 60 patients treated for oropharyngeal cancer with either RT (with or 
without chemotherapy) (n=40) or surgery and post-operative RT (n=20) provides support for 
this assertion (Allal et al., 2003). Using the Performance Status Scale for Head & Neck Cancer 
(PSSHN) (List et al., 1996a), Allal et al. (2003) found significant group differences for the 
understandability of speech domain but not for other PSSHN domains or any functional 
domains of the EORTC QLQ-C30. However, when the patients were divided into two groups 
based on tumour size (T1/2 vs. T3/4), significant differences emerged. Patients with larger 
tumours (T3/4) who had undergone surgery, showed significantly worse scores on the PSSHN 
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for; eating in public (p=0.002), understandability of speech (p=0.005) and normalcy of diet 
(p=0.008) than those with larger tumours who had non-surgical treatment. In addition, the 
T3/4 surgical group reported significantly more pain than the T3/4 RT group (p=0.008). 
However, patients with smaller tumours treated surgically, had significantly better scores for 
social functioning (EORTC QLQ-C30) than RT patients. 
As before, it is also interesting to note that the time since treatment for these surgical patients 
was much longer (median: 78 months, range: 16-200 months) than that of the RT group 
(median: 27months, range: 12-82 months). Although multivariate analyses were not conducted, 
these results suggest there may also be important time considerations when comparing the HR- 
QoL between treatment groups. For example, high dose radiotherapy is associated with late 
toxic effects, therefore, depending on the timing of HR-QoL measurements, RT patients may 
still be experiencing serious side-effects of treatment. At a similar time point, surgical patients 
may be entering their recovery phase. Evidence suggests, however, that after 1 year, RT alone 
produces functionally superior results and better HR-QoL. 
A study by Tschudi et al. (2003) provides partial support for a differential treatment effect on 
HR-QoL in 99 post-treatment oropharyngeal cancer patients. Functional (EORTC QLQ-C30) 
scores were reported to be unaffected by treatment type (surgery, RT, or surgery +RT), 
however, comparison of the head and neck specific scores (EORTC QLQ-HN35) revealed 
significantly less problems with swallowing (p=0.006), social eating (p=0.007), social contact 
(p=0.008), dry mouth (p<0.0001), sticky saliva (p=0.0001) and mouth opening (p=0.001) in 
non RT patients. Surgical patients reported significantly less pain (p=0.04) than non-surgically 
treated patients. All analyses were univariate and therefore, no adjustments were made for 
other potentially confounding factors. 
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Disregarding the treatment modality, studies suggest that maintaining the ability to wear a 
denture is also an importance factor in HR-QoL, affecting mastication, appearance and speech 
(Terada et al., 2003). 
2.1.3.5.1.3 The impact of neck dissection on HRQoL 
Neck dissection (ND) is often needed in the management of the HNC patient. Known 
complications and morbidities after ND often include numbness and/or pain in the neck or 
ear, shoulder and neck discomfort, functional problems with the arm and shoulder and lower 
lip weakness. Preservation of the spinal accessory nerve (i. e. selective ND) has been found to 
be associated with better HR-QoL in the few studies that have reported the impact of ND on 
HR-QoL. In a cross-sectional study of 51 HNC patients, Shah et al, (2001) used their own 
validated Neck Dissection Quality of Life Questionnaire (Shah, Har-El, & Rosenfeld, 2001) 
and found that neck tightness and shoulder discomfort were the most common symptoms that 
interfered with daily life after ND. The exact time since ND was unreported but was in the 
range of <11 months to >36 months. Multivariate analyses indicated that the type of ND 
performed (radical versus selective) (p=0.03) and chemotherapy (p=0.01) explained 21% of the 
variance in neck-dissection specific HR-QoL (R2=0.21). Time since surgery was not significant. 
Tumour stage and radiation therapy were not entered into the regression model due to their 
association with type of ND. Similarly, Taylor et al (2002) devised and validated their own 
Neck Dissection Impairment Index (Taylor et al., 2002) to investigate factors influencing QoL 
in a convenience sample of 54 HNC patients (List et al., 1996a). Using multiple regression, the 
variables contributing most (R2=0.44; p<0.001) to shoulder-related HR-QoL were, age (p=0.1), 
weight (p<0.001), radiotherapy (p=0.04) and type of ND (p=0.14). 
In another cross-sectional study, Terrell et al (2000) (Terrell et al., 2000) also found that the 
spinal accessory nerve status (type of ND) (p=0.002), HR-QoL emotion score (p=0.0001), as 
measured by the HNQoL (Terrell, Nanavati, Esclamado, Bradford, & Wolf, 1999), and time 
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since treatment (p=0.001), were all independent predictors of HNQoL `shoulder or neck' pain 
score in 175 HNC patients. This indicated that those who had a selective ND, better HR-QoL 
emotion scores and surgery over 2 years previously, were less likely to score highly for 
`shoulder/neck' pain. Kuntz & Weymuller (Kuntz et al., 1999), analysed data from 84 HNC 
patients who had undergone ND and had completed a pre-treatment and 6& 12 month post- 
treatment UW-QoL (Hassan et al., 1993) `shoulder domain'. They also found that radical ND 
was associated with worse pain scores after treatment. There was a significant improvement in 
pain over time with selective ND only (p=0.02). However, it was also found that improvement 
in pain was also associated with T1-T3 tumours. Multivariate analysis was not performed. 
2.1.3.5.2 Demographic factors 
2.1.3.5.2.1 Gender 
Data from studies investigating the influence of gender on HR-QoL are conflicting. Some 
studies report no gender differences at any stage of assessment (Rogers et al 1998; Morton, 
2003) whereas others suggest females report worse symptoms and physical functioning 
(Allison, Locker, Wood-Dauphinee, Black, & Feine, 1998; De Boer et al., 1995; de Graeff et al., 
2000a; Languis, 1995) and worse emotional functioning over time than males (Hammerlid et 
al., 2001 a). 
Conversely, results from a longitudinal study using a normative population sample (n=871) for 
comparison purposes, found that females 3 years after diagnosis scored the same or better than 
males on all domains of the SF-36 than an age and gender matched sample (Hammerlid et al., 
2001c). Comparisons between HNC patients only (n=135) showed that females scored better 
than males on all scales except mental health. Although many of the gender differences in 
domains were clinically significant (physical, role physical, general health, vitality and role 
emotional), none proved statistically significant. Moreover, regression analyses with gender, 
age, disease stage, tumour site, treatment modality and number of co-morbidities as predictor 
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variables, indicated that gender did not explain a significant proportion of the variance in any 
SF-36 domain (Hammerlid et al., 2001c). 
2.1.3.5.2.2 Age 
Similarly to gender, the influence of age on HR-QoL is also not consistent in the literature. 
Studies have reported that age has no influence on HR-QoL except on physical functioning (de 
Graeff et al., 2000a; Rogers et al., 1998). A recent study comparing the HR-QoL of 54 elderly 
(2270 years) and 75 younger patients (45-60 years) with HNC after surgery, supports this 
finding (Derks, de Leeuw, Hordijk, & Winnubst, 2003). The groups proved significantly 
different for gender, site, co-morbidities, Karnofsky performance status, radiotherapy and 
alcohol and tobacco use, with older patients scoring worse for co-morbidity and performance 
status. There was no age group difference in tumour stage. Despite this, no significant 
differences were found in HR-QoL (EORTC QLQ-C30 and QLQ-H&N35) or depression 
(CES-D) between the younger and older samples both before and 3 months after surgery, 
controlling for tumour site. 
Advancing age was found to be predictive of worse global HR-QoL in a study by Allison et al. 
(1998). Univariate analysis demonstrated no association of age with global HR-QoL (EORTC 
QLQ-C30) in a cross-sectional sample of 188 HNC patients but multivariate analyses revealed 
age to be a significant predictor (p=0.0003), in addition to employment (see later), gender, 
dental status, stage and site (F=5.117, p<0.0001; R2=0.21). 
Paradoxically, older patients (>75 years) have been reported at diagnosis as having clinically 
better HR-QoL scores on emotional functioning than younger patients despite having worse 
scores for domains reflecting physical functioning and symptoms. Significant correlations 
between high age and better social functioning (p<0.05) and emotional functioning (p<0.01) 
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were also reported by Hammerlid et al (2001a) (Hammerlid et al., 2001a). However, these were 
all based on univariate analyses. 
Age as an independent variable has been divided into different groups for purposes of analyses, 
which may explain the contradictory findings amongst the literature. For example, Pourel et al. 
(2002) found no age effect on HR-QoL in multivariate analyses using age dichotomised around 
the median (561 vs. >61yrs), whereas Allison et al. (1998) used a continuous measure of age in 
their study. In addition, many of the studies used different time frames to assess HR-QoL. 
2.1.3.5.2.3 Ethnicity/cultural factors 
No studies have reported the effects of ethnicity on the HR-QoL of HNC patients. The 
majority of papers in this area do not describe the ethnicity of their patient samples. A recent 
cross-sectional study by Morton (2003) attempted to compare the HR-QoL in two 
geographically separate and culturally distinct populations. The 45 pairs of patients recruited 
from Canada and New Zealand were largely Caucasian and matched for age, gender, primary 
site, T and N stage and overall cancer stage. Psychological distress (GHQ-12) and country of 
residence were found to account for more than 40% of the variance in global QoL (LS-10) 
(Morton, 2003). The exact figures are not provided. 
Although there were treatment differences between the groups, these did not appear to 
contribute to overall QoL on multivariate analysis. From analysis, it was suggested that patients 
from Canada had a worse HR-QoL than patients from New Zealand. The only other cross- 
cultural data on the HR-QoL of HNC patients was supplied from Europe as a result of a large- 
scale validation study of the EORTC QLQ-H&N35 (Bjordal et al., 1999; Bjordal et al., 2000). 
Although baseline differences in HR-QoL were found between patients from Norway, Sweden 
and The Netherlands, any variation was attributed to differences between patients (site, stage 
and performance status). 
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2.1.3.5.2.4 Employment and educational level 
Employment status and educational level of the patient are rarely analysed in relation to HR- 
QoL in this patient group but in the few papers that have, results are conflicting. No 
relationship was found between educational level (high school diploma or less vs. higher level) 
and HR-QoL (FACT-G & HNS, UW-QoL and PSS subscales of eating in public, speech and 
normalcy of diet) with multivariate analyses of a cross-sectional sample of 50 HNC patients up 
to 6 years post-surgery (Long et al., 1996). However, a prospective study (Sehlen et al., 2002) of 
83 HNC patients 6 weeks after radiotherapy, found that five socio-demographic variables (no 
children, unemployment, male sex, low secondary education and ethanol abuse) could predict 
26% of the variance in HR-QoL (FACT-G). It was also emphasised that only socio- 
demographic variables could predict HR-QoL and not the various clinical and treatment related 
factors that were also analysed. 
Four studies highlight the relationship between poorer HR-QoL and unemployment. Allison et 
al. (1998) demonstrated that a range of clinical and socio-demographic factors could explain 
global HR-QoL (EORTC QLQ-C30) in a cross-sectional study of 188 post-treatment HNC 
patients. A multivariate model including clinical (dentate, stage and site) and socio-demographic 
factors (unemployment, age and gender) was found to explain a significant (p<0.0001) 21% of 
the variance in HR-QoL (although this was not adjusted R2). The three strongest predictors of 
HR-QoL were unemployment (p=0.0001), age (p=0.0003) and gender (p=0.017). 
Similar results regarding the relationship between unemployment and HR-QoL were also 
reported by Fang et al. (2002) using the SF-36, Pourel et al. (2002) using the EORTC QLQ- 
C30 global QoL and Sehlen et al. (2002) using the FACT-G. 
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2.1.3.5.2.5 Marital status 
Long et al. (1996) found that married patients and those living with someone else had higher 
HR-QoL (using the FACT-G but not with the FACT-HNS or UW-QoL). However, Allison et 
al. (1998) failed to find a significant relationship between living arrangements (living alone vs. 
living with others) and HR-QoL, although the mean global QoL score was higher for those 
living with someone (mean=64; 95% CI: 60-68) rather than living alone (mean=60; 95% CI: 51- 
69). Similarly, Fang et al. (2002) failed to find a relationship between any of the functional 
domains of the SF-36 and marital status in 182 post-treatment nasopharyngeal patients (Fang et 
al., 2002). 
2.1.4 LIMITATIONS OF RESEARCH 
Great variability has been shown in the HR-QoL of patients with HNC. The minority of 
research studies to date have been longitudinal in design and very few have explicitly tested 
hypotheses or used psychological models. Potential biases within the data are likely to have 
been uniform across studies, namely, unavoidable selection bias for treatment decisions, since 
randomisation is rarely feasible or ethical. In addition, variation in HR-QoL may be accounted 
for by the heterogenous samples often included in analyses, in terms of site, stage and 
treatment modality. Although many studies do not have the statistical power for sub-analyses 
by site, stage or treatment modality, multivariate analyses have not been attempted in order to 
control for the effect of other variables on HR-QoL. When stratification by site, stage and 
treatment is carried out, the resultant small sample numbers do not achieve enough statistical 
power to allow for accurate between-groups comparisons. This is especially problematic for the 
longitudinal analyses of advanced stage tumours, where 40-50% of patients do not survive for 
2-year follow-up (Weymuller, Jr. et al., 2000). This is highlighted by the cross-sectional study by 
Rogers et al (1999), in which only 38 (17%) of the original 220 patients were included in the 
longitudinal analysis. The small number of survivors after several years makes Type 2 statistical 
57 
errors more likely when comparing groups. In addition, it is likely that those who drop-out are 
more at risk of poor HR-QoL. 
Frequently in cross-sectional studies, the time since treatment and baseline HR-QoL are not 
included in the analyses, thereby limiting the validity of the results. Important time differences 
in psychological adaptation and symptom perception may occur, which would be obscured 
when the patient sample shows great variation in time since treatment. 
Although particular types of HNC have been grouped together for analyses because they have 
been considered sufficiently homogenous, the question of whether they are homogenous in 
terms of HR-QoL has never been explored. In multivariate analysis, the complex interaction 
between stage, site and treatment means that it is likely that one of these factors is erroneously 
forced out of the statistical model. 
This review highlights the insensitivity of general measures of HR-QoL (for example, the 
EORTC-QLQC30 or SF-36) to accurately illustrate long-term H&N specific problems or 
treatment related effects. Many studies that have failed to find differences between treatment 
groups or site/stage of cancer have frequently used general measures of HR-QoL. Many 
studies have also not interpreted HR-QoL scores in terms of clinical relevance. 
Weymuller et al (2000) have reported the problems when examining global HR-QoL scores 
only, particularly when assessing the impact of treatment. The functional changes created by 
different treatment modalities affect different domains and this causes a cancellation effect 
when examining total scores only. Therefore, using a global or total score for examining effects 
of treatment induced change in HR-QoL may not be appropriate. 
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None of the studies assessed the effect of ethnicity on QoL, probably due to the small sample 
sizes involved. Although a few of the measurement instruments have been validated cross- 
culturally, many of the larger samples published have been based on white, frequently 
Scandinavian or Dutch, populations. Patient's perceptions of HR-QoL and factors affecting 
adaptation could conceivably differ across countries and cultures. 
2.1.5 CONCLUSIONS 
Treatment for HNC results in medium term morbidity and depression, much of which has 
been shown to improve within one year. In the long-term, despite an initially high level of 
depression, there is a gradual improvement in psychological functioning and global QoL over 
the next few years. However, there is subgroup of patients who continue to experience high 
levels of psychological morbidity years after treatment and it is important to note that this has 
been shown to be unrelated to physical functioning. 
Although a patient's characteristics are clearly important, there is no clear evidence for the 
impact of disease and treatment on outcomes such as QoL and many studies have reported 
that somatic symptoms and scores of dysfunction are not associated with emotional distress or 
QoL either (de Graeff et al., 1999b; Hammerlid et al., 1998). In addition, socio-demographic 
factors and the majority of clinical/treatment related factors are not amenable to modification. 
Authors in the field are beginning to acknowledge that an individual's QoL is probably 
determined more by their perceptions of the disease than the disease itself (Sehlen et al, 2002) 
and adaptational processes may be responsible for distorted interpretations of changes in QoL 
over time. However, it has been argued that the absolute changes in QoL are not important but 
the experience of the patient at the time of completing the questionnaire is (by definition the 
actual standard). If QoL is defined as the perceived discrepancy between what one has and 
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what one wants, then this implies that QoL should always be related to the actual standard (de 
Graeff et al, 2000). 
To date there has been little or no attempt to explain these discrepancies in QoL and although 
factors such as stage, site of disease and type of treatment, have some impact on HR-QoL, it is 
unclear what additional factors account for the large variation evidenced in patient outcomes. 
In the last few years, more interest has been generated in the area of psychological factors 
(although most commonly the influence of depressive symptoms) to account for variation in 
HR-QoL. The following section (2.2), systematically appraises the literature for answers to 
what these `other factors' may be and whether they are open to modification, as the primary 
value of understanding individual variation in HR-QoL is to minimise the impact of HNC on a 
patient's life. By understanding the relationship between HR-QoL and potentially modifiable 
patient factors, such as psychological factors, interventions can be designed with the aim of 
maximising a patient's long term QoL. 
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PART 2: ARE PSYCHO-SOCIAL AND BEHAVIOURAL FACTORS RELATED TO 
HEALTH RELATED- QUALITY OF LIFE IN PATIENTS WITH HEAD AND 
NECK CANCER? A SYSTEMATIC REVIEW 
This chapter has been published: Llewellyn CD, McGurk M, Weinman J. (2005) Are psycho- 
social and behavioural factors related to Health Related- Quality of Life in patients with head 
and neck cancer? A systematic review. Oral Oncology; 41: 440-454. 
Part two of the literature review: the systematic review, was undertaken to assess the following 
research questions: 
1) What psycho-social or behavioural factors are associated with HR-QoL? 
And more specifically: 
2) What is the relationship between depressive symptoms and HR-QoL? 
2.2.1 METHODS 
2.2.1.1 Search techniques and terms 
2.2.1.1.1 Databases 
The following databases were searched: MEDLINE 1966-present; MEDLINE daily update; 
CANCERLIT 1975-2002; CINAHL 1982-present; EMBASE 1980-Present; PsycINFO 1974- 
present; the Institute for Scientific Information (ISI) databases of Science Citation Index 
Expanded (SCI-EXPANDED) 1981-present and Social Sciences Citation Index (SSCI) 1981- 
present via the Web of Knowledge (WOK). 
2.2.1.1.2 Scanning reference lists and hand-searching 
Reference lists of articles and non-systematic reviews found through database searches were 
also used as a literature source. In addition, the following relevant journals were hand searched 
to identify very recent publications (from January 2003-present) which may not have been 
entered onto the databases: Cancer; Head & Neck; Journal of Clinical Oncology; 
Laryngoscope; International Journal of Oral & Maxillofacial Surgery; British Journal of Oral & 
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Maxillofacial Surgery; Otolaryngology Head and Neck Surgery; Quality of We Research, 
Psycho-Oncology. 
2.2.1.1.3 Grey literature 
Comprehensive identification of `grey literature' is hard to achieve, however, an attempt was 
made to identify any peer-reviewed but unpublished work. The following database containing 
conference proceedings was searched: Web of Science Proceedings (formerly Index of 
Scientific and Technical Proceedings), also via Web of Knowledge (WOK) and any peer- 
reviewed dissertation abstracts listed from the searches. An attempt was also made to identify 
any peer-reviewed but unpublished work by asking leading researchers/clinicians in the field. 
2.2.1.1.4 Search terms 
Two search strategies were conducted on each database separately, based on searching subject 
headings (i) and a free-text search (ii), these were then combined using the boolean operator 
`OR'. 
i) For the subject heading search, the term `head and neck cancer' was exploded to include the 
following subject index terms: neoplasms of; head and neck, hypopharyngeal, laryngeal, 
oropharyngeal, pharyngeal, tongue, tonsillar, esophageal, mouth, oral cavity, salivary gland, 
tracheal, submandibular gland and otorhinolaryngolic. This was combined with the subject 
heading `Quality of life', which would also serve to include health related quality of life (HR- 
QoL) as a subject heading. 
ii) For the free text search, terms of: Cancer$, carcino$, neoplas$, tumo? r$, "head and neck", 
oral, mouth$, hypopharyn$, tongue, laryn$, oropharyn$, pharyn$, tonsil$, esophag$, 
oesophag$, salivary, tracheal, submandibular$, otorhinolaryn$, quality of life, qol, health 
state$, as text words (in title and abstract) were combined. 
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A more detailed breakdown of each database search can also be found in Appendix I. 
2.2.1.1.5 Limitations 
The searches were limited by including only literature published in the English language 
between the years 1980 to present and only involving human participants. The year of 1980 
was considered a good cut off point due to the relative recency of literature on quality of life. 
All commentaries, editorials, case-reports and review articles were excluded. 
2.2.1.2 Study inclusion criteria 
2.2.1.2.1 Patients 
Patients diagnosed with any form of malignant neoplasm (cancer) of the head or neck. 
2.2.1.2.2 Outcome measures 
Data were sought on HR-QoL and studies were only included if the measurement instrument 
was either recognised as a reliable and valid measure of QoL or if the psychometric properties 
of any novel measurement instruments were reported as adequate. Assessment of HR-QoL 
typically includes physical, psychological and social domains, therefore, measures of purely 
functional status were not included. Instruments such as the Hospital Anxiety and Depression 
Scale (HADS) and measures of disfigurement were not considered measures of HR-QoL for 
the purposes of this review. 
2.2.1.2.3 Data extraction 
Data were extracted from full-version articles using data extraction sheets (Appendix II) to 
ensure that data extraction was standardised. 
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2.2.1.2.4 Data synthesis 
Disease characteristics of the patient, (ie. site and type of cancer, treatment type and outcomes) 
were too heterogeneous to apply formal meta-analytical pooling. Individual studies were 
reported separately, with their specific design features and results, in accordance with accepted 
guidelines (NHS Centre for Reviews and Dissemination, 2001). 
2.2.1.2.5 Critical appraisal of study quality 
Each of the studies was scored for quality according to seven criteria. A critical appraisal form 
(Appendix III) was used to score seven factors deemed most important for judging the quality 
of the studies. These included; the study aims or research question, study design, sample 
characteristics, choice of measurement instrument, statistical analysis, statistical power and 
validity of conclusions. Each factor was valued on a three-point scale with 0 indicating poor, 1 
for adequate and 2 for good and an overall score for the study was thus calculated by summing 
these out of a possible total score of 14 points. 
2.2.2 RESULTS 
A total of 16 studies fulfilling the inclusion criteria were identified and reviewed. These were 
identified by reading all abstracts documented by the database search and reading the full 
papers of any ambiguous abstracts. The final selection of studies showed wide variation in 
terms of the factors that were assessed, patient sample and study design. Key data are 
summarized in Tables 2.2 and 2.3. Four main factors were identified in relation to HR-QoL in 
HNC patients. The results are discussed below under the main headings of. Personality; Social 
support; Satisfaction with consultation and information; and Behavioural factors. The 
relationship between depression and HR-QoL is discussed afterwards and includes studies that 
have analysed the extent to which depressive symptoms affect HR-QoL as well as vice versa. 
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2.2.2.1 Personality 
Personality may be defined as a person's characteristics that are responsible for relatively stable 
patterns of feeling, thinking and behaviour (Pervin & John, 1996). There are many ways of 
conceptualising and measuring personality `traits' however, few have been applied in the 
assessment of potential relationships between personality and QoL in HNC. Four studies were 
identified that attempted to examine the relationship between personality and HR-QoL. One 
study implemented Eysenck's early model of personality (Aarstad, Aarstad, Birkhaug, Bru, & 
Olofsson, 2003) whereby the personality dimensions of `Extraversion' and `Neuroticism' are 
assumed to account for a large proportion of variation in personality. Three additional studies 
focused on the relationship between optimism and HR-QoL (Allison, Guichard, & Gilain, 
2000; Yu, Fielding, Chan, & Sham, 2001; Yu, Fielding, & Chan, 2003). 
2.2.2.1.1 Neurotieism and Extraversion 
A recent cross-sectional study by Aarstad et al. (Aarstad et al., 2003) demonstrated an 
association between personality, as measured by The Eysenck Personality Inventory (Eysenck 
& Eysenck, 1975), and HR-QoL in two different samples of successfully treated primary HNC 
patients. The patients consisted of one sample of 96 HNC patients (including primary tumour 
sites of: lip, tongue, salivary gland, gingiva, floor of mouth, oral cavity, oropharynx, 
rhinopharynx, hypopharynx, sinus, larynx and unknown primary sites) and another sample of 
104 laryngectomised patients who were also members of the Norwegian Society of the 
Laryngectomized (NSL). This sample of laryngectomy patients is also discussed later in the 
review, in a study by Birkhaug et al. (Birkhaug, Aarstad, Aarstad, & Olofsson, 2002). The 
EORTC QLQ-C30 version 3 (Aaronson et al., 1993) and EORTC QLQ-H&N35 module 
(Bjordal et al., 1994) were used to measure HR-QoL, and Eysenck's Personality Inventory 
(EPI) (Eysenck et al., 1975) was used to measure personality traits of neuroticism and 
extroversion. 
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Table 2.2: Summary of variables studied in relation to HR-QoL 
Variable Specific component Study 
Personality Neuroticism and extraversion 
Dispositional Optimism 
Social support Satisfaction with family physician support 
Extent of social contact with family, friends, 
neighbours 
(Aarstad et al., 2003) 
(Allison et al., 2000; Yu et al., 2001; Yu et 
al., 2003) 
(Mathieson, Logan-Smith, Phillips, 
MacPhee, & Attia, 1996) 
(Birkhaug et al., 2002) 
Information Satisfaction with information and consultation. (Yu et al., 2001) 




(Duffy et al., 2002) 
(Birkhaug et al., 2002; D'Antonio et al., 
1998; de Graeff et al.,; de Leeuw et al., 
2000; de Leeuw et al., 2001; Duffy et at., 
2002; Gritz et al., 1999; I Iammerlid, 
Silander, I Iornestam, & Sullivan, 2001b; 
Nordgren et al., 2003) 
Aarstad et al. (2003) found that high neuroticism was associated with a lower HR-QoL in both 
patient samples. Specifically, neuroticism was negatively correlated with scales of global 
health/QoL (HNC patients r=-0.50, p<0.001; NSL patients r=-0.33, p<0.01), all general QLQ- 
C30 functional subscales (duster score: HNC patients r=-0.50, p<0.001; NSL patients r=-0.57, 
p<0.001) and positively correlated with the majority of general QLQ-C30 symptom scales in 
both samples (duster score: HNC patients r=0.47, p<0.001; NSL patients r=0.46, p<0.001) 
and positively correlated with the majority of H&N35 QLQ scores in the laryngectomised 
(NSL) sample only (duster score: r=0.49, p<0.001). These associations were reported as stable 
after adjustments were made for gender, age, marital status, educational level, number of 
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children and level of treatment. Significant positive associations were found between 
extraversion scores and general health/QoL (r=0.27, p<0.05), Physical functioning (r=0.20, 
p<0.05) and Emotional functioning (r=0.20, p<0.05) in the HNC sample but only with Role 
functioning (r=0.23, p<0.05) in the laryngectomised sample. This finding demonstrated that 
higher extraversion scores were associated with better QoL functioning. 
Regarding the psychometric properties of the measurement instruments, the reliability of the 
three HR-QoL cluster scores were found to be acceptable, with Cronbach's a values at <0.70. 
The EPI was subject to test-retest analysis using a small sample of n=22 HNC patients only 
that had previously completed the EPI during diagnostic procedures. Only the neuroticism 
scores (r=0.76, p<0.01) were reported to be test-retest reliable using Pearson's correlation 
coefficients (extraversion scores r=0.22, p>0.05). 
2.2.2.1.2 Dispositional Optimism 
The role of dispositional optimism on HR-QoL in HNC patients was assessed in three papers, 
but was the primary focus of only two (Allison et al., 2000; Yu et al., 2003). 
In a prospective study by Allison et al. (2000), dispositional optimism was associated with 
better HR-QoL in a consecutive sample of 101 French HNC patients. The sample consisted of 
oral, pharyngeal and laryngeal cancer patients and measures were taken at baseline and three 
months following treatment. The dependent variable of HR-QoL was measured using the 
EORTC QLQ-C30 only and optimism was evaluated using a French version of the Life 
Orientation Test (LOT) (Scheier & Carver, 1985). Translation was performed using the 
multiple forward and backward translation protocol. The French LOT (FLOT) demonstrated 
internal reliability with Cronbach's a=0.66 and external (test-retest) validity was assessed with 
an infra-class correlation coefficient (ICC) of r=0.55. Optimism scores were dichotomised 
around the median (score of 20) to divide the sample into `optimists' and `pessimists'. In 
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multivariate analyses of the pre-treatment data, the dichotomised LOT rating significantly 
predicted HR-QoL domains of. role, cognitive and emotional functioning; global HR-QoL; 
pain and fatigue, whilst adding treatment as another independent variable and controlling for 
disease site and stage. A similar result was gained from multivariate analyses conducted on 
three month follow-up HR-QoL data. Bivariate analyses indicated that `optimistic' patients 
were more likely to report better HR-QoL than `pessimists', however, specific results from the 
multivariate analyses were not reported. 
In a recent repeated measures design study by Yu et al. (Yu et al., 2001), the association 
between satisfaction with information and QoL in 211 nasopharyngeal cancer patients was 
examined. In addition to these main variables of interest, trait optimism was included as part of 
a battery of psychosocial variables. Based on interviews, optimism was measured using a single 
visual analogue line of 10cros. The item stated, `My attitude towards life is.... ' scored 0 for 
completely pessimistic to 10 for completely optimistic. HR-QoL was measured with the 
Chinese version of the Functional Assessment of Cancer Therapy -General Scale: FACT-G 
(Ch) (Yu, Fielding, Chan, & et al, 2000) which was reported as having good psychometric 
properties but which was not psychometrically tested within the present study.. Optimism at 
follow-up Time 1 (at the completion of radiotherapy but 4 months post-baseline) was initially 
found to be a significant predictor (fl=0.14, p<0.05) of HR-QoL 4 months later (8 months post 
baseline), in addition to variables of `satisfaction with the information provided' V--0.20, 
p<0.005), `worry about family' (fl=-0.15, p<0.05), treatment (T=-0.17, p<0.01) and recurrence 
after baseline (8=-0.16, p<0.01). However, after adjusting for baseline QoL scores, optimism 
became insignificant (ß=0.12, p>0.05). 
In the same patient group (Yu et al., 2003), the mediating role of optimism between eating 
ability and post-radiation QoL was reported. The patient sample, data collection and measures 
of HR-QoL and optimism were identical to that described in their earlier study, however a 
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measure of eating ability was also reported. Eating ability was rated on a single 11-point item in 
the form of a statement, `my eating ability is... '. 0 indicated `very bad' and 10 indicated `very 
good'. In order to test their hypothesis that optimism mediated the relationship between eating 
ability and QoL, a series of regression analyses were run following the procedure suggested by 
Baron and Kenny (Baron & Kenny, 1986) and were adjusted for baseline HR-QoL scores, 
family income (as a measure of economic status) and cancer stage at baseline. The results 
indicated that eating ability at the completion of radiotherapy was independently predictive of 
both optimism (ß=0.24, p<0.001) and QoL 4 months later 0=0.52, p<0.001). However, this 
relationship was no longer significant when optimism was controlled for (T=0.11, p>0.05). 
These data suggest that optimism was exerting a mediating effect between the two variables. 
The dataset used in the studies by Yu et al. (Yu et al., 2001; Yu et al., 2003) was collected using 
a mixed sampling strategy. Firstly, particular clinics were targeted and every patient was invited 
with the aim of recruiting at least 50%. When fewer interviewers were available, systematic 
sampling methods of 1 patient in 5 or 1 patient in 10 were used to achieve power targets. This 
mixed method lead to the inclusion of only 28% of eligible patients and thus was not a 
consecutive sample. In addition, data collection was a mixture of face-to-face and telephone 
interviews, which firstly may have lead to a selection bias by the interviewer and secondly, may 
have lead to concerns over the reliability of measurements due to the different method of data 
collection between baseline and follow-up. 
2.2.2.2 Social support 
Two cross-sectional studies analysed the impact of social support on HR-QoL (Birkhaug et al., 
2002; Mathieson et al., 1996). In the earlier study of 45 patients by Mathieson et al. (1996), 
social support was measured using the Social Support Questionnaire (SSQ) (Sarason, Levine, 
Basham, & Sarason, 1983). The results of a stepwise regression analysis conducted using HR- 
QoL as the dependent variable (derived from the Functional Living Index -Cancer scale, 
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(FLIC)), showed four main factors predicted quality of life. Satisfaction with family physician 
support (partial R2 =0.45; F=31.85; p<0.001); severity of cancer (partial R2 =0.12; F=10.26; 
p<0.01); gender (partial R2 =0.07; F=6.95; p<0.05) and type of cancer (partial R2 =0.04; 
F=4.90; p<0.05) yielded a total R2 of 0.68. Socio-economic status, marital status, time since 
diagnosis, history of smoking and drinking and disruption of functional activities were also 
entered as potential predictors. These factors were not found significant. Satisfaction with 
family physician support was found to be the most important contributor to patients' QoL, 
thus, the more satisfied the patient was, the better their QoL. Gender was also a significant 
predictor of QoL, whereby, women were found to be more at risk of a poorer QoL than males. 
In addition, the more advanced the cancer, the poorer the QoL. 
In contrast, in a study by Birkhaug et al. (2002), social support was not found to be associated 
with QoL in 104 patients with cancer of the larynx. All of the patients had undergone surgery 
and more than 90% of these patients had received radiation therapy. Social support was 
measured using an inventory developed by Murberg et al. (Murberg, Bru, Aarsland, & Svebak, 
1998). The inventory consisted of 15 questions in which the respondent was asked to indicate 
the extent of social contact with family, friends and neighbours. HR-QoL (as measured by the 
EORTC QLQ-C30 + H&N35) was collapsed into three dependent variables of. Functional 
and general scales; symptoms and H&N35 items. Regression analyses were adjusted for age and 
gender. No significant relationship was determined between HR-QoL and the amount of 
reported social support by family, friends and neighbours, however, specific data were not 
included in the paper. Depressive symptoms were also measured (discussed later). 
The sample of patients in the study by Mathieson et al. (1996) included a wider range of cancer 
sites than normally reported in the head and neck cancer literature. For example, the 45 
patients recruited included, cancer of the larynx, pharynx, glottis, skin, thyroid, tongue, sinus 
cavity as well as unknown primary cancers. Obviously, with such a small sample size, 
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controlling for site of cancer was not feasible, in addition, treatment modality was not reported 
in this study. Both studies were limited by their cross-sectional design and the study by 
Birkhaug et al. (2002) by a lack of multivariate analyses. Although, Birkhaug et al. (2002) had a 
larger sample in their study of 104 laryngectomy patients, their response rate was only 50%. 
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2.2.2.3 Satisfaction with information and consultation 
The association between satisfaction with information and QoL was assessed in a sample of 
patients with nasopharyngeal cancer (NPC) undergoing radiotherapy (Yu et al., 2001). In this 
follow-up study, Yu et al. sampled 211 newly referred patients from five hospitals in Hong 
Kong, China, from a cohort of 748 eligible patients. The aim of the study was to assess 
whether satisfaction with the information provided by physicians during consultation 
immediately after the completion of radiotherapy (but approximately 4 months after baseline), 
predicted QoL four months later, after appropriate adjustment for medical, demographic and 
psychosocial variables. Patients were interviewed (either face-to-face or by telephone) by social 
workers. QoL was measured by the FACT-G (Ch) (Yu et al., 2000). Predictor variables were 
measured using the Medical Interview Satisfaction Scale (MISS) (Wolf, Putnam, James, & 
Stiles, 1978), which measured patients' satisfaction with the way in which physicians provided 
information, and comprised cognitive, affective and behavioural subscales, including a 5-item 
cognitive subscale with items selected based on their relevance to NPC patients. The full nine- 
item cognitive scale assessed the adequacy of the physicians' explanations and ability to provide 
information, and the patient's understanding of the medical information. Psychosocial variables 
of `patient satisfaction with hospital services' (measured with the Patient Satisfaction Scale 
(PSQ-9)), `optimism' (measured using a single item visual analogue scale) and two affect scales: 
' worry about family' and `anger' (both measured using single items) were used for statistical 
adjustment. 
Forced entry multiple regression models indicated that QoL at Time 2 (8 months after referral) 
was predicted by the five-item cognitive sub-scale of the MISS (ß=0.21, p<0.01). This 
suggested that NPC patients reporting more satisfaction with the information provided 
approximately 1 month after the end of radiotherapy, had a better QoL 4 months later. Other 
variables of optimism (fl=0.14, p<0.05) and worry at time 1 (f=-0.15, p<0.05), treatment (8_- 
0.17, p<0.01) and recurrence after baseline (8 -0.16, p<0.01), were also found to significantly 
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predict QoL at Time 2. All other variables were insignificant. However, when baseline QoL 
and stage of disease at time of diagnosis were adjusted for, the most significant predictor 
remained the MISS (8=0.20, p<0.01). Worry, treatment and recurrence after baseline also 
remained significant and all other variables, including optimism, were found to be insignificant. 
R2 or R2 adjusted values were not presented. 
2.2.2.4 Behavioural factors associated with HR-QoL: Alcohol consumption and 
smoking 
Three recent studies have investigated the relationship between alcohol intake and HR-QoL in 
HNC patients, with differing results. Allison (Allison, 2002), conducted a cross-sectional survey 
of 191 patients with either carcinoma of the oral cavity, pharynx or larynx. Dependent variables 
were measured using the EORTC QLQ-C30 and H&-N35 module. Alcohol intake was 
measured with a single item question, "during the past month have you drunk alcohol on one 
or more occasions? " This was analysed as a dichotomous variable. The results from 
multivariate regression analyses showed that alcohol consumption was significantly associated 
with HR-QoL domains of physical functioning (p=0.005), role functioning (p=0.001), global 
HR-QoL (p=0.002), fatigue (p=0.02), pain (p=0.003), swallowing p=0.05), dry mouth 
(p=0.008) and feeling ill (p=0.03), whilst controlling for age, gender, employment status, 
disease site and stage, time since treatment and treatment modality. Data indicated that patients 
consuming at least one alcoholic drink in the past month had better HR-QoL functional scores 
and lower levels of symptoms than participants reporting no alcohol intake. However, the 
results presented in the paper lack the detail to make any more assumptions regarding these 
relationships. 
In contrast, in a prospective study by Sehlen et al., excess alcohol consumption was found to 
be associated with worse HR-QoL (Sehlen et al., 2002). A sample of 83 patients with HNC 
(cancer sites of pharynx, tongue, floor of mouth, larynx, thyroid gland, nose, nasal sinus and 
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salivary glands, as well as extensive tumours) were assessed with the FACT-G questionnaire 
prior to radiotherapy (TI), at the end of radiotherapy (T2) and six weeks after (T3). Socio- 
demographic variables were measured with the Current Situation in Personal Life 
questionnaire, which was developed by the authors. Patients with a Karnofsky performance 
status score of <50 were excluded from recruitment. 
Logistic regression models were used with the FACT-G sum score dichotomised into low 
(<70) and high HR-QoL (>70). After testing various models based on medical and socio- 
demographic variables, having children, current employment, alcohol abuse, level of secondary 
education and gender were found to account for 26% of the variance in HR-QoL at T3 (6 
weeks after radiotherapy). On examination of the odds ratios, patients with no or low 
secondary education had a four-fold higher risk of having a low HR-QoL than patients with 
medium secondary education and an eight to nine-fold higher risk than patients with a high 
education. Male patients were at a higher risk of poor HR-QoL, as were patients without 
children and unemployed. However, it was found that those at highest risk of poor HR-QoL 
were patients reporting alcohol abuse (OR=29). The confidence intervals were not reported 
which, again, makes it difficult to ascertain their significance. 
In contrast to both of the above studies, Duffy et al., (2002) failed to find any relationship 
between alcohol intake and HR-QoL (Duffy et al., 2002), although a significant relationship 
between nicotine and HR-QoL was found. Alcohol was measured with the Alcohol Use 
Disorder Identification Test (AUDIT) (Saunders, Ashland, Babor, de la Fuente, & Grant, 
1993) which is a ten item screening instrument that assesses both level of alcohol intake and 
related problems, including hazardous drinking, alcohol abuse and dependence. Nicotine usage 
was measured with the Fagerstrom Test for Nicotine Dependence (FIND) (Fagerstrom, 
Heatherton, & Kozlowski, 1990) which is a six item questionnaire. Both of these measures 
were dichotomised prior to analyses into Nicotine problem (FIND score of>0 vs 0) and 
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Alcohol problem (AUDIT score of >_8 vs <8). HR-QoL was measured by the SF-36V (Kazis, 
1998) and HNQoL (Terrell et al., 1997). 
All 12 regression models conducted, with smoking, alcohol and depression as predictor 
variables, and age, tumour site and stage as control variables, proved significant (p<0.001). 
Smoking was found to be negatively associated with five scales of the SF-36V; physical 
functioning (p<0.05), general health (p<0.01), vitality (p<0.05), social functioning (p<0.05) and 
role-emotional health (p<0.05), however, alcohol was not associated with any of the HR-QoL 
scales. Gender was not controlled for in the analyses. 
2.2.2.5 Depressive symptoms 
Nine papers were identified examining the relationship between depressive symptoms and HR- 
QoL. Three of these used cross-sectional designs, which make it impossible to tease out causal 
relationships, and the others were prospective studies with short and longer-term outcome 
assessments. In addition, two further prospective studies examined the relationship between 
depression and HR-QoL using depression as the outcome (dependent) measure. These four 
groups have been presented separately below. 
2.2.2.5.1 Cross-sectional studies 
Significant relationships between depressive symptoms and HR-QoL were found in all three of 
the cross-sectional studies. Duffy et al. (2000) used the Geriatric Depression Scale - Short 
Form (GDS-SF) (Lewinsohn, Seeley, Roberts, & Allen, 1997) to assess levels of depression in a 
mixed sample of 81 HNC patients and found that 44% scored higher than 3, which indicated 
that they had significant depressive symptoms. HR-QoL was measured using the SF-36V 
(Kazis, 1998) and the HNQoL (Terrell et al., 1997). All 12 multiple regression analyses 
conducted on the 77 patients who completed the GDS-SF (from a total of 81 patients 
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recruited), indicated strong negative associations between significant depressive symptoms and 
HR-QoL, when controlling for age, tumour site and stage, nicotine and alcohol problems. 
Similarly, Birkhaug et al., (2002) also found significant relationships between HR-QoL and 
depression, in a sample of 104 laryngectomy patients. HR-QoL was measured using the 
EORTC QLQ-C30 and EORTC QLQ-H&N35. Using the 13 item version Beck Depression 
Inventory (BDI) (Noyes et al., 1990), 35% of patients reported either possible or probable 
depression. The BDI measures mood by a sum scale where 0 indicates a neutral mood and 39 
indicates maximum depression. Significant negative correlations existed between all HR-QoL 
functional scales, global health/QoL score and depression, indicating that the lower the HR- 
QoL score, the higher the depression score (17 out of 20 correlations between HR-QoL 
symptoms and depression were significant). 
An earlier study (D'Antonio et al., 1998) with 50 patients evaluated from 6 months to 6 years 
post-surgery also found an inverse relationship between HR-QoL, as measured by the FACT- 
G, FACT-HNS and the UW-QoL scales, and depression. Depression was assessed using two 
versions derived from the BDI; a 13-item version (which omitted somatic items) and the full 
21-item version. Using the full version of the BDI, 22% of the sample demonstrated moderate 
to severe levels of depression (scores >13), however the range of scores were between 0 to 28 
(out of a possible 73) for the full version BDI and 0 to 21 (out of a possible 39) for the 13-item 
version The mean value for the 13-item BDI was reported as 4, which indicated possible 
depression but only 9 on the 21-item version which was well within the range for non- 
depression. Despite this obvious discrepancy, no explanation was forwarded by the authors. 
Spearman's correlation coefficients showed no relationship between depression scores and 
demographic variables such as; age, gender, marital status, employment, religion, living 
situation or medical variables such as; time since diagnosis, or clinician rated disfigurement or 
dysfunction. However, time since most recent surgery was significantly associated with 
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depression (r=0.28, p<0.05). There was no relationship reported between the clinician 
evaluation of a patient's emotional well-being and the patient's score of emotional well-being 
(derived from the FACT-G) or depression. All analyses were uni-variate, therefore, no 
adjustments were made. 
2.2.2.5.2 Prospective studies 
2.2.2.5.2.1 Short-term relationship between depression and HRQoL" 12 months post treatment 
The relationship between depression and HR-QoL during the first year post-treatment was 
reported in two papers. 
de Graeff et al., revealed a predictive relationship between HR-QoL and depression in a sample 
of 153 HNC patients (de Graeff et al., 2000b) derived from the same dataset as two other 
studies (de Leeuw et al., 2000; de Leeuw et al., 2001). The amount of variance in HR-QoL 
explained by depressive symptoms was assessed with 16 regression analyses, with HR-QoL as 
dependent variables. Only the EORTC QLQ-C30, EORTC QLQ-H&N35 and CES-D were 
used in these analyses. 26% of the sample at baseline, 24% and 22% of the sample at 6 and 12 
months respectively, scored ? 16 on the CES-D, indicating possible depression. 
The total amount of variance explained was slightly greater for the prediction of the EORTC 
QLQ-H&N35 scales than for the EORTC QLQ-C30 scales. Overall, depression, tumour stage 
and Karnofsky performance status were the most important predictors of HR-QoL. 
Depressive symptoms at baseline were the most important predictor of most of the scales of 
the EORTC QLQ-C30 (with the exception of physical functioning and nausea/vomiting) and 
some of the scales of the H&N35 (pain, sexuality and social contacts). In the multiple 
regression models, gender and age had only minor predictive value. 
However, another 12 month prospective study (Gritz et al., 1999) involving 105 HNC patients, 
failed to find any relationship between depressive mood and HR-QoL. Patients were originally 
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recruited as part of a larger randomised controlled trial comparing two differently delivered 
smoking cessation programmes and as such the paper only included patients who had reported 
tobacco use within the last year prior to diagnosis. HR-QoL was measured using the Cancer 
Rehabilitation Evaluation System - Short Form (CARES-SF) (Schag, Ganz, & Heinrich, 1991) 
which is a generic cancer measure that yields a global score and five summary scores (physical, 
psychosocial, marital, sexual and medical interaction). Depressive mood was measured as part 
of the Profile of Mood States (POMS) scale (McNair, Lorr, & Droppleman, 1971). Six mood 
states have been identified from the POMS - Tension-Anxiety, Anger-Hostility, Confusion- 
Bewilderment, Fatigue-Inertia, Vigor-Activity and Depression-Dejection. The Depression- 
Dejection factor reflects sadness, guilt, emotional isolation, worthlessness and futility. The 
results of multivariate analyses showed that only treatment type, Vigour subscale of the POMS 
and 1 month HR-QoL scores, were predictive of HR-QoL at 12 months. The amount of 
variance in HR-QoL explained by these variables ranged from 11% to 35%. 
2.2.2.5.2.2 Relationsh p between depression and HRQoL" > 12 months post treatment 
The prospective relationship between depressive symptoms and HR-QoL, as an outcome 
measure, over a longer period, has been investigated in only two studies (Hammerlid et al., 
2001b; Nordgren et al., 2003). Hammerlid et al. (2001) reported significant relationships 
between depressive symptoms and HR-QoL in 133 patients (57% of the original sample) at 3 
years post-treatment. It is unclear what percentage of total eligible patients the recruited sample 
represented. To identify predictors of HR-QoL, three scales of; Global QoL, emotional 
functioning and H&N35 item of pain, were measured using the EORTC QLQ-C30 and 
H&N35. Depression was measured using the HADS (Zigmond & Snaith, 1983). The cut-off 
score for a possible case of depression is 8 to 10 (inclusive) and >10 points for probable 
depression. At 3 years post-treatment, only 9% of patients had possible/probable depression 
compared to 24% of patients just after finishing treatment. 
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The authors report that stepwise multiple regressions were conducted using the three HR-QoL 
outcomes as dependent variables. However, it is unclear whether these analyses were multiple 
linear regressions or logistic regressions and again, it was unclear how these dependent 
variables would have been dichotomised for entry into a logistic regression. Despite this, it was 
reported that age, gender, tumour stage, tumour site and `selected' HR-QoL domains measured 
at diagnosis (global QoL, physical functioning scale, H&N35-swallowing, pain, fatigue, loss of 
appetite and feeling ill) were considered possible predictors of long-term HR-QoL. 
Independent predictors of global QoL 3 years post-treatment were; physical functioning 
(p<0.005) and depression at diagnosis (p<0.05). For emotional functioning, pain was the only 
predictor. 
In contrast, Nordgren et al. (2003)(Nordgren et al., 2003) failed to find any relationship 
between baseline depression and HR-QoL 5 years after diagnosis, in a sample of patients with 
cancer of the larynx. The EORTC QLQ-C30 and H&N35 were used to measure HR-QoL and 
the RADS was used to measure depression. The percentage of patients with possible or 
probable depression was not reported. Regression analysis was conducted with dichotomised 
HR-QoL scores, however, it is unclear how many scales were regressed against or how the 
scales were dichotomised. Only global QoL at diagnosis was reported to be statistically 
significant as a predictive factor for HR-QoL 5 years after diagnosis, although it is also unclear 
which particular variable HR-QoL outcome was based on. 
2.2.2.5.3 Depression as an outcome variable 
The role of HR-QoL in predicting depression was examined in 2 papers based on the same 
dataset. De Leeuw et al. (2000) collected data on 155 HNC patients at 6 and 12 months 
following treatment, in order to assess whether pre-treatment factors, including HR-QoL, 
could be used to predict depression at these time points. HR-QoL was represented by three 
scales of: general cancer related physical symptoms derived from 12 items from the EORTC 
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QLQ-C30+3, the Physical Functioning scale from the EORTC QLQ-C30+3 and head and 
neck tumour specific and treatment related physical symptoms derived from the 21 items of 
the EORTC QLQ-H&N37 (Bjordal et al., 1999). Social support, coping and locus of control 
were also measured as predictive variables. Different types of social support were assessed with 
the Social Support List Interactions (van Sonderen, 1991), items from the Inventory of Socially 
Supportive Behaviours (Barrera, Sandler, & Ramsey, 1981), the Social Provisions Scale 
(Cutrona & Russel, 1987) and separate items asking about the extent of formal and informal 
networks. Coping was measured with the short version of the Utrecht Coping List (Schreurs, 
1997) and locus of control was measured with the short version of the Cancer Locus of 
Control Scale (Watson, Pruyn, Greer, & van den Borne, 1990). 
Stepwise multiple regressions were conducted to predict depression at 6 and 12 months post- 
treatment, entering tumour stage, age, sex, depressive symptoms at baseline, coping, cancer 
locus of control, support, the extent of social network, openness to discuss cancer in family, 
HR-QoL - general cancer related physical symptoms, HR-QoL - tumour and treatment related 
physical symptoms and HR-QoL - Physical Functioning. The total amount of variance 
explained in depressive symptoms was 66% at 6 months and 52% at 12 months. In addition to 
tumour stage (R2 change=0.04) and sex (R2 change=0.03), current HR-QoL - general cancer 
related symptoms (R2 change=0.41), tumour related symptoms (R2 change=0.03) and physical 
functioning (R2 change=0.03) explained 47% of the variance at 6 months. Psychosocial 
variables measured prior to treatment explained an additional 12% of the variance (depressive 
symptoms, avoidance coping and the extent of formal social network). However, it is clear that 
most of this variance was from depressive symptoms (R2 change=0.09). At 12 months, 14% of 
the 52% of variance in depression was accounted for by baseline psychological measures. 
Depressive symptoms accounted for half of the variance (R2 change=0.07). 
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Unsurprisingly, a similar relationship also emerged from another study by de Leeuw et al. 
(2001), reporting a slightly higher recruitment rate of 197 patients with 6 months post- 
treatment data and 171 patients with 12 months post-treatment data. (See de Leeuw et al, 2000) 
for description of methodology, measurement instruments and statistical analyses. ) Again, it 
was demonstrated that depressive symptoms prior to treatment were the best predictor of 
depressive symptoms at each time point (with R2 change=0.32 at 6 months and R2 
change=0.18 at 12 months). The three measures of current HR-QoL - general health and 
tumour related symptoms and physical functioning, accounted for only 19% of the variance at 
6 months and 14% of the variance at 12 months. Stepwise multiple regressions were also 
conducted to predict depression at 2 years and 3 years post-treatment, entering the same 
variables as described previously. Data from 139 patients at 2 years post treatment and 123 
patients at 3 years post-treatment, indicated that depression at those time points was mostly 
explained by baseline (pre-treatment) depression. HR-QoL could explain a further 20% 
approximately. Patients who had a recurrence during this time-period were not excluded from 
these analyses. 
2.2.3 LIMITATIONS 
2.2.3.1 Study design and quality 
The majority of studies included in this review are limited by methodological and statistical 
problems or missing data. However, seven of the studies (Table 2.3) included in this report 
attracted the highest `quality' score of `good' (scores of at least 11 out of 14) when critically 
appraised according to the criteria (Appendix III). Three studies were deemed to be of a `poor' 
quality (scores of between 0 and 4). The majority of studies did not forward any specific 
hypotheses for testing and all of the studies lacked any hypothetical or theoretical framework 
on which to base their research questions. 
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The studies varied in sample sizes and response rates, ranging from sample sizes of 45 
(Mathieson et al., 1996) to 232 (Hammerlid et al., 2001b). Response rates for the studies ranged 
from 28% of the original number of patients eligible for inclusion (Yu et al., 2001; Yu et al., 
2003) to 99% (Allison et al., 2000), however, many of these were based on convenience 
samples and in many studies the exact number of patients eligible for inclusion at the time of 
the study has not been reported, therefore, the response rates cannot be ascertained. This limits 
the ability to generalise from these studies. 
2.2.3.2 Health-Related Quality of Life as an outcome measure 
The majority of the studies used the EORTC QLQ-C30 & HN35 to assess HR-QoL. 
However, many different dependent (or outcome) variables were selected to measure 
relationships between variables. The lack of concordance between results may have been due in 
part to using different measures of HR-QoL or using different subscales of the same measure. 
For example Mathieson et al. (1996) used a composite score from a general measure of HR- 
QoL in cancer patients and Birkhaug et al. (2002) used both general cancer and head and neck 
cancer specific scales in their assessment of the relationship between HR-QoL and social 
support. In addition, studies used different methods to collect data. For example, data were 
collected from mail-outs, face-to-face interviews, telephone interviews and by different 
members of staff, for example, trained social workers, researchers, consultants, nurses etc, all 
of which may have affected the response. 
2.2.3.3 Statistical limitations 
Few studies included any analyses of the psychometric properties of the measurement 
instruments with their own samples, although most used standardised instruments. In general 
the level of statistical detail provided proved poor. In many cases it was difficult to ascertain 
how results had been statistically derived from the data. Many of the studies relied on uni- 
variate analyses between variables and many of the regression analyses poorly controlled for 
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factors already known in the literature to affect HR-QoL (e. g. various socio-demographic and 
medical/treatment factors). HR-QoL at baseline was not always adequately controlled for when 
analysing data from prospective studies. 
It was unclear whether much of the data published met assumptions for parametric testing and 
the lack of detail made it difficult to determine whether variables entered into regression 
models were statistically appropriate. Authors rarely mentioned whether skewed data had been 
transformed before analyses. Similarly, there was a general lack of detail regarding missing data 
and how this was dealt with before analyses. Despite the small sample sizes generally recruited 
in the field of head and neck cancer, few of the studies reported actual power calculations or 
provided comment about the power of study based on their method of analyses. 
2.2.3.4 Determining causality 
Many of the studies described in this review have been cross-sectional in design.. This may be 
sufficient to determine relationships, however, causality cannot be determined and therefore 
the variables under study cannot be assumed to be `predictive' of HR-QoL. 
2.2.4 DISCUSSION 
Health related quality of life is now considered an important patient centred outcome variable 
following treatment for head and neck cancer. This has lead to a dramatic increase in the 
number of studies incorporating assessments of HR-QoL. Despite this increase in interest, the 
majority of studies investigating HR-QoL in this population have mainly been aimed at 
comparing the impact of different treatment modalities and have therefore only commented 
upon the effects of treatment and disease related variables. This has resulted in knowledge 
about the effects of disease site and treatment on HR-QoL, however, few studies have 
attempted to explore the role of non-clinical variables in relation to impact on HR-QoL. 
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The limited data regarding the role of personality traits on reported HR-QoL indicated 
significant predictive and associative relationships. All four studies examining trait 
characteristics of either neuroticism/ extraversion or optimism were considered `adequate' or 
`good' in quality (Aarstad et al., 2003; Allison et al., 2000; Yu et al., 2001; Yu et at, 2003). 
Results demonstrated that the higher the extraversion or optimism score of the patient, the 
better they rated their HR-QoL. In contrast, patients scoring highly for neuroticism were more 
likely to have a low HR-QoL. Personality is thought to influence health outcomes either 
directly or indirectly through a number of mechanisms. It has been suggested that 
psychological constructs such as `optimism' and `neuroticism' may actually reflect negative 
affectivity (NA) (Clark & Watson, 1991). High trait NA individuals are characterized by the 
tendency to experience a range of distressing negative emotions such as anxiety and depression 
and studies have also shown that high NA is associated with more symptom reporting across a 
wide range of illnesses, regardless of objective physical illness (Petrie, Moss-Morris, Grey, & 
Shaw, 2004; Watson & Pennebaker, 1989). Another pathway between personality and health 
outcome has been investigated by examining coping styles. Dispositional optimism has been 
found to correlate positively with problem-focused coping, the positive reinterpretation of a 
problem and the attempt to accept the reality of situations that are perceived to be 
uncontrollable (Scheier et al., 1985). Coping may be an important mediator between personality 
and outcome and thus may be more open to psychological intervention than directly targeting 
relatively stable personality traits. 
The role of social support on HR-QoL is less clear. Of the two `adequately' rated cross- 
sectional studies, one study failed to find any relationship between the `extent of social support 
from family, friends and neighbours' and HR-QoL (Birkhaug et al., 2002), whereas, another 
study demonstrated that `satisfaction with physician support' accounted for 45% of the 
variance in HR-QoL (Mathieson et al., 1996). The `support' assessed in these two instances 
illustrates not only the wide differences in underlying construct between different types of 
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social support measure but of the subsequent implications that arise from employing different 
types of support measure. Interestingly, the study finding no relationship between level of 
support and HR-QoL involved laryngectomy patients who may have more complex issues 
involving communication, social support needs and subsequent HR-QoL. The direct beneficial 
effect of social support on outcome appears paradoxical in the literature. Social support is a 
complex interactive construct, which may only be effective when matched with the patients 
needs. Potential forms of support have been described (House & Kahn, 1985) as emotional, 
appraisal, informational and instrumental. 
Schreurs and de Ridder (1997) have described four ways of relating social support to coping: as 
a coping strategy, as a coping resource, as a consequence of coping and fully integrated into a 
coping process of a social system (Schreurs & de Ridder, 1997). Evidence suggests that social 
support is differentially related to coping style and personality. Studies with breast cancer 
patients have shown that important support lies in the spouse's reactions to cancer, and 
interpretations of spousal support and coping style relate to the coping style adopted by the 
patient (Ben-Zur, Gilbar, & Lev, 2001). Other studies also confirm that it is the perceived 
quality of the social support that affect outcomes such as well-being and depression (Marsire, 
Schulz, Wrosch, & Newsom, 2003). It is these components and categories of support which 
need to be explored in more detail in future work in order to have a clearer understanding of 
their possible effects on QoL. 
Alcohol and nicotine usage was found to be associated with HR-QoL in two ways. An 
`adequately' rated cross-sectional study by Allison (2002), found having had at least one 
alcoholic drink in the past month (post-treatment) was associated with higher levels of HR- 
QoL. This may have been due to better functional abilities in swallowing and drinking rather 
than alcohol influencing HR-QoL. In a `poorly' rated study by Sehlen et al. (2002), excess 
alcohol was associated with a worse HR-QoL, which may have been representative of worse 
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disease and an addiction to alcohol. Similarly, Duffy et al. (2002), found a negative relationship 
between nicotine dependence and HR-QoL, demonstrating that those with a high dependence 
to nicotine reported worse HR-QoL. The relationship between behavioural factors such as 
smoking and drinking alcohol and HR-QoL is confounded by the severity of symptoms the 
patient is experiencing. The scope for providing support and intervention in treating addictions 
such as these for particular at risk patients would be beneficial not only in terms of an 
individual's QoL but also to limit the chance of cancer recurrence in the future, as alcohol and 
tobacco are well known aetiological agents of HNC. 
A fairly inconsistent picture emerges from the literature regarding the relationship between 
depressive symptoms and HR-QoL. Of the nine studies included in this review, seven reported 
significant relationships between depression and HR-QoL (Birkhaug et al., 2002; D'Antonio et 
al., 1998; de Graeff et al., 2000a; de Leeuw et al., 2000; de Leeuw et al., 2001; Duffy et al., 2002; 
Hammerlid et al., 2001b), despite the wide range of depression measures applied and the range 
in quality ratings of the studies. However, three of the studies reporting associations were 
cross-sectional in design and analyses were uni-variate. Therefore direction of causation is 
unknown. Regarding depression as a predictor of HR-QoL, the results appear inconclusive as 2 
out of 4 of the studies failed to find a significant relationship in either the short-term or the 
longer term. Of the two studies examining the role of HR-QoL on depression, it was found 
that although significant relationships existed, depression at baseline was a far better predictor 
of depression than current HR-QoL. These last two studies were rated highly as `good', but 
were actually based on the same data set and similar analyses and, therefore, should not be 
taken as providing `double' the support for this particular finding. 
Of the two studies that failed to find significant relationships alternative explanations can be 
put forward. Although the study by Gritz et al. (1999) was considered `good', the contradictory 
finding may have been due to the measurement instrument. The factor of `depression- 
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dejection' may not have been tapping the same underlying constructs as more widely used 
measures of depressive symptoms, as the POMS is usually used as a measure of transient mood 
state in clinical settings. However, an `adequately' rated study by Nordgren et al. (2003) also 
failed to find any significant relationship. It is not surprising that depression is related to HR- 
QoL, however, it is difficult to ascertain which has the overriding influence on the other as the 
relationship between depression and HR-QoL is complex and dynamic. The lack of 
consistency regarding the relationship between depression and other outcomes, not just HR- 
QoL, reflects a fundamental problem in all areas of the literature and not just HNC. This 
discrepancy also illustrates that lower HR-QoL may not necessarily lead to depressive 
symptoms or conversely that those who are depressed may have a relatively good HR-QoL 
compared to others. The underlying mechanism for this inconsistency may be due to adaptive 
or non-adaptive processes, such as `burnout' as a result of long periods of stress as suggested 
by Rapoport et al (Rapoport, Kreider, Chaitchik, Algor, & Weissler, 1993) or adjustment to the 
illness and threat (de Graeff et al., 2000b), both of which may be related to mediational factors 
such as coping or effectiveness of support networks as mentioned previously. The relationship 
between physical symptoms/impairment and depression is far from understood. Further 
research is needed to unravel these relationships. 
This systematic review highlights the relative lack of research exploring the influence of 
psycho-social factors on HR-QoL in HNC and demonstrates the need for more robust and 
theoretically based studies in this area. As the clinical disease and treatment related factors are 
not open to alteration, the psychological reaction to these factors may be modified. Further 
research may elucidate which psychological factors would be best targeted for psychological 
intervention, either for at risk groups or individuals at risk of poor outcome. 
The following chapter provides a critical overview of additional psychological factors that have 
been established as influential on outcomes, such as quality of life and mood, in other illness 
92 
groups. This was conducted in order to inform the selection of appropriate variables for the 
main study, based on the wider literature. The chapter also introduces the theoretical context to 
the subsequent studies presented in the thesis, in terms of a self-regulatory framework which 
has not been widely applied in the field of HNC previously, and discusses the processes by 
which psychological factors could influence perceptions of QoL. 
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CHAPTER 3 
APPLYING A SELF-REGULATORY FRAMEWORK TO EXPLORE ADAPTATION 
AND OUTCOME IN CANCER: PSYCHOLOGICAL DETERMINANTS 
3.1 INTRODUCTION 
The studies discussed in Chapter 2 demonstrate two points. Firstly, that not much is known 
about the more subjective and patient centred aspects of QoL in patients with head and neck 
cancer, and secondly, that there is inadequate knowledge of the psychological determinants of 
outcomes such as quality of life or depression. 
Models typically used in health psychology, such as social cognition models (SCM), provide 
good theoretical frameworks for examining variables that could be influential in explaining 
outcomes, and for providing a context for the underlying processes. The importance of 
applying a theoretical model to research lies in the ability to then identify appropriate targets 
for intervention based on sound theoretical underpinnings. 
SCM's such as the Health Belief Model (Rosenstock, 1974), the Theory of Planned Behaviour 
(Ajzen, 1985) and the Health Action Process Approach (Schwarzer, 1992) are all theoretical 
approaches to the understanding of health related behaviours. However, the main criticism is 
that many of these models do not address the dynamic nature of how people make judgements, 
such as coping and quality of life, based on a particular health threat. 
One such model that is commonly applied in the investigation of patient outcomes in chronic 
illness is the Self-Regulatory Model proposed by Leventhal and colleagues (Leventhal, Meyer, 
& Nerenz, 1980). The central proposition of this theory is that the cognitions (or 
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representations)' patients have about their illness are the key to understanding patient 
outcomes based on judgements (such as QoL and mood). This model could be useful in 
explaining variation in outcomes between patients that cannot be explained by either socio- 
demographic, or disease and treatment related factors. 
The following chapter begins with an overview of Leventhal's Self-Regulatory Model (SRM) 
and the key explanatory factors or process variables central to the theory. A review of studies 
examining the relationship between illness cognitions and outcome in patients with a variety of 
illnesses are discussed with special reference to any studies involving cancer patients. 
This section is followed by a discussion of how other psychological predictors of outcome, 
such as the role of expectations, could be related to judgements of outcome from the 
perspective of the SRM. 
The third section briefly introduces a specific phenomenon inherent in outcome studies such as 
QoL research, which is known as `response shift'. Response shift is of particular importance 
when individuals undergo a change in health state, and refers to the dynamic process of 
changing internal standards, values or conceptualisation of QoL. This adaptational process has 
important implications for the measurement and interpretation of QoL scores and is described 
and discussed in relation to longitudinal outcome studies. 
Chapter 3 closes with suggested implications of the review to the present series of studies, and 
thus establishes the key objectives of the thesis based on the three literature reviews presented 
in both chapters 2 and 3. 
1A number of other terms are often used in the literature: illness cognitions, perceptions, schemata and 
beliefs. These terms are considered to be synonyms of illness representations (Scharloo & Kaptein, 1997) 
and are used interchangeably throughout the thesis in reference to how people think about their illness 
and treatment. 
95 
3.2 THE SELF-REGULATORY MODEL: AN OVERVIEW 
The Self-Regulatory Model (Leventhal, Nerenz, & Steele, 1984), originally and alternatively 
referred to as the `Common-Sense' Model (Leventhal et al., 1980), has provided a theoretical 
basis for the understanding of how cognitive factors influence coping behaviours and 
outcomes in illness. The SRM was developed to identify and predict how individuals represent 
and respond to a health threat. 
Leventhal & Nerenz (1985) originally based their approach to the study of cognition on a few 
basic assumptions that had been noted some time previously. Firstly, that individuals are active 
problem solvers, not passive responders (Kelly, 1955), and that behaviour is directed by 
perceptions and interpretations of specific situational stimuli (Lewin, 1935). This lead to the 
observation that experience and behaviour are not new with each stimulus, but reflect an 
interaction between external events and a personal knowledge base consisting of both cognitive 
and emotional schemata (Leventhal, 1980; Leventhal, 1984). In addition, there is a time-frame 
to the construction of a representation of, and response to a health threat. As the 
representation is constantly updated with the processing of new information, the proposed 
theory can be considered `dynamic', to the extent that individuals are engaged in a constant 
process of interpreting and evaluating the health threat (Leventhal & Nerenz, 1985). The last 
important assumption is that although successive episodes will reflect prior episodes, unique 
situational factors and variation in individuals schemata will lead to wide variation in the 
common-sense models that individuals generate. This has lead to the critique that prediction 
over situations and time is essentially problematic (Nelson, 1983). 
The construction of a personal common sense model to a health threat is the product of an 
underlying control system which can be divided into three broad processes which are shown in 
figure 3.1. Firstly, the cognitive and emotional representations of the health threat are 
constructed. These representations are a result of the individual's interpretation of the health 
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threat and can be a result of internal cues, for example, symptoms, and/or external cues such 
as sources of information. Secondly, an action plan is developed. The coping strategy used is 
perceived by the individual to be appropriate to the representation of the problem. The third 
stage is the process of coping appraisal. This is a process of evaluating the effectiveness of the 
coping strategy on the outcome or goal. Each of these steps or processes is examined in more 
detail below, but the two key attributes of the SRM are that these three stages occur in parallel 
(the SRM is a `parallel processing' model) on both an emotional and cognitive level (as shown 
in figure 3.1), and that the interaction between each level is `dynamic', meaning that each 
component is influenced by a process of feedback. Thus, representations of the health threat 
and coping strategies are subject to adjustment. A core assumption of this self-regulatory 
system is that individuals are attempting to make sense of and minimise threats to `self' and 
their self-goals. It is in these ways that the system can be considered self-regulatory. 
3.2.1 Cognitive and emotional representations of a health threat 
The SRM proposes that individuals form beliefs about their illness based on both abstract and 
concrete sources of information available to them (see figure 3.1). This assists them in making 
sense of the threat and deciding on a method to deal with the problem. However, it is the 
interpretation of the information (the resulting belief) that decides the management of the 
problem e. g. seeking help or adhering to medical intervention, etc (Bishop & Converse, 1986). 
Leventhal and colleagues suggest that beliefs are potentially formed by three sources of 
information (Leventhal et al., 1980; Leventhal et al., 1984). The first source being the general 
pool of `lay' information that the individual has previously assimilated. The second source is 
derived externally from friends, family and authoritative resources. The third source of 
information is the current experience of the illness, such as somatic experiences and symptoms. 
If the illness has been experienced before, previous experience of symptoms and coping will 


































































Extensive qualitative and quantitative research has established that the content of illness 
representations is organised around a number of dimensions. Originally, four main themes of: 
illness identity, consequences, causes and were identified (Leventhal et al., 1980). 
The identity dimension represents both concrete and abstract components of providing an 
identity to the health threat. Illnesses are identified abstractly by labels (e. g. cancer, heart attack 
etc) and concretely by signs and symptoms. Together they result in a belief about the likely 
illness. Leventhal and colleagues have shown that this process can work in both ways as 
proposed by the rymmety rule. The symmetry rule holds that individuals will, 1) seek symptoms 
when given a diagnostic label (such as a name of a disease or condition), and 2) seek a 
diagnostic label when experiencing symptoms. This ensures that there is consistency between 
internal states (or somatic states) and the interpretation of the problem. Most measures of 
illness identity only use a simple sum of the symptoms experienced as part of the illness. 
The perceived consequences of the illness are assessed in terms of the physical, social and 
economic impact to the individual. The cause dimension represents beliefs regarding the likely 
cause of the illness. A number of key factors have been identified from research using different 
illness groups, such as: a genetic predisposition, biological causes (immune system, germs and 
viruses), environmental pathogens (pollution or toxic waste), the individuals own behaviour 
(risk behaviours such as smoking, poor diet etc), stress or bad luck. It has been noted that there 
can be considerable overlap between these causal constructs (Hagger & Orbell, 2003) and some 
researchers have used single item measures to ensure only one main causal belief is interpreted 
(Kemp, Morley, & Anderson, 1999). Many researchers choose not to include a measure of 
cause due to the inherent problems with meaningful interpretation and analysis. The timeline of 
the illness refers to the perceived time frame of the course of the illness and time scale of 
symptoms. Recently, timeline beliefs have been considered as two separate dimensions: 
providing information on the beliefs relating to the chronicity of the illness, in addition to beliefs 
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about the cyclical nature of the illness (Moss-Morris et al., 2002). In 1983, cure/control beliefs 
were included (Lau & Hartman, 1983), which refers to beliefs regarding the potential for cure 
or control of the illness. Recently, this dimension was also considered as two distinct 
constructs relating to personal control and self-efficacy beliefs and the other related to beliefs 
regarding the ability of the treatment to control or cure the illness (Moss-Morris et al., 2002). 
The emotional representation of the health threat is also an important component of the SRM. 
The model proposes a parallel system of developing both cognitive representations and 
emotional responses to an illness (figure 3.1). Each of these representations then lead to 
respective problem-based and emotion-focused coping procedures (Moss-Morris et al., 2002). 
In addition, it is plausible that emotional representations affect the emotional outcome of the 
self-regulatory process. 
The extent to which an individual's illness representation provides a coherent understanding of 
the overall illness has been investigated recently. The illness coherence subscale is now included 
in assessments, however, this `meta-cognition' refers to the extent to which an individual 
considers their illness representations are coherent rather than a separate belief as such (Moss- 
Morris et al., 2002). Common methods of assessing cognitive and emotional representations 
are evaluated in section 3.2.4 
The role of personality and cultural contexts has also been acknowledged as potentially 
influential in the formation of representations (Diefenbach & Leventhal, 1996; Landrine & 
Klonoff, 1992). 
3.2.2 Coping procedure 
The coping behaviours or strategies employed by the individual in response to their illness and 
representations are important components of the SRM. Checklists of measures are usually used 
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to assess specific types of coping processes and again, due to the parallel processing of 
cognitive and emotional representations about the health threat, coping can be considered 
either cognitively based or emotion-focused. Using coping scales to assess coping does not 
typically provide a specific idea of the coping process but are useful for giving a general idea of 
the strategies used at a given time. However, it has long been asserted by Leventhal and 
colleagues that the way that coping is measured (i. e. using checklists) could be problematic and 
using the terminology of `procedure' is preferable to the term `coping', as it helps to avoid the 
conceptual pitfalls underlying much of coping research (Leventhal et al., 1997). Nevertheless, 
the term `coping' is used throughout the thesis to maintain continuity with the literature with 
the caveat that the above is taken into account. 
It must also not be overlooked, that coping or procedures for coping, occur in the context of 
the situation. 
3.2.3 Appraisal of coping procedure 
The process of appraisal also demonstrates the dynamic aspect of the SRM. Appraisal occurs 
when the individual evaluates the effectiveness of the coping strategy being employed, on the 
outcome or goal. According to whether the appraisal is considered effective on the goal, a 
feedback system allows for the reinterpretation of symptoms and thus the modification of the 
cognitive and emotional representation and a different coping strategy may then be tried. 
Assessment of the appraisal process itself is not common and may be best achieved through 
open-ended interviewing. 
3.2.4 Measurement of illness representations 
A number of standardised questionnaires have been developed to assess Leventhal et al. 's 
(1980) theoretically derived domains discussed in section 3.2.1, best known amongst these are 
the Illness Perception Questionnaire (IPQ) (Weinman, Petrie, Moss-Morris, & Horne, 1996), 
101 
the revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2002), the Brief 
Illness Perceptions Questionnaire (BIPQ) (Broadbent, Petrie, Main, & Weinman, 2005) and the 
Implicit Models of Illness Questionnaire (IMIQ) (Turk, Rudy, & Salovey, 1986). 
Alternatively, a quantity of the research on illness representations has been based on qualitative 
methods. For example, the Personal Models of Diabetes Interview (PMDI) (Hampson, 
Glasgow, & Toobert, 1990) assesses constructs such as beliefs about the seriousness of 
diabetes, treatment effectiveness, cause and symptoms, and, similarly for osteoarthritis with the 
Personal Model of Osteoarthritis Interview (Hampson, Glasgow, & Zeiss, 1994). Some studies 
have reported the use of open-ended interviews to investigate beliefs (Lau, Bernard, & 
Hartman, 1989) and some have used more structured approaches to interviewing (Heijmans, 
1998; Heijmans, 1999; Heijmans & de Ridder, 1999; Heijmans & de Ridder, 2005), in a wide 
range of illness groups. 
3.2.5. Empirical evidence of the relationship between components of the SRM 
The SRM as a whole is difficult to empirically test due to its complexity as a feedback system. 
However, many studies have sought to answer research questions based on key facets of the 
SRM, such as the relationships between illness representations and coping behaviours, or 
between illness representations and outcomes. Many studies have been cross-sectional 
`snapshots' of relationships at a given time, and therefore cannot provide any indication of the 
direction of the associations. Sections 3.2.5 to 3.2.6 provide a discussion of a selection of the 
literature to highlight the main relationships found between components of the SRM. It is 
beyond the scope of this thesis to include all of the empirical evidence to date. 
3.2.5.1 Illness representations and coping 
Many studies have examined coping behaviours in relation to the SRM overall, in particular the 
influence of coping on outcomes (Groarke, Curtis, Coughlan, & Gsel, 2004; Scharloo et al., 
2000; Sharpe, Sensky, & Allard, 2001; Whitmarsh, Koutantji, & Sidell, 2003), however few 
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studies have been published which assess the relationship between coping and illness beliefs. 
Two such studies published in 2002 investigated the direct associations between illness 
representations and coping, and also in relation to outcome (Helder et al., 2002; Rutter & 
Rutter, 2002). Helder et al, (2002) investigated the role of illness perceptions and coping 
mechanisms on well-being in a cross-sectional study of 77 patients with Huntington's disease 
(HD). Using the IPQ, The COPE Inventory (Carver, Scheier, & Weintraub, 1989), and the 
MOS SF-36 (Ware & Sherbourne, 1992) (perceptions in relation to outcomes are described in 
more detail in section 3.2.6), patient beliefs were found to be related to specific coping 
subscales. Illness identity scores were found to be positively correlated with `mental 
disengagement', whereas beliefs regarding the duration of HD were negatively correlated. 
These results indicated that having a strong illness identity and believing that the illness would 
only last a short time were associated with mental disengagement. Beliefs regarding a possible 
cure were positively associated with seeking emotional social support, and also mental 
disengagement. Beliefs regarding the controllability of HD were positively associated with 
`positive reinterpretation' of the situation and `growth' (Helder et al., 2002). The cross-sectional 
design of this study, however, makes it impossible to determine the direction of associations 
between components of the SRM. 
In another cross-sectional study by Rutter and Rutter (2002), the IPQ and The COPE were 
again used to assess the illness representations and coping strategies of 209 patients with 
irritable bowel syndrome (IBS). This study was intended to examine whether representation 
components could predict outcome (QoL), and to evaluate whether coping was a mediating 
variable. Uni-variate analyses showed that individuals who expected their illness to last a long 
time were more accepting of their IBS. Strong perceptions of the negative consequences of the 
disease were associated with the use of restraint coping, venting emotions and mental and 
behavioural disengagement. Stronger cure/control beliefs were associated with more active 
coping, planning and positive reinterpretation. Path analyses demonstrated that coping 
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mediated the associations between representations and outcome, which indicates some support 
for Leventhal's SRM. However, similar to much of the work in this area, this study neglected to 
take into account the emotional branch of the SRM and chose to focus only on cognitive 
beliefs. It is likely that the emotional response to IBS would equally contribute to coping 
behaviour and outcome. Again, due to the cross-sectional design, this study does little to 
provide any enlightenment as to the causal direction of associations between components, 
despite the model's premise that the relationship is causal. 
The main difficulty with determining causality between illness representations and coping is 
that researchers have used many different methods to assess coping procedures. Some have 
used behavioural markers of coping, for example, attendance at clinics or a general practitioner 
(Hampson et al., 1994; Lau et al., 1989), adherence to treatment (Horne & Weinman, 2002), 
levels of self-care (Heijmans et al., 1999) or standardised coping checklists such as The COPE 
or the Utrecht Coping Questionnaire (Schreurs, Willige, Tellegen, & Brosschot, 1993). 
A clearer picture has emerged from recent work that classified studies into seven main 
categories based on the coping behaviour or strategy used, and reported associations between 
illness beliefs and coping using meta-analytic techniques (Hagger & Orbell, 2003). The seven 
coping categories were as follows: Avoidance/denial; cognitive reappraisal; number of visits to 
the doctor; expressing emotion; problem focused coping - generic; problem focused coping - 
specific; and seeking social support. An important finding revealed from the meta-analysis, was 
that perceived controllability was related to active coping and positive reappraisal. Patients who 
believe their illness to be controllable were more likely to use cognitive strategies to help them 
reappraise their situation. This process of reappraisal is further discussed in terms of `response 
shift' in section 3.4. 
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Seeking social support was not found to be consistently related to illness beliefs in the meta- 
analysis. This may have been an artefact of the generalised nature of measures of social support 
used in the studies. Perceptions of identity and consequence were found to be related to 
avoidance/ denial and expressing emotions. Timeline was most strongly related to cognitive 
reappraisal and also with avoidance/denial (Hagger et al., 2003). 
Although attempts have been made to measure coping on a more behavioural level, i. e. specific 
problem focused strategies and measuring doctors' visits, the majority of the studies still rely on 
previously validated questionnaires. Measures such as these have been criticised in terms of 
their general nature and their failure to account for individual differences in coping styles and 
the personal goals of coping strategies used (Coyne & Racioppo, 2000). More importantly, they 
do not capture the relationship between the coping strategy employed and the reason for it 
based on SRM specifications. For example, the `if-then' rule suggests that a person's beliefs 
about the likely cause of the condition will be influential in deciding on the appropriate coping 
strategy to use. 
3.2.5.2 The relationship between treatment perceptions and components of the SRM 
Based on Leventhal's self-regulatory model, it would seem plausible that any coping procedures 
and subsequent outcome could also be influenced by the perceptions held about their 
treatment. In order to maintain coherence between concrete symptoms, beliefs, coping, and 
outcome, the patient as `active problem solver' seeks to close the perceived gap between 
current health status and goal state. Whether the proposed treatment makes sense in light of 
these beliefs will influence the outcome (whether this is in terms of well-being or adherence to 
treatment). An extended version of the SRM has been proposed by Horne and colleagues, 
which stipulates that self-regulating patients will `notjust have their own ideas about the illness, but also 
about the treatment being ofered' (Horne et al., 2002). This extended model was originally used to 
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provide an explanation for adherence to medication, however, treatment beliefs could equally 
be important in the perception of outcomes, such as QoL. 
Research has identified two important treatment constructs: beliefs about the necessity of 
treatment for maintaining or improving health, and concerns regarding the potential harmful 
effects of treatment. A study of asthma patient's adherence to preventer medication concluded 
that significant relations existed between illness perceptions and treatment beliefs (Horne et al., 
2002). Patient's models of their illness and treatment were noted to interact in a logical way, for 
example, patients who believed their asthma to be a chronic condition with negative 
consequences, were more likely to perceive their preventer medication to be necessary to their 
health. This provided preliminary support that the amount of variation in outcome (in this case 
adherence to treatment) explained by the illness perceptions framework could be enhanced by 
including patient's beliefs about the treatment (Horne, 1997; Horne & Weinman, 1998). 
3.2.6 Quality of life as an outcome of a self-regulatory process 
The use of QoL measures is abundant in outcome studies involving patients and, as shown in 
chapter 2, HNC is no exception. However, the cognitive processes underlying its judgement 
have largely been neglected. Establishing predictors of QoL could be useful for targeting 
interventions towards those patients who are most likely to experience poor QoL. 
Leventhal and Colman (1997) argue that by exclusively focusing on QoL as an explicit 
outcome, the view of QoL as a subjective judgement of life quality and not just a marker of 
physical or cognitive function or mood, is obscured. They propose a framework for a process 
model which emphasises firstly, that QoL should be reflected by functioning within a number 
of life domains and the value placed on these domains, and secondly, that judgements are 
affected by many contextual factors. The context for this process model is the person's 
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cognitive representation and emotional response to the disease and treatment (Leventhal & 
Colman, 1997). 
3.2.6.1 Measures of function versus quality of life 
Researchers have recently acknowledged that the majority of QoL measures tend to assess 
symptoms and functioning and ignore the importance placed on them (Hyland, 1992; O'Boyle, 
McGee, & Joyce, 1994; Schwartz & Sprangers, 1999). Whether this is on an emotional, physical 
or cognitive basis, and general or specific to the illness, instruments essentially assess symptoms 
and not QoL as a complex construct. In addition, treatment side-effects or functional 
impairments may mean different things to different people according to the views they hold 
about them. For example, the toxic side-effects of chemotherapy experienced by breast cancer 
patients may be considered more threatening to QoL than the disease itself, whereas, the side- 
effects may be viewed by some people as positive indictors of the treatment's effectiveness in 
controlling the cancer (Nerenz, Leventhal, Love, & Ringler, 1984). Leventhal & Colman (1997) 
stress that, `the judgement of quality is a product of both the individual's assessment of his or herpersonal 
experience n'ithin a variety of domains and the integration of these observations into an overalljudgement... ' 
Research based on the subjective experience of the patient has attended to this viewpoint and 
is discussed in more detail in section 3.4. 
It could also be argued that in order to understand the process of how QoL judgements are 
made by patients with cancer or other life-threatening conditions, a model of QoL needs to go 
beyond disease and treatment related factors (see chapter 2, part I), and incorporate the 
patient's representation of the disease and treatment. These representations may affect the 
meaning and importance of domains involved in making QoL judgments (Leventhal & 
Colman, 1997). This may explain why patients experience different levels of QoL, despite 
having comparable disease and treatment related factors. 
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3.2.6.2 Empirical evidence of the relationship between components of the SRM and illness 
outcome 2 
Research studies have made explicit links between illness representations and illness outcomes 
such as psychological adjustment and QoL. The mediational model proposed by Leventhal et at 
(1980) shows how the beliefs people hold about their illness influence the coping strategies 
used, which, it is proposed, affect the outcome (figure 3.1). Due to the mediational effects of 
coping, there is also evidence of direct effects between illness representations and outcomes. 
Many dimensions and subscales of QoL or `well-being' have been assessed as outcomes in 
relation to components of the SRM. For example, depression and anxiety have been used as 
outcome variables, (Rutter et al., 2002; Vaughan, Morrison, & Miller, 2003), in addition to HR- 
QoL, both disease specific (Han et al., 2005), general HR-QoL (Conic, Seica, Gusbeth-Tatomir, 
Gavrilovici, & Goldsmith, 2004; Moss-Morris & Chalder, 2003), components of HR-QoL such 
as physical functioning (Han et at, 2005; Vaughan et at, 2003), as well as general well-being 
(Helder et at, 2002), overall QoL (Rutter et at, 2002) and adjustment (Groarke et at, 2004; 
Jopson & Moss-Morris, 2003). 
The contribution of illness representations to the well-being of patients with chronic illnesses 
has also been assessed using a wide-range of illness groups, including most commonly, 
rheumatoid arthritis (Groarke et al., 2004; Murphy, Dickens, Creed, & Bernstein, 1999; 
Scharloo et al., 1998; Schiaffino, Shawaryn, & Blum, 1998; Sharpe et al., 2001), chronic fatigue 
syndrome (Heijmans, 1998; Heijmans et al., 1999; Moss-Morris, Petrie, & Weinman, 1996), 
diabetes (Eiser, Riazi, Eiser, Hammersley, & Tooke, 2001; Hampson, Glasgow, & Stryker, 
2000; Hampson, Glasgow, & Foster, 1995; Skinner & Hampson, 1998), myocardial infarction 
(Petrie, Weinman, Sharpe, & Buckley, 1996), Addison's disease (Heijmans, 1999; Heijmans et 
2A discussion of the literature assessing relationships between illness beliefs and other important outcomes 
such as adherence to medical regimens or attendance at clinics is beyond the scope of this chapter. 
108 
al., 1999), chronic obstructive pulmonary disease (Scharloo, Kaptein, Weinman, Willems, & 
Rooijmans, 2000), psoriasis (Fortune, Richards, Main, & Griffiths, 2000; Scharloo et al., 1998; 
Scharloo et al., 2000) and irritable bowel syndrome (Rutter et al., 2002). 
The evidence presented above is too lengthy to describe in full, therefore, a few recent key 
studies specifically reporting the relationships between either illness representations, or coping 
and QoL (or facets of QoL) will be critiqued. 
Studies have demonstrated that illness beliefs may be more strongly related to, and better 
predictors of outcomes such as QoL than coping strategies (Heijmans, 1998; Moss-Morris et 
al., 1996; Orbell, Johnston, Rowley, Espley, & Davey, 1998; Scharloo et al., 1998). In particular, 
having a strong illness identity has been significantly related to poorer outcomes (Heijmans, 
1998; Moss-Morris et al., 1996; Scharloo et al., 1998) likewise, strong perceptions of negative 
consequences have also been reported to be associated with greater impairments on a variety of 
outcomes (Heijmans, 1998; Jopson et al., 2003; Moss-Morris et al., 1996; Rutter et al., 2002; 
Scharloo et al., 1998; Vaughan et al., 2003). 
The majority of the evidence has been derived from cross-sectional studies, as mentioned 
previously, however, a recent longitudinal study (Scharloo et al., 2000) investigating the 
functional status of psoriasis patients one year after recruitment, demonstrated similar results 
whereby, a strong illness identity was associated with worse outcomes as measured by physical 
health, social functioning, mental health, health perceptions and depression. Strong perceptions 
of the negative consequences, were related to negative health perceptions. Illness 
representations accounted for 3% of the variance in physical functioning at 1 year (baseline 
physical functioning accounted for 44% of the variance) and passive coping accounted for 2% 
of the variance. Illness representations (duration and identity) accounted for 12% of the 
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variance in social functioning. Perceptions of consequence accounted for 4% of the variance in 
health perceptions. 
Another longitudinal study examining whether patient beliefs shortly after myocardial 
infarction (MI) influenced recovery six months later (HR-QoL), found that initial beliefs were 
independent predictors of HR-QoL (Home et al., 2005). Consistent with the findings to date, 
strong beliefs about the negative consequences of the MI, and that the event was caused by 
chance, were significantly predictive of poorer physical functioning 6 months later. Similarly, 
those who perceived the consequences to be high were less likely to recover mental 
functioning. However, despite their statistical significance, these cognitive variables only 
accounted for approximately 6-9% of the variance in outcome. Longitudinal studies provide 
support for causal assumptions made by the authors, however, other explanations for 
relationships between SRM components cannot be ruled out. 
The findings from these individual papers, have been supported by a recent meta-analysis 
examining the relationship between illness representations and outcomes (Hagger & Orbell, 
2003). Six illness outcome categories of: disease state, physical functioning, psychological 
distress, psychological well-being, role functioning, social functioning and vitality, were 
identified from the literature. The majority of these could be considered facets of QoL. It was 
reported that illness representations of consequences, identity and timeline were negatively 
associated with psychological well-being, role functioning, social functioning and vitality. 
Consequences, identity and timeline were positively related to psychological distress, suggesting 
that individuals who perceived their illness to have serious negative consequences, a chronic 
timeline and a strong identity were more likely to report distress. Likewise, beliefs about 
cure/control were negatively related to psychological distress. From these results and others, 
Nagger and Orbell (2003) conclude that their meta-analysis supports the hypothesis that 
adaptive outcomes, i. e. role, social and physical functioning, psychological well-being and 
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vitality are associated with lower perceived consequences and a weaker illness identity. 
Furthermore, these outcomes are also related to beliefs about control. Again, the cross- 
sectional nature of the majority of the evidence, prohibits any statements regarding causality. 
The meta-analysis also served to provide support for the consistency of the illness 
representation dimensions and the strong pattern of relationships between SRM components, 
however, the possibility of the presence of moderating variables has lead to a certain amount of 
caution when discussing direct relationships between beliefs and outcomes. 
A potential limitation of the research using the SRM, particularly when testing for separate 
effects, is that many representations demonstrate multi-collinearity, making relationships 
between outcomes and beliefs difficult to interpret. For example, the association between a 
chronic timeline and illness identity is accounted for by negative consequences. Another 
consideration when measuring and interpreting relationships, is that the SRN1 has been 
proposed as a feedback model and as such perceptions of outcome could influence the re- 
evaluation of coping strategies, which may in turn, affect beliefs. This constant re-appraisal 
makes evaluation of the model difficult and therefore, any findings derived from the model 
(particularly based on cross-sectional data) may not be static. In addition, lots of different 
measures of adaptive outcome have been used, with similar patterns between variables 
emerging, therefore it could be suggested that any relationships found may be measurement 
artefacts and not indicative of true relationships. 
It has also been suggested that cognitive representations should be conceptualised as clusters 
(or groups) of beliefs rather than interpreted as single cognitions (Heijmans, 1998), however, 
most of the research presented in this chapter has relied on examining relationships between 
individual cognitions and outcomes. Similarly, if the intention of the study is to use the results 
for the basis of an intervention, it must be acknowledged that only fairly small percentages of 
variance in outcomes are typically accounted for by illness beliefs. 
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Although this chapter was not intended to provide a systematic review of research using the 
SRM as a framework, it is clear from the variety of studies presented that there is a distinct lack 
of published research on the beliefs of general cancer patients in relation to perceptions of 
outcome. Two papers examining beliefs based on the illness perceptions framework have 
studied understanding of cancer risk in healthy individuals undergoing testing for a genetic 
mutation (BRCA 1/2) associated with cancer risk (Kelly et al., 2005) and the validity of healthy 
women's perceptions of breast cancer patients receiving treatment (Buick & Petrie, 2002). Both 
of these studies included healthy individuals as the target population and did not assess 
perceptions in relation to outcomes such as well-being or QoL. 
To date, there have been no studies published which have explicitly assessed the illness beliefs 
of patients with HNC, based on the SRM, and their relationship with outcomes such as QoL 
or depression. However, Kreider et al., (1996) investigated the hypothesis that HNC patients' 
beliefs affect psychological adjustment using the framework of cognitive orientation (CO) 
theory. CO theory is a general cognitive-motivational theory describing how cognitive contents 
and processes guide behaviour, including external and internal responses to physical disease 
and health (Kreider & Kreider, 1991; Kreider, Chaitchik, Kreider, Rapoport, & Algor, 1996). 
Based on this theory, four main types of beliefs were identified (beliefs about goals, norms, self 
and general) that accounted for 40% of the variance in adjustment (as measured by the Patient 
Adjustment Questionnaire (Rapoport et al., 1993)). Previous studies have shown that scores on 
these four belief types are successful in predicting behaviours such as overeating (Kreider & 
Chemerinski, 1988), smoking behaviours (Kreider, Shahar, & Kreider, 1976; Tipton & 
Riebsame, 1987), and undergoing examinations for the early detection of breast cancer 
(Kreitler, Chaitchik, & Kreider, 1994). These studies provide some evidence that behaviour is 
determined by the endorsement of enough relevant beliefs. Similar to the SRM, CO theory 
assumes that behaviour is `the product of interactions among cognitive contents rather than of rational 
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decisions' (Kreider et a1,1996). However, the types of beliefs described in this work focus on 
beliefs about the self, and the self in relation to the world, whereas beliefs based on the illness 
perceptions framework focus on the beliefs the individual holds about the illness and the 
effects of the illness to themselves. Both of these frameworks imply that adjustment to a health 
threat can result from the modification of relevant beliefs. 
3.3 PATIENT EXPECTATIONS AND QOL 
Campbell and colleagues have argued that QoL refers to the perceived discrepancy between 
ideal and real states, and therefore, QoL is higher if this discrepancy is small, and lower if the 
discrepancy is larger (Campbell, Converse, & Rogers, 1976). Therefore, interventions could be 
aimed at reducing the mismatch between ideals and experience. One target could be aimed at 
the expectations people have regarding their QoL after being treated for a disease or illness. 
The measurement and definition of expectations is diverse throughout the literature, with many 
studies not being theoretically based. This has not aided the interpretation of results. For 
example, Williams and colleagues define expectations in terms of needs, requests or desires 
(Williams, Weinman, & Dale, 1995), whereas Buetow defines expectations as distinct from 
wants (Buetow, 1995). However, Like and Zyzanski distinguish between patient expectations 
and requests by arguing that the former relates to anticipation and the latter refers to hopes 
(Like & Zyzanski, 1987). This provides a more apposite definition and is expanded upon in 
chapter 4. Therefore, expectations could be considered as types of cognitive representation, i. e. 
beliefs about what will happen in the future. With this definition in mind, expectations may 
play an important role as process variables in outcome judgements. 
Calman's contention that QoL assesses the `difference, or the gap, at a particular period of time 
between the hopes and expectations of the individual and that individual's present experience' 
(Calman, 1984a; Calman, 1984b), indicates that QoL will be deemed `good' when expectations 
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are fulfilled by experience. Furthermore it may be possible to enhance QoL by narrowing the 
gap between an individual's expectations and their experience. This could feasibly be done by 
modifying expectations through accurate information concerning the benefits, risks, 
alternatives, and outcomes of treatment. Calman (1984b) suggests that reducing expectations 
does not deny hope, but helps patients develop realistic goals. 
Based on Calman's definition of QoL, Wan and colleagues conducted a cross-sectional study of 
the effects of expectations on HR-QoL (Wan, Counte, & Cella, 1997). A convenience sample 
of 466 cancer patients (including 32 HNC) completed the FACT-G (Cella et al., 1993) and also 
rated each of the items on the FACT-G according to whether their expectations had been met 
(worse, better or as expected). Expectations (amongst other variables) were found to exert a 
significant effect on HR-QoL, whereby patients reporting better than expected HR-QoL were 
more likely to have higher overall HR-QoL scores. An important limitation of these findings is 
that if a significant gap existed between expectations and experience, patients may have 
changed their ratings to ease any discomfort they might have felt (Festinger, 1957). 
The SRM has been applied to one study of the pre-operative expectations of patients 
undergoing oral surgery to extract third molars, in order to test the predictive power of 
expectations on recovery (McCarthy, Lyons, Weinman, Talbot, & Purnell, 2003). Expectations 
were derived from rewording the IPQ in order to elicit patient beliefs about what they thought 
would happen after surgery in terms of the five key illness representations (identity, timeline, 
consequences, cure/control and cause). It was found that pre-operative expectations predicted 
symptom severity, psychological distress, speed of return to work and healing rates at follow- 
up, better than medical factors. More specifically, pre-operative expectations of symptom 
severity (illness identity) were a primary predictor of symptom severity after surgery, controlling 
for length of stay, number of teeth removed, difficulty of surgery or anxiety. 
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Pre-treatment expectations have been found to be predictive of nausea after chemotherapy in 
patients with cancer (Hickok, Roscoe, & Morrow, 2001). Similarly, another study reported that 
pre-treatment expectations were related to post-treatment nausea whilst controlling for levels 
of emotional distress. It was also indicated that the influence of expectations on nausea 
changed with patients experience of chemotherapy (Montgomery & Bovbjerg, 2000). In 
contrast, a study by Andrykowski and Gregg found nausea post-chemotherapy was not related 
to pre-treatment expectations but levels of state anxiety (Andrykowski & Gregg, 1992). 
Other evidence from the literature has shown that pre-treatment expectations influence other 
outcomes such as; QoL (Koller et al., 2000), HR-QoL (Staniszewska, 1999; Wan et al., 1997) 
and functioning (Iversen, Daltroy, Fossel, & Katz, 1998; Mahomed et al., 2002) in a wide range 
of illness groups such as cancer, cardiac and arthritis patients. 
Methods of assessing expectations have varied across studies and many of the studies have 
been cross-sectional which means questions regarding the predictive role of expectations 
remain unanswered. In addition, it has long been suggested that expectations and optimism are 
closely linked and many studies assessing the effects of expectations on outcome have not 
controlled for levels of optimism. Accumulating evidence has demonstrated that dispositional 
optimism is beneficial for many psychological and physical outcomes. A study by Scheier and 
colleagues for example, reported that optimistic men evidenced a more rapid physical recovery 
after coronary artery bypass surgery and reported a higher quality of life 6 months later than 
the more pessimistic males in the sample (Scheier et al., 1989). Differences in outcome have 
been suggested to derive from differences in the way optimists and pessimists cope with the 
challenges of life. As Scheier and colleagues (1994) have noted, `optimists are people who tend 
to hold positive expectancies of their future; pessimists are people who tend to hold more 
negative expectations for the future' (Scheier, Carver, & Bridges, 1994). Optimists have been 
found to differ from pessimists in the way in which they cope with serious disease (Friedman et 
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al., 1992) and with concerns about serious health threats (Carver et al., 1993; Taylor et al., 
1992). Much of the research suggests that optimists tend to use more problem-focused coping 
strategies than pessimists, and when this is not possible, optimists turn to more adaptive 
emotion focused strategies such as acceptance, use of humour and positive reframing of the 
situation (Seheier et al., 1994). These findings are consistent with their model of behavioural 
self-regulation (Carver & Scheier, 1981; Scheier & Carver, 1988) whereby individuals are seen 
as remaining engaged in efforts to overcome adversity to reach goals as long as their 
expectancies of success are high. These differences in expectancies are also paralleled by 
variations in affect. If goal attainment is slower than anticipated, people will experience 
negative affect, whereas if it is faster than positive affect will result. This can be equally applied 
to individual differences (e. g. optimism) as a process underlying behaviour. Little is known as 
to whether expectations are purely the product of dispositional optimism or a result of 
situational factors such as the information the patient has been given about likely outcomes. 
Despite these limitations, evidence suggests that positive expectations are associated with better 
health outcomes in patients with a variety of clinical conditions. A greater understanding of the 
role of expectations on outcomes such as QoL, anxiety and depression, independent of 
optimism, may improve the process of care and outcomes after treatment. In addition, 
clarifying the influence of other factors, such as the role of information, on the formation of 
expectations, may assist with the targeting of appropriate interventions to enhance outcomes. 
3.4 ADAPTATION TO CHANGING HEALTH - THE PROBLEM OF 
'RESPONSE-SHIFT' IN QOL DATA 
The previous sections have highlighted how the perception of QoL could be considered a 
dynamic construct due to judgements varying over time and with experience of illness and 
treatment. Secondly, outcomes such as QoL, health status and depression, have been shown to 
be influenced by psychological factors such as perceptions about the illness, coping strategies 
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and expectations. The inclusion of QoL measures in health related research is well accepted 
and is valuable in the context of understanding how ill people adapt to their changing health 
state and any functional limitations. However, it has long been recognised that QoL research 
sometimes yields findings that are paradoxical; in terms of the QoL of in samples as compared 
to healthy samples, and also in terms of improvements in QoL despite deteriorating physical 
condition. It is likely that individuals, when faced with a serious health threat such as cancer, 
redefine their internal standards of what constitutes health and reflect upon the meaning of 
their lives, this may lead to a shifting of goals. Similar to the dynamic process of constant 
reappraisal of beliefs and coping strategies outlined in the SRNI, the construct of 'response- 
shift' may be able to account for any disparities between clinical indicators of health and 
patient's own perceptions of QoL. 
3.4.1 The construct of response-shift 
Response-shift is of particular importance when individuals undergo a change in health state as 
this is when changes in internal standards, values or conceptualisation of QoL may occur in 
order to accommodate the illness or condition. The working definition of response-shift refers 
to a change in the meaning of one's self-evaluation of a target construct, such as QoL, as a 
result of three interrelated constructs (Schwartz, Sprangers, Carey, & Reed, 2004). 1) A change 
in the individual's internal standards (process of recalibration); 2) a change in values or 
priorities (reprioritisation); or 3) a change in the definition of the target construct 
(reconceptualisation) (Schwartz et al., 1999; Sprangers & Schwartz, 1999). Similarly, attitudes 
towards a construct do not remain stable over time and are modified by psychological factors 
such as adaptation, coping, expectancy, optimism and self-concept, (Allison, Locker, & Feine, 
1997), judgements concerning QoL are amenable to fluctuation. As highlighted above, this is 
not necessarily as a result of changes to physical parameters but may be due to changes in the 
person's point of reference. 
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The literature provides examples of counter-intuitive findings which could be interpreted as 
evidence of response-shift. For example, Cassileth and colleagues found the psychological well- 
being of skin cancer patients to be significantly better than that of a sample of patients with 
other skin disorders and slightly better than that of the general population (Cassileth, Lusk, & 
Tenaglia, 1984). Similarly, in a study of transplant recipients, haemodialysis patients and others, 
patients' levels of happiness, satisfaction or life quality often exceeded that of a healthy 
population (Evans, 1991). Other research has demonstrated that people with severe chronic 
illness do not report worse levels of QoL than less severely ill or healthy samples 
(Andrykowski, Brady, & Hunt, 1993; Breetvelt et al., 1991; Groenvold et al., 1999). In addition, 
studies highlight the discrepancy between clinical measures of health and patients' own 
evaluations (Daltroy, Larson, Eaton, Phillips, & Liang, 1999; Kagawa-Singer, 1993) and thus 
demonstrate the problems in the area of QoL research. 
Recent research has demonstrated that individuals seek to make sense of traumatic experiences 
and find benefits from them. A study by Taylor in 1983, found approximately half of women 
diagnosed with breast cancer reported finding benefit in the form of positive changes in their 
lives since diagnosis (Taylor, 1983). More recently, research with cancer patients has 
demonstrated many types of benefit derived from the situation (Antoni et al., 2001; Cordova, 
Cunningham, Carlson, & Andrykowski, 2001; Sears, Stanton, & Danoff-Burg, 2003) and an 
association between benefit finding and lower distress and depression at follow-up (Carver & 
Antoni, 2004). Benefit finding has been likened to a profound shift in priorities which 
promotes personal growth, arising from the challenge of serious illness (Sears et al., 2003). 
Sprangers and Schwartz propose a theoretical model which addresses how response-shift may 
affect outcomes such as QoL (Sprangers et al., 1999). This model consists of five components: 
The catalyst refers to the change in health status, the antecedents refer to stable characteristics 
of the patient i. e. socio-demographic variables, personality traits and expectations. The 
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mechanisms refer to behavioural, affective and cognitive processes in response to the catalyst. 
Examples of mechanisms provided by Sprangers & Schwartz (1999) include using coping 
strategies; making social comparisons; seeking social support; reordering goals; reframing 
expectations and engaging in spirituality. The model as shown is simplistic, but shares 
similarities with theories of self-regulation, in that the model is meant to represent a dynamic 
process of feedback (similar to the SRM) and response shift may be influenced by optimism 
and affect as suggested by Carver and Scheier's self-regulatory model (Carver et al., 1981; 
Scheier et al., 1988) . 
Figure 3.2 A theoretical model of response shift and QoL based on Sprangers & 
Schwartz (1999) 
Antecedents 




Catalyst j Mechanisms Response shift -º Perceived QoL 
(health 
1 
based on the SRM i. e. change in: 
threat) e. g. cognitive beliefs internal standards 
emotional beliefs values 
coping conceptualisation 
The theoretical model has been reproduced in Figure 3.2 and modified to include explanatory 
variables based on the SRM. It is plausible that the mechanisms for response-shift may be 
explained by the dynamic interaction between beliefs and coping. For example, QoL 
judgements may indirectly result from a process of reappraisal of coping based on their beliefs 
about the illness and treatment. If the individual feels they have successfully coped with the 
health threat then a positive reinterpretation of the situation may occur. This leads to a 
response shift due to a change in internal standards (recalibration) or a change in values or 
119 
priorities (reprioritisation). This in turn leads to the reconceptualisation of what QoL means to 
the person. 
The meta-analysis by Nagger and Orbell (2003) described previously, demonstrated that illness 
beliefs such as controllability of the illness influenced coping strategies. It is plausible that these 
particular beliefs and others such as, identity and consequences, influence and drive the process 
of response shift through the use of adaptive coping strategies such as cognitive reappraisal. 
3.4.2 Measurement issues 
Although response-shift has recently been applied in the context of QoL research (Schwartz & 
Sprangers, 2000), the concept has its foundation in educational training (Howard & Dailey, 
1979; Howard, Dailey, & Gulanick, 1979) and organisational research (Golembiewski, 
Billingsley, & Yeager, 1976) both of which provide differing definitions of the phenomenon. 
Howard and colleagues defined response shift in terms of changes in internal standards, 
whereas, Golembiewski and colleagues combined the idea behind reconceptualisation with 
scale recalibration. The extent that the three components of response shift as defined by 
Schwartz and Sprangers are interconnected or distinct is unknown and it has been suggested 
that the interconnection between aspects may be hierarchical in nature. For example, 
Golembiewski and colleagues assumed that changes in internal standards cannot be assessed if 
reconceptualisation of the target has occurred. However, Schwartz and Sprangers (2000) have 
argued for a more dynamic theory, whereby changes in internal standards may affect the 
conceptualisation of the construct, therefore, the reverse will occur. 
Researchers of response-shift are essentially critical of standard methodologies to assess 
longitudinal outcomes typically involve the traditional `pre-test, post-test design', which assume 
conclusions can be made about the relationship of variables over time. This standard 
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methodology is based on the common assumption that an individual's internal standard of 
measurement is stable and will not change over time. 
Early response shift research utilised Golembiewski et al's (1976) methods of measurement of 
change that distinguished actual change (a change) from changes in internal standards (ß 
change) and meaning (y change). Beta change allows for the fact that a persons terms of 
reference may have changed in the light of their experience for example, the `worse possible 
pain' changes when pain does actually get worse. Gamma change involves a redefinition or 
reconceptualisation of a domain, for example, a major change in the perspective or frame of 
reference, especially with complex multidimensional constructs such as QoL. Gamma change is 
the most profound change, which can confuse the evaluation of alpha change. Therefore this 
has to be controlled for in the covariance analysis typically used to assess this type of response- 
shift. This methodology does not allow for the evaluation of the reprioritisation component of 
response shift. 
Howard et al., (1979) proposed an extension of the pre-test, post-test design by using a `then- 
test' (a retrospective pre-test). At post-test, two measures are completed - how people presently 
perceive themselves, and how people perceive themselves to have been prior to the 
intervention (or disease). This is to provide a renewed judgement of their pre-treatment 
functioning. It is hypothesised that most work using a traditional pre-test, post-test design are 
biased by `response-shifts'. However, one major critique of this method is that it relies on an 
accurate memory regarding previous situations. Whether this is valid in the light of any 
recalibration that may subsequently have occurred is open to debate. 
There are many other methods for accounting for response-shift biases, including `informed 
questionnaire' approaches, whereby patients are given access to their pre-test responses and 
asked to rate how they are in relation to scores provided previously. This is to avoid the 
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problem of recall biases, however, this method may actually serve to prompt individuals to act 
in a consistent way and not as they really feel. 
One of the major problems with assessment is that response-shift is an abstract concept that is 
difficult to measure directly. One solution is to use specially constructed questionnaires that 
allow for the assessment of reprioritisation. Instruments to assess QoL (or individualised QoL) 
overcome problems with the traditional pre-and post-test by examining how domains change 
over time and with experience of a changing health state. Two such measurement instruments 
are the Schedule for the Evaluation of Individualised Quality of We (SEIQoL) (O'Boyle et al., 
1994) and the Patient Generated Index (PGI) (Ruta, Garratt, Leng, Russell, & MacDonald, 
1994) both of which assess changes in values and priorities (reprioritisation). 
A full discussion of the methods for assessing response shift are beyond the scope of this 
chapter but can be found in the following references (Patel, Veenstra, & Patrick, 2003; 
Schwartz et al., 2000). A critique of the PGI as a suitable methodology for the assessment of 
individualised QoL in HNC patients can be found in chapter 10. 
3.4.2.1 Clinical implications 
Response shifts are more likely to occur in some domains of HR-QoL than others. As 
biological and physiological parameters are not in general assessed by self-report, these are not 
subject to response shifts, likewise some measure of functioning are more concrete than others 
(Wilson, 1999). For example, functioning such as activities of daily living (e. g. walking without 
assistance) are unlikely to undergo response shift as they are not tasks at risk of scale 
recalibration, however the priority a person places on the functional limitation may change 
(reprioritisation). Similarly, perceptions of symptoms can vary in meaning, intensity and 
concern which means they are feasibly subject to recalibration or reconceptualisation 
(comparable to changes in illness identity as assessed by the illness perceptions framework). 
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Response shift is a part of routine clinical practice and as such poses particular challenges for 
clinicians. 
In addition, the absence of response-shift may account for maladaptive outcomes after a health 
threat, seen for example, in situations where the health status or functioning does not actually 
deteriorate but perceptions of QoL and other outcomes such as depression and anxiety do 
decline. In summary, explicitly considering response shift may lead to a better understanding of 
the process of adaptation and may increase the benefit of assessing QoL as an outcome. 
3.5 IMPLICATIONS OF REVIEWS TO THESIS 
The reviews presented in chapters 2 and 3 have highlighted the paucity of theory driven 
research examining the predictive factors of patient outcomes such as QoL in patients with 
HNC. 
Of particular interest are the informational requirements of patients with HNC. It has not been 
established in the literature as to whether the mismatch between patients' informational 
requirements and the information received plays a role in outcomes such as QoL, and anxiety 
and depression. 
As discussed in this chapter, the complex relationships between processes detailed in the SRM 
and health outcome such as QoL are difficult to disentangle. This is due to much of the 
evidence being based on cross-sectional designed studies. Therefore, in the thesis, a 
longitudinal study design is adopted to allow for the assessment of components of the SRM 
and cognitive and emotional outcomes to be assessed at multiple time-points, which may assist 
in unravelling some of these complex relationships. It also allows for more proximal predictive 
relationships between illness representations and outcomes to be defined. 
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A third main implication to arise from a review of the literature, is the use of an individualised 
measure of QoL in order to assess aspects of response shift and also to investigate whether this 
would provide a more appropriate measure of QoL than standardised measures traditionally 
used with HNC patients. Suggestions made by Leventhal and Colman (1997), indicate that 
individualised measures may provide better outcomes for predictive studies based on SRM 
components. 
In conclusion, the study of QoL using a theoretically driven approach, may provide a deeper 
insight into the nature of QoL and the psychological processes that determine it. Furthermore, 
it is anticipated that factors found to be predictive of outcomes may be subject to modification 
and used to inform future intervention studies to enhance patient outcomes after treatment for 
HNC. 
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3.6 MAIN AIMS AND OBJECTIVES OF THESIS 
The main aim of the thesis was to investigate the role of psychological factors in predicting 
quality of life in patients diagnosed and treated for head and neck cancer. A self-regulatory 
framework was used as reference for guiding the selection of psychological factors related to 
adaptation and outcome. 
There were seven key objectives for the research: 
1) To explore the informational needs of HNC patients and the relationship between 
satisfaction with information and key outcomes (Chapters 4,5: Part 2& 6). 
2) To assess the impact of HNC on QoL using two distinct measures: a) standardised measures 
of HR-QoL (generic and cancer specific) and b) an individualised (patient centred) measure of 
QoL (Chapters 7 &8). 
3) To assess the degree of concordance between the two main types of outcome measures 
(Chapter 7). 
4) To apply Leventhal's Self-regulatory model (SRM) to guide understanding of the processes 
by which HNC patients understand and react to their illness and to assess how these change 
over time (Chapters 7& 8). 
5) To investigate how particular variables specified within the SRM (e. g. illness representations 
8). and coping responses) are related to outcomes (Chapters 7& 
6) To explore whether additional factors such as the extent to which patients are satisfied with 
information, can partially explain outcomes (Chapters 6& 8). 
7) To explore whether psychological factors (illness and treatment beliefs) or clinical and 
treatment related variables are better predictors of adaptation over time (Chapters 8& 9). 




AN IN-DEPTH EXAMINATION OF THE EXPECTATIONS AND 
INFORMATIONAL NEEDS OF HNC PATIENTS: A QUALITATIVE PILOT 
STUDY 
This chapter has been published: Llewellyn CD, McGurk M, Weinman J. (2005) Striking the 
right balance: a qualitative pilot study examining the role of information on the development of 
expectations in patients with head and neck cancer. Prychology, Health &Medicine, 10: 2; 180-193. 
4.1 INTRODUCTION 
The diagnosis of cancer itself is frightening for patients and their families. Cancer of the H&N 
not only poses a threat to life but, as highlighted in chapter 2, the consequences of the disease 
and treatment can be far-reaching and especially traumatic if unanticipated. These unexpected 
consequences may, in turn, lead to long-term difficulties with adjustment and therefore affect 
patient outcome in terms of QoL and depression. Evidence from the literature (see chapter 3) 
has shown that pre-treatment expectations influence recovery from surgery, (McCarthy et al., 
2003) and HR-QoL after radiotherapy (Koller et at., 2000) and HR-QoL during in-patient stays 
(Staniszewska, 1999) in a wide range of illness groups. 
Although unforeseen complications can arise, some of the uncertainty and trauma could be 
lessened with accurate and timely information at a level that patients can understand. For 
example, Leydon et al., (Leydon et al., 2000) demonstrated that not all patients want extensive 
information about their condition and treatment at all stages of their illness. However, patients 
undergoing surgery often experience considerable anxiety as a result of receiving too little 
information or information that they cannot understand (Krupat, Fancey, & Cleary, 2000). 
Studies have shown that the majority of written pre-operative instructions are not understood 
by patients (Livingston, 1989) and in another study, that only 60% of cancer patients could 
correctly describe their treatment (Cassileth, Zupkis, Sutton-Smith, & March, 1980). 
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In addition to the timing and format of the information supplied, another key issue is the 
mechanism by which information benefits the patient. Janis (Janis, 1958) argued that pre- 
operative information allows patients to engage in `work of worrying'. He proposed that 
information is useful because it allows patients to anticipate and rehearse the stressful events 
they are about to encounter and therefore cope more successfully with them. However, it has 
also been recognised that the benefits of information may vary considerably according to the 
timing of the information (Pinder, 1990) and the personality and demographics of the patient 
(Mahler & Kulik, 1991; Miller & Mangan, 1983). 
Despite the growing volume of research into the informational needs of patients with cancer in 
general, little is known specifically about the informational requirements of patients with highly 
traumatic diseases such as HNC. It is also not known whether the mismatch between these 
informational requirements and the information received plays a role in the development of 
expectations. 
4.2 AIMS 
This qualitative study sought to examine in depth: 
1) The types of expectations patients had prior to treatment and the extent to which patients 
considered that these expectations had been met post treatment. 
2) The role of information on the development of expectations. 
4.3 METHOD 
4.3.1 Recruitment of participants 
Patients were recruited from head and neck cancer clinics run at two London Hospital NHS 
Trusts (King's College Hospital NHS Trust and Guy's & St Thomas' Hospitals NHS Trust) 
and were based on a convenience sample. This was to minimise any bias that may have been 
created by pre-selecting patients into the study. Patients may have been more likely to talk 
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about their experiences in the context of a clinical review visit than returning on a separate 
occasion. Recruitment criteria were any post-treatment patient up to eighteen months post- 
diagnosis and currently free of disease. The cut-off point of eighteen months post-diagnosis 
was for several reasons. Most importantly to ensure that experiences were relatively recent to 
avoid problems with recall, secondly, to explore a spectrum of opinions at different stages of 
treatment and recovery and, thirdly, for more practical reasons of increasing the sample eligible 
for recruitment. Patients were recruited during the period from 10th January 2003 to 5th March 
2003. Ethical approval for this study was granted by the local research ethics committee and 
consent was obtained from all participants. 
4.3.2 Data collection 
The interviews were conducted in various quiet rooms in the clinics. The interviews were semi- 
structured in design although many interviews were based quite loosely around the topics 
determined by the interview schedule (Appendix IV) and the schedule was used more as an 
aide memoire according to the patient and the type of responses given. The interviews were 
iterative from the beginning, meaning that the first interview schedule was transformed over 
the first few interviews according to the usefulness and responsiveness to certain questions. 
Interviews typically began with a short discussion about why they were in the clinic that day 
and how long it had been since they had first been diagnosed, in order to establish rapport. A 
broad opening question such as; `could you describe for me some of the experiences you have 
gone through since your diagnosis? ' then followed and participants were prompted to think 
back over their experiences and expectations if required. Questions were presented in as 
neutral way as possible to minimise potential bias. The interviewer encouraged the participant 
to elaborate on stories and situations to illustrate important points. 
All interviews were tape-recorded and lasted between approximately fifteen to fifty-five 
minutes, the average being about thirty minutes in duration. Transcripts were produced shortly 
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after each interview. Demographic and medical data were collected from hospital medical 
records. 
4.3.3 Data Analysis 
Data were analysed using a Framework Analysis Approach (Ritchie & Spencer, 1994). This is a 
matrix-based approach to qualitative data analysis, which is based on transcripts produced 
verbatim from the taped interviews. This technique involves identifying recurring and 
important themes based on a combination of a-priori issues, emergent themes and recurring 
attitudes or experiences. Major themes in the data arising in these transcripts (determined by an 
initial read through of all the transcripts and then an in-depth analysis of the first seven 
transcripts) were then used as headings/themes under which the systematic charting of the 
content of all the transcripts was carried out. This ensured that the themes could be refined. 
Any new themes that subsequently arose were added to the framework. This method ensured 
that the diversity of the participants' experiences was encapsulated. Analysis was carried out 
after all the participants had been interviewed and this was to minimise the potential bias of the 
results of one interview influencing the next based on any framework that subsequently 
emerged. 
4.3.4 Reliability of the data 
In order to comment on the reliability of the data, a second rater (CK) was given the 
framework of emergent themes/headings and the verbatim transcripts and asked to appraise 
them according to their content. The few discrepancies that arose were discussed until inter- 
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4.4 RESULTS 
4.4.1 Profile of participants 
Participants wcrc fifteen patients treated for head and neck cancer and under the care of two 
maxillo-facial/ oral surgery consultants, attending clinics at twoo S milli IA lfllfln lu)sl, itals. ( )nc 
male patient refused to take part and one taped interview (also a male patient) had toi be 
discarded due to extraneous background noise. 'I'bis ga\'e a response rate of 88 
Table 4.1 provides a breakdown of the demographic and treatment profiles of the participants. 
Ten participants (67°Y>) were female. Ages ranged from 38 toi 75 (mean--5 1; median=51; 
S1)=10.5). All patients except two (one Asian and one Iranian) classified themselves as white 
UK ethnic origin. The time since diagnosis ranged from 11/ to 18 months (median=9; 
mean=9.7; S1)=4.8). .W tumours except one (adenocarcinoma) were scluatnous cell carcinomas 
(SCC). "Three patients had carcinoma of the tongue, three of the mandible, four of the maxillary 
region, three floor of mouth and one each of the tonsil and palate. All patients except one had 
surgical treatment and the majority also had radiation therapy-. All patients were free of disease 
at the time of interview. 
Two main themes of `patient expectations' and `the role of information' were explored, which 
resulted in a number of sub-themes (sec "Fable 4.2). 
Table 4.2: Structure of main themes, sub-themes and examples of issues to emerge 
from interviews 
Main Theme Sub-theme Example of issues to emerge 
1. Patient Expectations: Global Unexpected enormity of treatment / recovery 
Expectations being surpassed by reality 
Specific Side-effects of treatment 
Aesthetical outcome 
Recovery as a process 
2. Information influencing Too much information Limits to how much info can be 'taken in' 
expectations through: Repercussions on ability to cope 
Too little information `Missing' information 
Lack of clarity 
Timing of information Knowledge gap 
Uncertainty 
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4.4.2 Part 1: Patient Expectations 
Respondents described expectations reflecting two central themes: 1Global' expectations 
regarding the whole cancer `experience' and more `. specific' expectations, centred around side- 
effects, aesthetic aspects and the recovery process. This was interwoven with explanations as to 
the origins of their expectations and their views on their satisfaction with the information they 
had received about their treatment and recovery. 
Figures after quotes refer to the interview no., sex and age of the participant. 
4.4.2.1 Global Expectations 
A large proportion of respondents described the whole experience as being worse than they 
had imagined. A few patients expressed a sense of unexpected `enormity' about the surgical 
treatment and the subsequent physical recovery process, particularly those who had also 
received radiotherapy, as emphasised by: 
T didn't realise how big it was allgoing to be... Even bad I been told, I don't think I would 
have expected what happened : [2, F, 42] 
..... he (the surgeon) tells me it's not dangerous- it's not a big operation. But when I come 
here I was surprised -it was a big operation : [4, M, 51] 
I'll be quite honest, I didn't realise the operation at the time would pull me down as regards 
health so much. I think because I lost so much weight, I felt so weak. It affected me more 
than I thought it was going to at the time. ' [9, F, 70] 
Similarly, patients reported feeling surprise (post-treatment) at the extent of the operation due 
to the relatively small part of the lesion visible to the patient. The fact the tumour was 
extensive but not visible had obviously not been explained to the patient: 
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T wasn't expecting such a large are a (affected)from what seemed such a small, well, not a 
small operation, but such a large affected area from a small area that was involved in the 
surgery : [12, F, 59] 
A few respondents reported that the whole cancer experience had been better than they had 
been expecting. One woman described how she felt physically better now than she had thought 
she would: 
Well, I did think that I may feel worse actually. Everybody saysyou'll feel tire d and you 
won't be able to do this or won't be able to do that but I'm doing everything so... ' [10, F, 48] 
Similarly, another woman reflected on her ability to cope, despite not having any concrete 
expectations: 
7 think I've actually done better than what I thought I might. Becauseyou don't know. You 
just don't really know, well, I didn't know what to expect. Perhaps I didn't ask enough 
questions but then I didn't want to know ... I think I've coped a lot better than I thought I 
would : [1, F, 47] 
4.4.2.2 Specific Expectations 
4.4.2.2.1 Side-effects 
Expectations regarding specific outcomes of treatment and recovery reflected both positive 
and negative aspects. Respondents were able to describe their experiences of specific side 
effects that had exceeded their expectations, for example, 
`Then was a lot less pain than I e%pected I was able to eat quite quickly and I was able to 
talk better than I thought I would : [12, F, 59] 
7 was also told that they didn't think that I would speak for six months, but I did As soon 
as they took me off tracheostomy, they could understand we basically, so that was a bonus 
[14, F, 38] 
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Conversely, a few respondents recalled their surprise at experiencing arm and shoulder 
mobility problems (due to the neck dissection): 
7 had mobility problems for quite some time which I hadn't expected I couldn't raise my left 
arm very much...? wasn't expecting as much numbness... ' [12, F, 59] 
One patient, at a relatively early stage since diagnosis (5 months) described his current situation 
after undergoing radiotherapy: 
'It's all a lot worse than I thought it would be. I can't eat because I have no saliva both sides, 
it's very dry : [4, M, 51] 
4.4.2.2.2 Aesthetics 
Aside from functional aspects, disfigurement immediately after the operation was a particularly 
emotive issue due to the uncertainty surrounding the extent of surgery. Many respondents 
chose not to look at themselves immediately afterwards due to the large amount of swelling, 
however, one woman's expectations were surpassed when she finally looked at herself a week 
later: 
7 actually looked a hell of a lot better than I thought I would.. 'cos I thought I might lose a 
cheek or outer skin whereas all mine is internal. [1, F, 47] 
Respondents tentatively expressed expectations and hopes regarding future aesthetic 
improvement, either for further cosmetic procedures or healing with time. 
4.4.2.2.3 The recovery process 
Expectations regarding the recovery process seemed realistic in some people who recognised 
that recovery would take place over an extended period of time and would be challenging. For 
some people, pre-treatment expectations had been less realistic in hindsight, with expectations 
that after a couple of months they would be feeling the same or better than they had at 
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diagnosis. For example, expectations regarding current health status, were mentioned by a 
couple of respondents. One woman struggled to conceal her disappointment at not recovering 
as quickly as she was expecting and attempted to put it in perspective by suggesting her 
expectations may have been unrealistically optimistic: 
7 bad expected it to be a little better. Maybe I was just being overly optimistic, jou know 
(pause) but I don't expect (pause) I mean, the important thing is that the cancer is gone but I 
had some major setbacks on the ward : [15, F, 43] 
Additionally, one woman described how she was expecting physical changes but was uncertain 
how they would manifest. She also recalled not expecting any psychological problems. 
However, she was currently experiencing panic attacks related to her loss of confidence and 
altered appearance: 
Well, I did expect that there might be some big changes, perhaps physically. I didn't expect any 
psychological problems but I did expect to be physically different and I wasn't sure what that would 
mean : [12, F, 59]. 
Expectations regarding recovery were also revealed through expectations of returning to work. 
Expectations appeared to be related to prior advice from the consultant and comparison with 
other patients who had undergone similar procedures. These proved to be exceeded in some. 
For example; 
Mr X said it would be minimum 6-7 months up to ayear, 2jears depending on 
individuals. I was actually back at work in November, the November after the April (7 
months) : [1, F, 47] 
Prior expectations had not been met in others: 
7t had been my expectation to go back to work at the end of this month, having finished the 
radiotherapy at the end of October. I thought 4-5 weeks recovery, back to work. But no 
[5, M, 49] 
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4.4.2.2.4 Early optimism versus later realism 
Despite respondents later being able to concentrate on specific expectations they recalled 
having, many patients denied having any pre-treatment expectations or thoughts about what 
was going to happen to them in the future. The reasons given for this ranged from being too 
busy at the time to having difficulty trading off the need to be realistic whilst trying to be 
optimistic. This may have been due to the coping strategy employed at that particular time. 
For example: 
`I didn't really have any [expectations]. I was too busy and I was just trying 
to cope with things'. [11,13,63] and `My expectations (pause). I can't really 
give you a straightforward answer because again it's this, you know, being 
realistic and being optimistic (laughs).. so I don't have a clear 
cut... '[13, F, 47] 
Moreover, another respondent talked about the difference between her expectations for the 
future and her hopes: 
`I hoped to feel like I had before. Those were my hopes but not necessarily 
my expectations'. [12, F, 59] 
Patients' expectations were reported to change over time. Many post-treatment patients 
confided how shocked they were at the extent to which life in general had actually changed 
afterwards, despite expecting some alteration. A few respondents mentioned that their 
expectations changed throughout the recovery and the post-treatment period, lowering with 
experience of complications or problems. One respondent reported that she had learnt to be 
more patient regarding the speed of recovery after her expectations had not been met. This 
appeared to suggest that many people were optimistic in the early stages of the recovery 
process, but, with time and experience, people later developed more realistic expectations, 
suggestive of adaptive processes taking place. 
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4.4.3 Part 2: The role of information on the development of expectations 
Many respondents presented a conflicting picture of needs and requirements, between not 
wanting too much information on the possible complications and side-effects associated with 
treatment but feeling in hindsight that they were `missing' information regarding specific 
events. Explanations for this variation were forwarded by respondents, mainly relating to pre- 
treatment fear and perceived ability to cope with too much knowledge. The mismatch between 
informational requirements and satisfaction with the amount of information actually received, 
appeared to affect their ability to cope, feelings of `preparation' in some people, amount of 
anxiety experienced before and after treatment and uncertainty and conflict in others. 
4.4.3.1 Too much information 
Many respondents reflected that they had not wanted `too much' information pre-operatively. 
This appeared to be related to two factors. Firstly, fear over having too much knowledge about 
the potential negative effects of treatment, and secondly, a perceived lack of ability to cope. 
These factors were illustrated by statements such as: 
7 only, needed to know what was needed to be known. Because if I'd had too much 
informationyou would have found me in the corner with a vodka bottle : [1, F, 47] 
and also; 
`there's a limit to how much one can take in actually on something like this and how much 
you can actually cope with. Sometimes if you knew, like, any challenging thingyou have togo 
through - if you knew all the horrible things that were going to happenyou'd be like, `no way! 
Thanks a lot : [13, F, 47] 
When asked whether respondents were satisfied with the information they had received, the 
majority expressed satisfaction. Satisfaction with information also corresponded to feelings of 
preparation before and amount of worry after surgery for some of the respondents. One 
respondent, in hindsight, felt that preparation was tied into knowing the extent of the `long- 
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haul' of recovery. However, it was felt by some people that there was a limit to how prepared 
they could feel before such a major operation. One respondent asserted that being prepared 
and ability to cope were linked to personality not the information supplied, in addition, a 
further respondent did not consider preparation to be linked to knowledge as she had not felt 
at all prepared. However, this particular respondent had been very fearful of the whole 
procedure and admitted she hadn't read or taken in any of the information due to her strong 
apprehension. 
4.4.3.2 Too little information 
Although the general level of satisfaction with information was reported to be high, a few 
respondents reflected that there had been a distinct lack of information on the long-term 
impact on life and information on financial benefits available. For many respondents who 
reported `missing' information pre-treatment or misunderstandings between the explanation 
provided and their experience, psychological consequences (such as anxiety and depression) 
were revealed post-treatment. A few respondents reported unexpected long-term side effects 
which they related to `missing information'. For example: 
One thing I was very shocked by was that I couldn't speak after the operation. -It took a 
couple of weeks until I was sun I was going to be able to talk. The other thing I was very 
numb.... No, I hadn't known about that. So it was quite missing information. I was quite 
shocked by that because I really had been expecting that the numbness would be temporary 
[13, F, 47] 
Expectations were dearly related to the information given by the treating staff and the risks 
associated with the particular treatment recommended. Many respondents reported some 
aspect of treatment or recovery that they were not told of (or could not recall being told). 
There was a common lack of clarity regarding the effects of radiotherapy, from hardening of 
the scar tissue from surgery or developing bald patches on the head, to major complications of 
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failure of facial skin grafts. Many respondents reported a lack of understanding regarding how 
the effects of radiotherapy would make them feel `setback' after recovery from surgery. 
The variance between what to expect derived from detailed information and the actual 
experience was dramatically highlighted by one respondent: 
Nearly all that's happened, the doctors told me beforehand I was given a massive amount of 
literature, booklets which I studiously read, so I could almost foretell what was going to 
happen. The only thing that has changed, that was quite srgnj cant, was that after the 
radiotherapy (pause) I didn't expect the radiotherapy to burn holes in my face : [5, M, 49] 
A few of the patients contracted post-surgical Methicillin-Resistant Staphylococcus Aureus 
(MRSA) and felt particularly anxious and uninformed. This was emphasised by one woman 
who described her distress at the lack of information: 
7t was a nightmare in that nobody could tell you it, would tellyou anything. . 
And everybody 
was embarrassed about it... Somebody had foiotten to tell the anaesthetist that I had 
MRSA and there was all this kerffufle whilst they sorted that out : [11, F, 63] 
Another respondent reported miscommunication between her consultant and her 
understanding leading to uncertainty and fear. Moreover, although this respondent felt 
articulate enough to ask questions she expressed her lack of ability to do so out of fear: 
... it was another surgeon who looked at me and kinda went and said to me "well" and it 
was kind of chilling `there's nothing we can do foryou'... I really, couldn't bring myself to 
ask like, "nothing at all to save my life or nothing with the reconstruction? " It wasn't made 
clear to we what was happening.... I didn't have the resources to ask it: [13, F, 47] 
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4.4.3.3 Timing of information 
The lack of specific information or `missing' information appeared to be related to the timing 
of information. Previous quotes have demonstrated that not all patients wanted detailed 
information at all stages of the illness, however, one respondent suggested that patients should 
have full knowledge of all possible side-effects and outcomes of treatment, prior to treatment, 
regardless of the anxiety this may provoke. The same respondent later mentioned that not 
knowing the full facts when complications arose was a major source of anxiety for him: 
the times when things were going wrong and nobody was telling me wert the times that I 
became anxious, agitated and concerned... '[5, M, 49] 
This was further emphasised by a couple of respondents who considered that the lack of 
information or clarity stemmed from a `knowledge gap, 'between a full understanding of what going 
to happen toyou and what information can convey : [12, F, 59]. This was perceived to be caused by two 
factors, namely, the lack of time between diagnosis and treatment and the fact that traumatic 
experiences are indescribable until they've been experienced (likened to childbirth by a couple 
of women). The shock of diagnosis and the lack of time to assimilate the information were 
highlighted thus; 
At that time, when they've just told you, you have cancer and you're just about to have 
major surgery, you're not Wally listening ... your mind's not on it : [3, M, 56] 
and; 
7t was all carefully explained but it doesn't really register in the short timeyou have to think 
about it. You're trying to cope with a lot of information and you're not feeling very well: 
[12, F, 59] 
4.5 DISCUSSION 
The findings from this qualitative study give increased insight into how pre- and post-treatment 
expectations in a sample of head and neck cancer patients are derived in part from information 
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received throughout the pre-treatment and subsequent recovery process. Respondents 
described expectations reflecting two sub-themes relating to: `specific' expectations centred 
around: side-effects; aesthetic aspects of treatment and the recovery process; and `global' 
expectations regarding the whole cancer experience. Favourable experiences were underpinned 
by expectations being surpassed. A large proportion of patients described the whole experience 
as being worse than they had expected. This was highlighted by a sense of `enormity' about the 
treatment they had undergone and the recovery process, but also due to unexpected 
complications from treatment. 
This pilot study also highlighted the individual nature of the information giving process, 
whereby many patients did not want too much detailed information about their illness and 
treatment, especially at the early stages between diagnosis and treatment, yet many respondents 
required a detailed breakdown of all the possible complications and variables associated with 
the recovery process. These differences in requirements may have been due to differences in 
personality and/or coping strategies between patients. Research has indicated that stable 
individual differences exist between patients' tendencies either to seek or to avoid potentially 
stressful information about cancer and other threatening medical procedures. Miller (1992) 
proposed that people react to health threats by coping in one of two ways. Either by trying to 
avoid or minimize obtaining stressful information and by distracting themselves from 
threatening information (blunting coping style) or by attending and scanning for threat relevant 
information about aversive medical events and rehearsing and amplifying them cognitively 
(monitoring coping style) (Miller, 1992; Miller, 1997). Tentative support for these coping styles 
was evidenced in the present study whereby some patients explicitly stated that they had not 
wanted to know in detail pre-operatively what was going to happen to them, as exemplified by; 
7 only needed to know what was needed to be known. Because if I'd had too much informationjou would have 
found me in the corner with a vodka bottle' and `there's a limit to how much one can take in actually on 
something like this and how muchyou can actually cope with.. ' Although the level of information 
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actually received by `blunters' in this sample may have been less than for `monitors', they 
tended to be more satisfied with the amount of information they had received, which is also 
supported by the literature (Steptoe & O'Sullivan, 1986). In contrast, those with a `monitoring' 
coping style tended to be generally less satisfied with the standard amount of information and 
communication with the staff which has been previously demonstrated in other medical 
contexts (Miller, Brody, & Summerton, 1988; Steptoe et al., 1986). The data from the 
interviews also indicated that there was probably a dynamic relationship between a patient's 
need for information, expectations and coping. Modifying this cycle by intervention either at 
the informational level or through targeting specific coping strategies may influence patients 
expectations. 
Patients' understanding and expectations regarding the actual treatment and recovery are likely 
to be influenced by information received from a range of health care professionals and patients 
they come into contact with. Patients value the expertise that the treating staff have, therefore 
they are essential in influencing patient's understandings. However, not surprisingly, 
contradictory information was a source of anxiety for a few patients in our study. 
The role of information has previously been investigated in relation to a range of outcomes 
after treatment for head and neck cancer. Perceptions of adequate information from specialists 
were found to be predictors of positive rehabilitation outcomes in laryngectomy patients 
treated 2-6 years previously (De Boer et al., 1995). Similarly, satisfaction with information 
provided shortly before the end of radiotherapy was found to be a significant predictor of QoL 
in nasopharyngeal cancer patients 4 months later (Yu et al., 2001). (See Chapter 2 for more 
information about this study). The relationship between information and QoL has not been 
found to be straightforward. Kreider et al., (1995) concluded from a study of 55 head and neck 
cancer patients that `the psychosocial effects of the information the patient has at his or her 
disposal about the disease and its prognosis are greater than the effects of the severity of 
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disease per se' (Kreider, Chaitchik, Rapoport, & Algor, 1995). This suggests that the psycho- 
social effects of the disease and treatment are not necessarily direct functions of disease severity 
but are mediated by the meanings the patient assigns to the disease and the total situation. 
Information is a major determinant of the meanings assigned along with the cognitive 
representation of a health threat. However, Kreider et al., found that the effects of providing 
information were in some respects beneficial and in others detrimental from a psychological 
point of view (Kreider et al., 1995). Our study also found that for some people, too much 
information meant that they were unable to cope with the health threat due to strong feelings 
of anxiety and fear. Although we did not seek to investigate the role of information on 
subsequent QoL or mood in our study, the evidence suggests that pre-treatment information is 
relevant to post-treatment adaptational processes /rehabilitation and these could be mediated 
by the individual's expectations. Indeed, as Calman proposed in 1984, QoL should be 
considered `the extent to which our hopes and ambitions are matched by experience'. He 
argued that to improve QoL, health care should `narrow the gap between a patient's hopes and 
expectations and what actually happens' (Calman, 1984b). Through tailoring information to the 
individual, the mismatch between unrealistic expectations and experience could be narrowed 
thus potentially improving outcome. 
This study highlighted that patients' needs were frequently not being met. This is consistent 
with a report by The National Cancer Alliance (National Cancer Alliance, 2002), who 
highlighted through discussions with a focus group that although some patients had received 
written information, this was inadequate for their needs. A study by Edwards (1998), also 
highlighted the lack of satisfaction regarding information giving. It was suggested that patients 
wanted to have more information about the impact of their treatment and about different 
treatment options rather than details of the operation. 
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Many extraneous factors contribute to the information giving process (such as the time 
available to the patient, the presence of a multidisciplinary team, patient or clinician factors 
etc). However, many patients would like to be provided with written information and 
explanations about their treatment, advice on how to manage the effects of the treatment on 
their daily lives and adequate preparation prior to discharge from hospital. Written information 
is especially pertinent in cases where the patient is being subjected to `too much information' 
around the time of diagnosis. It may even be feasible to provide the patient with a tape 
recording of early consultations to listen to at a time appropriate to them. Information about 
the late onset of symptoms (particularly with radiotherapy) should be provided on a written 
basis as contact with the relevant health care professional may not be feasible after treatment 
has ended. 
Evidence, involving patients with other illnesses, suggests that pre-treatment expectations can 
have an influence on post-treatment outcomes in both a negative and positive way. For 
example, Iversen et al (1998), found that patients having surgery for lumbar spinal stenosis who 
had ambitious pre-surgery expectations for physical functioning were more likely to have 
improved function and satisfaction 6 months later (Iversen et al., 1998). Conversely, having 
unmet expectations regarding outcome (e. g. high expectations regarding pain relief) resulted in 
worse perceptions of outcome, such as more pain and less satisfaction with pain relief post- 
surgery. This highlights the importance of patients to have an optimistic stance regarding 
outcomes but without expectations being unduly unrealistic. 
Research on lay experiences of illness has found that coming to terms with an illness event 
involves patients interpreting why the event has happened, how it can be further prevented and 
how its effects can be overcome (Bury, 1991). This process may be better understood by 
applying a framework such as Leventhal's Self-Regulatory Model (SRM) (Leventhal et al., 
1980). A recent novel study by McCarthy et al., (2003) illustrated that the SRM proved a useful 
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theoretical framework with which to test the predictive value of pre-operative expectations in 
recovery from oral surgery (McCarthy et al., 2003). The SRM proposes that people organise 
cognitions regarding their health threat along five coherent themes; symptom identity, timeline; 
cause; consequence and control/cure (see chapter 3 for a detailed description of this approach). 
The model suggests that these five aspects may influence an individual's outcome from 
treatment such as surgery. McCarthy et al. (2003) found that pre-operative expectations 
(expectations regarding the five aspects outlined above) predicted symptom severity, 
psychological distress, speed of return to work and healing ratings seven days later. 
Extensive research indicates that psychological preparation for surgery can improve patients' 
ability to recover from major surgery. These positive outcomes are more likely to reflect a 
complex set of processes involving information, the patient's emotional reactions to surgery 
and the subsequent perceptions of the underlying medical condition and treatment. According 
to the SRM, threat appraisal and the emotional distress it generates can be reduced by 
providing the patient with information that fosters an accurate representation of the surgical 
procedure and its effects, as well as information describing cognitive and behavioural strategies 
for coping (Contrada, Leventhal, & Anderson, 1994). Pre-surgical interventions based on self- 
regulatory theory have tended to focus on conveying two types of information to the patient, 
procedural and somato-sensory information (Contrada et al., 1994). Procedural information typically 
involves information about when and where procedures will occur accompanied by a 
discussion of the purpose of each aspect of the procedure. This is designed to add to the 
patient's disease representation or schema and serves to minimise the threat by reducing 
uncertainty. Somato-sensory information focuses on what sensations or symptoms the 
operation will produce and how these can be distinguished from the disease and the emotional 
reactions likely to be experienced. This more subjective information provides the patient with a 
script describing the internal sequence of somato-sensory and emotional events in order to 
reduce uncertainty and worry. However, more relevant to patients undergoing treatment to the 
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head and face, are concerns about the aesthetic outcome and the subsequent threat this poses 
to their sense of `self-identity'. These considerations along with information on coping 
strategies for managing an altered appearance could perhaps be incorporated into interventions 
based on the SRM model in parallel with procedural and sensory information. 
4.5.1 Limitations 
Regarding the potential limitations, the data gained from the present study may be biased 
towards patients who have coped relatively well since diagnosis and who return for review 
visits. The majority of the patients had speech impediments to various degrees. This provided 
difficulty with transcribing, however, with careful listening and transcription shortly afterward 
conducting the interviews, this was not a problem, excluding one male case which combined 
with extraneous background noise, had to be discarded. The sample of patients interviewed 
were not representative of a typical sex ratio expected with HNC and this has to be 
acknowledged as a limitation of using a convenience sample. Although the nature of 
qualitative research is not to provide generalisable data, and the aim of the study was to explore 
patient expectations regarding recovery and outcome, in an area such as HNC where there are 
clear gender implications of having a disease that impacts aesthetically, a more representative 
sample may have provided different results. 
The patients interviewed were at different periods of recovery, which provided a range of 
retrospective accounts. Patients were generally more upset when in the first stages of 
adjustment and patients having a longer period of recovery may have forgotten the pre- 
treatment expectations they had. A few patients did become upset during the interview 
although all refused to terminate the interview, many verbalising that they weren't upset per se 
but were just experiencing a cathartic emotional release as many had not felt able to express 
their emotions, especially regarding disappointments with recovery, previously. 
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More pertinent to qualitative research is the issue of introducing biases into the data. This can 
occur at the time of the interview due to the person interviewing, whilst interpreting the data or 
even due to variables such as the time of interview, the interview room and interruptions by 
other staff. A more linear approach to data analysis was adopted in terms of analysing the data 
after all the interviews had been conducted which could also be considered a limitation of the 
study. However, the intention was to elicit the patient's perspective before forming a 
framework and therefore introducing any biases into the data, before all the interviews had 
been conducted. 
In conclusion, this pilot study produced a rich amount of material about the types of 
expectations individuals with HNC had at various stages of their treatment and recovery. Large 
variations were revealed between patient expectations and the actual experiences that were 
described. Expectations, both global and specific, seemed to be derived in part from the 
information received. Satisfying patients' needs for information has important implications for 
patient outcome. Reducing the uncertainty pre-treatment and narrowing the gap between 
expectation and actual experience may reduce feelings of depression and anxiety, as a result of 
experiencing unexpected negative events. This could easily be achieved by providing more 
written information on topics of importance to patients on a timely basis. Further research 
would be needed to explore the relationship between the fulfilment of pre-treatment patient 




This chapter describes the general methods used in this thesis. The specific details of how 
these methods were implemented, why particular measures were chosen and how the data were 
analysed, are presented in the relevant chapters. 
The chapter is divided into two parts: Part 1 consists of a summary of the methods used for 
the main longitudinal study and additional cross-sectional study, including information about 
study design, participants and measures used. Part 2 consists of a description of the methods 
used to develop and psychometrically test a novel measure to assess patient's satisfaction with 
information about cancer treatment: the Satisfaction with Cancer Information Profile (SCIP). 
5.1 PART 1: GENERAL METHODS 
5.1.1 Prospective outcome study 
5.1.1.1 Study design 
A prospective (repeat measures) design was chosen for the main study in order to address the 
main research questions regarding the nature and processes associated with adaptation and 
QoL over time. The method of data collection was by questionnaire (with additional data 
supplied from hospital records with permission). 
Newly diagnosed head and neck cancer patients were recruited into the study (see section 
5.1.1.2 for exact procedural details). Assessments were made at three time points: at baseline 
(after diagnosis but before cancer treatment started), one month after the end of treatment 
(Time 2), and six-eight months post-treatment (Time 3). Due to the time constraints of 
recruiting patients with a relatively rare disease into a longitudinal study, follow-up was 
completed at approximately eight months. Follow-up was terminated at 8 months, at 
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recurrence of disease, on entering palliative care or death. All clinical information was derived 
from patient's medical records. 
5.1.1.2 Procedure 
Potentially eligible patients were first identified from attending head and neck cancer clinics at 
Guy's and St Thomas' Hospitals, London, The Royal Sussex County Hospital, Brighton, 
University College London Hospital, London and The Royal Marsden Hospital, London. 
Patients currently under investigation or referred from other hospitals after histological 
confirmation of cancer were advised of their diagnosis in these clinics. Patients were not 
directly approached on their first visit, although some were informed by the consultant that 
various research studies were being conducted in the clinic and that they would be approached 
at a later date. Eligible patients at Guy's and St Thomas' Hospitals were also identified at the 
weekly multi-disciplinary meetings (MDM) for head and neck oncologists, ear, nose and throat 
(ENT) specialists and members of the treating team, such as, dieticians, dentists, specialist 
HNC nurses, house officers, registrars and speech therapists. Any queries as to the suitability of 
potential participants could then be discussed with the relevant consultant if the patient hadn't 
been assessed in the clinic initially by the researcher (see section 5.1.1.3 for inclusion criteria). 
Once patients were identified, participants were subsequently invited to take part in `a study 
assessing patients' views about their cancer and treatment'. After being informed of what 
involvement would be required, participants were given a patient information letter (appendix 
V), a consent form (appendix VI), a questionnaire pack (appendix VII), and postage paid 
envelope in which to return the questionnaire. It was emphasised that responses would be 
confidential and anonymous and that no members of the treating team would have access to 
individual questionnaires. As the content of the questionnaire was quite lengthy, participants 
completed the questionnaires at home and returned them by post or handed them in on their 
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next visits. Participants were also advised that assistance was available if required. Where 
patients had given their consent but did not return the questionnaire at baseline, patients were 
either given a verbal reminder at subsequent clinic attendances prior to treatment, or phoned, 
and given further questionnaires if required. 
5.1.1.2.1 Follow-up assessment 
At follow-up assessments one month after the end of treatment and at six-eight months after 
the end of treatment (T2 and T3), a letter, a questionnaire and a pre-paid reply envelope were 
sent out by post. If patients did not respond within two weeks, a further questionnaire was sent 
out, which was followed up with a reminder phone-call if required. Follow-up assessment was 
discontinued if the patient required further treatment for a recurrence or patients entered a 
palliative phase. 
5.1.1.3 Participants 
Patients with a histologically confirmed diagnosis of cancer of the head or neck were eligible 
for inclusion in this study. However, patients were not eligible for recruitment if any of the 
conditions below were met: 
" Under eighteen years of age 
" Previous head and neck cancer diagnosis (not dysplasia) 
" No known primary tumour 
" Any mental / cognitive impairments e. g. Alzheimers disease or psychiatric conditions 
" Undergoing treatment with palliative intent 
" Those who had started treatment (for the current diagnosis) at another hospital prior 
to referral to the recruiting hospitals 
" Metastatic disease in other parts of body (excluding neck nodes). 
" Diagnosis of Lymphoma. 
3 Occasionally, participants were recruited as in-patients if they required direct medical intervention prior 
to starting cancer treatment. Therefore, questionnaires were completed during their stay on the ward, 
which were then collected by the researcher. 
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" 'Chosc without a sutticicnt undcrstanding of Iý, nglisha 
5.1.1.3.1 Nlulti-ccntrc study patient recruitment 
Table 5.1 prescnts the breakdown of patients recruited from each recruitnicnt site. Rccruitinciit 
at Guv's and St Thomas' started on the ist 1ulV' 2003 and thus the maj<ýritý' (70"/o) of the 
recruited patients were primarily treated at either of these hospitals. Recruitment at 'h ie Royal 
Sussex County I Ios[)ital started in late August 2003 and a further seventeen patients (21 ) 
were recruited. Despite recruitment start dates of Septcnmber 2003 only six (7tt) and two 
patients (2"%)) from The Royal Klarselen I lospital and I. nivcrsity (; Ollcge London I IOsl)itals 
respectively, were recruited. The recruitment period of ten months finished at the end of May 
20(4. 
i\Iulti-centre studies are considered to be more desirable as they enhance the gcncralisability of 
the findings outside the treatment centre (Bowling, 1997). 1 Iowcvcr, it is recognised that in the 
present study, no sampling procedure was adopted due to the difficulty recruiting sufficient 
patients. 
Table 5.1: Breakdown of patients eligible for recruitment from each site 
Hospital No. of No. of Response 
patients patients rate 
eligible recruited 
(; t, N, 's & St "1'hotnas' I lospitals 79 57 72" 
The Royal Marsden I lospital* 6 6 N/A 
Ehe Royal Sussex County I lospital 21 17 81 °'o 
UCLII* 2 2 N/A 
No approached rather than number eligible. 
Unfortunately, this study could not support the services of a translator and therefore patients who could not 
read and write 1? nglish were not eligible. It 
is acknowledged that this severely limits the cross-cultural 
generalisabilit} of this study. 
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Results from Guy's and St Thomas' hospitals have been combined as some consultants see 
patients at either sites and both provide treatment for the same catchment area. The response 
rate based on the three main recruitment sites (Guy's & St Thomas' Hospitals, and The Royal 
Sussex County Hospital) were patients were recruited systematically was 76% overall. 
The clinical and socio-demographic characteristics of responders versus non-responders can be 
found in the results. Likewise, the numbers of patients retained at follow-up, with details on 
survival/ drop out rates are described within the relevant chapter (chapter 8). 
5.1.1.3.2 Difficulties with patient recruitment 
During the recruitment phase, three main problems arose which affected patient recruitment. 
Firstly, the head and neck oncology services at Guy's, King's and St Thomas' Hospitals 
underwent a period of reorganisation and merging. This meant that clinics that were originally 
run over three sites on different days eventually took place at Guy's Hospital at the same day 
and time. This had advantages and disadvantages. Originally, recruiting from the three separate 
sites meant the researcher could see all patients firsthand and explain participation in the study 
face to face. However, there was no central list of all patients being seen and inevitably some 
eligible patients were not identified and contacted in time (i. e. prior to starting treatment). After 
the merger, services were streamlined into one head and neck cancer service thus, only one 
clinic could actually be attended by the researcher which reduced the number of patients seen 
face to face. However, patients could be identified at the MDM which included patients seen 
by all consultants. Patients identified this way were contacted by post. This was not as 
successful as firsthand contact with the patient. 
Secondly, The Royal Marsden Hospital (RMH), London was chosen in order to increase 
patient recruitment. The RMH is another of the major cancer treatment centres in the South 
East of England. Recruitment was overseen by a specialist HNC research nurse which was a 
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condition of local research ethics approval. Despite initial enthusiasm from the research nurse 
and consultants, two further clinical cancer trials involving IINC patients commenced. This 
lead to an overload of duties on the research nurse but more importantly, eligible patients were 
initially entered into in-house trials and staff felt that patients were overburdened with too 
many research studies. Unfortunately, despite repeat enquiries into recruitment, there was a 
general reluctance to inform us of the situation until quite late on. Recruitment was eventually 
stopped and therefore was not as successful as originally anticipated. 
In addition, The Royal Sussex County Hospital was approached in the early stages of planning 
in order to bolster recruitment rates, but unfortunately, LREC approval took approximately six 
months to gain. 
A third, albeit minor problem with recruitment, centred around the definition of what a `new 
cancer case' was. Patients are considered to be new patients if they are diagnosed with a `new 
primary' cancer, even if they have had HNC in the past. These incidences are considered to be 
recurrences by some specialists, but if a cancer is diagnosed in a different head and neck site to 
the original cancer, it is recorded and treated as a new cancer. The patient is recorded as a new 
patient in the notes or database, especially if the patient was originally treated at a different 
hospital. Therefore, it was apparent quite quickly that there were not as many eligible patients 
as originally anticipated. It was decided that these patients would not be eligible for inclusion in 
the current study (unlike other studies where this is not made explicit), as these patients would 
have undergone some form of cancer treatment and would have prior experience of a cancer 
diagnosis with the associated emotional reactions and representations. 
Another important issue affecting both recruitment and follow-up assessment was the timing 
of the start of treatment and the actual length of treatment. Treatment was commenced as 
soon as possible with waiting times of approximately two to three weeks for surgery and 
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approximately 4-6 weeks for radiotherapy (RI), depending on the time of year. Timing was 
particularly pertinent with surgical patients whereby the period between initial diagnosis and 
treatment was sometimes very short. In cases where patients were posted the questionnaire, 
there was very little time for the patient to consider participating and completing the 
questionnaire. Many patients that refused to participate replied that they were too busy putting 
their lives in order in the short time left to take part. A few patients were contacted as in- 
patients due to this time constraint. Likewise, it was also not anticipated that the period of 
treatment would be so lengthy. In cases where patients also required post-surgical RT, a period 
of wound healing would be required of typically four to six weeks (if no complications) and 
then a further period of four to six weeks of RT. This meant that it was not unusual for a 
period of four and half months to elapse between diagnosis and T2 assessment. This resulted 
in a recruitment period that was quite short in order to complete all assessments within the 
time limits. 
5.1.2 CROSS-SECTIONAL STUDY OF POST-TREATMENT ADAPTATION 
5.1.2.1 Study design 
This cross-sectional questionnaire based postal study was conducted with three main 
intentions. Firstly, due to the relatively short period of follow-up assessment in the prospective 
study, more data was required to explore adaptation issues over a longer period since 
treatment. This study aimed to assess factors, which contributed to emotional and cognitive 
adaptation after treatment for HNC. Secondly, in order to examine wider issues of adaptation, 
pertaining to life satisfaction, a different questionnaire was required. Therefore, a separate 
sample of post-treatment patients was selected who were not part of the main study. In 
addition, this was a comparison study, whereby three other samples were collected in order to 
control for factors such as the effects of having surgery, or coping with a cancer diagnosis. The 




5.1.2.2.1 Identification of main sample of patients treated for malignant tumours of the head 
Details of all surviving patients from one oral surgeon (Mn at the Department of Oral 
Surgery, at Guy's Hospital were collected from the Head and Neck Cancer Database 
(INFOFLEX). Patients were eligible if they were at least 6 months post treatment (to allow 
time for physical healing) and had been diagnosed and treated for carcinoma of the head 
region, with no active recurrences or further treatment planned. This database contains details 
of patients treated over the last ten years (approximately). 
5.1.2.2.2 Identification of patients treated for malignant tumours of the glottis/larynx (Throat 
cancer group) 
Patients within this sample were recruited from two hospitals. The original aim of this 
comparison group was to recruit early stage (stage 1 or 2) patients diagnosed with a malignant 
tumour of the neck (larynx or glottis), who had been treated with radiotherapy only. This was 
to provide a cancer comparison group for the effects of surgery. Early stage cancers of the 
larynx and glottis are generally only treated with radiotherapy, hence the rationale for only 
selecting early stage carcinomas. In addition, these patients could also have provided a 
comparison for the effects of cancer stage on adaptation. Hospital records (hand written) from 
the Department of Radiotherapy at Guy's Hospital were hand searched for details of patients 
treated for early stage (T1 or T2) tumours in the last ten years (there is no electronic database 
containing the treatment details of patients treated up to ten years ago). Patients identified from 
these records were then checked against the departmental RT database for the hospital 
number, which was then checked on PIMS (Guy's Hospital Trust patient database) for patient 
survival status and address for mailout. This process was conducted by a senior house officer. 
At each stage of the process, some patient's records could not be identified and thus the final 
patient sample was greatly reduced. 
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Due to this and in order to achieve a larger patient sample, we also recruited similar patients 
treated with radiotherapy for early stage cancer of the larynx/glottis from The Royal Marsden 
Hospital (LREC amendment to protocol 2300, dated 27/04/04). A list of patient's names and 
addresses was provided by a RMH Consultant Oncologist from the departmental database. 
Unfortunately, it was subsequently found that nearly half of the recruited sample had also 
undergone surgical intervention in addition to radiotherapy. Therefore, the main intentions 
behind recruiting this comparison group could not be fully realised. Instead, this sample was 
used as a comparison group for the effect of treatment for cancer with less severe aesthetic 
consequences to the facial region than a head cancer. 
5.1.2.2.3 Identification of patients treated for benign salivary gland conditions 
Participants within this sample consisted of patients treated by one oral surgeon (consistent 
with the head cancer patients) for a benign tumours of the salivary glands requiring surgery. 
Inclusion criteria were that all patients should have been treated surgically and that the final 
histological diagnosis was benign. 
5.1.2.2.4 Age and gender matched non-clinical sample 
Participants were recruited from the community in the UK using a market research agency 
(Research Initiatives Ltd). This sample was purposefully matched with the sample of recruited 
head cancer patients on factors of age and gender. Thus, this sample was collected after the 
main sample had been recruited. The market research agency was requested to recruit 115 
people in the age range of 37 to 95 years old with a ratio of 2 males to every female to match 
the gender ratio in the main sample. All participants recruited through the market research 




All participants (excluding the age and gender matched non-clinical sample) were posted a 
patient information sheet (e. g. Appendix VIII), two consent forms (Appendix IX), a reply paid 
envelope and the questionnaire consisting of the four measures detailed in section 9.3.4. The 
questionnaire pack administered in this study was kept to a minimum (four brief 
questionnaires) in order to avoid placing excessive demands on patients who were not 
approached face to face. 
Ten additional questions asked about socio-demographic factors, type of treatment (choice of 
four categories: surgery, radiotherapy, chemotherapy and other), time since last being treated, 
whether patients were still undergoing treatment, and whether any further illnesses or diseases 
had been diagnosed since being treated for the particular condition of interest. Participants 
recruited into the normative sample were asked whether they had suffered from any major 
illnesses / diseases in the last ten years. Patients found to be still undergoing treatment for their 
condition were excluded from analysis. After three weeks, all non-responding patients were 
sent a further reminder letter, additional questionnaire, consent forms and reply-paid envelope 
in order to encourage participation. In order to establish more accurate response rates, the 
survival status of non-responders were investigated by a research nurse. Where listed in the 
medical records, the patient's general practitioner was phoned and asked whether they had a 
record of the patient's current survival status or whether the patient's address was different to 
the one listed in our hospital medical records. In order to protect the patient's privacy, the new 
address was not requested and the patient was not contacted again. 
5.1.2.2.5 Infoflex Database 
Prospective information about all cases treated by one consultant (MN) from the Department 
of Oral Surgery is entered onto a database designed and made by InfoFlex. Data that are 
recorded on this database include patient details, histological, medical and treatment details. 
The non-medical data contained on this database are primarily collected from departmental 
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Senior House Officers when the patient is first clerked in the Head and Neck Cancer Clinic. 
Thus some of the data is derived from patients and house officers and the reliability of the data 
cannot be commented on. 
5.1.2.3 Participants 
One hundred and ninety-two patients with cancer of the head were originally identified from 
the database as fulfilling the criteria. Of these, thirty were later confirmed to have died and 
twenty-three were not contactable (were abroad or confirmed to have moved from the address 
supplied). Only two patients refused to participate. One hundred and fifteen patients returned 
completed questionnaires. The response rate calculated from those potentially contactable was 
therefore 84%. A breakdown of the clinical and socio-demographic characteristics of the 
responders and non-responders (age, gender and cancer staging) can be found in chapter 9. 
Ninety-seven eligible patients who had been treated for a benign salivary gland condition were 
eligible for inclusion in this study. Four were confirmed as deceased, and twelve were not 
contactable. Forty-seven participants returned questionnaires, giving a response rate of 58%. 
5.1.2.4 Tumour staging 
The staging of head and neck carcinoma has changed little in the past decade (Forastiere, 
Koch, Trotti, & Sidransky, 2001). Traditional staging methods are weak and systems that use 
rating methods by means of the standard tumour-node-metastasis (INN) staging method are 
commonly used (American Joint Committee on Cancer, 2002). The following TNM definitions 
for each of the main sites are originally derived from The National Cancer Institute via 
www. cancerindex. org. 
5.1.2.4.1 TNM definitions for cancer of the oropharynx 
Primary tumour (T) 
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TX: Primary tumour cannot be assessed 
TO: No evidence of primary tumour 
Tis: Carcinoma in . situ 
T1: Tumour 2 cm or less in greatest dimension 
T2: Tumour more than 2 cm but not more than 4 cm in greatest dimension 
T3: Tumour more than 4 cm in greatest dimension 
T4a: Tumour invades the larynx, deep/extrinsic muscle of tongue, medial pterygoid, hard 
palate, or mandible. T4b: Tumour invades lateral pterygoid muscle, pterygoid plates, lateral 
nasopharynx, or skull base or encases carotid artery 
Regional lymph nodes (N) 
NX: Regional lymph nodes cannot be assessed 
NO: No regional lymph node metastasis 
N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension 
N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm 
in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in 
greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in 
greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but 
not more than 6 cm in greatest dimension. N2b: Metastasis in multiple ipsilateral lymph 
nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or 
contralateral lymph nodes, none more than 6 cm in greatest dimension 
N3: Metastasis in a lymph node more than 6 cm in greatest dimension 
Distant metastasis (M) 
MX: Distant metastasis cannot be assessed 
MO: No distant metastasis 
Ml: Distant metastasis 
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5.1.2.4.2 TNM definitions for cancer of the larynx 
Primary tumour (l) 
TX: Primary tumour cannot be assessed 
TO: No evidence of primary tumour 
Tis: Carcinoma in situ 
5.1.2.4.2.1 Site. Supraglottis 
Ti: Tumour limited to one subsite* of supraglottis with normal vocal cord mobility 
T2: Tumour invades mucosa of more than one adjacent subsite* of supraglottis or glottis 
or region outside the supraglottis (e. g., mucosa of base of tongue, vallecula, medial wall of 
pyriform sinus) without fixation of the larynx 
T3: Tumour limited to larynx with vocal cord fixation and/or invades any of the following: 
postcricoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage 
erosion (e. g., inner cortex) 
T4a: Tumour invades through the thyroid cartilage, and/or invades tissues beyond the 
larynx (e. g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, 
strap muscles, thyroid, or oesophagus). T4b: Tumour invades prevertebral space, encases 
carotid artery, or invades mediastinal structures. 
Subsites include the following ventricular bands (false cords); arytenoids; suprahyoid epiglottis; 
infrahyoid epiglottis; aryepiglottic folds (laryngeal aspect) 
5.1.2.4.2.2 Site., Glottis 
T1: Tumour limited to the vocal cord(s) (may involve anterior or posterior commissure) 
with normal mobility 
Ti a: Tumour limited to one vocal cord 
T1b: Tumour involves both vocal cords 
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T2: Tumour extends to supraglottis and/or subglottis, and/or with impaired vocal cord 
mobility 
T3: Tumour limited to the larynx with vocal cord fixation and/or invades paraglottic space, 
and/or minor thyroid cartilage erosion (e. g., inner cortex) 
T4a: Tumour invades through the thyroid cartilage and/or invades tissues beyond the 
larynx (e. g., trachea, soft tissues of neck, including deep extrinsic muscle of the tongue, 
strap muscles, thyroid, or oesophagus). T4b: Tumour invades prevertebral space, encases 
carotid artery, or invades mediastinal structures 
5.1.2.4.2.3 Site., Subglottis 
Ti: Tumour limited to the subglottis 
T2: Tumour extends to vocal cord(s) with normal or impaired mobility 
T3: Tumour limited to larynx with vocal cord fixation 
T4a: Tumour invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx 
(e. g., trachea, soft tissues of neck, including deep extrinsic muscles of the tongue, strap 
muscles, thyroid, or oesophagus). T4b: Tumour invades prevertebral space, encases carotid 
artery, or invades mediastinal structures 
Regionallymph nodes (N) 
NX: Regional lymph nodes cannot be assessed 
NO: No regional lymph node metastasis 
Ni: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension 
N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm 
in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in 
greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in 
greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but 
not more than 6 cm in greatest dimension. N2b: Metastasis in multiple ipsilateral lymph 
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nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or 
contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a 
lymph node more than 6 cm in greatest dimension 
Distant metastasis (M) 
MX: Distant metastasis cannot be assessed 
MO: No distant metastasis 
M1: Distant metastasis 
5.1.2.4.3 TNM definitions for cancer of the Hypopharynx 
Primary tumour (T) 
TX: Primary tumour cannot be assessed 
TO: No evidence of primary tumour 
Tis: Carcinoma in situ 
T1: Tumour limited to 1 subsite* of the hypopharynx and 2 cm or less in greatest 
dimension 
T2: Tumour invades more than 1 subsite* of the hypopharynx or an adjacent site, or 
measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of 
hemilarynx 
T3: Tumour measures more than 4 cm in greatest dimension or with fixation of hemilarynx 
T4a: Tumour invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, oesophagus, or 
central compartment soft tissue (including prelaryngeal strap muscles and subcutaneous 
fat). T4b: Tumour invades prevertebral fascia, encases carotid artery, or involves 
mediastinal structures 
*Subsites of the hypopharynx are as follows: Pharyngoesophageal junction (postcricoid 
area), extending from the level of the arytenoid cartilages and connecting folds to the 
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inferior border of the cricoid cartilage. Pyriform sinus, extending from the 
pharyngoepiglottic fold to the upper end of the oesophagus, bounded laterally by the 
thyroid cartilage and medially by the surface of the aryepiglottic fold and the arytenoid 
and cricoid cartilages. Posterior pharyngeal wall, extending from the level of the floor 
of the vallecula to the level of the cricoarytenoid joints. 
Regional lymph nodes (N) 
NX: Regional lymph nodes cannot be assessed 
NO: No regional lymph node metastasis 
N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension 
N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm 
in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in 
greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in 
greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but 
not more than 6 cm in greatest dimension. N2b: Metastasis in multiple ipsilateral lymph 
nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or 
contralateral lymph nodes, none more than 6 cm in greatest dimension 
N3: Metastasis in a lymph node more than 6 cm in greatest dimension 
Distant metastasis (M) 
MX: Distant metastasis cannot be assessed 
MO: No distant metastasis 
Ml: Distant metastasis 
Final pre-treatment staging systems are all clinical, based on the best possible estimate of the 
extent of disease before treatment. The assessment of the primary tumour is based on 
inspection and palpation when possible, and by indirect mirror examination where possible. 
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The tumour must be confirmed histologically, and any other pathologic data ohtaincd from a 
biohsv may be included. Additional radiographic studies may be included. As an adjunct to 
clinical examination, positron-emission tomography (IT A) and magnetic resonance imaging 
(NIRI) are universally accepted as vital tools for clinical staging. As pre-treatment staging is 
based on clinical data it may in some cases not be an accurate representation o the true size of 
the tumour. 
Post-surgery pathological staging occurs at ter surgcrv and is sometimes lýrý>ý iclccl On pathcýi)ty 
reports. I [cowevcr, not all pathologists provide a'I NNI staging c)n their reports (e. g. RS(: I I) and 
patients that do not have surgery will not be provided with a final staging. 
In this thesis a mixture of pre-and post-treatment staging was used clclýcnciiný can the 
circumstance. To provide a simple measure of tumour size/severity, for comparative and 
statistical purposes, the overall stgge was used and not the actual '1'N y1 stage for co titinuitVV across 
cancer sites (see Table 5.2). 
Table 5.2: General summary of overall staging based on TNM system (American Joint 
Committee on Cancer, 2002) 
NO Ni N2a N2b N2c N3 MI. 
Tl Stage 1 Stage 3 Stage 4a Stage 4a Stage 4a Stage 4b Stage 4c 
T2 Stage 2 Stage 3 Stage 4a Stage 4a Stage 4a Stage 4b Stage 4c 
T3 Stage 3 Stage 3 Stage 4a Stage 4a Stage 4a Stage 4b Stage 4c 
T4 Stage 4a Stage 4a Stage 4a Stage 4a Stage 4a Stage 4b Stage 4c 
5.1.3 Ethical approval 
Multiple research ethics committee (NIRFC) approval was not originally sought, as the 
intention was only to recruit from two trusts (King's College I lospital NI IS Trust and Guy's & 
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St Thomas' Hospital Trust). In order to harness more recruits into the study and increase the 
likelihood of achieving the study aims, it was realised that more recruitment sites would have to 
be included. This was a gradual process and is reflected in the staggered patient recruitment 
from each of the sites. 
Local Research Ethics Committee and Research & Development committee approval was 
granted from the following NHS Trusts: Guy's & St Thomas' Hospital Trust (ref: 02/03/07), 
King's College Hospital NHS Trust (ref: 02-03-053), Lewisham Hospital NHS Trust (ref: 
03/08/01), The Royal Marsden NHS Trust (ref: 2300), Brighton and Sussex University 
Hospitals NHS Trust (ref: (B)03/10), University College London Hospitals NHS Trust (ref: 
03/0263) Letters of approval can be found in Appendix X. 
5.1.4 MEASURES 
All the measures included in the questionnaire booklet are intended for self-administration. 
Not all of the measures detailed below were used at all time periods or with all of the study 
samples. For a list of which of these measures were used in each study refer to Appendix IV(b), 
and each specific chapter. 
5.1.4.1 Outcome measures 
The following well-used and validated measures were used to assess outcome in terms of 
standardised (traditional) HR-QoLS. 
5 The British Association of Head and Neck Oncologists (BAHNO) Council recommends the adoption of 
the University of Washington Quality of Life questionnaire (Hassan et al., 1993; Rogers et al., 2002) as part of 
the minimum dataset (http: //www. bahno. org. uk/bulletin. htm). It was decided not to use this questionnaire 
in the present thesis for a number of reasons. Firstly, from the literature review it can be seen that most 
European studies use the EORTC QLQ-C30 and, therefore, for comparison purposes it was decided that this 
would be the most appropriate. Secondly, for academic research the EORTC QLQ-C30 provides more 
detailed information on the patient's HR-QoL. However, for clinical audit, the UW-QoL is recommended, 
for ease of use for both clinicians and patients. 
166 
5.1.4.1.1 The European Organisation for Research and Treatment of Cancer (EORTC) 
QLQ-C30 (version 3) and Head and Neck Module (H&N35) 
Core questionnaire: QLQ-C30 (pages 406-407) 
The EORTC QLQ-C30 is a well-known and validated questionnaire for use with general 
cancer patients (see chapter 2) (Aaronson et al., 1993). This core questionnaire was designed to 
be: 1) cancer specific, 2) multidimensional in structure, 3) appropriate for self-administration 
(i. e. brief and easy to complete), and 4) applicable across a range of cultural settings. The 
questionnaire consists of thirty items, with the first twenty-eight items scored on a four-point 
response scale coded `not at all', `a little', `quite a bit' and `very much'. The QLQ-C30 
incorporates five functional scales (physical, role, cognitive, emotional and social), three 
symptom scales (fatigue, pain, and nausea and vomiting), and a number of individual items 
assessing symptoms commonly associated with cancer (dyspnoea, loss of appetite, insomnia, 
constipation and diarrhoea) and financial difficulties. 
A global health status/QoL scale can be calculated, which consists of two items on a 7-point 
response scale, from, 1= very poor to 7=excellent. 
All of the scales and single item measures range in score from 0-100. A high score on a 
functional scale or global health status/QoL represents a high level of functioning, however, a 
high score for a symptom scale/item represents a high level of symptoms/problems. Version 3 
is currently the standard version of the QLQ-C30. 
Scoring procedure (Fayers et aL, 2001) 
Firstly, the average of the items that contribute to each scale is calculated, this is the raw score. 
Raw score (RS) _ (items + item2 +... itemn)/n 
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Secondly, the raw scores are linearly transformed to standardise them, so that scores range 
from 0-100. 
Linear transformation 
Functional scales = {1- ((RS-1)/range)} x100 
Symptom = {(RS-1)/range} xlOO 
Global health status/QoL = {(RS-1)/range} x100 
Missing items 
Missing items from multi-item scales were addressed by applying a method of imputation. If at 
least half of the items were completed from a subscale (or domain), it was assumed that the 
missing items had values equal to the average of the items completed. The equations under 
`scoring procedures' for calculating scale scores were applied ignoring the missing items. Hence 
the above equations can be used whenever at least half the items are completed. For example, 
Role Functioning and Cognitive Functioning each contain 2 items and therefore these scales 
can be estimated whenever one of their constituent items is present. Physical Functioning 
requires at least 3 items completed from the 5 items. Using this method, none of the single- 
item measures can be imputed. 
A note on missing data 
The rules used above to deal with missing data have been exercised with caution. The number 
of items in a subscale that were originally missing was noted in order to indicate how much of 
the original data has been amended. 
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Head & Neck cancer module: QLQ-H&N35 (pages 408-409) 
The head and neck cancer specific module QLQ-H&N35 (Bjordal et aL, 2000) is for use with 
HNC patients of varying disease stage and treatment modality (Bjordal & Kaasa, 1992; Bjordal 
et aL, 1994). 
The module comprises 35 questions assessing symptoms and side-effects of treatment, social 
function and body image/sexuality. The module was developed according to the guidelines, 
and pre-tested on patients from countries in Europe and field tested in Norway, Sweden and 
The Netherlands and in a large cross-cultural study involving more than ten countries (Bjordal 
et aL, 2000). All items are scored on a 4-point response scale coded `not at all', `a little', `quite a 
bit' and `very much'. The H&N35 incorporates seven multi-item scales that assess pain, 
swallowing, senses (taste and smell), speech, social eating, social contact and sexuality. In 
addition there are also eleven single items. For all items and scales, high scores indicate more 
problems (in contrast to functioning scales of the core questionnaire). 
An additional exploratory item was also added to this questionnaire in order to identify 
particular problems with arm and shoulder function commonly resulting from neck dissections. 
There is currently no item addressing this area in the EORTC QLQ-H&N35 module. The item 
was: `Have you had any problems in the area of your shoulder/arm e. g. pain or mobility 
problems? ' This item was presented with the same format as the previous H&N35 items (i. e. 
on a4 point scale scored as above). This item was scored separately and therefore did not 
effect the scoring of the subscales. 
Scoring procedure 
The scoring procedure and handling of missing items are identical to those for the symptom 
scales and single items of the QLQ-C30. 
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5.1.4.1.2 SF-12 Health Survey (SF-12v2) (pages 410-411) 
The SF-12 is a well known and validated multi-purpose short-form comprising 12 questions 
selected from the SF-36 Health Survey (Ware et aL, 1996). Version 2of the SF-12 is currently 
the version of choice and for the following studies the standard version (4 week recall) was 
considered most appropriate for this study. The SF-12 produces an eight scale profile of health, 
comprising subscales of. Physical Functioning, Role Physical, Bodily Pain, General Health, 
Vitality, Social Functioning, Role Emotional and Mental Health. Two aggregate scores of 
`Physical Component Summary' (PCS) and `Mental Component Summary' (MCS) can also be 
calculated. This version was chosen because of its improvement in precision from previous 
versions, in conjunction with a reduction in respondent burden. 
Scoring procedures 
Multi-item Scales 
SF-12v2 items are scored so that a higher score indicates a better health state. For example, 
functioning items are scored so that a high score indicates better functioning and the pain item 
is scored so that a high score represents more freedom from pain. Items are scored in three 
steps: Firstly, items are recoded for 4 of the items. One item - General Health requires 
calibration, for which recoding values are given by the authors (Ware, Kosinski, Turner- 
Bowker, & Gandek, 2002). 
After item recoding, a raw score is computed for each scale. This score is the simple algebraic 
sum of responses for all items in the same scale. This simple method is possible because items 
in the same scale have roughly equivalent relationships to the underlying health concept being 
measured and no item is used more than once. Therefore, it is not necessary to standardise or 
weight items. 
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The last step involves transforming each raw scale score to a 0-100 scale using the formula 
shown below. 
Transformed scale = Actual raw score - lowest possible raw score x100 
Possible raw score range 
It is not recommended to derive an overall measure of health status from the responses to the 
12 items, however, two aggregate scores of `Physical Component Summary' (PCS) and `Mental 
Component Summary' (MCS) can be derived in line with SF-36 scoring. 
Component Summary Scales 
Following the scoring of the eight scales as described above, scoring of the PCS and MCS 
measures involves three additional steps. Standardisation using British norms cannot be 
computed as UK scoring algorithms have not been developed for the SF-12v2 (private 
correspondence, Qualitymetric Inc., 2004). It was also recommended by Qualitymetric Inc. 
Scientific Support Unit, to use standard scoring algorithms derived from the 1998 general U. S 
population published in the manual regardless (Ware et aL, 2002). This is to ensure the results 
can be meaningfully compared with other published scales and values. 
1) Standardisation of SF-12v2 scales (z scores) 
A z-score for each scale is computed by subtracting the mean 0-100 score observed in the 1998 
general U. S. population (Table 5.3) for each SF-12v2 scale score (0-100 scale) and dividing the 
difference by the corresponding scale SD (Table 5.3) from the general 1998 general U. S. 
population. 
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'fahle 5.3: 1998 general U. S. population means, standard deviations and 1990 factor 
score coefficients used to derive PCS and MCS scale scores, standard form 
SF-12v2 Scale Mean* SD* Factor score coefficients 
PCS MCS 
Physical Functioning (PI") 81.18122 29.10558 U. 42102 (). 22999 
Role Physical (RP) 80.52856 27.13526 0.35119 0.12329 
Bodily Pain (ßl') 81.74015 24.53019 0.3175-1 0.09731 
General I Icalth ((; 1 1) 72.19795 23.19041 0.24954 0.01571 
Vitality (V'I) 55.59090 24.84380 0.02877 0.2353-1 
Social functioning (SI") 83.73973 24.75775 -0.00753 0.26976 
Role I? motional (RI? ) 86.41051 22.35543 -0.19206 0.4311)7 
dental I Icalth (NII I) 70.18217 20.50597 -0.2200) It. 18581 
*The means and standard deviations for each SF-12v2 scale are based on the 0-100 
scoring (i. e. the steps explained in the previous section) 
For example: 
Physical Functioning-Z= (PF-81.18122) / 29.10558 
2) Aggregation of scale scores, standard form 
Computation of the aggregate p{)ysic"al summary store consists of multiplying the z-score of each 
SF-12v2 scale by its respective physical factor score coefficient and summing the eight 
products. Similarly, an aggregate mental summary score is produced by molt iplvin ; the z -score of 
each SF-12v2 scale by its respective mental factor score coefficient and summing the eight 
products. 
Formulas for aggregating scales in estimating aggregate physical and mental summary scores: 
ý1GG_PIIYS = (PF_Z*. 42402) + (RP_Z*. 
35119) + (BP_Z*. 31754) + (GI I_'l. *. 24954) + 
(VT_Z*. 02877) + (SF_Z*-. 00753) + (RI? _Z*-. 
19206) + (MI I_Z*-. 22069) 
AGG_MEN'i' = (PF_Z*-. 22999) + (RP_Z*-. 12329) + (BP_Z*-. O9731) + (GI I_Z*-. 01571) + 
(VT_Z*. 23534) + (SF_Z*. 26876) + (RF? _Z*. 
43407) + (Nil I_Z*. 48581) 
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3) Transformation of summary scores, standard form 
Transformation of the aggregate physical and mental summary scores to norm based (50,10) 
scoring is achieved by multiplying each aggregate summary score from step 2 by 10 and adding 
the resultant product to 50, using the formulas below: 
Formulas for t-score transformation of summary scores: 
Transformed Physical (PCS) = 50 + (AGG_PHYS*10) 
Transformed Mental (MCS) = 50 + (AGG_MENT*10) 
Missing items 
If a respondent was missing any one of the eight SF-12 scales, summary scales were not 
calculated. 
As the above measures do not take into account any judgement of the relative importance of 
areas affected by the cancer and treatment, an individualised (patient centred) measure of the 
impact of head and neck cancer on an individual's QoL was included: 
5.1.4.1.3 The Patient Generated Index (PGI) (page 412) 
Individualised QoL was assessed with The Patient Generated Index (PGI) (Ruta et al., 1994), 
which is a well used and validated questionnaire that has been used with a wide range of patient 
groups, such as cancer patients(Camilleri-Brennan, Ruta, & Steele, 2002), rheumatological 
conditions (Ruta et aL, 1994; Tully & Cantrill, 2000), ankylosing spondylids (Haywood, Garratt, 
Dziedzic, & Dawes, 2003), in disabled populations (Untern, Beaumont, Kenealy, & Murrell, 
2001; MacDuff & Russell, 1998) and individuals with lower limb amputations (Callaghan & 
Condie, 2003). The measure has acceptable reliability and validity (Ruts et aL, 1994), however, 
its use with certain populations and clinical trials remains controversial (Patel et al., 2003; Tully 
et al., 2000). 
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The PGI is a three-stage self-completed measure. The first stage involves identifying a 
maximum of five areas of life that are affected by the disease. Two other completed boxes are 
provided in addition, consisting of `areas affected by other health problems' and `all other non- 
health areas of life'. In the second stage, the respondent provides a rating of the degree to 
which reality meets expectations in each area listed (on a scale of 0 to 10,0 representing the 
area as being the worst imaginable and 10 being exactly as wanted). In the third stage, the 
respondent is asked to imagine that any of these areas of life could be improved. The 
respondent is given fourteen imaginary points to be spent on whatever areas are deemed to be 
the most important at that time. Finally an overall PGI score of between 0 and 10 is calculated, 
with higher scores representing better individualised QoL. 
The version of the PGI used in this thesis is also disease specific, meaning that respondents 
were prompted to think about areas of their life affected by their cancer and treatment. In 
addition, the trigger list of suggested areas (provided as a precursor to stage 1) was modified 
from the original to include examples of difficulties commonly mentioned by head and neck 
cancer patients in the qualitative interviews. For example, loss of independence, other people's 
reactions, lack of confidence, difficulty eating, etc were added as areas that other patients had 
mentioned. The trigger list is intended to help people think about areas of life that may have 
been affected by their condition. 
The PGI can be self-completed, however, patients were advised that the researcher was able to 
provide assistance and explain how to fill it in correctly if required. 
For follow-up assessment, two main methods are commonly used. One is the `open' format, 
whereby patients are simply asked to complete the questionnaire, as in the first instance, where 
any areas affected can be added at stage 1. The alternative `closed' method is where patients are 
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supplied with the areas they suggested in this section of the questionnaire on initial assessment, 
and asked to score how they currently feel they are performing in that area and how they would 
currently allocate points. This allows for the measurement of change over time within the same 
areas, which would be important for evaluating an intervention study. In this thesis, the former 
`open' method has been adopted, as it is more important to investigate how people change 
their priorities over time and explore whether there are any common life priorities that people 
have at certain periods that can be associated with adaptive processes rather than the `closed' 
method. 
Scoring procedure 
The following equation is used to derive the overall PGI score: 
PGI score = (score 1x (spend 1/14)) + (score 2x (spend 2/14) + (score 3x (spend 3/14)) + 
(score 4x (spend 4/14) + (score 5x (spend 5/14)) + (score 6x (spend 6/14) + (score 7x 
(spend 7/14) 
Missing data 
A PGI response was considered incomplete and not scored if any of the three stages was not 
completed, or if the allocation of points in stage three did not add up to 14, as this made it 
impossible to generate a final score. 
In the cross-sectional study of post-treatment adaptation, a measurement instrument designed 
to elicit the cognitive component of Subjective Well-being was selected as the main outcome 
measure. After assessing in detail patient's perceptions about their illness and treatment and 
including many different measures of QoL in the main prospective study, in order to reveal 
change over time, wider issues of adaptation relating to satisfaction with life in general, were 
assessed. 
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5.1.4.1.4 The Satisfaction With Life Scale (SWLS) (page 440) 
The Satisfaction with life Scale (SWLS) is a well-validated measure that assesses the cognitive 
component of subjective well-being (Appendix XI). The SWLS allows respondents to weigh 
domains of their lives in terms of their own values (Diener, Emmons, Larsen, & Griffin, 1985; 
Pavot & Diener, 1993). It consists of five statements measured on a seven-point Likert scale 
(completely agree to completely disagree). Cronbach's alpha (0.80 to 0.89) and test-retest 
reliability (0.54 to 0.83) have been reported to be within an acceptable range. Factor analysis 
have indicated that all five items load onto one general factor of well-being (Pavot, Diener, 
Colvin, & Sandvik, 1991). A total life satisfaction score is obtained by summing the five items 
(range 5-35). 
One term included in item 4 of the questionnaire that was considered an `Americanism' was 
changed (from `gotten' to `gained'. 
5.1.4.2 Measures for predictive/ explanatory factors 
Some of the psychological measures applied in this research have previously been used with 
HNC samples, for example the Hospital Anxiety and Depression Scale, the Life Orientation 
Test and the COPE inventory, however some have never been used with HNC patients. 
Specific measures were chosen for this very reason, i. e. in order to be able to compare 
outcomes across the literature, in addition to providing novel data from a psychological 
perspective. 
Illness representations were assessed using the Revised Illness Perception Questionnaire (IPQ- 
R) (Moss-Morris et aL, 2002) and the Brief Illness Perception Questionnaire (BIPQ) (Broadbent 
et al., 2005). 
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5.1.4.2.1 The Revised Illness Perception Questionnaire (IPQ-R) (pages 403-405) 
The IPQ-R comprises eight scales providing a quantitative assessment of nine components of 
illness representations, as described in Leventhal's self-regulatory model of illness (Leventhal et 
al., 1980; Leventhal et al., 1984; Leventhal et al., 1997). The psychometric properties of the 
original IPQ measure (Weinman et al., 1996), assessing five cognitive components of illness 
representation, have been well established in the literature (see chapter 3). The five component 
IPQ assesses a patient's illness identity (symptoms attributed to the illness), cause (personal 
perceptions of the likely cause of the illness), cure/contml (beliefs about the likelihood of cure or 
control of the illness), time-line (beliefs about the duration of the illness) and consequences (the 
personal repercussions of having the illness on the patient). Quantitative support for the 
structural relations between these constructs and a wide range of psychological outcomes such 
as coping (Helder et al., 2002; Rutter et al., 2002); mood (Vaughan et al., 2003); functional 
adaptation (Han et al., 2005) and adherence to medical regimens (Llewellyn, Miners, Lee, 
Harrington, & Weinman, 2003) have also been documented. After extensive retesting, the new 
version of the IPQ, the IPQ-R, also incorporates another important component of Leventhal's 
model, emotional representations that were previously overlooked. The addition of representations 
of cyclical timeline beliefs (perceptions of the unpredictability of the symptoms or illness), 
perceptions of treatment control (beliefs about the ability of treatment to control the illness), 
illness coherence ( the patients understanding of the illness through their own representations) and 
emotional representations (the feelings produced by the illness), assesses the dualistic nature of 
Leventhal's model (i. e. the cognitive components and the emotional components) that result in 
response to the health threat. The psychometric properties of the nine component measure has 
been evaluated with many different patient samples, such as, patients with asthma, diabetes, 
chronic and acute pain, multiple sclerosis and HIV (Moss-Morris et al, 2002). 
177 
A short (18-item) version of the IPQ-R was used in the present study in order to reduce 
responder burden (Appendix VII), in addition, treatment control beliefs were not included as 
these were assessed by items of the Beliefs about Medicines Questionnaire (BMQ). 
Scoring 
The identity scale in the current study is comprised of fifteen core symptom items that the 
patient is asked to rate in two ways. Firstly, the patients are asked to rate whether or not the 
symptom has been experienced since the onset of the illness (yes/no format). Secondly, they 
are asked whether each symptom experienced is specifically related to their illness (yes/no 
format). The sum of yes rated items from the second step results in the illness identity score. 
The symptom list consisted of items from the IPQ-R and additional items commonly known 
to be associated with HNC e. g. difficulties eating or difficulties speaking. It is recommended 
that the core list of symptoms can be added to in order to make the scale more specific. 
The subscales of acute/chronic timeline, cyclical timeline, consequences, illness coherence, 
personal control and emotional representations each consist of three items and are rated on a 
five point scale (1=strongly agree to 5= strongly disagree). Scores can range from 3 to 15 with 
higher scores indicating a stronger belief. Some of the items require reverse scoring. 
The cause scale was assessed by asking patient's to list in rank order the three most important 
factors believed to have caused the illness. This scale is not scored but assessed qualitatively for 
content. No prompt box was supplied. 
5.1.4.2.2 The Brief Illness Perception Questionnaire (BIPQ) (pages 442-443) 
The BIPQ is a new theoretically derived 9-item scale designed to assess the cognitive and 
emotional representations of illness based on the IPQ-R (Broadbent et al., 2005). All of the 
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dimensions except the causal dimension (not included in this study) are assessed using single 
items on 0 to 10 response scales. Six of the items assess cognitive illness representations, of, 
identity, consequences, time-line, coherence, personal control and treatment control. The 
psychometric properties of this new measure have been assessed using six illness groups of: 
myocardial infarction, renal disease, type 2 diabetes, asthma, minor illnesses (allergies, colds, 
headaches) and a sample undergoing stress-exercise testing prior to diagnosis. The measure has 
demonstrated good retest-reliability, and good concurrent, predictive and discriminant validity 
within these patient groups. 
The BIPQ was chosen for use in follow-up assessments, in order to reduce responder burden. 
The qualitative causal items were not included in this study as they had been assessed 
previously (Appendix XII). 
5.1.4.2.3 The Beliefs about Medicine Questionnaire (BMQ) modified (page 405) 
Patient's representations regarding the treatment for cancer were measured using a modified 
version of the `Specific' subscale of the Beliefs about Medicines Questionnaire (BMQ) (Horne, 
Weinman, & Hankins, 1999). The Specific scale assesses two further subscales of treatment 
Necessity and treatment Concerns. Treatment Necessity contains five items pertaining to beliefs 
about the need for and efficacy of treatment (in this instance, surgery, radiotherapy and for 
chemotherapy), whereas, the five items of the treatment Concerns subscale assesses beliefs 
about the possible harmful effects of treatment. The following original item from the Concerns 
subscale was not included in this thesis, `I sometimes worry about becoming too dependent on 
my medicines', as it was not considered relevant to the types of treatment modalities commonly 
used with head and neck cancer patients. Cronbach's alpha based on the four remaining items 
of the scale proved acceptable (see Chapter 8)6. 
6 Only two items from the Necessity subscale and two items from the Concerns subscale were 
administered in the follow-up assessments (at time 2 and time 3). This was due to issues of relevance after 
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Whilst, the IPQ and BMQ are generic instruments, they are intended to be modified for use 
within specific illness groups. In this instance, the term `medication' was replaced with the 
word `treatment' (which remained generic in order to apply to all different treatments). 
Scoring 
Responses to each of the statements are scored on a five-point Likert scale from strongly 
disagree to strongly agree. Scores for each scale range between 4 and 20 for the treatment 
Concerns subscale, and 5 and 25 for the treatment Necessity subscale. Higher scores on each 
subscale indicate increasing concerns over the harmful effects of treatment but stronger beliefs 
about the necessity of treatment. 
The psychometric properties of the BMQ have not previously been tested in HNC patients, 
however, the internal consistency, reliability and validity of the scales have been reported as 
acceptable with many acute and chronic illness groups (Horne et al., 1999; Horne et al., 2002; 
Llewellyn et al., 2003). 
5.1.4.2.4 The Hospital Anxiety and Depression Scale (HADS) (pages 415-416) 
Depression and anxiety was assessed with the Hospital Anxiety and Depression Scale (RADS) 
(Zigmond et al., 1983). The RADS is a well known and validated 14-item scale developed to 
provide a brief measure of both anxiety (seven items) and depression (seven items) in out- 
patient settings. It was chosen to measure state and not trait anxiety and depression, without 
the contamination of scores by physical symptoms. In addition, this relatively brief measure 
reduces responder burden when used with other measures. The two subscales have been 
reported in the literature as having Cronbach's alphas of approximately 0.90 for both anxiety 
and depression (Moorey et al., 1991). 
treatment had been discontinued. These items can be found in Appendix XIII. Scores can range from 2- 
10. The internal reliability of the two subscales consisting of two-items each can be found in Chapter 8. 
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Scoring 
Each item is scored from 0 to 3, therefore the total scores range from 0 to 21 for each of the 
two subscales (some of the items require reverse coding). High scores indicate greater levels of 
anxiety or depression. Zigmond and Snaith (1983) suggest that scores from 8 to 10 on each 
scale indicate a possible clinical disorder and scores from 11 to 21 indicate a probable clinical 
disorder. 
5.1.4.2.5 Life Orientation Test - Revised (LOT-R) (page 419) 
Dispositional optimism (habitual style of anticipating favourable outcomes) in patients was 
assessed using the revised version of the Life Orientation Test (LOT-R) (Scheier & Carver, 
1987) which is a brief version. The LOT was developed to assess individual differences in 
generalised trait optimism versus pessimism and originally consisted of eight items. Although 
the LOT has been widely used, it was found to have some problems. Most importantly, its 
original items did not all focus as explicitly on expectations for the future as theory dictated. In 
part to remedy this deficiency, a modest revision of the LOT, called the LOT-R has since been 
developed. The revised version contains six items (plus filler items) and was developed in order 
to assess generalised optimism amongst many other measures whilst reducing responder 
burden. The LOT-R has been used in a variety of research studies with cancer patients (Carver, 
Lehmann, & Antoni, 2003; Penedo et al., 2003) and has been reported in the literature as 
having a Cronbach's alpha level of approximately 0.75 (Carver et al., 2003). 
Scoring 
Each of the six items is rated on a 5-point scale of agreement from 1=` disagree a lot' to 5= `I 
agree a lot'. These are summed to provide a single score. High scores indicate high optimism. 
However, it has been argued that high scores on the LOT may actually reflect low neuroticism 
(Smith, Pope, Rhodewalt, & Poulton, 1989). 
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The four filler items that were designed to disguise the purpose of the test, were not included, 
in order to reduce the overall number of items. 
5.1.4.2.6 Brief COPE (pages 417-418) 
Coping style in response to the recent cancer diagnosis was assessed using the Brief COPE 
inventory (Carver, 1997). This is a brief, 28-item inventory, consisting of 14 scales. The Brief 
COPE is an abbreviated and slightly adapted version of the full version COPE inventory 
(Carver et al., 1989), developed from theory and previous research which demonstrated the 
role of the subscales in facilitating or impeding adaptive coping in different contexts. The 
shorter set of items was developed due to responder burden not only with the length of the 
questionnaire but with redundancy of items within the full version. The coping scales of the 
Brief COPE are as follows: Self-distraction, active coping, denial, substance use, use of 
emotional support, use of instrumental support, behavioural disengagement, venting, positive 
reframing, planning, humour, acceptance, religion and self-blame. The Brief COPE has been 
used by the authors in research with breast cancer patients and community samples recovering 
from natural disasters. 
Internal consistency reliability coefficients (Cronbach's alpha) have been found to vary from 
0.40 to 0.90 (Carver, 1997; Vosvick et al., 2003). The variability in the reliability coefficient 
across studies may indicate that this scale is more reliable when measuring acute stressors than 
when measuring chronic, ongoing stressors such as patients living with a chronic illness. 
Clearly, more studies that use this scale across different types of life stressors, both acute and 
chronic, are needed to fully understand this observed difference. 
182 
Scoring 
Scales are computed by summing the scores from the appropriate 2 items, and since the scores 
for each item range from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot), the 
scores range from 2 to 8. 
Missing data 
In general, if there were only 2 items in a subscale, missing data could not be replaced and the 
subscale was not computed. If a scale consisted of at least 5 items, one or two missing values 
were calculated from the mean value for the scores that existed. 
Novel measures to assess patient satisfaction with information and expectations 
Where no appropriate validated measures could be found in the literature, novel measures were 
devised and subsequently validated. 
5.1.4.2.7 Satisfaction with Cancer Information Profile (SCIP) (pages 413-414) 
No measures explicitly to assess satisfaction with information for use with HNC patients could 
be found. Informational needs and satisfaction with information was therefore assessed with a 
novel questionnaire. The items were derived in part from the Satisfaction with Information 
about Medicines Scale (SIMS) (Horne, Hankins, & Jenkins, 2001)and common themes arising 
from the qualitative study (chapter 4). See Methods Part 2 for development and psychometric 
testing of this measure. 
The questionnaire consists of 21 items and two open-ended questions giving two sub-scale 
scores. 
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Subscale one: Satisfaction with the amount and content of information 
A rating of the satisfaction with the amount and content of information is achieved by scoring 
items 1 to 14. Participants responding to items with either ` about right' or `none needed' are 
given a score of 1. If the participant is dissatisfied with the amount of information of 
information received i. e. responding with `too little' or `too much', are scored 0. Scores range 
from 0 to 14 with high scores indicating a high degree of overall satisfaction with the amount 
and content of information received. 
Subscale two: Satisfaction with the form and timing of the information received 
A rating of the level of satisfaction with the form and timing of the information received is 
achieved from responses to items 15-21. Each item is rated on a five-item response scale from 
`very satisfied'=5 to `very dissatisfied'=1 with a neutral category of `neither'=3 in the middle. 
The responses are summed to give the overall satisfaction score with the form and timing of 
information. Scores range from 7 to 35 with higher scores indicating higher levels of 
satisfaction. 
Measures of internal consistency for each of the subscales were high and within the acceptable 
level. Inter-correlations between the subscales proved good demonstrating that the two 
components of the SCIP were measuring related constructs of `satisfaction'. Two types of 
criterion- orientated validity were demonstrated: concurrent validity and predictive validity. The 
measure was also shown to be easily completed by patients and responsive to change. 
5.1.4.2.8 Patient Expectations (page 447) 
Expectations regarding treatment and recovery are assessed using three novel questions derived 
from the qualitative study asking to what degree expectations have been met by the patient's 
experience to date (Appendix XIV). Specific questions and their method of scoring are shown 
overleaf: 
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Expectation 1. To what degree have your expectations regarding the outcome of 
treatment been met? (i. e. cosmetic and/or physical effects of treatment) 
Expectation 2. At present, to what degree have your expectations regarding the extent 
of recovery currently been met? 
Expectations 1 and 2 have four category responses in order to gauge whether expectations had 
been surpassed or unfulfilled: `better than expected', `about the same as expected', `worse than 
expected' and `no expectations at all'. Each question is analysed separately according to the 
specific research question. 
Scoring of items 1 and 2 
Items 1 and 2 are scored to provide a dichotomous measure of the extent of fulfilment. 
Responses of `same as expected' and `better than expected' are scored 1 indicating expectations 
fulfilled. Responses of `worse than expected' are scored 0 to indicate that expectations were not 
fulfilled. A response of `no expectations at all' are not included in analysis but can be used for 
descriptive purposes. 
Expectation 3. To what extent have your expectations regarding the whole treatment 
and recovery period to date been fulfilled by your experiences? 
Item 3 has a different response frame to items 1 and 2 above as it does not allow the individual 
to answer that they had no expectations. The four response categories are scored as an ordinal 
measure as follows: `not at all as I expected'=0, `somewhat as I expected'=1, `mainly as I 
expected'=2 and `completely as I expected'=3. This measure provides a score of the degree of 
fulfilment of more general expectations after treatment. For all three items, higher scores 
indicate that expectations have been met more fully. 
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5.1.4.2.9 Additional data 
Socio-demographical information was collected by questionnaire. Where data were missing 
from the questionnaire, medical notes were hand-searched and information abstracted (where 
available). 
Clinical and treatment related information was collected through information returned with 
the questionnaire. Where data were missing, medical notes were hand-searched and 
information abstracted (where available). 
5.1.5 Statistical analysis - General Methodology 
5.1.5.1 Treatment of data prior to analysis 
Outliers shown to be extreme with stem and leaf plots were removed prior to analysis after 
checking to ensure they were not typing errors. 
Assumptions for parametric data were explored by plotting the frequency distribution of scores 
(histograms) and summary statistics for the distribution of values (kurtosis and skewness). The 
values of kurtosis and skewness should be 0 in a normal distribution, however, the actual 
scores provided by SPSS are uninformative. The scores were standardised using the following 
formulae (Field, 2000): 
Zskewness = skewness -0 
SEskewness 
Zkrt = SQRT Kurtosis -0 LSEs15 
The values of skewness, kurtosis and their respective standard errors (SE) are calculated by 
SPSS. The z scores can then be compared against values that could be expected from chance. 
A value above 1.96 is considered significantly different from chance to be problematic. In small 
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samples this criterion should be increased to 2.58 (Field, 2000). However, ±3.2 can be 
considered a reasonable cut-off point. Kolmogorov-Smirnov (K-S) tests were also run as a final 
check of whether distributions were normal. Many series of data are characterized by greater 
oscillations when series values are bigger in magnitude than when they are smaller (a form of 
heteroscedasticity). Therefore, variables violating parametric assumptions (i. e. a significant K-S 
test) and shown to be negatively skewed, were subject to attempts at logarithmic 
transformation, either to base e (the LN function) or base 10 (the LG10 function), in order to 
make variation constant across levels of the series (base e transformation requires that all values 
be positive) Variables violating parametric assumptions (i. e. K-S test was significant) and 
shown to be positively skewed, were subject to attempts at square root (SQRI) transformation. 
Variables still non-normally distributed were analysed using non-parametric tests. 
5.1.5.2 Statistical analysis 
Data were analysed using the Statistical Package for the Social Sciences versions 11 and 12 
(SPSS for Windows, SPSS Inc., Chicago, IL, U. S. A). A variety of parametric and non- 
parametric techniques were used throughout the thesis. Details of specific statistical procedures 
can be found in chapters 6,7,8 and 9. 
Data obtained from the majority of these questionnaire measures were considered to be 
ordinal, which is usually thought to preclude parametric statistical techniques such as 
parametric correlations, multiple regression etc. However, in regard to the use of multiple 
regression, (which assumes interval data), with ordinal Likert scale items, Jaccard and Wan 
(1996) summarize in a review of the literature on this topic, "for many statistical tests, rather 
severe departures (from intervalness) do not seem to affect Type I and Type II errors 
dramatically" Qaccard & Wan, 1996). Similarly, other researchers have demonstrated the 
robustness of correlation and other parametric coefficients with respect to ordinal distortion 
(Binder, 1984; Kim, 1975; Labovitz, 1970; Zumbo & Zimmerman, 1993). Use of ordinal 
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variables such as 5-point Likert scales with interval techniques is the norm in contemporary 
social science. Use of scales with fewer values not only violates normality assumptions but also 
runs a heightened risk of confounding.? 
5.1.5.2.1 Differences between responders and non-responders 
Independent t-tests (for continuous parametric data), Chit tests (for categorical data) or Fishers 
exact tests (where Chit cells were less than 5) and Cramer's V tests (for nominal data) were used 
as appropriate to investigate any differences in socio-demographic and clinical characteristics 
between responders and non-responders. 
5.1.5.2.2 Relationships between explanatory variables and study outcomes 
To test for any relationships between explanatory factors (independent variables) such as socio- 
demographic, clinical and psychological factors, and study outcomes (HR-QoL, individualised 
QoL, mood etc), univariate and multivariate tests were conducted. Univariate 
relationships were assessed using Pearson's correlation coefficients (or Spearman's correlation 
coefficients if data proved non-parametric). In order to assess the amount of variance 
explained by each contributing factor, linear regression models were constructed. 
Where multivariate linear regression models were used, in the majority of cases correlational 
analyses were conducted first in order to reduce the number of factors entered into final 
models. All significant correlates identified from univariate analysis were included as 
explanatory variables. Variables were entered in the regression analyses at p<0.05 and removed 
from the model at p>0.10. Generally hierarchical multiple regression models were used in 
order to test explicit hypotheses. When multicollinearity between variables were present, a 
stepwise method of entry was chosen in order to reduce this problem (Tabachnik & Fidell, 
1996). 
7 Readers should be aware that there is an opposing viewpoint. Thomas Wilson (1971), for instance, 
concludes, "the ordinal level of measurement prohibits all but the weakest inferences concerning the fit 
between data and a theoretical model formulated in terms of interval variables. " (Wilson, 1971) 
188 
5.1.5.2.3 Tests for linearity, homoscedasticity, multicollinearity, normality and independence of 
residuals of final regression models 
A scatterplot of the models standardised residuals against the standardised predicted values was 
used to determine the extent of heteroscedasticity and linearity in the data. The plot should be 
fairly random and evenly dispersed to meet assumptions of homoscedasticity and linearity. 
The assumption of normally distributed errors was assessed by plotting a p-p plot of the 
model's residuals (a straight line should be indicated) and a histogram of standardised residuals 
(a normal distribution should be demonstrated). 
The assumption of independent errors was investigated by examining the Durbin-Watson 
statistic. This should be 2 or approximately 2 if assumptions are met. Collinearity statistics of 
tolerance and variance inflation factors (VIF) should be within acceptable ranges (>0.2 and 
<10 respectively) in order to indicate there is no multicollinearity in the data (Bowerman & 
O'Connell, 1990). 
5.1.5.3 Power calculations 
Correlations and multiple linear regression models were constructed to test the main 
hypotheses. Previous studies (Rutter et al., 2002; Rutter, Durham-Hall, Weinman, & Fidler, 
2003; Scharloo et al., 2000) have reported explained variance in outcome (such as QoL or 
functional status) using illness representations, of approximately 20%, giving an effect size of 
0.25. Based on this effect size and the expected number of predictor variables (15), 89 cases 
would be sufficient to detect an R2 of 0.20 with 80% power at the 0.05 level of significance. 
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For 20 variables, 101 cases are deemed sufficient to detect an R2 of 0.20 with 80% power at the 
0.05 level of significance. With R-squared of 0.35, the effect size is very large at 0.54. Therefore 
the sample size needed would be 49 cases. 
5.2 PART 2: Development and preliminary validation of a new measure to assess 
satisfaction with information amongst head and neck cancer patients: The Satisfaction 
with Cancer Information Profile (SCIP) 
This chapter has been accepted for publication: Llewellyn CD, Horne R, McGurk M, Weinman 
J. Development and preliminary validation of a new measure to assess satisfaction with 
information amongst head and neck cancer patients: The Satisfaction with Cancer Information 
Profile (SCIP). Head & Neck 
5.2.1 Introduction 
Recent United Kingdom Department of Health recommendations (Department of Health, 
2000) state that NHS Trusts and cancer services must provide high quality information for 
cancer patients. Research indicates that cancer patients are being provided with good generic 
information (Semple & McGowan, 2002), however, recent studies suggest that cancer patients 
are frequently reporting a mismatch between the level of information that is supplied and their 
individual informational requirements (Ziegler, Newell, Stafford, & Lewin, 2004). This is 
consistent with a report by the National Cancer Alliance (National Cancer Alliance, 2002), who 
highlighted through discussions with a focus group that although some patients had received 
written information, this was inadequate for their needs. A study by Edwards (Edwards, 1998), 
also underlined the lack of satisfaction regarding information giving. It was suggested that head 
and neck cancer patients wanted to have more information about the impact of their treatment 
and about different treatment options rather than details of the operation. In addition, Mesters 
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and colleagues, (Mesters, van den Borne, De Boer, & Pruyn, 2001) found that more supportive 
information about access to help and solutions was required. 
The following questionnaire was developed as a result of findings from both the literature and 
the qualitative pilot research (Chapter 4). It was apparent from the pilot study that patients 
received (or retained) different amounts of information, and there were many aspects of the 
treatment and recovery that many patients were not prepared for. Moreover, there were 
differences in the amount of information that patients required and some patients reported that 
they did not feel able to ask particular questions during the consultation, especially those 
related to non-medical factors, for example, QoL related issues after treatment. It also became 
apparent from talking to patients and staff in different treating departments that the amount 
and type of information given to HNC patients were diverse. It has previously been reported 
that unmet informational needs and low satisfaction with information provided is related to 
unfavourable patient outcomes, such as, lower HR-QoL and higher levels of depression and 
anxiety (Edwards, 1998; Mesters et al., 2001), therefore, it is valuable to address these issues 
prior to treatment. 
A search of the literature found no questionnaires suitable for assessing the extent to which 
cancer patients (particularly HNC patients), undergoing a variety of treatment regimens, receive 
enough information about the amount and content, and the format and timing of the 
information with a wide range of aspects of the illness, treatment, recovery and long-term 
consequences of the disease. Although other measures of informational need in cancer exist 
(Degner et al., 1997; Graydon et al., 1997; Mesters et al., 2001), they fail to capture the patient's 
perspective in terms of whether they have received too much or too little information and thus 
how satisfied they are with the level of information supplied. This approach however, has been 
applied to the assessment of satisfaction with information relating to medication which resulted 
in a published and validated measure The Satisfaction with Information about Medicines Scale 
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(SIMS) (Horne et al., 2001) which assesses the extent to which individuals perceive that the 
information given to them about their medication has met their needs. The SIMS was 
developed in response to published recommendations of the Association of the British 
Pharmaceutical Industry for the type of information patients require in order to facilitate the 
safe self-management of medication (Association of the British Pharmaceutical Industry, 1988). 
Based on the SIMS framework and in response to the outstanding issues highlighted by The 
National Cancer Alliance and other recent studies, a novel measure was developed to assess the 
extent to which head and neck cancer patients are satisfied with information received about 
their treatment. The current objectives of this preliminary study were to describe the 
development of a new measure and to establish its psychometric properties. 
5.2.2 Methodology 
5.2.2.1 Questionnaire item development 
The Satisfaction with Cancer Information Profile (SCIP) was developed as a result of 
qualitative interviews with a convenience sample of fifteen post-treatment head and neck 
cancer patients and a search of the literature for existing measures. Four of the items were 
adapted from a validated questionnaire, the Satisfaction with Information about Medicines 
Scale (SIMS) (Horne et al., 2001) with the author's permission (items included: whether the 
treatment has any unwanted side-effects; what the risks of you experiencing side effects are; 
what you should do if you experience unwanted side-effects; whether your treatment interferes 
with other medicines you may be taking). Additional items regarding specific aspects of the 
treatment and recovery were derived from the qualitative pilot interviews. For example, some 
participants mentioned that alternative types of treatment had not been discussed thoroughly 
and some had been unsure of what the risks of side-effects had been. On a more practical level, 
participants had also not been given any information regarding whom to ask about possible 
financial assistance and the availability of support groups for patients with head and neck 
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cancer. The response framework for the first subscale of the new measure (extent of 
satisfaction with the amount and content of information) was also based on the SIMS 
framework, whereby, patients are asked to indicate whether they have received enouih g 
information. 
Key issues of a general nature also emerged from the qualitative interviews. For example, 
participants indicated that one of the main issues had been around the amount of information 
and the detail. This was demonstrated on a continuum of not having enough information to 
having too much information (see chapter 4). Related to this was the issue of timing. The 
majority of newly diagnosed patients felt that too much detailed information early on was 
overwhelming, which has clear implications for the provision of written information, which can 
then be taken home to read at an appropriate time. Similarly, issues of relevance and 
understanding of the information were key concerns that emerged from the interviews and are 
consistent with other findings (Newell, Ziegler, Stafford, & Lewin, 2004). Post-treatment 
patients were selected for interview, as opposed to pre-treatment patients, in order to elicit 
whether there had been any aspects of information that had been missing after actually 
experiencing treatment and the beginning of the recovery process. It is often in retrospect that 
patients wish they had been told certain aspects. Therefore, key issues of. the usefulness of the 
information to themselves and their family; the medium of the information i. e. the amount of 
written and verbal information; the appropriateness of the timing of information; the detail and 
the subsequent level of understanding, formed the basis for items in the `Satisfaction with the 
type and timing of information' subscale. As these items were measuring overall levels of 
satisfaction with each aspect, a five-point likert scale was chosen for the response framework. 
Two open-ended questions were also added to allow participants to add their thoughts on any 
aspects of the information giving process they thought important for us to know. This section 
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is also pragmatic, as it allows the clinician to be aware of any aspects that the patient is unsure 
about, that they may not wish to raise verbally during the consultation. 
The questionnaire was prefaced with the statement, `we would like to ask you about the 
information you have received about your treatment for cancer. Firstly, please answer whether 
you have received any information about the following aspects of your treatment and secondly, 
rate the amount you have received (if applicable). If you are having or have had more than one 
type of treatment please give your overall feeling about the information you have received. 
5.2.2.2 Participants 
The analysis is based on data supplied from 82 participants recruited into the main prospective 
study from hospitals in the south east of England (see chapter 5: Part 1 for more details). Data 
were collected at two time points, prior to treatment (baseline) and one month after the end of 
treatment. Follow-up data were supplied by 68 participants (83% of the original cohort). More 
details regarding these samples of patients can be found in chapters 6 and 8. 
5.2.2.3 Item analysis 
The original questionnaire containing 27 items can be found in Appendix VII. Prior to testing 
the reliability and validity of the final questionnaire, item analysis was conducted on the original 
items. In order to check that each item was measuring a wide range of responses, the standard 
deviations of responses to each of the items were examined. Items were rejected if their 
standard deviations were lower than 0.4. This was to ensure that the distribution of scores for 
each item was relatively widely dispersed. Four items (items 1 to 4, see Appendix XV) with 
standard deviations of lower than 0.4 were deleted from the final questionnaire. In addition, in 
order to assess whether all the statements were measuring similar constructs, the item-total 
correlations were examined. Any item with a low item-total correlation (i. e. <0.3 or negative) 
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was removed. No additional items were removed (see Appendix XVI). Table 5.4 displays the 
items retained and items deleted from the final questionnaire. 
5.2.2.4 Scoring of the SCIP 
The final questionnaire consists of two subscales and a free-response section, which require 
different responses. 
" Subscale one: Satisfaction with the amount and content of information 
The `satisfaction with the amount and content of information' subscale consists of items 
relating to the quantity and content of the information. Participants are asked to rate the 
amount of information they received on items 1 to 14 using the following response scale: `too 
much', `about right', `too little' and `none wanted' (see Appendix XVI). Satisfied participants 
responding to items with either ` about right' or `none needed' are given a score of 1. If the 
participant is dissatisfied with the amount of information received i. e. responding with `too 
little' or `too much', items are scored 0. A subscale score is obtained by summing the scores for 
each item. Total scores range from 0 to 14 with high scores indicating a high degree of 
satisfaction with the amount and content of information received. This response format is the 
same as the previously published and validated SIMS measurement tool (Horne et al., 2001). In 
addition, an individualised information profile can be obtained for each patient by examining 
the ratings on each specific item. Any deficiencies in information can then be given to the 
patient prior to treatment. 
Missing data 
If more than 50% of the items are not completed a summary score cannot be calculated. 
Where at least seven of the fourteen items are completed, mean values are estimated for the 
missing items, and a subscale score calculated. 
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Subscale two: Satisfaction with the form and timing of the information received 
A rating of the level of satisfaction with the form and timing of the information received is 
achieved from subscale two. This section contains seven items (items 15 to 21), each rated 
on a five-item response scale from 'very satisfied'=5 to `very dissatisfied'=1 with a neutral 
category of `neither'=3 in the middle. Examples of the items are: `the amount of written 
information supplied', `the amount of verbal information supplied', and' how 
understandable the information was to you'. The responses are summed to give a 
satisfaction score with the type and timing of information. Scores range from 7 to 35 with 
higher scores indicating higher levels of satisfaction. 
Missing data 
Where at least four of the seven items are completed, mean values are estimated for the 
missing items and a final score calculated. 
The last section consists of two open-ended questions `is there any further information you 
wish you had received? ' and `is there anything else you would like to add regarding the 
information you received? ' Participants can then add any recommendations or concerns they 
have in their own words. The responses can then be content analysed for research purposes or 
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5.2.2.5 Psychometric validation of the final questionnaire 
The new measure underwent psychometric validation in order to comment on the reliability, 
validity, sensitivity to change and ease of completion of the instrument, through a series of tests 
described below. One outlier was removed from the pre-treatment subscale 2: the form and 
timing of information. Kolmorogov-Smirnov tests demonstrated that the majority of the data 
were non-normally distributed (p<0.05) and, therefore, non-parametric tests were conducted 
throughout. The following additional measures were used in the validation process of the 
SCIP: 
" The Revised Illness Perception Questionnaire (IPQ-R) 
" The Brief Illness Perception Questionnaire (BIPQ) 
" The Beliefs about Medicine Questionnaire (BMQ) 
" The Hospital Anxiety and Depression Scale (RADS) 
" The Life Orientation Test - Revised (LOT-R) 
" The European Organisation for Research and Treatment of Cancer (EORTC) QLQ- 
C30 (version 3) 
The measures used and rationale for their use can be found under each test heading. 
5.2.2.5.1 Reliability 
5.2.2.5.1.1 Internal consistency 
The internal consistency of a scale estimates the extent to which items are measuring the same 
construct. Cronbach's alpha was calculated for each of the subscales and the overall 
satisfaction score. Scores range from 0 to 1, whereby 0 indicates no internal consistency (items 
are unrelated) and 1 indicates a high level of consistency. An acceptable level for Cronbach's 
alpha are scores >0.8. 
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5.2.2.5.1.2 Subscale inter-correlations 
Spearman correlation coefficients between the two subscales were conducted to assess the 
degree to which the two types of satisfaction (amount & content versus form & timing) were 
correlated. This was to ensure that the two subscales were assessing related but distinct 
constructs of `satisfaction'. 
5.2.2.5.2 Validity 
Validity refers to the degree to which an instrument accurately reflects or assesses the specific 
concept that the researcher is attempting to operationalize. While reliability is concerned with 
the consistency of the actual measuring instrument or procedure, validity is concerned with the 
instrument's success at measuring what the researchers set out to measure. 
5.2.2.5.2.1 Criterion related validity 
Criterion related validity, also referred to as instrumental validity, is used to demonstrate the 
accuracy of a measure or procedure by comparing it with another measure, which has been 
demonstrated to be valid (referred to as the `gold standard). This is often not possible if gold 
standard tools are not available, therefore, criterion validity is judged on the basis of 
relationships between the measure and proxy measures. Hypotheses can then be tested based 
on the relationships between the constructs. Criterion validity is usually divided into two types: 
concurrent (convergent) and predictive validity. 
5.2.2.5.2.1.1 Concurrent (convergent) validity 
Concurrent validity was assessed using Spearman correlation coefficients to assess the 
relationships between satisfaction with information and pre-treatment illness beliefs. It was 
hypothesised that patients' requirements for information and thus their satisfaction with the 
information received would be dependent upon key beliefs about the personal controllability of 
the illness (i. e. what they could do to get better), how well they understood their illness and 
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how ill they currently felt (i. e. how many symptoms they were experiencing). Thus, patients 
with more symptoms (a stronger illness identity), weaker perceptions about the personal 
controllability of the illness and a low sense of illness coherence would require high levels of 
information and, therefore, may be less satisfied with the information received. 
Scores on IPQ-R subscales of illness identity, personal control and coherence were used to test 
these hypotheses. 
5.2.2.5.2.1.2 Predictive validity 
The ability of the instrument to predict levels of future variables, in the expected directions, 
was assessed by testing hypotheses regarding the relationships between pre-treatment 
satisfaction with information and key outcome variables and beliefs one month after treatment. 
It was hypothesised that low satisfaction with information pre-treatment (unmet needs for 
information) could affect psychological well-being after treatment and thus the SCIP would be 
correlated with high scores on indicators of emotional distress and outcomes such as QoL. 
Cross-lag Spearman correlation coefficients were calculated to test the following research 
questions and hypotheses: 
1) Does level of satisfaction with information prior to treatment predict a number of key 
outcomes related to psychological well-being after treatment? It was hypothesised that low 
levels of satisfaction with information prior to treatment would be related to low levels of 
quality of life and high levels of depression after treatment. 
The level of information received prior to treatment may be an important influential factor in 
the formation of patients' post-treatment beliefs about their illness and treatment. Patients' 
who were less satisfied with the level of information they received may not be fully aware of 
the high necessity of treatment for their current health status (given that the experience of side- 
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effects one month after treatment may still be severe). Similarly, patients' may be less aware of 
the treatment's ability to control the disease due to overriding perceptions of the high negative 
consequences of having the illness and treatment. 
Therefore the following research question was investigated: 
2) Does level of satisfaction with information prior to treatment predict key illness and 
treatment beliefs after treatment? It was further hypothesised that low levels of satisfaction 
with information prior to treatment would be related to: weaker beliefs about both the 
necessity of treatment and the controllability of the illness through treatment, a higher number 
of symptoms and perceptions of high negative consequences of the disease, after treatment. 
The EORTC QLQ-C30 overall QoL score, the HADS depression subscale, BIPQ subscales of 
treatment control, consequences and illness identity, and the necessity subscale of the BMQ- 
specific were used to test these hypotheses. 
5.2.2.5.2.2 Discriminant validity 
Discriminant validity is a type of construct validity and is used to establish whether scores on the 
new measure are distinguishable from a non-related construct. This was tested by calculating 
Spearman correlation coefficients between pre-treatment satisfaction with information and a 
measure of personality (using the LOT-R). This was to ensure that responses on the satisfaction 
questionnaire could not be explained by differences in personality. 
5.2.2.5.3 Responsiveness to change 
The ability of the instrument to detect actual changes over time, particularly after an event of 
clinical importance, i. e. after treatment in this case, was also assessed. It was hypothesised that 
informational requirements and therefore aspects of satisfaction with pre-treatment 
information received would change after treatment as a result of the experience of treatment. 
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Responsiveness to change was assessed by examining individual items of the questionnaire in 
addition to subscales. This was in order to be able to detect change in specific areas important 
to head and neck cancer patients and, secondly, to be able to assess the direction of change that 
could be masked by analysis at the subscale level. 
Binary data (items 1 to 14 of the satisfaction with the amount and content of information 
subscale) were tested using McNemar tests for repeated measures. Wilcoxen Signed Ranks tests 
for two-related samples were conducted on ordinal data (items 15 to 21 of the satisfaction with 
type and timing of information subscale). 
5.2.2.5.4 Ease of completion 
Ease of completion of the questionnaire by patients was assessed by examining the number of 
items missing and the response rates of completed questionnaires. 
5.2.3 RESULTS 
The distribution of pre- and post-treatment scores for each of the subscales and the levels of 
overall satisfaction are presented as histograms in Appendix XVII. Scores on the Satisfaction 
with content and amount of information subscale were negatively skewed pre- (mean=9.9; 
SD=9.9) and post-treatment (mean=10.1; SD=4) with ranges of 14. The median score at both 
time points was 11. Scores on the Satisfaction with form and content of information were 
more normally distributed with a pre-treatment range of 13 (mean=28.8; SD=3.5) and post- 
treatment range of 21 (mean=27.4; SD=5.1). 
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5.2.3.1 Reliability 
5.2.3.1.1 Internal Consistency 
Croi bach's alpha cocfficicnts for the two subscalcs are shown in "Cable 5.5 Both of the 
subscalcs demonstrated good internal consistencies. 
Table 5.5: Internal consistency of each subscale derived from the Satisfaction with 
Cancer Information Profile 
Cronbach's a Std item a 
Satisfaction with the content of information 0.89 0.90 
Satisfaction with the form and timing of 0.87 0.89 
information 
r= Spearman 0 rrctatii>n cocfticicnts, "p<O. O I, ý "pp<O. OOI 
5 
. 
2.3.1.2 Subscalc inter-correlations 
Subscaic inter-correlations at baseline and one month post-trcatmciit pr( wed good at r=0.589 
(p<0.001) and r=0.658 (p<0.001) respcctivcly. The moderate magnitude of coctticicnts 
indicates that the scales tap complementary facets of patient satisfaction but are not redundant. 
5.2.3.2 Validity 
5.2.3.2.1 Criterion related validity 
5.2.3.2.1.1 Concurrent (convergent) validity 
To assess concurrent validity, it was hypothesised that key illness beliefs would be associated 
with satisfaction with information, due to patients' differing needs for information. Analysis 
demonstrated that patients with a strong illness identity (i. e. reporting more symptoms 
attributed to I INC), weaker perceptions about the personal controllability of the illness and a 
weak sense of coherence regarding their illness were less likely to be satisfied with the 
information received (fable 5.6). 
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Table 5.6: Correlation coefficients to demonstrate concurrent validity 
Subscale coefficients r (n) 
Variable (pre-treatment) 
Beliefs about: 
Sv'irnpt<mis (illness identity) 
Personal Control 
Satisfaction with content & 
amount of information 
Satisfaction with form & 
timing of information 
O 28** (76) 
-0.32 (7-1) 
O. 29** (75) 
Illncss Coherence (). 30** (76) 
r= Spcarman's correlation coefficients, °p<0.05, II p<0.01 
5.2.3.2.1 .2 
Prcdictivc validity 
Predictive validity was asscsscd by examining whcther the level of satisfaction with info rmatio n 
prior to treatment predicted a number of key variables after treatment. It was hypothesised that 
low levels of satisfaction with information prior to treatment would be related to low levels of 
QoL and high levels of depression after treatment. Correlation coefficients (Table 5.7) 
demonstrated that levels of satisfaction were associated with Q o]. and depression scores in the 
directions hypothesised. Patients who were less satisfied with information pre-treatment were 
more likely to have lower global Qol, scores and high levels of depression post-treatment. It 
was further hypothesised that low levels of satisfaction with information prior to treatment 
would be related to weaker beliefs about the necessity of treatment and the controllability of 
the illness through treatment, more symptoms and stronger beliefs of high consequences of the 
illness, after treatment. Coefficients demonstrated that patients who were less satisfied with 
information prior to treatment were more likely to believe that treatment was less necessary 
and less able to control their illness, suffer more symptoms and feel that the consequences of 
the illness were high. 
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Necessity of treatment 
Subscale coefficients r (n) 
Satisfaction with content Satisfaction with form & 
& amount of information timing of information 
0.38 11 (64) 
-0.42** (63) 
-0.45 *1 (65) 
0.40«1, (65) O. 48 (65) 
0.401 1 (65) 
Symptoms (illness identity) -0.30" (64) 
r= Spcarman's correlation coefficients, 'p<0.05, ''p<0.005 
5.2.3.2.2 [)iscriminant validity 
Coefficients between the subscalcs and the LO'l'-R ranged from r=(1. ()1 to (1.1(1 (p>(). 05). 
'I'hcrcforc, satisfaction with information was not affected by general personality traits such as 
life orientation (optimism). 
5.2.3.3 Responsiveness to change 
Satisfaction with form and timing of information (items 19 to 25) were assessed prc- and post- 
treatment in order to ascertain whether patients' ratings of satisfaction changed after 
experiencing treatment. It was hypothesised that patients' ratings of satisfaction with 
information would be significantly worse post-treatment, than ratings made prior to treatment. 
\Vilcoxen signed ranks tests demonstrated that the following areas were rated significantly 
lower post-treatment compared with ratings pre-treatment: the usefulness of the information 
(personally useful) (z=-2.01, p<0.05), the detail of the information (z=-2.99, p<0.005) and 
understanding of the information (z=-1.97, p<0.05). Satisfaction ratings of the amount of 
verbal information supplied pre-treatment showed a trend towards being worse although this 
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was not significant (z=-1.89, p=0.059). The subscale of satisfaction with the form and timing 
of information was significantly lower post-treatment than pre-treatment (z=-2.13, p<0.05). 
There were no significant post-treatment changes in items 1 to 14 (p>0.05). 
5.2.3.4 Ease of completion 
Ease of completion for patients was found to be satisfactory, especially as the new measure was 
completed as part of a large battery of measures. Table 5.8 shows the percentage of participants 
completing each item. The response rate of items in subscale one (items 1-14) ranged from 
79% to 95%, demonstrating an improvement at follow-up with response rates ranging from 
90% to 93%. The acceptability of subscale two was better still, with baseline response rates 
ranging from 91% to 98% and follow-up response rates ranging from 93% to 97%. The better 
response rates on the second subscale may have been due to the different response framework. 
The acceptability of the SCIP was greater at follow-up, with higher completion rates, possibly 
due to the natural bias of patients completing the second questionnaire battery. For example, 
follow-up patients consisted of those who felt well enough to still participate in the study. In 
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5.2.4 CONCLUSIONS AND APPLICATIONS 
5.2.4.1 Reliability, validity and acceptability 
The final version of the SCIP satisfied psychometric tests and was therefore considered reliable 
and valid as a measure of satisfaction with information for head and neck cancer patients. 
Measures of internal consistency for each of the subscales were high and within the acceptable 
level. Inter-correlations between the subscales proved good demonstrating that the two 
subscales of the SCIP were measuring related constructs of `satisfaction with information'. 
Two types of criterion- related validity were demonstrated: concurrent validity and predictive 
validity. As there was no gold-standard tool with which to compare the new measure, a series 
of hypotheses were tested examining the relationships between the new instrument and other 
constructs. Concurrent validity proved to be good, with significant correlations between both 
subscales of satisfaction with information scores and key illness beliefs. As predicted, higher 
levels of satisfaction were associated with fewer symptoms, stronger beliefs in the ability to 
personally control their illness and a greater understanding of the illness. Associations were 
primarily between satisfaction with the content and amount of information and beliefs, 
although personal control beliefs were associated with the format and the timing of the 
information provided. 
Predictive validity was demonstrated by examining whether satisfaction could predict a number 
of key outcomes and patient beliefs after treatment. As predicted, low levels of satisfaction with 
the content and amount of information pre-treatment were related to lower levels of global 
quality of life and higher levels of depression after treatment. In addition, it was demonstrated 
that patients who were less satisfied with this aspect of information were less likely to believe 
that their treatment could control their illness, were suffering more symptoms and were more 
likely to perceive that their illness would have high negative consequences. Scores on the 
subscale `satisfaction with the amount and content of the information' proved more predictive 
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of key outcomes and illness beliefs than satisfaction with the method or timing of the 
information. Interestingly, satisfaction with the form and timing of the information were 
predictive of beliefs regarding how necessary the treatment was and similarly, perceptions of 
how important the treatment was in controlling their disease. One explanation for this could be 
that patients are getting the information too late and the importance of the treatment has not 
been fully recognised. Another plausible reason could be that patients are not satisfied with the 
format of the information, for example, the information may have been imparted verbally and 
patients then forget the detail of why the treatment is necessary and how it works. This would 
lead to recollections of the topic covered but not in sufficient detail. Although all the patients 
in this sample underwent some form of treatment, this finding is noteworthy and it would be 
valuable to investigate whether beliefs about treatment and control after undergoing primary 
treatment are predictive of adherence to further treatment, or are influential in the decision 
making process prior to primary treatment. In the present study we did not have the data to 
ascertain these relationships. 
The ease with which patients completed the SCIP proved satisfactory with fairly low 
proportions of missing data. This was noteworthy due to the new measure being completed as 
part of a large battery of measures. Higher completion rates were evidenced at follow-up, 
possibly due to the bias of patients completing the second questionnaire battery. For example, 
follow-up patients consisted of those who felt well enough to still participate in the study. In 
addition, the follow-up questionnaire would have been familiar. 
5.2.4.2 Responsiveness to change 
Subscale two of the SCIP, `satisfaction with the form and timing of information', was shown to 
be responsive to change, with significantly lower satisfaction post-treatment compared to pre- 
treatment levels. This may have been due to a mismatch between the information supplied pre- 
treatment and the actual experience of treatment and recovery. It has been suggested that in 
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order to understand satisfaction, patient's expectations must be taken into account. The 
relationship between expectations and satisfaction has been demonstrated (Hsieh & Doner 
Kagle, 1991; Korsch, Gozzi, & Francis, 1968; Williams et al., 1995), however, many studies 
have failed to find any association between expectations and satisfaction (Sanchez-Menegay, 
Hudes, & Cummings, 1992), indicating that the relationship is probably more complex than 
previously thought. 
5.2.4.3 Measuring informational needs 
Only a few instruments seeking to assess a wide range of informational needs in cancer patients 
exist and these have tended to focus on the degree to which patients have `no need' or `high 
need' for information on a range of topics (e. g. the patient information need questionnaire 
(PINQ) by Mesters and colleagues (Nesters et al., 2001). The key difference between the PINQ 
and other generic informational need measures, and the SCIP is that the informational need 
instruments only address what patients needs are and not whether these needs have been met. 
Mesters et al (2001) conclude that future research should focus on the interaction between the 
need for information and the actual provision in order to predict rehabilitation outcomes. It 
could be argued that the key is to assess this discrepancy in terms of patient satisfaction. 
The SCIP attempts to quickly and easily assess the extent to which individuals perceive that 
their needs have been met and are satisfied with the amount and content and form and timing 
of the information provided. Consequently, the measure accounts for the fact that some 
individuals have higher needs for information than others. 
In concordance with our results, it has previously been reported that higher informational 
needs are related to higher levels of anxiety, depression and psychological complaints in HNC 
patients (Edwards, 1998; Mesters et al., 2001). These findings could equally be due to patients 
experiencing unmet needs and not higher needs per se. The few studies published assessing 
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levels of satisfaction with information, have demonstrated significant associations between 
satisfaction and outcomes such as HR-QoL (Yu et al., 2001) and rehabilitation (De Boer et al., 
1995). During the current validation process it was found that satisfaction with information 
was also associated with particular patient beliefs before and after treatment. The current tests 
did not allow for analyses to examine whether the types of beliefs patients hold about their 
illness and treatment mediate the relationship between informational requirements and 
outcomes, such as depression and HR-QoL. It could be proposed that information is a major 
determinant of the meanings assigned to the disease (i. e. the cognitive representation). This 
may explain why patients who are less satisfied with the information they have received (i. e. 
unmet informational needs) may hold erroneous beliefs about their illness, for example, about 
how much personal control they have over their health or the consequences of the disease. 
Of greater concern was the finding of a relationship between satisfaction and beliefs regarding 
the necessity of treatment. Patients who were less satisfied with information were more likely 
to believe that their treatment was less necessary to their health. There is a wealth of research 
detailing the consequences of beliefs such as these on levels of adherence to medication and 
medical regimens (Horne & Weinman, 1999; Ilewellyn et al., 2003). This is discussed more 
fully in chapter 6. 
5.2.4.4 Limitations 
The SCIP may be limited by indicating higher levels of satisfaction than are actually present, 
due to weaknesses with the scoring methods employed. Firstly, the first subscale may lack 
sensitivity due to collapsing four responses into a binary variable of essentially satisfied/not 
satisfied. This was in order to investigate the main research question. This may have resulted in 
the disguising of more subtle relationships between varying levels of satisfaction and other 
variables. Additional ways of scoring these data could be investigated in further research. 
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Secondly, similar to other coding systems, a percentage of missing values are taken into account 
by calculating the mean score of the completed items. It is possible that a non-response is an 
indicator of a negative answer (low satisfaction) as patients may be hesitant to give socially 
undesirable responses. It has been argued that satisfaction questionnaires lack validity as they 
may be measuring other concepts such as general attitude towards expressing criticism towards 
the NHS or treating staff, or loyalty towards the NHS (Baker & Whitfield, 1992; Fitzpatrick, 
1993). If non-responses were indicative of low satisfaction, then using a score based on the 
mean of binary responses would give an over-estimation of satisfaction. Therefore, final scores 
should be interpreted with a certain amount of caution. 
Finally, direct measures of satisfaction have been criticised for tending to yield highly skewed 
response distributions when used to evaluate specific medical encounters (Ware & Hays, 1988), 
however, Ware & Hays concluded in their own study comparing direct and indirect measures 
of satisfaction, that both methods are adequate. 
Another potential limitation is that the SCIP predominantly assesses satisfaction with 
information related to treatment and outcome. Many instruments exist that measure different 
types of patient satisfaction, and Hall and Dornan's (1988) meta-analysis of satisfaction studies 
highlight this diversity. The most commonly studied aspects of satisfaction with care were 
informativeness, overall quality and competence. The least frequently studied were patient 
outcomes, continuity of care and attention to psycho-social problems (Hall & Dornan, 1988). 
Although a gold standard measure of patient satisfaction with information does not exist, the 
SCIP could have been compared against other generic measures of informational need. These 
other instruments may not directly capture satisfaction, however, the construct of patient 
satisfaction is probably correlated to some extent with level of information requirement. 
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An additional weakness is that it was not possible to assess the SCIP's test-retest reliability as 
we did not have the data to do so. Although weak correlations existed between baseline scores 
and follow-up scores, it is likely that informational needs and thus satisfaction with information 
are subject to change over time and with major events such as surgery or radiotherapy. A 
recommendation would be to assess the test-retest reliability of the SCIP by sending the repeat 
questionnaire to a sub-sample of patients one week after completing the first and prior to 
treatment. 
This chapter only presents preliminary validation based on one sample of HNC patients. 
Although the results are encouraging and are based on patients recruited from several hospitals 
in order to reduce systematic bias, further research is needed to determine whether these 
psychometric properties remain stable when a different sample of HNC patients, or indeed 
other cancer patients are assessed, and also to examine the relationships between patient's 
actual level of knowledge and satisfaction. 
5.2.4.5 Applications and further research 
Despite the limitations, preliminary analyses demonstrate that the SCIP has acceptable levels of 
reliability and validity. Therefore, this new instrument has the potential to be applied in both 
clinical practice, training and research settings. 
In terms of uses in training, the SCIP could be used as an assessment tool during the 
communication skills training of medical students. The SCIP could be given to patients after 
consultation with the medical student, in order to assess the efficacy of communication skills 
training on information giving practice. 
As many HNC patients, and indeed many other cancer patients, undergo treatment regimens 
that are managed by multidisciplinary teams, the SCIP could be used to audit patients' 
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satisfaction with the information they have received as part of their routine care and therefore 
identify departmental or local targets for improvement. 
Providing patients with concise and clear information about their illness and treatment is a 
fundamental principle of the NHS (Department of Health, 2000) and therefore assessing 
individuals' satisfaction and need for information would be a major step towards achieving 
these goals. The SCIP takes into account individual differences in patients' requirements and 
could aid clinicians in identifying which particular aspects are inadequately addressed during the 
consultation. Moreover, the open-ended questions at the end of the SCIP allow the patient to 
identify specific information that they would like to know more about which can then be easily 
supplied by the healthcare provider (HCP) or referred onto a more specialist team member if 
appropriate. This section is particularly important if patients have difficulty expressing their 
uncertainties or questions verbally, consistent with the literature (Van der Molen, '1999). 
The SCIP has demonstrated an association between outcomes such as global QoL and 
depression and patient's cognitive representations of their illness in this patient sample. 
Consequently, satisfaction with information could be an important target for intervention in 
order to improve short-term and long-term patient well-being. Targeting unmet informational 
needs could prove a cost-effective and relatively simple intervention, that could be performed 
using the SCIP and through dialogue with the relevant HCP. Although Mesters et at, (2001), 
suggest that informational need is a relatively stable characteristic of the patient, it has been 
suggested that patients' satisfaction with information could not be expected to be static 
(Barber, 2001), and thus the SCIP could be administered at multiple time points from diagnosis 
through to the post-treatment recovery period. 
Despite the SCIP's development in response to HNC patients' informational needs, this 
measure could be applicable to all cancer patients due to its suitability for use with all treatment 
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modalities. Further research is needed with a wider range of cancer patients in order to 
revalidate the findings from these preliminary analyses. Moreover, more research is required to 
improve our understanding of the needs and satisfaction with information in a larger sample of 
HNC patients in order to improve current information provision. 
The findings indicate that patients with lower levels of satisfaction have unmet requirements 
for information. Although this could be in the direction of `too much information', it is 
probable that low levels of satisfaction are indicative of lack of information. Low levels of 
information may lead to erroneous beliefs about the benefits of treatment and a lack of 
coherence regarding the illness, which subsequently results in worse outcomes in terms of 
higher levels of depression and lower levels of QoL. Although this was only demonstrated with 
uni-variate analysis for validation purposes, further analysis will clarify these and other 
relationships, for example, the relationship between coping strategy and informational need, in 
order to inform possible targets for intervention. 
215 
CHAPTER 6 
HOW SATISFIED ARE HNC PATIENTS WITH THE INFORMATION THEY 
RECEIVE PRE-TREATMENT? RESULTS FROM THE SATISFACTION 
WITH CANCER INFORMATION PROFILE (SCIP) 
This chapter has been accepted for publication in Oral Oncology. 
6.1 INTRODUCTION 
Whilst accumulating evidence indicates that lower levels of anxiety and depression are 
experienced by well-informed individuals (Fallowfield, Baum, & Maguire, 1986), the majority of 
the literature tends to focus on information needs relating to clinical and treatment factors. 
Some of the uncertainty and trauma that cancer patients face could be lessened with 
information that matches their needs. For example, Leydon and colleagues, (Leydon et al., 
2000) demonstrated that not all patients wanted extensive information about their condition 
and treatment at every stage of their illness. However, patients undergoing surgery often 
experience considerable anxiety as a result of receiving too little information or information 
that they cannot fully understand (Krupat et al., 2000). 
It is now recognised that there are large variations in patients' need for and satisfaction with 
information. The qualitative pilot study (chapter 4) emphasised that cancer patients received (or 
retained) different amounts of information, and there were many aspects of the treatment and 
recovery that many patients were not prepared for. Moreover, there were differences in the 
amount of information that patients required. Some patients reported that they were not able 
to ask questions relating to non-medical factors during the consultation, for example, how their 
quality of life would be impacted after treatment. It has previously been reported that unmet 
informational needs and low satisfaction with information provided is related to unfavourable 
patient outcomes, such as, lower HR-QoL, higher levels of depression and anxiety (Edwards, 
1998; Mesters et al., 2001), and the use of maladaptive coping strategies. (Van der Molen, 
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1999) Therefore, it is clearly important to address unmet informational needs prior to 
treatment. 
Chapter 3 highlighted the possible role of pre-treatment expectations in the judgement of post- 
treatment outcomes such as HR-QoL and functioning (Iversen et al., 1998; Koller et al., 2000; 
Mahomed et al., 2002; Staniszewska, 1999; Wan et al., 1997). Evidence from studies such as 
these suggests that positive expectations are associated with better health outcomes in patients 
with a variety of clinical conditions. In addition, investigating the influence of pre-treatment 
information on the formation of post-treatment expectations, may assist with the targeting of 
appropriate interventions to enhance outcomes. 
6.2 OBJECTIVES 
The objectives of this preliminary study were firstly, to explore how satisfied patients were with 
the information given to them about treatment and to assess whether patients' ratings 
significantly changed after experiencing treatment. In addition, it was anticipated that key areas 
could be identified that could be recommended for improvement. The second objective was to 
investigate the extent to which satisfaction with information pre-treatment was related to 
psychological constructs such as particular beliefs about the illness and treatment. The third 
and fourth objectives were to examine the extent to which pre-treatment factors could predict 
satisfaction post-treatment and investigate the extent to which patients expectations were 
fulfilled after treatment. 
6.3 HYPOTHESES 
The following hypotheses were tested in this chapter: 
1) Ratings of satisfaction with information will be significantly worse after treatment has 
finished, than ratings of satisfaction prior to treatment. 
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2) Baseline psychological factors such as negative illness and treatment representations and/or 
the use of maladaptive coping strategies will be predictive of lower levels of satisfaction with 
information post-treatment. 
3) Lower levels of satisfaction with information pre-treatment will be associated with unmet 
expectations regarding the outcome of treatment and extent of recovery at one month post- 
treatment and longer term (6-8 months post-treatment). 
6.4 METHODS 
6.4.1 Design 
This chapter describes analyses using data from the prospective questionnaire based study. For 
further details see Chapter 5 for methods of data collection. 
6.4.2 Procedure 
Following patient consent, patients with a histological confirmation of carcinoma were 
consecutively recruited into the study. Eligible patients were recruited in the period between 
confirmation of diagnosis but prior to treatment. Data were collected from self-completed 
questionnaires and medical records. For further information on procedures see chapter 5. 
6.4.3 Measures 
The SCIP a new measure described in the previous chapter was used to assess the extent 
to which head and neck cancer patients were satisfied with information received about 
their treatment and the consequences of treatment. 
The Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2002) 
to elicit illness representations. 
0 The Beliefs about Medicine Questionnaire (BMQ) (Horne et al., 1999) subscales of 
Necessity and Concerns to measure treatment representations. 
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0 The Hospital Anxiety and Depression Scale (HADS) (Zigmond et al., 1983) to 
measure state depression and anxiety. 
" The Life Orientation Test - Revised (LOT-R) (Carver, 1997) to measure personality 
in the form of life orientation (dispositional optimism). 
" Brief COPE (Carver, 1997) to examine coping strategies. 
" Expectations: Three expectations regarding the experience of treatment and recovery to 
date were assessed at two time points: 1 month after treatment and 6-8 months after 
treatment. Two specific expectations were assessed: 1. Expectations regarding the 
treatment outcome (i. e. cosmetic and/or physical effects) and 2. expectations regarding 
the extent of recovery. One overall item was assessed measuring the extent to which 
expectations regarding the whole treatment and recovery period to date have been 
fulfilled. A higher score indicated that expectations had been met. 
For a more detailed description of the measures and the scoring procedures, refer to chapter 5. 
6.4.4 Participants 
The same sample as previous, consisting of eighty-two patients newly diagnosed with a cancer 
of the head and neck, were recruited at the pre-treatment stage. The socio-demographic and 
clinical characteristics of this sample of participants versus non-participants are described in 
this chapter. The following analyses also uses data derived from participants followed-up one 
month and six-eight months after treatment. The characteristics of these samples are described 
in more detail in a subsequent chapter (chapter 8). 
6.4.5 Statistics 
The following clinical and socio-demographic variables were dichotomised: Stage of cancer 
(early vs. advanced), marital status (living with partner vs. living alone), ethnicity (white vs. non- 
white) and highest qualification (none/O' levels vs. further education and above). Site of 
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cancer, treating hospital and type of treatment were dummy coded. In addition, stage of cancer 
was also used as an ordinal measure. Skewed depression scores were successfully transformed 
using a square root transformation (the transformed variable is used throughout the thesis). 
Both subscales of satisfaction with information were used in these analyses. Both subscales 
were non-normally distributed and attempts at transformation were unsuccessful. Therefore, 
where satisfaction with information was treated as the dependent variable (or outcome), non- 
parametric tests were conducted. 
In order to assess the associations between baseline clinical/treatment related factors, 
psychological factors and baseline levels of satisfaction with information, Spearman's rank 
correlation coefficients were conducted. 
In order to ascertain whether there were any predictive factors for low satisfaction with 
information either pre- or post-treatment, regression analyses were conducted. Although both 
subscales showed skewed distributions, subscale 1 was completely positively skewed and 
therefore was dichotomised into `high' and `low' satisfaction for use with logistic regression. 
Subscale 2 was more evenly distributed with a wide range of scores (see Appendix XVII) and 
therefore was suitable for use in linear regression models (with caution). The advantage being 
that the full range of scores would then be used. The two outcome measures of subscale 1 
(satisfaction with amount & content of information at two different time points) were 
dichotomised around the median values. Low satisfaction was coded 0 and high satisfaction 
was coded 1. Psychological predictor variables were all assessed pre-treatment. Stepwise 
methods of variable entry were chosen, for both linear and logistic regression, for exploratory 
purposes and as hypotheses were not explicitly theory driven. This method provides the best 
model to fit the data (Menard, 1995) and is the most appropriate for data consisting of small 
samples, however, as such it may not provide the best models to generalise from. A backward 
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stepwise method was used for variable entry into the logistic regression as it is preferable to a 
forward method. This is due to suppressor effects, which occur when a predictor has a 
significant effect but only when another variable is held constant (Field, 2000). Backward 
elimination is less likely to exclude predictors involved in suppressor effects and as such 
reduces the probability of making a type II error than forward methods. A conditional method 
removes variables according to criterion. 
Only factors which were established as significantly associated with satisfaction scores were 
entered into the regression models. Variables were entered in the regression analyses at p<0.05 
and removed from the model at p>0.10. 
Residual diagnostics from each of the logistic models were examined in order to determine the 
degree to which the models fitted the data and Hosmer-Lemeshow goodness-of-fit statistics 
reported. The Hosmer-Lemeshow goodness of fit test should be non-significant in order to 
conclude that the model fits the data to an acceptable level. Odds ratios (exp. B), 95% 
confidence intervals (95% Cl), standard errors and Wald statistics are reported for each 
variable. The Nagelkerke R2 statistic is also reported to give an estimate of the amount of 
variance predicted by the variables in each model, in addition to the model's coefficient which 
demonstrates whether the model is significant. Tests for linearity, homoscedasticity, 
multicollinearity, normality and independence of residuals from the linear regression models 
are also reported. 
Relationships between satisfaction with information pre-treatment and fulfilment of 
expectations post-treatment were assessed with point-biserial Spearman's rank correlation 
coefficients (as expectations regarding specific outcomes of treatment and extent of recovery 
are dichotomously scored) and Spearman's rank correlation coefficients for overall 
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expectations regarding the whole treatment and recovery period (see chapter 5 for more details 
on scoring items about expectations). 
The results section of this chapter is presented under four main headings (following a 
description of the study sample): 1) a description of levels of satisfaction pre- and post- 
treatment within the HNC sample; 2) the influence of clinical and treatment related variables 
and baseline psychological factors on pre-treatment satisfaction with information, 3) the 
influence of clinical and treatment related factors and pre-treatment beliefs on satisfaction with 
information post-treatment and 4) the extent to which pre-treatment levels of satisfaction 
predict whether expectations regarding treatment are subsequently fulfilled. 
6.5 RESULTS 
Sample characteristics 
The sample consisted of 82 newly diagnosed HNC patients, which represented a 76% 
recruitment rate. Table 6.1 provides a breakdown of patient demographics and clinical 
characteristics. In the sample, 66% of participants were male, which is typical of the disease, 
and age ranged from 23 to 89 years, with a mean of 60 (SD=13). The majority of the sample 
(92%) was white. A more detailed description of each of the psychological measures (means, 
medians, ranges etc) can be found in Chapter 7. 
Stage of disease was fairly evenly distributed with approximately half diagnosed with early stage 
disease (stages 1&2) and half with advanced stage disease (stages 3&4). Site of cancer was 
mixed but with the most common sites being tongue (ICD-10 C01&2) and larynx/ glottis 
(ICD-10 C32). 
There were no statistical differences in age, gender, ethnicity, stage and site of cancer, between 
those who took part in the study and those that did not. 
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Some of the reasons for non-participation in this baseline sample are known. Six of the 26 non- 
responding patients originally consented but failed to respond. Three additional patients felt 
they had too little time before treatment to take part. Two patients were inpatients at the time 
of diagnosis and felt too unwell. Two patients were known to be alcoholics. One patient was 
suffering from depression at the time and another said he was too nervous and anxious to help. 
Two responded that they did not want to help with research at all. Reason for non- 
participation in the remaining nine patients was not known. 
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Table 6.1: Socio-demographic and clinical characteristics of responders and non-responders 
Characteristic Responders Non- 
responders Test statistict 
n =82 n=26 
No. (%) No. (%) 
(; cndcr 
Male 54 (66) 16 (61.5) x'=(1.1 > i'-0.69 
1-einale 28 (34) to (38.5) 
Age (yrs) 
Mean (Sly) 59.9 (12.5) 63.1) (13.3) t(106) -1. u8; p=o 28 
Range 23-89 26-81 
l thnicity 
White 75 (92) 23 (89)* (: ramcr's V 0.17; 1) -0.21) 
Other 7 (8) 2 (8) 
Marital Status 
Single/ widowed/divorced 32 (39) 
Married /cohabiting 50 (61) 
1 lighest Qualification 
None 27 (33) 
GCSE/O' level 15 (18) 
GCI". /zA' level 11 (13) 
ligher education 10 (12) 
Degree or higher 16 (20) 
; JCC Stage of cancer 
Stage 1 19 (23)* 5 (19)* (: ramcr's V 0.10; 1) -0.96 
Stage 2 20 (24) 6 (23) 
Stage 3 12 (15) 5 (19) 
Stage 4a, b &c 26 (32) 8 (31) 
Stage dichotomised 
Early stage (1 & 2) 39 (47) 1 11 (42) CramWs \'=0.04; 1, -0.68 
Advanced stage (3&4) 38 (47) 13 (50) 
Treatment planned 
Surgery only (S) 22 (27) 
Radiotherapy only (R'1) 21 (26) 
S&R"1' 26 (31) 
WI' & Chemotherapy (C'! ) 9 (11) 
S&R'F&CI' 4 (5) 
Site of cancer (ICD-10 code) 
Lip (COO) 4 (5) 2 (8) 
Tongue ((: O1&2) 19 (23) 3 (12) 
Floor of mouth (C04) 12 (15) 6 (23) 
Palate (C05) 2 (2) 1 (4) 
Other& unspecified parts 4 (5) - CramWs A'=0.39; 1, =0.30 
of mouth (C06) 
Parotid/salivary gland ((, 07&8) 2 (2) - 
Tonsil (C09) 7 (9) 2 (8) 
Oropharynx (C10) 12 (15) 2 (8) 
Nasopharynx ((', 11) - 2 (8) 
Ilypopharynx ((: 13) 1 (1) - 
Laryngeal/glottic ((; 32) 17 (21) 5 (19) 
Skin (lion-melanoma) (C44) 2 (2) 1 (4) 
'T'hyroid (C73) - 1 (8) 
data missing/unobtainable 
t lndcpenrlcnt t-tests, Chit tests and Cramcr's V tests 
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6.5.1 A description of levels of satisfaction pre- and post-treatment within the HNC 
sample 
Scores on the Satisfaction with content and amount of information subscale were negatively 
skewed pre- (mean=9.9; SD=9.9) and post-treatment (mean=10.1; SD=4) with ranges of 14. 
The median score at both time points was 11. Scores on the Satisfaction with form and timing 
of information were more normally distributed with a pre-treatment range of 13 (mean=28.8; 
SD=3.5) and post-treatment range of 21 (mean=27.4; SD=5.1). 
Table 6.2 shows the number of pre-and post-treatment participants that reported that they had 
not received any information about areas related to treatment and recovery. 
6.5.1.1 Lack of information pre-treatment 
Pre-treatment perceptions of information provision demonstrated that many patients had not 
received (or could not remember receiving) information about a number of aspects related to 
their illness and treatment. One of the worst areas for receiving no information was about 
where to go for financial support or advice. The majority of participants in this sample (78%) 
were not given any information about financial support. In addition, approximately half of the 
sample reported they had not received any information about patient support groups for either 
themselves or a partner, or any information about what they should do if they experienced 
side-effects from the treatment. Approximately a third of patients reported that they had not 
been told how the treatment would affect their ability to work (35%) or whether there would 
be any long-term impact of the treatment on levels of functioning (32%). A large proportion of 
patients (43%) were also not made aware of how the treatment may affect their quality of life 
over the coming year. 
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Table 6.2: Number of participants who did not receive any informnation, based on SCIP 
items 
SCIP item 
Who to ask/where to go for 
financial support 
Patient support groups for you 
and your partner 
What you should do if you 
experience side-effects 
Whether your treatment 
interferes with other 
medications you may be taking 
I low your treatment may 
impact on our duality of life 
over the next year 
Whether you may need further 
treatment in future 
The effects of treatment on 
your ability to work 
\ti1tat the risks of you 
experiencing complications are 
The long-term impact of 
treatment on functioning 
I low long you expect recovery 
to take 
What the risks of you 
experiencing side-effects are 
\\iiether the treatment has any 
unwanted side-effects 
I low you may expect to feel 
immediately after treatment 
The effect of treatment on 
your appearance 


















Not supplied with any 
















6.5.1.2 back of information post-treatment 
Patients completed a repeat survey one month after treatment, after an appropriate time for 
information provision. Despite having undergone treatment, 60°%, of patients recruited at 
follow-up reported they had still not received any information regarding who to ask or where 
to go for financial support. I falf of the patients in this sample had not discussed how their 
QoL may be impacted over the next year, and a third (31%) had still not been informed of how 
treatment may affect their ability to work. Approximately a quarter of patients reported the' 
had not received any information on what the risks of experiencing complications had been 
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(25%) or what to do if they experienced side-effects (28%). The possibility of further treatment 
being needed in the future had not been discussed with 43% of patients and a third of patients 
(34%) had not received any information regarding support groups. 
From both pre- and post-treatment surveys of information provision, it appears that the areas 
most often discussed with patients were related to the more immediate physical effects of 
treatment. For example, the majority of patients reported that they had received information 
about how they might expect to feel immediately after the treatment (82-93%), whether the 
treatment had any associated side-effects (78-93%), and what the risks of experiencing these 
side-effects were likely to be (77-94%). Information about how treatment may have affected 
appearance was also discussed with more frequency (82-78%) than the topics outlined in the 
previous paragraph. 
6.5.1.3 `Is there any further information you wish you had received? ' 
A simple content analysis of the responses from the open ended question, `is there any further 
information you wish you had received? ' was conducted in order to investigate whether there 
were any key areas that had been omitted during the information giving process. The results 
from the pre- and post-treatment surveys are shown in Table 6.3. Fifty-two percent (n=43) of 
the pre-treatment sample reported they required no further information at the time compared 
with 31% of post-treatment patients, representing a reduction in `nothing required' of 21%. 
This indicated that after treatment, patients required more information or realised they were 
missing information in hindsight. These figures did not include patients who made no response 
(left the section blank). Many different topics were included as suggestions for further 
information. Pre-treatment patients (n=82) made 16 further suggestions for information 
provision compared to 28 suggestions by post-treatment patients (n=68) (patients may have 
made more than one suggestion). Areas for further information ranged from; more detail on 
the physical effects of treatment to more information on the long-term effects of treatment and 
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the likely length of recovery (see fable 6.3). It appears from this simple content analysis that 
patients were not fully informed before treatment of some of the spccific side-clfccts of 
trcatmcnt (both related to surgery and radiotherapy) and the severity of surgery. 
Table 6.3: Content analysis of open-ended item 26 (`further information? ) of the SCIP 
Content* Pre-treatment Post-treatment 
n=82 n=68 
nn 
Noms ponse (left blank 23 2O 
`Nothing required' 43 21 
Yes, more info needed (but not specified) 2 1 
More written information 2 1 
Information on Support groups 2 - 
More procedural detail/ further treatment 3 4 
Financial concerns 2 2 
Length of recovery 2 3 
Possibility of earlier diagnosis 1 - 
I. ong term prognosis/prognosis if treatment 
fails 
The name of my cancer I - 
Information on side-effects / specific side- - (, 
effects mentioned** 
More contact with staff/consultant/single - 4 
point of contact throughout 
Long term effects - I 
Severity of operation - 3 
General information regarding illness - I 
*Some participants gave more than one answer 
- e. g. numbness, effects on skin, soreness, no taste, shoulder problems, `dead area' after surgery etc. 
6.5.1.4 `Anything to add regarding the information you received? 
A second open-ended question was asked, `is there anything else you would like to add 
regarding the information you have received? ' The responses are tabulated in 't'able 6.4. The 
comments related to both positive and negative aspects of information giving and care 
received. The content of responses to this question related more to how the information was 
given and provided some support for the types of items included in subscale 2 of the SCIP (the 
form and timing of the information) originally derived from the qualitative interviews. The 
most frequent comments centred around `too little information given', and how the written 
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information was either lacking' or `too general'. Specific areas for improvement were given as; 
`nutrition', `stc c-effects and symptoms', `proccciures and diagnostic tests', 'support In the f(mn 
of Macmillan nurses and information about transport' and 'counselling from outside the 
medical profession'. Interestingly, no-one replied they had received too much information 
when surveyed after treatment. 











No responsc (left blank) 2} 
`Nothing to acid' 42 
`Yes' (not specified) I 
Too little information in general** 1) 
In addition to: 
More information on nutrition (disappointment in dietician) - 
More detailed information on side effects/ symptoms - 
Written information too general 
Received no written information 2 
Information regarding need for specific diagnostic tests I 
Too much information 1 
'l'iming: `Questions emerge slowly over time' 1 
Request that itifo re. R"1' to be given after operation 1 
Conflicting advice over procedures/ not enough information 2 
on procedures/ inconsistency 
Want counselling from outside medical profession 1 
Support provided not helpful 
Practical information on transport/ local hospice help/ - 
Macmillan nurses 
Positive responses about care received 4 
Some participants gave more than one answer 









Levels of patient satisfaction with information about treatment and the effects of treatment 
pre- and post-treatment, have been described in this section. The findings have highlighted a 
number of significant points. Firstly, although levels of satisfaction have been found to be 
skewed towards higher satisfaction, variability in levels does exist demonstrating that patients 
needs are complex and need to be addressed on an individual basis. Although the results 
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shown in table 6.2 do not directly represent perceptions of satisfaction for reasons discussed 
later, the findings highlight areas that are commonly not included when imparting information, 
but that could be considered essential for the well-being of the patient. For example, 
information about support groups either for the patient or the partner, the effects of treatment 
on the ability to work, where to go for financial support and how QoL may be impacted long- 
term were important areas reported to be lacking. 
Secondly, statistical analysis between pre-and post-treatment satisfaction scores (Chapter 5: 
Part 2) demonstrated a significant reduction in levels of satisfaction in key areas after treatment, 
as compared with scores at the pre-treatment stage. The qualitative aspects of this survey 
provide some support for this and highlight that patients' desire for information changes over 
time and particularly after experiencing treatment. 
6.5.2 The influence of clinical/treatment related factors and baseline psychological 
factors on pre-treatment satisfaction with information 
6.5.2.1 Uni-variate analyses 
The influences of baseline clinical, treatment related and psychological factors on satisfaction 
with information were investigated using the two subscales of the SCIP. None of the socio- 
demographic, clinical or treatment related factors were found to be associated with either of 
the satisfaction with information scales, excluding one particular site of cancer: the larynx 
(r=0.24; p<0.05). This uni-variate relationship was found to be positive, indicating that patients 
with cancer of the larynx were more likely to be satisfied with the form and the timing of the 
information given to them (Table 6.5). 
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Table 6.5: Correlation coefficients between pre-treatment satisfaction with information 
and socio-demographic and clinical/treatment related factors 
Variable Subscale 1: Satisfaction Subscale 2: Satisfaction 
with amount & content of with the form & timing 
information of information 
rr 
Socio-demographic factors 
\gc -ll. O( ns 
Gender -0.15 ns 
Marital status 0.02 ns 
}. thnicity -0.02 ns 
Qualifications -0.04 t1S 
Primary treating hospital 
& Si 'llu, mas' I fn>sl)ltals -0. (11 ns 
RO al Susses (aunty I IOshital -0.14 ns 
I nivcrsity College London I lospital 0.20 us 
The Royal Marsden O. 10 ns 
Clinical and treatment factors 
Stage Ot cancer (carly vs late) 0.01 ns 
Stage (ordinal) 0.02 ns 
Radiotherapy -0.01 ns 
Surgery -0.02 ns 
Chemotherapy 0.09 ns 
Site of cancer: I'll) -0.08 ns 
Tongue 0.0211s 
Floor of mouth -0.0911s 
Palate -0.01 ns 
Other sites in oral cavity 0.02 ns 
Parotid 0.02 ns 
'T'onsil 0.06 ns 
Oropharynx -0.17 ns 
I lypohharyns -0.05 ns 
Larynx 0.1811s 
Skin 0.1011s 
r= Spearman',, rank correlation coefficient 
ns= non significant; p<0.05 
Data in tables 6.5 and 6.6 based on approximately 78 patients due to missing data 
11.1)3 tis 
16 tis 
-O. (ll ns 
-0.20 ns 
-O. 11 ns 





















Table 6.6: Correlation coefficients between pre-treatment satisfaction with information 
and baseline psychological factors 
Variable Subscale 1: Satisfaction Subscale 2: Satisfaction 
with amount & content of with the form & timing 
information of information 
r 
Illness beliefs 
i 1ncs: iclcntitý -0.32** 
'1'1111clinc -0.05 11s 
C()nscytºcnccs -(1.13 ns 
C -clical dmclinc -0.19 is 
Personal control 0.29** 
Coherence 0.30** 
I"mo ti(mal representation -(l. lO ns 
Treatment beliefs 
Concerns -0.0511S 
Necessity (). ()1 ns 
Personality 
( )ptinn t11 O. lO ns 
Mood 
. 
Anxiety -0.03 ns 
Depression -0.06 tis 
Coping strategy 
'clt distraction 0.06 ns 
Active col)ltlg 0.11 ns 
Denial -0.16 us 
Substance Use -0.05 tls 
Using emotional support -0.06 ns 
Using instrumental support 0.14 ns 
Behavioural disengagement -0.1.1 ns 
Venting -0.05 ns 
+ve reframing 0.08 ns 
Planning 0.08 t)s 
1 lumour -0.20 us 
Acceptance 0. "06 ns 
Religion -0.27* 
Self-blame 0.02 us 
r= Spearman's rank correlation coefficient 
ns= non significant; *p<0.05; lp<0.01 





-(1.1(1 l is 
0.28* 
(). 17 gis 











0.16 ti s 








Significant correlation coefficients were found between pre-treatment satisfaction with 
information and baseline psychological factors (Table 6.6). In particular, illness and treatment 
beliefs were associated with both subscales. Three illness beliefs of: illness identity (r=-0.32; 
p<0.01), personal control (r=0.29; p<0.01) and coherence (r=0.30; p<0.01), were significantly 
232 
associated with satisfaction with the amount and content of information. The direction of 
coefficients indicated that patients with more symptoms, weaker beliefs in the personal 
controllability of their illness and those with a weak understanding of their illness, were less 
likely to be satisfied with information related to content and amount. Similarly, patients 
reporting weaker beliefs about the personal controllability of their illness (r=0.28; p<0.05) and 
the necessity of treatment (r=0.28; p<0.05), were also less likely to be satisfied with the format 
the information was supplied on and the timing. 
The only coping strategy which was significantly associated with levels of satisfaction on both 
subscales was the use of religion. The direction of coefficients indicated that patients reporting 
low levels of satisfaction, were more likely to use religion to cope (r=-0.27; p<0.05 and r=- 
0.29; p<0.01). Low levels of satisfaction with the form and timing of information provision 
were associated with feelings of self-blame (r=0.25; p<0.05). Therefore, patients reporting low 
levels of self-blame were less likely to be satisfied with that aspect of information. 
6.5.2.2 The explanatory value of pre-treatment factors on pre-treatment satisfaction with 
information 
For subscale 1, dividing the sample around the median, into those that were highly satisfied 
with information and those less satisfied, produced two fairly equal groups. Low satisfaction 
was indicated by scores 5 28, consisting of 57% of the sample (n=44). Table 6.7 shows the 
results of logistic regression. Findings indicated that only illness beliefs were significantly 
contributing to the overall regression model (R2=0.23; x2=13.83; df=2; p: _0.001). Individuals 
with strong illness identities were 20% less likely to be satisfied with the amount and content of 
information than those with weaker identities (OR=0.8; 95%CI: 0.7-1.0). Conversely, those with 
a good understanding of their illness (high coherence) were 30% more likely to be satisfied 
with the information received (OR=1.3; 95%CI: 1.1-1.6). Both of these representations 
accounted for 23% of the variance in satisfaction. 
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Fahle 6.7: Variables predicting pre-treatment satisfaction with information 
Outcome 1: Satisfaction with B SE Wald Exp (B) 95% (UI 
amount & content of information Lower Upper 
Beliefs 
Illness Identity 0.22 (1.111 4.96 0.8* 0.7 1.0 
1 )hcrcncc 0.26 0.11) '. I- 1.3** 1.1 I. 6 
Rz=0.23 
Model coefficient: X2 =13.83; df=2; p! 50.001 
Hosmer & Lemeshow Test: Xz =4.77; df=8; p>0.05 
t (A's have been rounded uh to I decimal place. 
Interestingly, the site of the tumour had a significant explanatory influence on satisfaction with 
the form and timing of information in the second (linear) regression model shown in 'f'able 6.8 
(. Adj. R2=0.22; I'=7.91; df=1,71; p<(). OOI). In addition, stronger beliefs in the necessity of 
treatment to health and perceptions that the illness was within personal control were predictive 
of higher satisfaction with information. "These three variables together accounted for 25'% of 
the variance in satisfaction with this aspect of information provision. 
Table 6.8: Variables predicting pre-treatment satisfaction with the form & timing of 
information 
Outcome 2: Satisfaction with form & Std 
timing of information 
Clinical factor 




Pcrson; II Control 0.25* 
R2 =0.25; adj. R2 =0.22; F=7.91; df=1,71 *** 
"p<U. US; .. p<U. Ul; ', 'p<U. UU1 
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6.5.3 The influence of clinical/treatment related factors and pre-treatment beliefs on 
satisfaction with information post-treatment 
6.5.3.1 Uni-variate analyses 
Age was found to be associated with satisfaction with the amount and content of information 
after treatment (r=0.29; p<0.05), however, none of the other socio-demographic factors were 
found to be related to either of the subscales (Table 6.9). Regarding clinical and treatment 
related factors, stage of cancer, in particular, having a lower stage tumour was associated with 
higher satisfaction with both aspects of information (r=-0.25; p<0.05 & r=-0.29; p<0.05). 
Incongruously, site of cancer was associated with satisfaction, but only with particular sites. 
Patients diagnosed with cancer of the floor of mouth were less likely to be satisfied with the 
amount and content of information than all other tumour sites (r=-0.26; p<0.05), and patients 
diagnosed with cancer of the oral cavity (excluding tongue, palate and FOM) were more likely 
to be satisfied with this aspect of information than patients with all other tumour sites (r=0.26; 
p<0.05). 
Several pre-treatment illness perceptions were found to be associated with satisfaction with 
information after treatment (Table 6.10). Illness identity was significantly associated with both 
aspects of satisfaction (r=-0.39; p<0.005 & r=-0.43; p<0.001) indicating that patients with 
stronger illness identities (reporting more symptoms related to HNC) were less likely to be 
satisfied than those with weaker illness identities. Patients with beliefs that the illness would last 
a long time (longer timeline perceptions) (r=-0.32; p<0.01 & r=-0.30; p<0.01), with high 
negative consequences to themselves (r=-0.25; p<0.05) were more likely to report low levels of 
satisfaction with information. 
Similar to the coping strategies found to be associated with satisfaction pre-treatment, religion 
was again related to both subscales of satisfaction after treatment. Coefficients were negative 
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indicating that paticnts reporting the use of religion as a coping strategy were again Icss likely to 
be satisfied with either aspects of information (r=-0.25; p)<O. O5 & r=-0.26-, 1p<O. U5). 
Table 6.9: Correlation coefficients between satisfaction with information post-treatment 
and socio-demographic and clinical/ treatment related factors 
Variable Subscale 1: Satisfaction Subscale 2: Satisfaction 
with amount & content of with the form & timing 
information of information 
Socio-demographic factors 
Age 




Primary treating hospital 
(; uv's & St f'hotnas' I lospitals 
Ronal Sussex Count)' I loshital 
University College London I lospital 












11. (17 tos 
0. (17 ns 
-U. 04 tis 
-0.11 ns 
-0.03 tis 
-1). 17 ns 
0.03 ns 
O? U ns 
(). l7us 
Clinical and treatment factors 
,, tage of cancer 





Site of cancer: 1.11 
Tongue 
Floor of tnouth 
Palate 














-0. l1 ns 
Oropharynx 0.08 ns 
I Iypopharynx -0.21 ns 
Larynx 0.16 
Skin - 
r= Spearman's rank correlation coefficient 
ns= non significant; *p<0.05; **p<0.01 

















Table 6.10: Correlation coefficients between pre-treatment psychological factors and 
satisfaction with information post-treatment 
Variable Subscale 1: Satisfaction Subscalc 2: Satisfaction 
with amount & content of with the form & timing 
information of information 
r 
Illness beliefs 
Illn, css identity -0.39*** 
l imclinc -0.32** 
(; onscyucn ccs -0.25* 
(; vclical timeline -0.03ns 
Personal control -0.03 ns 
(; olicrctuc/understanding 0.13 ns 
F motional rcpresentati<m -0.20 ns 
Treatment beliefs 
Concerns -U. 17 ns 
Nicccssity ll. 18 tis 
Personality (assessed at baseline) 
( )ptimism 0.07 ns 
Mood 
\nsicty A). 16 ns 
Depression -l). 19 tis 
Coping strategy 
Sclf distraction -0.05 Its 
Active coping 
0.07 tls 
Denial 0.004 ns 
Substance Use -0.20 us 
Using emotional support 0.01 ns 
Using instrumental support -0.02 ns 
Behavioural disengagement -0.08 ns 
Venting -0.001 ns 
+ve reframing -0.08 ns 
Planning -0.03 ns 




Self-blame -0.05 us 
r= Spearman's rank correlation coefficient 
ns= non significant; *p<0.05; * *p<0.01; ** lp<0.005; rn*p<0.001 









-U? 3 ns 
U. 1Gns 
-U. 02 n 
(l. 18 ns 





-O. O7 ns 
-0. O1 ns 









6.5.3.2 The explanatory value of pre-treatment factors on post-treatment satisfaction with 
information 
To assess how much of the variance in satisfaction with information was due to clinical or 
treatment related factors, such as: type of treatment; stage of disease and treating hospital, or 
the types of beliefs patients had about their illness and treatment, two regression models were 
conducted. In subscale 1, low satisfaction was indicated by scores <_ 28, which consisted of 
51% of the sample (n=32). 
Table 6.11 displays the results of logistic regression for the first subscale. Findings indicated 
that age, cancer site and illness beliefs were contributing to the overall regression model which 
accounted for 28% of the variance in satisfaction (R2=0.28; x2=13.67; df=3; p<0.005). However, 
the only significant pre-treatment explanatory factor of low satisfaction with information after 
treatment, was the representations patients had about the likely duration of their illness 
(OR=0.7; 95%CI: 0.6-0.9) and beliefs about the necessity of treatment (OR=0.8; 95%CI: 0.6-1.0). 
Patients who believed prior to treatment that their illness would last a long time were 20% less 
likely to be satisfied with information about the content and amount of information supplied, 
than those who believed their illness would last a short time. 
Similarly, perceptions of the illness timeline were predictive of satisfaction as assessed by 
subscale 2 (Table 6.12). The association was negative indicating that patients who believed 
prior to treatment that their illness would last a long time were also less likely to be satisfied 
with information about the form and timing of information supplied. In addition, patients who 
reported the use of religion to cope were less likely to be satisfied with this particular aspect of 
information. Together these two variables accounted for 20% of the variance in satisfaction. 
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Table 6.11: Pre-treatincnt variables predicting post-treatment satisfaction with amount 
and content of information 
Outcome: Satisfaction with 
amount & content of information 
B SE Wald Exp (l3) 95'%o C11 
Lower Upper 
Socio-demographic factors 
Age 0.05 0.03 3.58 1.1 1.0- I 1 
Clinical factors . 
, tnccr site: ( )thcr sites in oral cavity 8.10 29.29 (1.08 3292.7 
i(i) 
Beliefs 
I*imelinc (124 0.12 3.91 0.8* II. (0 l. n 
Rz=0.28 
Model coefficient: x2 =13.67; df=3; p<0.005 
Hosmer & Lemeshow Test: X2 =9.35; df=8; p>0.05 
*p- 0.05; **p<0.01; ***p<0.005 
('l's have been rounded up to I decimal place 
Table 6.12: Pre-treatment variables predicting post-treatment satisfaction with form & 
timing of information 
Outcome 2: Satisfaction with form & Std 
timing of information 
Belief 
l incline -0.31** 
Coping 
l "sr Ot Religion -0.26* 
R2 =0.20; adj. R2 =0.17; F=7.04; df=1,58 *** 
. P<U. O5; ``p<O. 01; . "[)<0.005 
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6.5.4 Are pre-treatment levels of satisfaction associated with the extent to which 
expectations regarding the outcomes of treatment and recovery are fulfilled, after 
treatment? 
It was hypothesised that lower levels of satisfaction with information pre-treatment would be 
associated with unmet expectations regarding the outcome of treatment and extent of recovery 
at one month post-treatment and longer term. Table 6.13 displays a summary of the three types 
of expectations assessed, with the degree to which patients thought these expectations had 
been met at two time points (1 and 6-8 months post-treatment). In order to ascertain whether 
the fulfilment of expectations was related to levels of satisfaction with information before 
treatment, correlations were conducted (Table 6.13). 
6.5.4.1 Fulfilment of expectations one month after treatment 
The majority of patients (65%) reported that their expectations regarding the physical and/or 
cosmetic outcome of treatment had either been the same or better than expected. Only 21% 
stated that their experiences had been worse than expected. Regarding expectations about the 
extent of recovery to date, 68% reported their experiences to be the same or better than 
expected. A quarter of patients stated that their recovery at one month post-treatment was not 
as they expected. Only a small fraction of patients reported having no expectations. A third of 
respondents reported that their overall experience of treatment and extent of recovery to date 
had not been as expected. Only about 10% of respondents felt that their experiences had been 
completely as expected. 
6.5.4.2 Fulfilment of expectations 6-8 months after treatment 
Ratings of the extent to which expectations had been met 6-8 months post-treatment were 
similar to those at one month. One slight difference could 
be found regarding expectations 
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about the cosmetic or physical outcome of treatment. More patients (49%) reported their 
experience at 6-8 months to be the same as expected. 
Correlation coefficients (Table 6.14) indicated that patients who reported lower levels of 
satisfaction with information on either of the subscales before treatment, were more likely to 
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The main objectives of this chapter were related to the assessment of patients' satisfaction with 
information given to them before treatment, in order to identify key areas for future 
improvement. In addition, investigating the determinants of satisfaction with information after 
treatment could assist with the targeting of appropriate interventions pre-treatment, with the 
aim of improving individual satisfaction and enhancing patient outcomes over time. 
6.6.1 The informational needs of HNC patients pre- and post-treatment 
In general patients were found to be satisfied with the information given to them pre- 
treatment, although variability existed within the distribution of scores. Despite this good level 
of satisfaction, the study demonstrated that many patients had not received information about 
many aspects of their life expected to be affected by their illness and treatment. One of the 
commonest areas neglected was where to go for financial advice. The majority of the sample 
(78%) was not given this information and although financial advice could be considered a `non- 
medical' aspect of care, treatment for HNC can last for many months and the financial 
repercussions can be severe if not expected. Recovery can also be lengthy and arduous, and 
return back to work is often delayed for many months after treatment has finished. More 
worrying were the results of the survey one month after treatment had finished. Of the sixty- 
eight patients who were recruited at one-month follow-up, 60% replied that they had still not 
received any information about financial support or where to go for financial advice. It could 
be argued that the NHS does not have a responsibility for providing information about the 
non-medical consequences of illness, however, patients could easily be informed of other 
organisations who could offer further advice or even simply advised that finances should be 
organised prior to treatment. 
Analysis of the open-ended questions, demonstrated that patients required more information 
after treatment. Whether this was as a result of not being provided the information prior to 
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treatment, or whether needs had changed is unknown. Key topics identified for future 
improvement included more information on the long-term effects of treatment and length of 
recovery. It also appears from comments that some patients were not fully informed of 
common side-effects of both surgery and radiotherapy and issues relating to the anticipated 
severity of surgery. These findings are supported by the qualitative pilot study presented in 
chapter 4 (involving a different sample of patients), in which it was demonstrated that patients 
were not always fully informed of the likely consequences of treatment and the likelihood of 
complications. 
Another key area for improvement was in the provision of information about support groups. 
over half of the current sample had not received any information about support groups prior 
to their treatment and a third reported the same one month after treatment. A report by The 
King's Fund (1997) found that many HNC patients did not know of the existence of support 
groups and that some professionals did not advertise support groups as patients did not ask for 
them (Edwards, 1997). Local support groups known specifically for HNC patients and partners 
exist at many of the recruiting sites, and information about these could be supplied regardless 
of whether patients explicitly ask or appear to have difficulties coping. 
Statistical analyses between pre- and post-treatment scores (chapter 5, part 2) demonstrated 
significant reductions in levels of satisfaction after treatment in key areas such as the 
usefulness, the detail and understanding of the information provided. The current analyses 
provided support that informational needs change over time and with experience of treatment 
(i. e. more information is generally required). Correspondingly, no participants replied that they 
had received too much information when asked after treatment. 
Recent publications have highlighted the mismatch between the type of information HCP's 
provide and what patients desire. Edwards (1998) found that HNC patients wanted to be 
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provided with more information about the impact of their treatment, whereas clinicians were 
reported as concentrating too much on the specific details of the operation. Mesters et al 
(2001) also provided support for this view in a larger scale study of 133 patients with HNC. It 
was suggested that although there was a high need for information about the disease and 
treatment (surgery) pre-treatment, more supportive information about access to help elsewhere 
and solutions was required which is in concordance with the present findings. Other authors 
have suggested that HNC patients need and want more written information (Semple et al., 
2002), similarly, Ramirez and colleagues, suggest that written detail about cancer and its 
management should reinforce and supplement information obtained from health professionals 
(Ramirez et al., 1994). 
6.6.2 The role of illness and treatment perceptions and coping mechanisms on 
satisfaction with information 
Multivariate analyses conducted to assess whether baseline factors could explain pre-treatment 
levels of satisfaction with information, demonstrated that illness beliefs alone explained 23% of 
the variance in satisfaction. Clinical and treatment related factors were not found to be 
significant explanatory variables. Patients with strong illness identities and those who did not 
have a good understanding of their illness were found to be less likely to be satisfied with the 
amount and content of the information provided at the time. Regarding the form and timing 
of the information, having cancer of the larynx, strong beliefs in the necessity of treatment to 
health, and perceptions that the illness was within personal control, were predictive of higher 
satisfaction. These variables accounted for a quarter of the variance in satisfaction with this 
aspect of information. It may be that patients diagnosed with cancer of the larynx were given 
more information due to the specific functional and emotional consequences of treatment to 
the throat and voice box. In addition, larynx cancer patients are generally referred to an Ear, 
Nose and Throat Department, which may supply information on a different basis to other 
units such as Departments of Oral Surgery. 
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Although patients in this sample were generally adherent to treatment, beliefs about the 
necessity of treatment have been found to be associated with adherence to treatment regimes 
and medication (Home et al., 1999). It is interesting and of importance to note that levels of 
satisfaction were related to perceptions of the need for treatment, indicating that those with 
weaker beliefs in the need for treatment were less likely to be satisfied with information. This 
alone has important implications for the provision of clear information before beginning 
treatment, but equally may have important implications for subsequent levels of adherence 
(especially with treatments requiring high levels of adherence such as chemo- and 
radiotherapy). 
Similar to the results from the cross-sectional analysis, baseline perceptions of timeline were 
also found to be predictive of satisfaction with information after treatment. Patients who 
believed their illness would last a long time were less likely to be satisfied with the information 
as assessed on both subscales. In addition, the use of religion as a coping strategy was 
predictive of lower levels of satisfaction with the form and timing of the information supplied. 
It was hypothesised that baseline psychological factors such as negative illness beliefs and the 
use of coping strategies would be predictive of lower levels of information post-treatment, 
therefore, this was rejected on the grounds that neither perceptions of a long time-line (in this 
case) and the use of religion as a coping strategy could be considered maladaptive. 
Due to the dynamic nature of beliefs resulting from the appraisal process, beliefs could feasibly 
change from diagnosis throughout the period of treatment. The current study focused on 
whether baseline beliefs would be predictive of levels of satisfaction after treatment. The 
implication of determining whether certain beliefs are related to satisfaction after treatment, lies 
in the identification of targets for preventative interventions. The direction of causation is not 
really known despite using longitudinal data, however, it is plausible that beliefs could be 
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modified through the provision of tailored information prior to treatment (see section 6.6.4), 
leading to higher levels of satisfaction with information after treatment and better longitudinal 
outcomes such as fulfilment of expectations and better emotional outcomes. 
6.6.2.1 Information as a coping strategy 
Although few direct relationships were found between coping and satisfaction with 
information, information seeking behaviour or need for information could be considered a 
coping strategy in itself. Information seeking is used as a means of coping with and reducing 
stress, however, as highlighted by the current study, individuals can still feel as if their needs 
have not been met (Van der Molen, 1999). In addition, as supported by present findings, 
identification of the type of information wanted, the amount and the circumstances, can be 
more difficult to elucidate than just whether information is available (Bagley-Burnett, 1992). 
Information could be conceptualised as a form of cognitive control as it allows patients to 
actively participate in their own care and decision-making. As the SRM stipulates, individuals 
use cognitive appraisal to evaluate the meaning of the health threat and to determine what 
coping resources are available to them to remedy the situation. The coping strategy used in 
response to the threat appraisal (in this case seeking information) is used to alter the 
relationship between the stressor and the individual's reaction to it. Consequently, seeking 
information and thus levels of satisfaction with information, could be considered a type of 
problem-focused coping strategy. 
The lack of a direct effect between coping strategies and levels of satisfaction with information 
may well have been due to the coping measure used, however it may have been because 
satisfaction with information scores reflect a different and unrelated aspect of coping, as 
mentioned previously. It may be that satisfaction with information mediates the relationship 
between the perceptions patients have about their treatment, and outcomes such as QoL or 
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anxiety/ depression. Chapter 8 examines the predictors of outcomes more closely to 
determine whether satisfaction with information is directly related to longitudinal outcomes. 
6.6.3 The relationship between pre-treatment satisfaction with information and 
fulfilment of expectations post treatment 
It was hypothesised that lower levels of satisfaction with information would be associated with 
unmet expectations after treatment. It was found that patients who reported lower levels of 
satisfaction before treatment, were more likely to have unmet expectations overall than patients 
who were satisfied with the information. This relationship was strongest at six-to eight months 
after treatment. It is plausible that patients who did not receive enough information before 
treatment may have had unrealistic expectations regarding the physical outcome of treatment 
and time needed for recovery. However, because these associations are uni-variate other factors 
such as levels of optimism may be influencing expectations, or that individual's that report high 
levels of satisfaction are more likely to report positive outcomes such as fulfilled expectations, 
for consistency. It is also worth noting that the items used to measure expectations have not 
been previously validated. 
A modest proportion (21-30%) of patients in the sample reported that their experiences had 
been worse than expected. Therefore, there is scope to reduce this discrepancy as much as is 
feasible (unforeseen complications not withstanding). One method, as previously suggested in 
chapter 4, could be through the provision of dear and relevant information. The fulfilment of 
expectations have been shown to exert significant effects on HR-QoL (Wan et al., 1997), as 
well as ratings of symptom severity and return to work (McCarthy et al., 2003). Therefore, it is 
of importance to ensure patients have a clear understanding of how their illness and treatment 
may affect them both short and longer term and to have achievable expectations. 
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6.6.4 Tailoring information to individual's needs 
Chapters 4 and 6 have highlighted that HNC patients have differing needs for information and 
thus have demonstrated variability in their levels of satisfaction. Written materials provided for 
HNC patients typically consist of generic information, often in the form of pamphlets or 
booklets and are designed for generic use amongst all patients with HNC. Although these 
materials are a cost-effective method for providing valuable information, it could be argued 
that their one-size fits all approach is not sensitive to the variation that exists between people in 
their desire for and understanding of information (Kreuter, Strecher, & Glassman, 1999). 
Satisfaction with information has been shown to be associated with particular patient beliefs 
(although the direction of causation is unclear) and has been shown to influence whether 
patient's expectations have been met after treatment. With this in mind and, as recommended 
by other authors (Newell et al., 2004; Semple et al., 2002), it would seem judicious to assess 
HNC patients needs for information on an individual basis. 
Research focusing on tailored communication interventions to change health behaviours can 
easily be applied to tailored information for patients undergoing treatment for cancer. Studies 
have shown that matching health education materials (HEM) or messages to patient's 
psychological characteristics (commonly style of coping) have been found to be more effective 
in promoting behaviour change in a wide range of areas than non-tailored materials (Bull, 
Kreuter, & Scharff, 1999; Holt, Clark, Kreuter, & Scharff, 2000; Prochaska, DiClemente, 
Velicer, & Rossi, 1993). In addition, tailored communications may also be appropriate for 
HNC patients post-treatment to address any functional and emotional difficulties they may 
have. However, more research is needed to address under what circumstances tailored 
communications are most and least effective. 
250 
Technological advances mean that highly customised materials can be designed for specific 
individuals. Materials could be tailored to multiple aspects of the individual, providing 
information that fits their lives better than generic materials currently used (Holt et al., 2000). 
Although this is a new area for providing health education messages, it could feasibly be 
applied for understanding patient's individual requirements for information instead of the 
professional providing information on the basis of what they think the patient wants to hear. 
6.6.5 Limitations 
The finding of a lack of information prior to treatment is perhaps not surprising as it is 
possible that some of the patients may have received information after completing the 
questionnaire on informational needs. Information is typically `trickled' down over time as a 
result of contact with different health care professionals. Due to contact with many different 
professionals at different sites, it has also previously been noted that this can be a source of 
conflicting information and omissions (Edwards, 1998). When collecting the data for the 
present study, an effort was made to only distribute questionnaires to patients on their second 
or third visit, despite the short time period between diagnosis and treatment. This was for a 
number of reasons, but primarily to ensure that patients had been seen by a consultant a few 
times in order to gain an understanding of their illness and treatment. 
The finding that clinical and treatment related factors had little value in explaining variance in 
levels of satisfaction with information could be for a number of reasons. Firstly, patients often 
have multiple treatments in different departments, sometimes in different hospitals altogether, 
leading to multiple information sources. This also serves to obscure the effects of particular 
treatments and particular hospital sites on satisfaction. In addition, as mentioned elsewhere, 
tumour stage was derived from a mixture of pre-treatment and post-treatment observations. 
Often during surgery, tumours are found to be more extensive than originally staged. It was 
difficult to get a `pure' sample of post-treatment tumour stages as many were missing from the 
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notes or pathology reports and therefore, the accuracy of the staging over all hospital sites is 
unknown. 
It is equally likely that the patients in the post-treatment group were skewed towards higher 
levels of satisfaction as they were probably feeling less ill than patients who dropped out of the 
study. In Chapter 8, there were significant differences in stage between the sample at 6-8 
month follow-up and the sample that dropped out. Unfortunately, it is not known how 
satisfied these patients were after treatment and it is likely that these patients are at higher risk 
of worse outcomes than those remaining in the study. 
Patient perceptions about the illness and treatment accounted for approximately 20-28% of the 
variance in pre- and post treatment levels of satisfaction with information. This amount of 
variance explained by beliefs is in line with reported variances of approximately 20% or less 
from other studies (Rutter et al., 2002; Rutter et al., 2003; Scharloo et at, 2000), however, these 
studies have explained outcomes such as QoL or functional status and not levels of 
satisfaction. In terms of providing interventions targeting beliefs based on these findings, it is 
worth noting that these results indicate that approximately three quarters of the variance in 
satisfaction is due to other unknown factors, such as, personality traits other than optimism, 
external factors such as interaction with staff, or satisfaction with the facilities. 
6.6.6 Conclusions 
In order to improve service provision and care, interventions could focus on providing better 
information about areas indirectly affected by illness, such as financial and social support, and 
consequences of the treatment long term. 
None of the clinical factors such as severity of cancer or treatment modality were found to 
influence satisfaction with information, however, beliefs and expectations were found to be 
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related to reports of satisfaction with information. Psychological aspects such as these, are 
however, open to modification unlike clinical related factors. Patient perceptions, in particular 
beliefs about the necessity of treatment, personal control, likely timeline of the illness and 
illness identity could be addressed through tailored interventions aimed at modifying these key 
perceptions and increasing levels of coherence regarding the illness and treatment overall. 
An additional positive aspect of enhancing patient satisfaction with information, by providing a 
good match between the provision of information and patients requirements, is the promotion 
of partnership between the patient and the health care professional. The need for good 
communication between health professionals and patients is emphasised in current NHS policy 
(NHS Centre for Reviews and Dissemination, 2000) and also serves to aid the decision making 
process by empowering the patient (Grahn, 1996). 
It has been suggested that low levels of satisfaction with information are associated with worse 
outcomes such as QoL (Yu et al., 2001), and this relationship has been preliminary explored 
during psychometric testing of the SCIP instrument (chapter 5 part 2). Further research to 
investigate whether pre-treatment levels of satisfaction with information are influential on long- 
term outcomes, such as QoL and depressive symptoms, is further investigated in chapter 8. 
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CHAPTER 7 
PRE-TREATMENT RELATIONSHIPS BETWEEN QOL MEASURES 
7.1 INTRODUCTION 
Chapter 2 demonstrates the wealth of literature published describing HR-QoL in HNC 
patients. However, studies of QoL in this patient group have made the assumption that a 
standard set of circumstances is required for optimal well-being, but measures of physical 
functioning, pain, psychological discomfort, social limitations and handicap do not take into 
account the fact that many patients may have come to terms with their limitations and 
consequently these areas of measurement may have little impact on levels of satisfaction or 
adaptation. Within this context, there has been little published on assessment of individualised 
QoL (i. e. how patients perceive their QoL with respect to areas most important to them) and 
how it compares with traditional measures. 
Standardised HR-QoL has been shown to vary with time and treatment modality (de Graeff et 
al., 2000a; Hammerlid et al., 1997b) but why those with similar stages of disease and treatment 
should experience different levels of quality of life is unclear. However, chapter 3 highlights 
that there is enormous variation in the ways patients adjust to illness and the nature of this 
adjustment may be crucial in determining psychological and physical health outcomes. In 
addition, this variation is not necessarily due to clinical factors such as illness severity. To gain a 
better understanding of how HNC and its treatment influences QoL, a theoretical framework 
is required. 
The Self-Regulation Model (Leventhal et al., 1980; Leventhal, Diefenbach, & Leventhal, 1992) 
provides a framework for understanding how patients perceive and adapt to a health threat, in 
this case, a cancer diagnosis and its treatment (see Chapter 3 for an in-depth discussion of this 
model). The framework suggests that four broad classes of factors influence patient 
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judgements and behaviour: the cognitive representation of the disease threat (i. e. the beliefs which 
patients have about their illness and treatment); the affective reaction (i. e. the emotional reaction to 
the illness); the coping mechanisms to deal with the health threat and the emotions elicited by the 
threat; and contextual factors such as social roles and cultural/ societal norms. 
There have been no published studies assessing the role of psychological factors on outcome 
from the perspective of HNC patient beliefs about the illness and treatment, and thus the main 
implications for this study were two-fold. Firstly, it was anticipated that the study would lead to 
a better understanding of the types of beliefs HNC patients had prior to treatment and 
demonstrate how these related to outcome. Secondly, potentially modifiable psychological 
factors found to be related to outcome could therefore be used as a basis for future 
intervention in order to maximise pre-treatment QoL. Specification of variables within the 
SRM framework lead to the development of hypotheses to test and further our understanding 
of QoL in patients with HNC. 
7.2 AIMS 
Therefore, this chapter seeks to address the issues outlined in the introduction. The results 
section has been divided into four parts relating to each of the main aims: 
1. To assess the extent to which measures of QoL are related to each other. 
2. To assess the extent to which psychological variables can explain different QoL outcomes: a) 
standardised HR-QoL and b) individualised QoL. 
3. To establish baseline levels of depression and anxiety in this sample of patients. 
4. To assess the extent to which psychological variables can explain levels of emotional 
adaptation (i. e. depression and anxiety). 
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7.3 HYPOTHESES 
The following null hypotheses were tested in this chapter: 
1: There will be no relationship between standardised assessments of HR-QoL and 
individualised QoL. 
2a: Illness and treatment beliefs will not explain a significant amount of variance in 
standardised HR-QoL. 
2b: Illness and treatment beliefs will not explain a significant amount of variance in 
individualised QoL. 
3a. Depression will not explain a significant amount of variance in standardised HR-QoL. 
3b. Depression will not explain a significant amount of variance in individualised QoL. 
4: Illness and treatment perceptions pre-treatment will not be associated with utilising adaptive 
coping strategies (e. g. active coping, positive reframing, planning, acceptance, use of emotional 
support and use of instrumental support) at baseline. 
5a. Illness and treatment beliefs will not explain a significant amount of variance in depression. 
b. Illness and treatment beliefs will not explain a significant amount of variance in anxiety. 
7.4 METHOD 
7.4.1 Design 
This chapter describes the results of analyses using cross-sectional data assessed at baseline 
(after diagnosis but prior to treatment). 
7.4.2 Procedure 
Following patient consent, patients with a histological confirmation of carcinoma were 
consecutively recruited into the study. Eligible patients were recruited in the period between 
confirmation of diagnosis but prior to treatment. Data were collected from self-completed 
questionnaires and medical records. For further information on procedures see chapter 5. 
256 
7.4.3 Measures 
Quality of life: 
EORTC QLQ-C30 (Aaronson et al., 1993). 
SF-12v2 (Ware et al., 2002). 
Patient Generated Index (Ruta et al., 1994). 
Psychological measures 
" IPQ-R (Moss-Morris et al., 2002) to elicit illness representations. 
0 BMQ-Specific (Horne et al., 1999) subscales of Necessity and Concerns to measure 
treatment representations. 
0 Brief COPE (Carver, 1997) to examine coping strategies. 
0 LOT-R (Scheier et al., 1994) to measure personality in the form of life orientation 
(dispositional optimism). 
" HADS (Zigmond et al., 1983) to measure state depression and anxiety. 
Full descriptions of these measures can be found in chapter 5, methodology part 1. 
Socio-demographic variables of. age, gender, socio-economic status, marital status and ethnicity 
were assessed as described in the methods section (chapter 5). Clinical factors such as site and 
stage of cancer, and treatment planning were also assessed as described in chapter 5. 
7.4.4 Participants 
A sample of eighty-two newly diagnosed HNC patients were recruited into the study prior to 
treatment (TI) out of 108 approached, giving approximately a 76% recruitment rate (see 
Methods: Table 5.1). 
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7.4.5 Statistical analysis 
QoL scores were standardised as per recommendations (see chapter 5). The following clinical 
and socio-demographic variables were dichotomised: Stage of cancer (early vs. advanced), 
marital status (living with partner vs. living alone), ethnicity (white vs. non-white) and highest 
qualification (none/ O'levels vs. further education and above). Cancer sites were dummy coded 
into variables of: lip; tongue; FOM; palate; parotid gland; tonsil; oropharynx; hypopharynx; 
larynx; skin and other. 
Relationships between individualised QoL and standardised HR-QoL measures were analysed 
using Spearman's rho correlation coefficients. Non-parametric correlations were used at this 
stage as some of the SF-12 and EORTC QLQ-C30 subscales were non-normally distributed 
and could not be successfully transformed. Main outcome variables (PGI, EORTC QLQ-C30 
Global QoL and SF-12 PCS & MCS) used in further analyses in this chapter could be 
considered normally distributed. 
Relationships between main outcome variables and independent variables were analysed using 
Pearson's product moment correlation coefficients and variables found to be significantly 
associated (p: 50.05) were entered into linear regression models using the Stepwise method. The 
stepwise method was chosen as most appropriate for statistically reducing the number of 
variables entered into the final model. Models were then re-run entering only significant 
contributing factors. Socio-demographic variables were entered first, followed by clinical 





"1'hc sample consisted of 92 newly diagnosed I INC patients (sec Chapter 6 for a detailed 
brcakdown of sample characteristics). 
Preliminary analysis 
7.3.1 Investigating the relationships between individualised QoI, and standardised I IR- 
QoL 
'fables 7.1 to 7.4 prescnt the mcans (SIB), medians and ranges for individualised OoI, and 
standardised measures of I IR-QoL. All domains proved reliable in this sample. 
Table 7.1: Mean (SD), median and range for individualised QoL (n=59) 
Patient Generated Index Mean (SD) Median Range 
4.27 (2.26) 4 u-1( ) 
Cronbach's alpha cannot be computed as overall Qol, only consists of 1 final score. 
Although scores on the PGI were within an acceptable range for a normal distribution, the 
mean and median values were slightly negatively skewed. The score is intended to represent the 
extent to which reality matches patient's expectations i. e. their perceived ( )ol,, in the areas of 
life that are most important to them. '1'herefore, values indicated that patient's functioning in 
the most important areas of life, was perceived to be on the low side (fable 7.1). 
Table 7.2 presents descriptive data for cancer specific I IR-QoL as measured by the l . ORTC 
QI, Q-C30. I ligher scores on the functioning domains indicate better pre-treatment Qol,. 
Unlike the scores for individualised QoL, all functional scales were positively skewed towards 
better functioning. Physical functioning scores were the highest and the most skewed indicating 
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that pre-trcatmcnt, patient's physical functioning was not very impaired. Despite this, mean 
scores for Global Qol and I? motional Functioning were found toi be the lowest. Als expected, 
mean values for general symptom scales and symptom items were low indicating that not many 
general symptoms were currently being experienced. 
'rabic 7.2: Means (SD), medians, range and Cronbach's alpha values for cancer specific HR-Qol 
EORTC QLQ-C30 Domain Mean (SD) Median Range Cronbach's at 
Global Qol, (n=82) 62.2 (23.69) 66.67 u 1011 ýLtt7 
Functional Domains: 
I'. motional Functioning (n=82) 65.48 (2'. 72) ,5 11 1(11) I(. 89 
Cognitive Functioning (n=82) 75.81 (28.47) 83.33 0 10(1 0.71 
Physical Functioning (n=81) 85.56 (18.87) 93.33 26.7111(1 0.78 
Social Functioning (n=82) 74.39 (27.24) 83.33 (I 100 0.70 
Role Functioning (n=80) 78.13 (30.88) 100 0100 (1.81 
Symptom Scales: 
Fatigue (n=81) 28.19 (26.73) 22.22 0-100 0.87 
Nausea and vomiting (n=81) 9.05 (19.37) 0 (1-100 0.86 
Pain (n=82) 25.41 (25.82) 16.67 0-100 0.81 
Symptom items: 
Dyspnoca (n=81) 16.05 (25.88) O 0-100 N/A 
Insomnia (n=80) 32.08 (34.14) 32.08 0-100 N/A 
Appetite loss (n=81) 27.16 (33.38) 0 0 100 N/A 
Constipation (n=82) 17.07 (28.32) 0 0-100 N/A 
lliarrhoca (n=82) 9.35 (21.77) 0 0-100 N/A 
Financial Difficulties (n=82) 32.52 (38.48) 16.67 0-100 N/A 
#Cronbach's alpha cannot be computed as symptom items consist of I it em uni . 
Similarly, the mean values for head and neck cancer specific symptom scales and symptom 
items (Table 7.3) were negatively skewed indicating that not many symptoms related to head 
and neck cancer were currently being experienced at that time. I lowever, the use of painkillers 
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was positively skewed indicating that high levels of painkillers were generally being used by this 
sample, which may have been responsible for negatively skewing specific and general symplon, 
'C ; Iles. 
Table 7.3: Means (SD), medians, range and Cronbach's alpha values for head and neck cancer 
specific HR-QoL 
EORTC QLQ-H&N35 Domain Mean (SD) Median Range Cronbach's a 
Symptom Scales (n=82): 
Pain 29.74 (25.1)2) 25 UI (((I 1). 78 
Swallowing 14.53 (21.11) 8.33 O 100 0.8.1 
Senses problems 12.2 (20.96) 0 0-83.33 ((. 7 
Speech problems 19.44 (22.9) 11.11 0 100 0.71 
Trouble with social eating 2)1.56 (26.58) 8.33 0-100 0.87 
Trouble with social contact 1(1.81 (18.01) (1 0 73.33 0.85 
Less sexuality' 28.89 (36.59) (1 (1 100 0.93 
Symptom items: 
Teeth (n=81) 16.05 (31.23) 0 0-100 N/A 
Opening mouth (n=82) 25.61 (34.47) 0 0-100 N/. 1 
Dry mouth (n=81) 23.05 (29.17) 0 0-100 N/A 
Sticky saliva (n=81) 15.64 (27.43) 0 0-100 N/A 
Coughing (n=82) 29.67 (27.72) 33.33 0-100 N/A 
Felt ill (n=82) 18.29 (25.74) 0 0 100 N/A 
Pain killers (n=81) 61.73 (48.91) 100 0-100 N/A 
Nutritional supplements (n=81) 22.22 (41.83) 0 0-100 N/A 
Feeding tube (n=81) 3.7 (19) 0 0-100 N/A 
Weight loss (n=81) 27.16 (44.76) 0 0-100 N/A 
Weight gain (n=81) 8.64 (28.27) 0 0-100 N/A 
Shoulder functions 9.45 (19.50) 0 0-75 N/A 
# Cronbach's alpha cannot he computed as symptom items consist of 1 item only. 
Data from 7 patients missing 
S I: xtra item added to yuestionnairc (see met hods chapter) 
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Table 7.4: Means (SD), medians, ranges and Cronbach's Alpha values for generalised II R-QoL 
(n=82) 
SF-12v2 Domain Mean (SD) Median Range Cronbach's a 
\lu"ni, il I Icalth 63.11 (23.73) 62.5 0 1000 0.75 
Role I? motional 75.61 (28.73) 87.5 0-10O 0.88 
Social Functioningt' 75.31 (29.71) 75 0-100 N/A 
Role Physical 69.82 (29.26) 75 0-100 0.9 
General Ilealth$ 60.12 (29.43) 60 I) 1U)) N/A 
Bodily Paint 74.7 (28.73) 75 O-100 N/A 
Vitalityt 50 (27.5) 50 0-1OO N/A 
Physical Functioning` 77.74 (29.14) 100 0-1O1) 0.79 
Mental Component Summary (\ICS)' 45.97 (11.72) 48.97 10 69 N/A 
Physical Component Summary (PCS)° 47.41 (10.22) 49.53 10-68 N/A 
t CronNich's alpha cannot be computed as domains only consist of 1 item. 
data from l person missing 
Regarding gencraliscd I high levels of functioning were also evidenced ('Table 7.4). 
Again, functional domains were positively skewed, in particular role emotional functioning and 
physical functioning. Vitality and mental health were found to be lowest but within the range of 
a normal distribution. Both the Mental Component Summary scores and Physical Component 
Summary scores were normally distributed after the removal of outliers. 
As shown in Table 7.5, standardised I IR-Qol, and individualised C)oI, measures were only 
partially correlated and therefore, the null hypotheses `there will be no relationship between 
standardised assessments of 11R-Qol, and individualised QoL' was rejected. The PGI was only 
significantly correlated with NOW1'C QLQ-C3() domains of. Global Qol, (r=0.39, p<0.005); 
Emotional functioning (r=0.38, p<0.005); Cognitive Functioning (r=0.39, p<0.005), and 
similarly with the SF-12 Mental Component Scale (r=0.44, p<0.001) and domains of Mental 
I Iealth (r=0.38, p<0.005); Role Emotional (r=0.47, p<0.001); Social Functioning (r=0.30, 
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1'<(). 115) and Role Physical (r=0.35, 'I'he two I IR-Qol, measures were highly 
correlated with each other as expected. 
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0.14 n/s 
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7.3.2 Relations between pre-treatment representations regarding HNC and treatment, 
QoL outcomes and coping strategy employed 
The majority of the scales had acceptable levels of internal reliability (Table 7.6). However, 
Brief COPE scales of self-distraction, use of instrumental support, behavioural disengagement 
and venting proved unacceptably low. As these scales only consist of 2 items each, deletion of 
unreliable items could not be conducted. 
Mean values indicated that levels of Illness Identity were low in this sample and perceptions of 
the consequences of the illness, the emotional representations and perceptions of illness 
coherence were fairly high at the pre-treatment stage. 
Beliefs about the necessity of treatment were very high in this sample, however, concerns about 
the treatment were a lot lower. 
The reported use of coping strategies was highest for active coping, use of emotional support 
and acceptance, all of which are considered adaptive coping strategies. The use of maladaptive 
coping strategies such as, substance use and behavioural disengagement, were reported as low. 
Levels of anxiety and depression were generally low, however, mean levels of anxiety were 
higher than levels of depression. 
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Table 7.6: Means (SD), mnedians, ranges and Cronbach's Alpha values for illness representations, 
treatment beliefs, coping strategies, anxiety, depression and optimism scores 
Psychological Factor Mean (SD) Median Range Cronbach's at 
lPQ-R subscale: - -- 
Illness Iticntity' (n =79) 3.95 (3.15) 3 0-12 N/, \ 
'T'imeline (n=81) 7.54 (2.52) 8 3-15 0.88 
(; onscyucnccs (n=81) 9.28 (2.68) 9 315 0.69 
1'inuline ()elical (n=79) 7.63 (2.68) 7 3-15 0.71 
Personal Control (n=80) 6.88 (1.70) 7 310 0.61 
Illness Coherence (n=81) 10.05 (2.97) 1() 3 15 0.78 
I: motional representations (n -80) 9.83 (3.1) 10 3 li (LAS- 
BMQ-Specific subscalc: 
\cccssity (n : 79) 21.05 (2.72) 20 14-25 0.75 
t: unrcrn: (n 80) 12.92 (3.16) 13 120 1). 75 
Brief COPE subscale (n=80): 
Self Distraction 4.16 (1.9) -1 28 0.53 
Active Coping 5.19 (1.9) 5 2-8 0.61 
Denial 3.53 (1.83) 3 2-8 0.76 
Substance Ilse 3.1 (1.85) 2 2-8 0.92 
I Tsc of I? motional Support 5.46 (1.98) 5 2.8 0.76 
L'sc of Instrumental Support 4.15 (1.62) 4 2-8 0.58 
lichavioucil l)iscngagcmcnt 2.61 (1.11) 2 2-6 0.29 
Venting 3.28 (1.51) 3 2-8 0.49 
Positive Rcframing 4.19 (1.98) -1 2-8 0.69 
Planning 4.65 (2.13) 4 2-8 0.78 
Ilumour 4.16 (2.21) 3 2.8 0.86 
Acceptance 6.25 (1.78) 7 2-8 0.62 
Religion 3.35 (1.83) 2 2-8 0.69 
Sulf-Blanc 3.73 (2.28) 3 2 1.1 (). 76 
I-LADS subscale (n=81): 
\nxicty- 7.89 (26.9) 7 0-20 0.89 
1)cpressiom 3.85 (3.45) 3 0-11 0.81 
LOT-R (n=78) 22.58 (4.88) 23 11-30 0.74 
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7.3.2.1 Assessing the extent to which psychological variables explain standardised I IR-Qol, 
Analysis indicated that the four different measures of I IR-QoL were explained by different 
factors. 'Cables 7.7 to 7.9 present the standardised betas for each of' the variables found to be 
significant contributors in each model. None of the clinical or sOciO-clcmogralphic variables, 
apart from age, proved significant explanatory factors for any of the variance in I IR-Qo1,. 
7.3.2.1.1 SF-12v2: Physical Component Summary (PCS) scores 
Illness Identity (II'Q-R), age and depression together explained 35""o of the variance in P(; S 
scores, with depression explaining the largest amount of variance (fahle 7.7). The direction of 
the coefficients indicated that a lower illness identity, younger age and lower levels of 
depression were associated with perceptions of better functioning on phwsical aspects of Ool .. 
Table 7.7: Explanatory factors of PCS 
Explanatory factor Std P 
IIIIICSs Identity (IPQ-R) -0.301 
Ucpression (IIA1)S) -0.37** 
; 1gc -0.25* 
Overall Model. - R` =0.38; adj. R"=0.35; 1, '=14.81; (#=3,73 ** 
"p<0.01, "P<0.005 
Although, this model proved highly significant (adj. R2 =0.35; F=14.81; df=3,73; p<0.005), 
again the distribution of standardised residuals from the PCS regression model plotted against 
standardised predicted values were not equal and therefore the model should be interpreted 
with some caution. 
7.3.2.1.2 SF-12v2: Mental Component Summary (MCS) scores 
Mental component scale scores could be significantly explained with a three-factor model 
consisting of depression, emotional representations and using substances such as alcohol and 
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drugs, as a coping strategy ('f'able 7.8). This model explained 54°/ of the variance in mental 
components of Qol. (udj. 1Z2=0.54; F; =31.21; d/=3,73; p<). OO5). 
Table 7.8: Explanatory factors of MCS 
Explanatory factor Std ß 
l )chression (I I; Al)S) -0.541' 
: m<)tional representation (I PQ-R) -()? 0* 
Substance Use ((; OPIý. ) -O. 17 
Overal Alode% R-'=O. 56; utlj. R' =0.54; l'=31.21; d/=3,73 ** 
'p<0.05, I'p<0. O05 
Relationships between variables were inverse, indicating that higher levels cat depression, 
stronger emotional representations and higher levels of reported suhstaiicc use were associated 
with poorer mental Oo1.. 
7.3.2.1.3 FORTC QLQ-C3() Global Qol, /health status 
A model with four factors significantly explained approximately 50° O of the variance in pre- 
treatment Global (dol. (Table 7.9). Perceptions of the illness lasting a long time, a strong illness 
identity, use of instrumental support such as getting advice from other hechle and high levels 
of self-blame were all associated with lower levels of global (. )()I, (adj. R' 0.48; 118.75; 
df=4,73; p<0.005). 
Table 7.9: Explanatory factors of Global QoL/health status 
Explanatory factor Std P 
Timeline (IPO-R) -0.201 
Illness Identity (IPQ-R) -0.38** 
Use of Instrumental Su pport (COP1? ) -0.25** 
Self-blame (COPE) -0.29* 
Overall Modek R-'=0.51; adj. R-'=0.48; F=18.75; dJ 4,73 
, p<0.05, "'p<0.005 
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It was hypothesised that illness and treatment beliefs would not explain a significant aºnOunt of 
variance in standardised I IRZ-`ol,, however, Illness Identity proved a significant explanatory 
variable of both the Physical Component Scale of the SF-12 and global OO1, of the I ý: ( )RTC 
OI, O-(; 3u. In addition, perceptions of the likely duration of the illness significantltiy impacted 
on global Ool,. Mental components of Ool, (as measured by the SIB-12) could be explained by 
the emotional representations patients had about their cancer. Beliefs about treatment were 
not, however, associated with pre-treatment I IR-Qol,. 
1'he null hypothesis that depression would not explain a significant amount of variance in 
standardised I IR-QoI, was also rejected, as a significant amount of the variance in both N ICS 
and PCS (SF-12) could be explained by depression. 
7.3.2.2 Assessing the extent to which psychological variables explain individualiscd Ool,. 
Anxiety was the sole explanatory factor remaining when entered into the tinal regression model 
(fable 7.10). 16% of the variance in 11G I scores could be explained by anxiety. The negative 
association indicated that higher levels of anxiety were associated with lower levels of 
individualised Qo1,. 
Table 7.10: Explanatory factor of individualised QoL 
Explanatory factor Std P 
_Anxiety 
(I LADS) -O. 42** 
Ovvera/lMllodel. " R =0.17; a¬ R' =O. /G; l 10.61; d/=1,57 ** 
e+p<p. 005 
It was hypothesised that illness and treatment beliefs would not explain a significant amount of 
variance in individualised QoL. "I'his was accepted as only anxiety proved to be a significant 
explanatory variable prior to treatment. 
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There were no significant relationships between personality (LOT-R) and any of the outcome 
measures or socio-demographic factors (p>0.05). 
7.3.2.3 The relationship between pre-treatment illness and treatment representations and 
coping 
Table 7.11 presents the correlation coefficients between illness and treatment representations 
and coping strategies used. Patients with more negative perceptions regarding the 
consequences of the illness were more likely to use emotional support (r=0.24; p: 50.05) and 
planning strategies (r=0.32; p! 50.01) in order to cope with the illness. Beliefs about the extent of 
personal control over the illness were also positively associated with planning strategies 
(r=0.25; p: 50.05) and active coping (r=0.27; p: 50.05). 
This indicated that patients who had 
strong beliefs about the personal controllability of their cancer were more likely to cope by 
devising strategies to deal with the problem and taking action. 
Emotional representations were also positively related to active coping (r=0.29; p<0.01) and 
positive reframing (r=0.25; p<0.01), therefore the stronger the emotional representations of 
the illness, the more likely the patient would engage in taking action to address the stressful 
situation or try to think of something beneficial to come out of the situation. 
Beliefs about the necessity of treatment were positively associated with active coping (r=0.31; 
p! 50.01) and use of emotional 
support (r=30; p: 50.01), whereas strong concerns about 
treatment were related to more positive reframing (r=0.26; p: 50.05). 
It was hypothesised that more negative pre-treatment illness and treatment perceptions would 
not be associated with utilising adaptive coping strategies (e. g. active coping, positive reframing, 
planning, acceptance, use of emotional support and use of instrumental support) at baseline'. 
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This was rejected. However, it is also worth noting that more maladaptive coping styles were 
also positively associated with more negative illness and treatment perceptions than the 
adaptive coping strategies outlined above. For example, higher levels of denial, substance use 
and venting were associated with perceptions of more negative consequences, greater concerns 
regarding treatment, and a greater emotional response to the illness. High levels of denial were 
also associated with lower levels of understanding (coherence) regarding their illness. 
There were no significant relationships between optimism (LOT-R) and coping strategies used 
(p>0.05). However, significant relations were found between optimism and IPQ-R Timeline 
(r=-0.24, p<0.05) and Personal Control (r=0.27, p<0.05), indicating that patients with higher 
levels of dispositional optimism had strong perceptions of personal control and beliefs that 
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7.3.3 Baseline levels of depression and anxiety 
Pre-treatment levels of anxiety and depression in this patient group were cstahlishc(i in order to 
be able to compare and control for this in later analyses. 
Hic cut-off score for a possible case of depression using the I I: AOS is 9 to IO (inclusive) and 
>I() points for probable depression. 
Table 7.12: Pre-treatment levels of depression and anxiety in sample of I INC patients 
HADS domain Within normal limits Possible clinical case Probable clinical case 
n (%) n (%) n (%) 
Anxiety \[alc 30 (56) 1() (18) I1 (26) 
Female 13 (48) 4 (15) 1() (37) 
'Total 43 (53) 14 (17) 24 (30) 
Depression \lale 44 (82) 8 (14) 2 (4) 
Female 21 (78) 4 (15) 2 (7) 
Total 65 (80) 12 (15) .1 (5) 
Levels of anxiety were reported to be higher than levels of depression prior to treatment, with 
47"o of the sample scoring within the limits for possible or probable clinical anxiety, but only 
2U' o scoring within the same limits for clinical depression. Independent samples t-tests 
indicated there was no significant gender difference between depression scores 
(t(79)=0.19, p>0.05) or anxiety scores (t(40.45)=-1.11, p>0.05). 
7.3.4 Depression and anxiety as outcome measures 
I)ue to the complex and dynamic relationship between depression and Qol, (discussed in 
chapter 2 part 1) it was decided that it would be informative to investigate what factors (aside 
from QoI, ) could explain variance in patient's levels of depression and anxiety. 
Approximately 50% of the variance in depression scores could be explained by anxiety, 
perceptions of illness identity and maladaptive feelings of self-blame (adj. R- =053; 1`=30.? 8; 
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dý=3,74; 1)<0.005). The relationship bctwccn these three variables and depression was positive 
indicating that higher scores on these measures were associated with lii ; her levels o depression 
('l'abte 7.13). 
Table 7.13: Explanatory factors of depression 
Explanatory factor Std P 
. 
Anxicty (I LADS) 0.461' 
Illness Identity (IPQ-R) 0.32* 
Self-Blame (COP! ) 0.20* 
Orerall, llode% R-'=O. 55; adj. R2 =0. >3; F= 30.28; d/=3,74 ** 
-1) -- 0.07, *, hG). 005 
A model consisting of emotional representations, depression, and the maladaptive coping 
strategies of venting and self-distraction explained 67% of the variance in pre-treatment anxiety 
(Table 7.14). ? motional representations of the illness explained the most variance and the 
direction of the coefficient indicated that stronger emotional representations were associated 
with higher levels of anxiety. 
Table 7.14: Explanatory factors of anxiety 
Explanatory factor Std 
I : motional rcprescntation (1PQ-R) 0.461 
I)cpression (1 IADS) 0.31** 
Venting (COPFI) 0.19* 
Self-Distraction (COPI? ) 0.15* 
OverallMoiel. " R- =0.69, aai. R2 =0.67; t'=, 10.07; d/=4,73 
, p<0.05, "p<0.005 
Similar to the Q0L models, the models of depression and anxiety also proved highlNI significant 
at p<O. 0O5, however, the distributions of standardised residuals from each regression model 
plotted against standardised predicted values were not normal and therefore these results also 
need to be interpreted with caution. 
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Null hypotheses 5a and b were subsequently rejected, as Illness Identity and emotional 
representations were significant explanatory variables of anxiety and depression. Treatment 
beliefs did not explain a significant amount of variance in pre-treatment anxiety or depression. 
7.4 DISCUSSION 
Although standardised (or traditional) HR-QoL measures are often used with HNC patients 
within a clinical setting, it has been suggested that they fail to capture the individual's sense of 
`quality of life'. This is because they focus on the individual's perception of QoL but only 
related to pre-selected domains. In contrast, patient generated outcome (individualised QoL) 
attempts to capture aspects of QoL that are most important to the individual at that particular 
time point. Given the interest in the use of individualised measures in clinical trials (Campbell 
et al., 2000; Patel et al., 2003) and with cancer patients in general (Camilleri-Brennan et al., 
2002; Lindblad, Ring, Glimelius, & Hansson, 2002; Waldron, O'Boyle, Kearney, Moriarty, & 
Carney, 1999), the use of patient reported outcomes could be beneficial in the area of HNC. 
There have been no published studies assessing the individualised QoL of HNC patients, 
therefore, little is known about how it compares with standardised HR-QoL. 
In the present study it was hypothesised that there would be no relationship between 
standardised assessments of HR-QoL and the individualised measure of QoL due to their 
conceptual differences. The results of our study suggest that there is partial overlap between 
these measures and that the main overlap appears to exist between individualised QoL and the 
cognitive, emotional and mental health QoL domains of the standardised measures. Therefore, 
the first null hypothesis was rejected. 
In contrast to our results, the PGI has been found to be more related to physical aspects of 
HR-QoL in other patient groups. For example, in a study of severely disabled patients with 
multiple sclerosis, results indicated that QoL as assessed by the PGI was dependent upon a 
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person's level of physical ability, as opposed to an alternate patient-centred measure (the 
SEIQoL) which appeared to be more related to feelings of health and vitality, (Lintern et al., 
2001) similar to the PGI in our study. 
The PGI has been found to be more responsive to change than the SF-36 and the EORTC- 
QLQ-C30 in surgical patients with rectal cancer (Camilleri-Brennan et al., 2002) and thus may 
prove to be a more meaningful assessment tool for the outcome of patients with cancer. 
The Self-Regulation Model (Horne et al., 1999; Leventhal et al., 1980; Leventhal et al., 1992) 
proposes that in response to a health threat, such as the diagnosis of cancer, individuals 
develop their own beliefs and emotional responses about their illness and treatment, which 
then influence the coping procedures they adopt. These beliefs, emotional responses and 
coping strategies then influence the outcome, which, in this study, were perceptions of QoL. 
As this is a constant process of reappraisal, patient beliefs and coping strategies may change 
over time. In the present study, a significant amount of variation in pre-treatment HR-QoL 
could be explained by patient's perceptions of their illness and treatment and by the coping 
strategy used. In particular, patients' Illness Identity (the amount of symptoms attributed to their 
HNC) and beliefs about the likely Timeline (perceptions about the length of time the illness 
would last) explained a significant amount of variance in HR-QoL and Global QoL. Therefore, 
null hypothesis 2a was rejected. 
However, surprisingly, it was found that components of the SRM could not explain any of the 
variance in individualised QoL. Individualised QoL was only associated with the emotional 
response to the illness in the form of anxiety levels, therefore, hypothesis 2b was accepted. It 
may be that individualised measure at baseline was tapping into an overriding anxiety due to 
the recent diagnosis with cancer. 
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In addition, coping was related to QoL in the present study. In particular, the use of more 
adaptive strategies, such as positive reframing, was associated with better QoL, and 
maladaptive strategies such as substance use and self-blame were associated with a worse QoL. 
Previous research has highlighted the relationship between the HR-QoL functional domain and 
coping. For example, Hassanein et al., (2001) found associations between worse functioning as 
measured by the University of Washington Quality of Life Questionnaire (Hassan et al., 1993) 
and ineffective coping styles, such as helplessness & hopelessness, anxious preoccupation and 
fatalism (Hassanein et al., 2001). List et al., (2002) found that maladaptive coping strategies of 
cognitive escape-avoidance (i. e. sleeping more than usual) and behavioural escape avoidance 
(not seeking help or waiting before taking action) were related to poorer global QoL (List et al., 
2002). 
As expected, depression explained a large amount of variance in HR-QoL, which is consistent 
with previous research (de Graeff et al., 2000b; Hammerlid et al., 2001b). However, it is 
interesting to note that variance in patient generated QoL was not explained by depressive 
symptoms. Items included on HR-QoL instruments include depressive symptoms and, 
therefore, it is not surprising if overlap with the RADS is found. Despite this, the relationship 
between physical symptoms, depression and QoL is far from understood and it is possible that 
this relationship is moderated by individual factors such as personality. Further research is 
needed to unravel these relationships. 
In contrast to previous research (Aarstad et al., 2003; Allison et al., 2000), personality was not 
found to be an important explanatory variable of QoL in this study. This may have been due to 
the measure used or may have been due to personality exerting an influence indirectly via 
beliefs. Indeed significant relations were found between optimism and beliefs about the 
timeline and personal controllability of the illness, indicating that patients with higher levels of 
dispositional optimism had strong perceptions of personal control and beliefs that their illness 
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would not last a long time. This is in line with discussions that personality is potentially 
influential in the formation of cognitive representations (Diefenbach et al., 1996). 
Levels of anxiety were reported to be higher than levels of depression prior to treatment, with 
47% of the sample scoring within the limits for possible or probable clinical anxiety, but only 
20% scoring within the same limits for clinical depression. There was no significant gender 
difference. Levels of depression in the literature have been shown to vary considerably (see 
Chapter 2), however, levels in the present sample were found to be similar to pre-treatment 
levels reported in both cross-sectional and prospective designed studies (D'Antonio et al., 1998; 
de Graeff et al., 2000b). It is possible, however, as levels have been reported as higher in the 
literature (Birkhaug et al., 2002; Duffy et al., 2002)that the sample is not representative of all 
patients with HNC and that patients with higher levels of depression did not take part. 
7.4.1 Limitations 
The main limitation of this study is its cross-sectional design. This means that no inferences 
can be made about the causal direction with which variables are exerting an influence on the 
other. In addition, the models were not stable indicating that they may not be generalisable 
outside of this data set. 
7.4.2 Implications 
Despite these limitations, the findings are potentially relevant to clinical practice. Clinicians 
could gain a better understanding of their patients' views about their illness and treatment, 
which would promote a better clinician-patient partnership. Our findings suggest that the 
illness and treatment perceptions approach, as used in this study, could be a useful method for 
eliciting and understanding patients' particular beliefs regarding HNC and its treatment. 
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In order to maximise post-treatment QoL and psychological adaptation, simple interventions 
could therefore address particular beliefs such as treatment concerns and the time scale of the 
illness, and focus on fostering more adaptive coping strategies such as acceptance and the use 
of emotional and instrumental support, whilst avoiding maladaptive coping strategies, such as 
self-blame and substance use. This may be achievable through cognitive-behavioural therapy or 
patient counselling aimed at altering the negative beliefs about the treatment and course of the 
illness whilst encouraging a sense of control over the illness. Other methods of coping such as 
seeking social support and accepting the situation could be offered as alternatives to avoidance 
coping such as self-blame and using substances such as drugs and alcohol. Friends and family 
could be involved if acceptable to the patient and practical. Since recent research has indicated 
that an approach focusing on illness perceptions can be successfully adopted to improve 
recovery in post- MI patients, (Petrie, Cameron, Ellis, Buick, & Weinman, 2002) this offers a 
very promising and novel way for improving QoL. 
7.4.3 Further research 
The patterns that have emerged from these preliminary cross-sectional analyses need to be 
confirmed longitudinally. Longitudinal data would give more insight into the causal relationship 
between variables, something that cross-sectional studies do not allow. 
7.4.4 Conclusions 
The results from these pre-treatment cross-sectional data have shown that key components of 
the SRM were explanatory factors of outcomes such as HR-QoL, depression and anxiety. 
Individualised QoL was partially correlated with HR-QoL measures, in particular, emotional 
and mental health HR-QoL subscales. This outcome measure was not however, found to be 
associated with any of the components of the SRM. 
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CHAPTER 8 
THE PREDICTIVE FACTORS OF LONGITUDINAL QOL: A REPEAT 
MEASURES STUDY 
8.1 INTRODUCTION 
The previous chapter assessing cross-sectional pre-treatment relationships, demonstrated that a 
number of illness representations and coping strategies were associated with outcomes such as 
HR-QoL, and depression and anxiety. However, surprisingly it was found that components of 
the SRM, emotional outcomes aside, could not explain any of the variance in individualised 
QoL. Individualised QoL was only associated with the emotional response to the illness in the 
form of anxiety levels. 
Although not much is known about how the beliefs of HNC patients relate to longitudinal 
outcomes such as QoL, research with other illness groups demonstrates that patient beliefs, in 
particular having a strong illness identity, perceptions of the negative consequences of the 
illness and chronic timeline beliefs, are related to worse HR-QoL and emotional distress (see 
chaptei 3). The literature also demonstrates that patient beliefs may be more predictive of 
outcomes than coping mechanisms (chapter 3), and that beliefs and outcomes change over 
time (chapters 2 and 3). Therefore, a longitudinal study was essential in order to determine 
whether the relationships between key components of the SRM and outcomes found at 
baseline were similar to those shown over time. The findings from this longitudinal study could 
have implications for both the need for longitudinal assessment and for informing the 
development of interventions to maximise longitudinal outcomes, at an earlier stage. 
Furthermore, if components of the SRM were found to be predictive of the extent to which 
expectations were perceived by patients to be fulfilled after treatment, then this could also have 
implications for the targeting of interventions. Realistic goal setting is related to adequate 
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information regarding the risks, benefits, alternatives and outcomes of treatment especially in 
terms of expected functional ability (Calman, 1984b), therefore, any common areas pinpointed 
to be worse than expected could be focused on for future information provision and increased 
attention. 
8.2 RESEARCH QUESTIONS 
Four main objectives or research questions were proposed for this chapter: 
1) To what extent are components of the SRM predictive of longitudinal outcomes? 
2) What factors are predictive of fulfilment of expectations after treatment? 
3) Is there any evidence for response shift occurring between baseline and follow-up at T3? For 
example, does reprioritisation (of QoL domains) occur between diagnosis and 6-8 months after 
treatment? Is reprioritisation associated with improvement in QoL over time? 
4) To what extent are baseline factors predictive of drop-out at T3? 
8.3 HYPOTHESES 
The following null hypotheses were tested in this chapter: 
1) Illness and treatment perceptions assessed at baseline will not explain a significant amount of 
variance in longitudinal outcomes of: 
a) Standardised HR-QoL, 
b) Individualised QoL 
c) Depression 
d) Anxiety 
2) Fulfilment of expectations after treatment will not be predicted by illness or treatment 
perceptions assessed at baseline. 
3) There will be no evidence for response-shift occurring between baseline and follow-up as 
measured by reprioritisation of QoL. 
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4) There will be no difference in baseline characteristics (socio-demographic and treatment 
related, or psychological factors) between patients who drop out of the study at T3 and those 
that do not. 
8.4 METHODS 
8.4.1 Design 
This chapter describes analyses using data from the prospective questionnaire based study at all 
time points. Longitudinal analysis focuses on baseline (T1) and 6-8 month follow-up (T3) data. 
(For further details see chapters 6 and 7). 
8.4.2 Procedure 
Procedural details can be found in chapter 5 part 1. 
8.4.3 Measures 
8.4.3.1 Outcome measures 
HR-QoL and individualised QoL: 
0 EORTC QLQ-C30 (Aaronson et al., 1993). 
" SF-12v2 (Ware et al., 2002). 
0 Patient Generated Index (Ruta et al., 1994). 
Emotional outcomes: 
" HADS (Zigmond et al., 1983) to measure state depression and anxiety. 
8.4.3.2 Predictive factors: 
0 IPQ-R (Moss-Morris et al., 2002) to elicit illness representations. 
0 BMQ-Specific (Horne et al., 1999) subscales of Necessity and Concerns to measure 
treatment representations. 
0 Brief COPE (Carver, 1997) to examine coping strategies. 
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LOT-R (Scheier et al., 1994) to measure personality in the form of life orientation 
(dispositional optimism). 
0 SCIP (see chapter 5 part 2) to measure satisfaction with information. 
" Expectations ratings (see chapter 5 part 1), to assess the extent to which patients 
expectations had been met post-treatment. 
Full descriptions of these measures can be found in chapter 5, methodology part 1. 
Socio-demographic variables of. age, gender, socio-economic status, marital status and ethnicity 
were assessed as described in the methods section (chapter 5). Clinical factors such as site and 
stage of cancer, and treatment planning were also assessed as described in chapter 5. 
8.4.4 Participants 
A sample of eighty-two newly diagnosed HNC patients were recruited into the study prior to 
treatment (T1) as described previously in chapters 6 and 7. One month after treatment had 
finished (T2), sixty-eight patients (83% retention rate) completed the first follow-up 
questionnaire. Six to eight months after treatment (T3), fifty patients completed the last follow- 
up questionnaire (61% retention rate). The socio-demographic and clinical characteristics of 
follow-up samples are described in this chapter. 
8.4.5 Statistical analysis 
Preliminary analysis 
To test for differences between measures at baseline and at follow-up assessments, within 
subjects ANOVAs (for repeat measures) were conducted, with plots of the mean values at each 
time point. Boxplots were obtained to check for extreme cases and any present were removed 
prior to ANOVA testing. Mauchly's test of sphericity between scores were conducted to test 
for homogeneity of covariance (Mauchly's test should be insignificant for sphericity to be 
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assumed). Where significant differences were shown, paired-sample t-tests were then conducted 
to further investigate the differences. Kruskall-Wallis tests were used for non-parametric data. 
For clarity, further analyses have been divided into four sections relating to each research 
question. 
8.4.5.1 Methods of analysis to investigate predictors of long-term QoL 
To test the associations between explanatory variables measured at baseline (T1) and 
longitudinal outcomes assessed 6-8 months post-treatment (T3), cross-lag correlations were 
conducted. In order to assess a range of outcomes encompassing: HR-QoL, individualised 
QoL and emotional outcomes, six outcome variables were used throughout these analyses. The 
EORTC QLQ-C30 global QoL score, SF-12: PCS and MCS scores were used as markers of 
HR-QoL, PGI scores for individualised QoL, and depression and anxiety scores for markers of 
emotional outcomes. 
Multiple regression analyses using the stepwise method for variable entry were conducted for 
each outcome variable, entering factors found to be significantly associated with outcome from 
the cross-lag correlations. Entry of variables and diagnostics were performed as described 
previously. 
8.4.5.2 Analysis to determine whether factors are predictive of fulfilment of expectations after 
treatment 
The three items assessing the extent of fulfilment of expectations 6-8 months after treatment 
were used in this analysis. Items assessing the fulfilment of expectations regarding the outcome 
of treatment and the extent of recovery were dichotomised into groups reporting their 
experiences to be `worse than expected' (scored 0) and `better' or the `same as expected' 
(scored 1). Data from patients reporting `no expectations' were not used in this analysis. The 
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item assessing expectations regarding the overall treatment and recovery period to date was 
used as an ordinal outcome measure scored 0 to 3. Point biserial cross-lag correlations were 
conducted between expectations one and two and baseline predictive factors. Any factors 
found to be significantly correlated were entered into regression models. A backward 
conditional method was used for variable entry into the logistic regression for the reasons 
outlined in chapter 6. 
Linear regression was conducted in order to assess which of the pre-treatment factors 
associated with the extent to which overall expectations were met, using cross-lag correlations, 
remained predictive when entered into a model together. Variables were entered in the 
regression analyses at p<0.05 and removed from the model at p>0.10. Residual diagnostics 
from each of the models were examined in order to determine the degree to which the models 
fitted the data. 
8.4.5.3 Analysis to determine response-shift in the data: Reprioritisation over time 
To determine whether reprioritisation had occurred in individualised QoL domains between T1 
and T3, the first and thus most important domain reported to be affected at T3 was compared 
with the highest priority baseline domain. Patients were given a+" if their most important area 
of their life affected by their HNC changed after treatment and given a'-' if it had remained the 
same throughout the period. In order to explore whether reprioritisation was associated with 
either an improvement or worse QoL over time, Spearman's rank correlations were conducted. 
QoL scores were derived by subtracting PGI scores at T1 from scores at T3 and dichotomising 
the resulting scores into either: 0=`decline in QoL over time' or 1='improvement in QoL over 
time'. 
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8.4.5.4 Analysis of the differences between full responders versus drop-outs at T3 
In order to ascertain whether patients who did not complete the whole study could be 
predicted from baseline psychological characteristics or variance in QoL, Mann-Whitney U 
tests for two independent samples were conducted. Psychological factors of: illness and 
treatment perceptions, depression, anxiety, coping mechanisms and satisfaction with 
information, and QoL indices of. PGI scores, global QoL (EORTC QLQ-C30), PCS & MCS 
(SF-12) were entered with the grouping variable of whether respondents were fully concordant 
or not. Level of painkiller use was also included in the unlikely event that pain was not tapped 
into by any of the other measures. 
In order to investigate what proportion of study compliance could be predicted from baseline 
characteristics, logistic regression analysis was conducted. Any socio-demographic or 
medical/treatment related factors found to significantly differ between the two groups were 
entered first into the regression, these were then followed by any significantly different 
psychological factors or outcomes variables also assessed at baseline. Full responders were 
coded 0 and drop-outs were coded 1. A backward conditional method was again used for 




A breakdown of the samples in relation to the original recruited sample can be seen in 'Fable 
H. 1. At first follow-up, sixty-eight patients responded giving an 83`%, response ratc. At second 
follow-up, fifty patients responded giving a 61% response rate. 
In total, W/o of patients died during the study, 17% had recurrences, 2°/ entered palliative care, 
and one patient had severe complications after surgery and took many months to heal before 
undergoing radiotherapy. "1'his left insufficient time to collect follow-up data. 
The reasons for non-compliance in 12% of the sample are known only for a few patients. One 
patient refused further treatment and did not want to continue with the study, and another 
patient was currently experiencing flashbacks from severe post traumatic stress disorder, due to 
a previous road traffic accident and would not continue with the questions. Similarly, another 
patient was too distressed to continue in the study. Two patients were found to have moved 
without leaving a forwarding address with the hospital. 
Table 8.1: Breakdown of sample of respondents at each time point 
Breakdown of original Reason (if known) n% 
sample (n=82) 
Full data set - 50 61% 
T2 data missing 14 17% 
Recurrence after fl 3 4°'; > 
Death after Ti 3 4% 
I? ntered palliative care after '11 1 l°io 
Severe complications after Tl -allowing 1 l% 
insufficient time for follow-up 
Moved without address 2 2% 
Non-compliant } 3° ö 
T3 data missing (as above +) 32 39% 
Recurrence after T2 11 13% 
Death after 12 2 2% 
Metastasis of disease - entered palliative 1 1% 
care 
Non-compliant 4 50,0 
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'Fable 8.2 shows the socio-demographic and clinical characteristics of the t<ýllow-uh samples. 
't'here were no significant differences between the sample of patients at '1'2 and those that 
dropped out, excluding stage of cancer, which was found to be higher in patients that were not 
included in '1'2 assessment. At longitudinal follow-up, stage was found to he significantly lower 
in the patients included in assessment ('1'3); in addition patients were significantly less likely to 
have combined therapy than those who were not included. 
Preliminary analysis 
'fables 8.3 to 8.7 prescnt the means (SD), medians, ranges and (; r<>iihach's Alpha's t'Or 
measures complctcd at "1'2 and "I'3 follow-up. 
I ndividualiscd (2o1. 
No significant differences between PGI scores at baseline (see '[able 7.2) and follow-ulp one 
month post-treatment and 6-8 months after treatment were found (F(2,62)=2.33; p>U. O5). Plots 
displaying changes in scores over time (figure 8.1), indicate that individualised Qol. decreased 
shortly after treatment. Scores on the PGI could range from 0 to 1U, therefore mean values at 
both time points indicate that individualised Qoi, was slightly negatively skewed and thus 
perceived to be fairly low (fable 8.3). 
Table 8.3: Mean (SD), median and range for individualised QoL at 1 month (n=54) 
and 6-8 months (n=40) post-treatment 
Individualised QoL Mean (SD) Median Range 
1 6-8 1 6-8 1 6-8 
mnth mnths mnth mnths mnth mnths 
Patient Generated Index 3.39 4.34 3.29 1.31) 0-8.7 
(1.77) (2.22) 
Cronbach's alpha cannot be computed as overall Qol, only consists of I final score. 
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Plot of PGI means at three time points 
Basefne Folbw-up at 1 rtnth Fobw-up at 6-8 mth 
Individualised Qo1. 

















Baseline Fobw -up at I rrnth Follow -up at 6-8 rtth 
GLOBAL, health status/ Qol, 










Followap at I moth Followop t 6A nth 
SF12v2 Component Summary scores 
8 The mean values displayed in these plots are not the same as those presented in the tables of chapters 7 and 8, 
as only data from patients with full data sets are included in the ANOVAs and plots. 
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Table 8.4: Means (SD), medians, range and Cronbach's alpha values for cancer 
specific HR-QoL at 1 mon th (n=68) and 6-8 months (n=50) p ost-treatment 
EORTC QLQ-C30 Domain Mean (SD) Median Range Cronbach's a 
1 6-8 1 6-8 1 6-8 1 6-8 
moth mnths mnth mnths mnth mnths mnth mnths 
Global health status/ QoL 58.58 66.49'' 58 h- 0 100 II (1 0.82 11.1; 
(21.17) (23.85) 
Functional Domains: 
I1motional Functioning 67.77 78.231 75 83 0-100 (1 100 0.85 0.88 
(24.47) (25.39) 
Cognitive Functioning 75.98 76.87, 83 83 0-100 (I 1011 0.74 0.79 
(23.64) (26.09) 
Physical Functioning 71.76 75.101 80 80 7-100 13 1(1(1 0.85 0.88 
(24.52 (24.94) 
Social Functioning 58.09 72.79' 67 83 0-100 (1 1(1(1 0.87 0.82 
(32.77) (29.20) 
Role Functioning 55.47* 71.77* 50 83 0-100 O-100 0.82 0.93 
(32.75) (33.3') 
Symptom Scales: 
Fatigue 43.451 34.491' 44 33 0-100 11 100 0.89 0.94 
(28.74) (31.20) 
Nausea and vomiting 15.44 12.59v 0 (1 0-100 083 0.86 0.76 
(25.65) (21.66) 
Pain 34.58* 26.87* 33 17 0-100 0-10(1 0.90 0.85 
(31.82) (33.47) 
Symptom items: 
Dyspnoca 16.67 19.73' 0 (1 0-100 (I 1(H) N/A 
(25.43) (27.15) 
Insomnia 39.90* 28.57* 33 33 0-100 (1-10(1 N/A 
(36.62) (3(1.43) 
Appetite loss 40.30** 32.65* 33 33 0-100 0-100 N/A 
(40.84) (37.57) 
Constipation 32.34** 21.091 33 0 0-100 0-100 N/A 
(34.80) (26.95) 
Diarrhoea 10.45** 14.97' 00 0-100 0-100 N/A 
(24.07) (27.27) 
Financial Difficulties 28.86** 19.73` 0O 0-100 0-100 N/A 
(37.11) (34.64) 
data from I participant missing 
** data from 2 participants missing 
# Cronbach's alpha cannot be computed as sympto m items consist of 1 item only. 
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Table 8.5: Means (SD), medians, range and Cronbach's alpha values for head and neck 
cancer specific HR-QoL at 1 mo nth (n=68) and 6-8 months (n=50) post-treatment 
EORTC QLQ-H&N35 Mean (SD) Median Min - max score Cronb ach's a 
Domain 
1 6-8 1 6-8 1 6-8 1 6-8 
ninth moths moth moths ninth mnths ninth ninths 
Symptom Scales': 
PaIll 37.63, 26.19' 33 8 0-100 0-11111 0.84 0.92 
(27.63) (31.04) 
Swallowing 30.51* 15.9611 24 8 0-100 0 83 0.90 0.82 
(30.23) (21.13) 
Senses problems 37.37, 16.33+ 33 0 0-100 0 100 0.74 0.76 
(33.60) (25.80) 
Speech problems 30.73* 23.8411 22 22 0-100 0-89 0.75 0.68 
(26.69) (23.03) 
Trouble with social eating 40.76* 30.78' 33 17 0-100 0 100 0.88 0.93 
(31.71) (33.43) 
Trouble with social contact 18.87* 13.74' 13 7 0-100 0-80 0.88 0.83 
(23.38) (20.34) 
Less sexuality 40.68t 26.251 33 I1 0-100 U 100 0.93 0.98 
(39.42) (35.38) 
Symptom itemst 
Teeth 26.26* 18.75 00 0-100 I) 100 N/A 
(33.34) (32.18) 
Opening mouth 45.45* 26.53` 33 0 0-100 U 100 N/A 
(40.36) (35.99) 
Dry mouth 45.45* 40.821 33 33 0-100 0-100 N/A 
(38.18) (35.53) 
Sticky saliva 49.49* 33.3311 33 33 0-100 0 10)) N/A 
(41.45) (36.39) 
Coughing 30.30* 23.13' 33 0 0-100 0-100 N/A 
(32.41) (28.22) 
Felt ill 23.74* 15.651 0 (1 0-100 0-100 N/A 
(31.36) (27.30) 
Pain killers 63.08* 36.73' 100 0 0-100 0-100 N/A 
(48.64) (48.71 
Nutritional supplements 64.62* 42.86' 100 0 0-100 1 100 N/A 
(48.19) (50.00) 
Feeding tube 24.62* 10.201 00 0-100 0100 N/A 
(43.41) (30.58) 
Weight loss 50.77* 26.53+ 100 0 0-100 0-100 N/A 
(50.38) (44.61) 
Weight gain 29.23* 28.571 00 0-100 0-100 N/A 
(45.84) (45.64) 
Shoulder functions 28.79* 22.961 25 0 0-75 0-75 N/A 
(29.50) (27.40) 
t Cronbach's alpha cannot be computed as symptom items consist of 1 item only. 
* Data from 1 participant missing 
** Data from 2-3 participants missing 
$ Extra item added to questionnaire (see methods cha pter) 
t Data from 10 participants missing or reported n/a at each time point. 
9 High scores for symptom scales or symptom items represent high levels of symptoms/problems, unlike 
functional scales and overall QoL, whereby higher scores represent higher levels of functioning. 
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HR-QoL 
Global health status/ QoL as measured by the EORTC QLQ-C30 was found to diminish 
between baseline (see Table 7.3) and one month after treatment (Table 8.4), however at 6-8 
months post treatment, ratings of global QoL had exceeded baseline levels (Figure 8.1). 
Neither of these ratings proved significantly different to baseline levels. However, 
significant differences were detected between follow-up at 1 month and 6-8 months after 
treatment (t(43)=16.24; p<0.001). 
The results shown in Table 8.4 indicate that mean scores for Emotional and Cognitive 
Functioning domains increased steadily from baseline to longitudinal follow-up. However, 
scores on the Physical, Social, and Role Functioning domains diminished at one month follow- 
up and did not reach baseline scores at longitudinal assessment. 
Scores on the general cancer symptom scales and symptom items (Table 8.4) indicated that 
symptoms peaked at the first follow-up after treatment then reduced after 6-8 months, as 
expected. Symptoms specific to the head and neck region remained high at both time points 
but similar to generalised symptoms peaked at first follow-up (Table 8.5). Scores on domains 
such as `trouble with social eating', `dry mouth' and `sticky saliva' remained high even after 6-8 
months post-treatment. Shoulder function remained impaired even at 6-8 months post 
treatment. Many of the problems seen at 6-8 months may reflect permanently impaired 
domains as a result of treatment. Despite these findings, perceptions of feeling ill diminished 
below baseline levels and the use of pain-killers dramatically reduced to half the score of that at 
baseline. Unfortunately, these improvements probably reflected the fact that responders in the 
longitudinal follow-up sample were less impaired and had lower stages of cancer at diagnosis 
than patients who had dropped out. 
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Scores for generalised I IR-OoI. (SF-12) showed similar trends (Table 8.6). IDomains of: Role 
Fm<)tional, Ro>Ic Physical and Bodily Pain rcmaincd similar to basclinc levels (scc'1'able 7.5) 6-8 
months after treatment demonstrating a reduction shortly after treatment. The Mental I Icalth 
domain demonstrated a slight improvement after 6-8 months from baseline levels. I lowever, 
domains of Social Functioning and Physical Functioning showcd scvcrc levels of decline and 
impairment even after 6-8 months post treatment. Levels of vitality were low at baseline 
(mean=50; S[)=27.5) and demonstrated a decrease even at 6-8 months. 
Table 8.6: Means (SD), medians, ranges and Cronhach's Alp ha values for generalised 
HR-QoL at 1 month (n=68) and 6-8 months (n=50) p ost-treatment 
SF-12v2 Domain Mean (SD) Median Min - niax Cronbac h's a 
1 6-8 1 6-8 1 6-8 1 6-8 
ninth mnths mnth mnths ninth ninths ninth mnths 
Mental I Iealth 61.95 68. -5 63 _5 0-100 12.5 0.75 u. -5 
(23.20) (22.34) 100 
Role Fmotional 63.62 73.47^ 75 -5 0-100 25 100 0.93 0.88 
(31.74) (25.08) 
Social Functioningt 55.88 47.45* 50 50 0-100 0-75 N/. \ 
(33.77) (28.06) 
Role Physical 43.47 66.07, 50 75 0-100 (1-100 0.92 0.93 
(29.54) (30.83) 
General ilealtht 44.25 55.00 25 60 0-100 0-100 N/A 
(29.60) (29.80) 
Bodily Paint 61.57 73.5 75 100 0-100 0-100 N/A 
(32.95) (33.28) 
vitalityt 33.46 44.5 25 50 0-75 0100 N/A 
(26.49) (26.86) 
Physical Functioning 58.21 56.63, 75 50 0-100 O-100 0.74 0.66 
(35.46) (34.53) 
Mental Component Summary 42.84 49.00 45 50 14-62 32-66 N/A 
( fCS) (11.04) (8.33) 
Physical Component Summary 38.88 42.92 41 45 19-56 14-60 N/A 
(PCS) (10.13) (11.84) 
data from I participant missing 
$ t: rombach's alpha cannot be co -putcd its dimlai s only c(msist of t itc, n . 
MMCS and PCS scores remained poorer 6-8 months after treatment than the normal 
population (US derived and not age or sex adjusted), however, it is interesting to note from 
the plot of mean PCS and NfCS scores at three time points (Figure 8.1) that although both 
summary scores showed the same pattern of decline and increase, physical Component 
Summary scores remained severely impaired with a mean of 43, whereas Mental 
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Component Summary scores rose above levels shown at baseline to approaching average. 
Multivariate analyses demonstrated that there were significant differences between both 
PCS and ýti1CS scores over time (F(2,92)=24.45; p=0.001, and I-(2,90)=3.66; pp : D. 03, 
respectively). "I'-tests revealed that there were significant differences between baseline and 
T2 follow-up scores on PCS scores (t(64)=7.92; p<0. OO1), and baseline and 1'3 follow-up 
scores (t(47)=4.1; p<0.001). There were no significant differences betwccn Nt(; s scores at 
baseline and either '12 or'1'3 scores (p>0.05). Ifowcver, there was a significant 
improvement in scores between '1'2 and '1'3 (t(46)=-2.99; 1)-(). ()05). 
Anxiety and depression 
Anxiety scores remained higher than depression scores at all three time points (Table 8.7). 
I Iowever the patterns of scores arc markedly different. From Figure 8.1 it can be seen that 
anxiety levels were high following diagnosis but quickly diminished after treatment, remaining 
stable over time. Levels of depression, however, were relatively low at baseline (sec table 7.7), 
peaking just after treatment then subsequently reducing over time. Levels throughout this 
period remain low. Analyses revealed significant differences between anxiety and depression 
scores over time (1, (2,92)=7.22; p=0.00l, and Iß(2,92)=3.2; p=0.05, respectively). Significant 
differences were shown between baseline anxiety and depression scores and each time-point. 
Both scales showed good levels of internal consistency. 
Table 8.7: Means (SD), medians, ranges and Cronbach's Alpha values for 1 month 
(n=68) and 6-8 month (n=50) post-treatment depression and anxiety scores 
Anxiety & Depression Mean (SD) Median Min - max score Cronbach's of 
1 6-8 1 6-8 1 6-8 1 6-8 
mnth mnths mnth mnths mnth mnths mnth mnths 
RADS subscale: 
; lnxicty 
6.51** 5.62 6.0 5.0 0-18 0-20 0.91 0.89 
(4.90) (4.55) 
I)cpression 5.74** 4.68 5.0 3.0 0-18 0-19 0.85 0.89 
(4.07) (4.45) 
data missing for 2 participants 
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Table 8.8: Means (SD), medians, ranges and Cronbach's Alpha values for i month (n=68) and 6-8 
month (n=50) post-treatment illness representations, treatment beliefs and coping strategies. 
Mean (SD) Median Min - niax score Cronbach's a 
Psychological Factor 1 6-8 1 6-8 1 6-8 1 6-8 
ninth ninths ninth ninths ninth ninths ninth ninths 
BIPQ subscalct°: 
Illnc. s Identity 3.60 3.30 3.0 3.0 0-10 lu N/A N/A 
(2.77) (2.93) 
'I'inulinc 4.35 4.52 4.0 4.0 0-10 O 11) N/A N/; \ 
(2.98) (3.62) 
Corse 1ucnccs 5.53 4.01 6.0 3.5 0-10 O 1(1 N/A N/, \ 
(2.91) (2.90) 
Personal Control 4.45 4.82 5.0 5.0 0-10 0 10 N/A N/A 
(3.08) (3.42) 
Treatment Control 8.57 8.90 9.5 1(1.0 0-10 5 It) N/A N/. \ 
(2.15) (1.58) 
Illness (; herence 7.13 7.36 8.0 8.0 0-10 1 10 N/A N 
(2.82) (2.33) 
I"; notiomal representations: 4.90 3.92 5.0 3.5 0-10 I) 10 N/A N/A 
I,: nu>tumal resp>>nsc (3.16) (3.00) 
Concerns 5.91 4.36 6.0 -1.0 0-10 Il 10 N/A N/A 
(3.37) (2.93) 
BMQ-Specific subscale3: 
\cccssityy 8.88 8.96 9.5 10 2-10 6 10 0.53 0.7 
(1.47) (1.32) 
( oTiccrns 6.79 5.96' 7.0 6.0 2-10 2 10 0.64 0.66 
(2.06) (2.35) 
Brief COPE subscalet: 
Solt I )istracrio u 4.06 3.76 4.0 3.0 2-8 28 0.61 0.59 
(1.70) (1.90) 
Active (;, hing 4.70 4.36 5.0 1.0 2-8 28 0.75 0.59 
(1.92) (1.88) 
Denial 3.43 2.56 3.0 2.0 2-8 26 0.73 0.34 
(1.82) (1.03) 
Substance Use 3.00 2.94 2.0 2.0 2-8 2-8 V 0.97 0.98 (1.85) (1.8()) 
Use of Emotional Support 4.94 4.1.1 4.0 4.0 2-8 2-8 0.79 0.81 
(1.97) (1.82) 
Use of Instrumental Support 3.95 3.58 4.0 3.0 2-8 2-8 0.76 0.81 
(1.68) (2.13) 
liehaviourall)isengagement 2.75 2.46 2.0 2.0 2-8 2-6 0.64 0.74 
(1.36) (1.09) 
venting 3.38 3.0.1 3.0 2.5 2-7 2-6 0.48 0.23 
(1.40) (1.23) 
Positive Rcframing 4.08 3.76 4.0 3.0 2-8 2-8 0.52 0.70 
(1.68) (1.88) 
Planning 4.16 3.72 4.0 3.0 2-8 2-8 0.65 0.65 
(1.72) (1.85) 
Ilumour 4.02 4.42 4.0 4.0 2-8 2-8 0.89 0.91 
(2.08) (2.31) 
Acceptance 6.05 6.86 7.0 8.0 2-8 2-8 0.78 0.74 
(1.99) (1.69) 
Religion 3.39 3.32 2.0 2.0 2-8 2-8 0.92 0.97 
(2.04) (2.09) 
Self-Blame 3.36 3.28 3.0 2.1) 2-8 2-8 0.78 0.71 
(1.8) (1.71) 
data missing for 1 participant, t Data missing for between 2 and 4 particip ants at Time I and () for "Pinte 2 . N/A= Cronbach's alpha can not be computed as scale only consists of 1 item. 
W The range of follow-up scores for both the BIPQ subscales and BMMQ subscales are different from those at 
baseline due to differences in items used at follow-up assessment (see chapter 5, part 1). 
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Psychological factors 
In order to compare pre- and post treatment illness and treatment beliefs, all scales were 
standardised on a range from 0 to 100. Tests revealed that there were no significant differences 
over time in individuals' level of concern about the treatment (F(2,92)=1.16; p>0.05); illness 
identity (F(2,92) =0.67; p>0.05) and timeline beliefs (F(2,94)=1.12; p>0.05). I lowever, 
significant differences over time were found regarding beliefs about the necessity of treatment 
(F(2,94)=8.33; p<0.001); perceptions about the personal controllability of the illness 
(F(2,96)=4.84; p<0.01); the consequences of the illness (F(2,96)=6.73; p<0.005) and levels of 
coherence (F(2,94)=6.70; p<0.005). 
Beliefs about the necessity of treatment became significantly stronger between baseline and 
first assessment (Tl) (t(66)=-2.79; p<0.01), whereas perceptions about the personal 
controllability of the disease significantly decreased between baseline and T1 assessment 
(t(66)=3.80; p<0.001). Perceptions of the negative consequences of the illness increased 
between baseline and first assessment, however, post-treatment beliefs significantly decreased 
over time (t(48)=4.28; p<0.001). Patients' overall understanding and perceptions of coherence 
regarding the illness increased steadily from baseline to longitudinal assessment (Figure 8.2). 
Figure 8.2 Plots of standardised mean scores for BMQ and IPQ subscales over time 
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The majority of the coping strategies were used at the time of diagnosis with subsequent 
reductions in their use over time (Figure 8.3). For example, the use of self-distraction, denial 
and use of emotional and instrumental support and planning techniques were highest after 
diagnosis and lowest 6-8 months after treatment. Interestingly, positive reframing also showed 
this trend. The reporting of substance use was highest at diagnosis and lowest shortly after 
treatment for obvious reasons; however, an increase was evidenced at 6-8 months (Figure 8.3). 
Behavioural disengagement and venting were at their highest just after treatment. The use of 
religion showed lowest levels at 1 month after treatment, however similar to acceptance and 
use of humour, demonstrated a sharp increase 6-8 months post-treatment. Active coping (z=- 
2.32; p<0.05), denial (z=-3.83; p<0.001), use of emotional support (z=-3.78; p<0.001), use of 
instrumental support (z=-2.05; p<0.04), planning (z=-2.78; p<0.005) and self-blame (z=- 
2.09; p<0.05) were all used significantly less 6-8 months after treatment than at baseline. 
Cronbach's alphas were within an acceptable range for all coping scales, aside from scales of 
venting and denial. Thus the findings for these two scales should be treated with caution. 
Figure 8.3: Plots of mean scores for coping strategies used over time 





























































































Kolmorogov-Smirnov tests demonstrated that key outcome variables at "l'3 w ere not 
sufficiently different from a normal distribution to be problcºnatic for entry into) parametric 
analysis ('Fable 8.9). 
'T'able 8.9: Kolmogorov-Smirnov (K-S) tests of normality for key outcome variables 
(after the removal of outliers) 
Outcome variable 
HR-QoL Individualised Emotional outcomes 
QoL 
Global PCS MCS PGI Anxiety Depression 
QoL 
n 46 49 41) 40 50 . }4) 
Mean (9.2O 42.92 49.00 4.34 5.62 1.39 
Std. 20.33 11.84 8.33 2.22 4.55 3.98 
Deviation 
K-S Z 1.07 0.86 0.67 0.45 1.32 1.20 
p-value (2- 0.20' 0.14' 0.76' 0.99' 0.06' 0.11 
tailed) 
" sample distributions are not significantly different from normal distributions 
8.5.1 The predictive factors of QoL after treatment for HNC 
It was predicted that illness and treatment perceptions assessed prier toi treatment would not 
explain significant amounts of variance in outcomes over time. Tables 8.10 to 8.15 show prc- 
treatment factors which were found to significantly contribute to variance in outcomes 6-8 
months after treatment. 
8.5.1.1 Standardised I IR-Ool. 
8.5.1.1.1 Global I Icalth status/Qol. 
Stage of tumour, acceptance as a coping strategy and pre-treatment Qol, scores were found to 
be significant predictors of global Qol, 6-8 months after the end of treatment. Together these 
variables explained 54% of the variance in global health status/Qol, (adj. R2 =0.54; F=17.23; 
df=3,38; p<-0.001). Stage of tumour predicted 24% of the variance, with a further 21% 
predicted by levels of acceptance and only 9% predicted by pre-treatment global Qol, scores. 
Table 8.10 presents the standardised beta values for the model and their direction of indicated 
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that lower levels of global Qo], were associated with later stage tumours, high levels of 
acceptance coping, and as expected, lower levels of global Qol, prior to treatment. 
Table 8.10: Predictive factors of Global health status/ Qol, after treatment (n=46) 
Predictive factors assessed at baseline Std 
Stage of tumour -0.51** 
. 
\cccptancc coping -0.43** 
l'rc-trcattncnt Global Ool. scores (). 33* 
Orerall, Wodek R 0.58; aulj. Rý =0.54 F- / 723; d/= 3,3S 
"p<0.005, Ilp<O. Ot)I 
8.5.1.1.2 Physical Component Summary (PCS) Scores 
Approximately two-thirds of physical component summary scores were predicted bv' two 
factors: pre-treatment PCS scores and gender (adj. R' =O. 66; F=46.63; dt 2,54; p<O. OO1). In 
the regression, 58%, of the variance in I IR-Qol related to physical components was accounted 
for by PCS scores at baseline and an additional 8°ýý) was accounted for by gender. Being female 
was associated with worse PCS scores over time (Table 8.11). 
Table 8.11: Predictive factors of PCS scores after treatment (n=49) 
Predictive factors assessed at baseline Std P 
I'rc-trcattiictit PCS scores 11.75"* 
gender -0.29 ** 
Overall Modek R2 =0.68; aai. R1=0.66; V=46.63; d/=2,45** 
, p<0.005, "p50.001 
8.5.1.1.3 Mental Component Summary (MCS) Scores 
Only about a third of the variance in I IR-QoI, related to mental components was predicted by 
three variables of: anxiety, optimism and satisfaction with information (adj. R2 =0.33; F=8.27; 
df=3,42; p<0.005). Levels of anxiety accounted for 19% of the variance, 8% was accounted for 
by levels of optimism, and a further 6% by satisfaction with information. The direction of 
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standardiscd beta values indicate that higher N1CS scores were associated with lower levels of 
anxiety, higher levels of optimism and greater satisfaction with information. 
Table 8.12: Predictive factors of MCS scores after treatment (n=49) 
Predictive factors assessed at baseline Std 
-1). 41 11 
Optimism 0.281 
Satisfaction with information 0.27* 
(, liTlount & Content) 
Or'eral/Alodek W =0.37; R2 _0.33; V =S. 27; d/= 3,42 ** 
, p<0.05, "p<O. 007 
8.5.1.2 Individualiscd Qol. 
Fifty percent of the variance in individualised Qol, scores was predicted by pre-treatment PG I 
scores and stage of tumour (ad). R2 =0.48; F=16.31; elf=2,3; p<0.00 1). 'I'hc majority of this 
variance was accounted for by pre-treatment levels of Oo1. (4U%) and a further 8"o was 
accounted for by stage of tumour. Later stages of tumour were associated with lower levels of 
Cool. (fable 8.13). 
Table 8.13: Predictive factors of individualised QoL after treatment (n=40) 
Predictive factors assessed at baseline Std P 
Pre-treatment PGI scores 0.581 
Stage of tumour -0.32* 
OrerallModel" R' =0S1; adj. R2 =0.4S; F=16.31; df 2,31 ** 
+p<0.05, *'p<O. 00l 
8.5.1.3 F motional Outcomes 
8.5.1.3.1 Depression 
Levels of depression after treatment were predicted by illness beliefs, coping strategies and 
satisfaction with information (adj. R2 =0.67; F=24.66; df=4,42; p<0.001). Stronger beliefs in 
the illness lasting a long time, high levels of self-blame for the illness, low levels of satisfaction 
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with information and high levels of acceptance at baseline, were related to high levels of 
depression over time. '1'imelitic beliefs and self-blame accounted tier the highest anlo>unts o 
variance in depression (28`% and 21% rcspcctivcly). 
Table 8.14: Predictive factors of depression scores after treatment (n=49) 
Predictive factors assessed at baseline Std ß 
I'imelinc 0.511 
Sclf-Blame 0.42* 
Satisfaction with information -O. 34* 
(amount & content) 
Acccptancc (). 33* 
Overall Modek. " 1Z' =0.70; ark. R =0.67; F =24.66; d/=4,42* 
; p<0.001 
8.5.1.3.2 Yluxicty 
Ehe only factor to prove predictive of lcvcls of anxiety 6-8 months after treatment was anxiety 
at baseline (adj. R2 =0.27; I`=19.37; df=1,48; p<0.001). '1'his factor accounted for 270 of the 
variance in anxiety ('Table 8.15). 
Table 8.15: Predictive factors of anxiety scores after treatment (n=50) 
Predictive factors assessed at baseline Std P 
]Ire-treatment anxiety scores 0.541 
Overa/l Alodek I =0.29; adj. R- ** 
*p<0.001 
In conclusion, hypotheses la, b and d were accepted, as illness and treatment beliefs were 
not significant predictors of standardised HR-QoI,, individualised QoI, or anxiety. 
However, hypotheses Ic was rejected as "Timeline beliefs at baseline were significantly 
predictive of levels of depression 6-8 months after treatment. 
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8.5.1.4 Tests for normality, linearity, homoscedasticity, multicollinearity and independence of 
residuals 
For each of the six models, plots of standardised residuals against standardised predicted values 
were fairly random and evenly dispersed, therefore, data were probably within the limits for 
meeting assumptions of homoscedasticity and linearity. Histograms of standardised residuals 
were normally distributed (excluding individualised QoL), indicating that assumptions had been 
met for normally distributed errors (individualised QoL displayed non-normally distributed 
errors). The P-P plots of normally distributed residuals represented normal distributions. The 
assumption of independent errors was met with Durbin-Watson statistics within the acceptable 
range. Collinearity statistics of tolerance and variance inflation factors (VIF) were well within 
acceptable ranges (>0.2 and <10 respectively) indicating that the assumptions of no 
multicollinearity were met for each model. 
8.5.2 What factors predict whether expectations are fulfilled after treatment? 
It was hypothesised that fulfilment of expectations after treatment would not be predicted by 
pre-treatment illness and treatment perceptions. This was rejected as two of the three fulfilled 
expectations assessed 6-8 months after treatment were predicted by particular pre-treatment 
illness and treatment beliefs. As mentioned previously, specific expectations regarding the 
outcome of treatment and the extent of recovery were dichotomised into actual experience 
being `worse than expected' or `better/the same as expected'. The third measure assessing the 
extent to which expectations regarding the whole treatment and recovery period overall had 
been fulfilled by actual experience was treated as a categorical variable. 
The first logistic regression analysis (Table 8.16) demonstrated that 62% of the variance in 
outcome expectations (Nagelkerke R2=0.62) was due to three factors of. undergoing 
chemotherapy; perceptions of the negative consequences of the disease; and substance use 
coping (x2=19.49; df=3; p<0.001). However, only perceptions of the negative consequences of 
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the illness were significant (p<0.05). Patients with strong perceptions of the negative 
consequences of the illness were 50% less likely to report that their expectations had been 
fulfilled post-treatment (()K=0.5; 95% 01.0.2-0.9). 
Table 8.16: Pre-treatment factors predicting fulfilment of expectations regarding the 
outcome of treatment 
Pre-treatment factor B SE Wald Exp (B) 95% CI 
Lower 
Upper 
Chcn )thcrapv -2.6d1 1.51 ?. ')G (1.1 11.111-1.4 
Cotisc(lucnccs -0.79 0.37 -1.71 0.5 11.2-0.91 
Substance Use -0.61 0.32 (º. (, 3.52 0.3 1. O 
" p<0.05 
Analysis examining predictors of the fulfilment of expectations regarding the extent of recovery 
demonstrated that four pre-treatment factors contributed to a significant model 
(x2=18.3; df=4; p'50. O0 1) explaining 56°/a of the variance (Nagelkerke R2=0S6). ( )nlv gender 
and NICS QoI, scores proved significant, indicating that females were 96' less likely than 
males to report having their expectations regarding the extent of recovery to date fulfilled, and 
patients with higher MCS scores before treatment were a fifth more likely to have their 
expectations met than those with lower NICS scores (Fable 8.17). 
Table 8.17: Pre-treatment factors predicting fulfilment of expectations regarding the 
extent of recovery 6-8 months after treatment 
Pre-treatment factor B SE Wald Exp (B) 95% CIt 
Lower 
Upper 
Gender -3.34 1.57 4.54 0.04 0.00 2-0.81 
Stage -1.84 1.15 2.54 0.16 0.02-1.5 
Chemotherapy -4.29 2.61 2.70 O. O1 0.01-2.3 
Mental Component Summary 0.21 O. 1 4.96 1.2 l. 03-1.5* 
score 
p<0.05 
Analysis of predictive factors for the fulfilment of overall expectations demonstrated that a 
quarter of the variance in outcome could be explained by pre-treatment factors of: humour as a 
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coping strategy; emotional response to the illness and satisfaction with the forth and timing o 
information received prior to treatment (adj. R2 =0.25; F=7.94; cif=ä, 60; p<U. 001). I tumour 
accounted for 12°/'o of the variance, emotional response 11"%,, and satisfaction with information 
accounted for a further 5%. I Iigher ratings of expectations being fulfilled by experience were 
associated with a less marked emotional response to the illness, less use of humour as a coping 
strategy and higher levels of satisfaction with int>rmation prior toi treatment (Table 9.18). 
Table 8.18: Pre-treatment factors predicting fulfilment of overall expectations 6-8 
months after treatment 
Predictive factors assessed at baseline Std ß 
I Iumour (coping strategy) _O. 3611 
, motional response -0.36* 
Satisfaction with information 0.23* 
(form & timing) 
Overall Mode% R2 =0.28; adj. R- =0.25; V=7.9.1; d/=3,60 ** 
, p<0.005, "tp<0.001 
8.5.3 Is there any evidence for a `response-shift' between baseline and post-treatment 
scores 
Patients identified a variety of areas that were affected by their I INC both before and after 
treatment. Table 8.19 shows the areas listed by each patient as top priority before treatment 
and 6-8 months after. "These included factors that were specific to I INC, for example, resulting 
problems with speech and communication, and also more general areas such as fear of 
recurrence and ability to work and maintain family life. Many of these areas were included in 
the domains of the generic and disease specific Qol, questionnaires, although man of the areas 
mentioned by patients were more specific, for example, letting people down, and not being 
able to sing anymore. 
After 6-8 months, eleven patients reported the same domain as being affected by their I INC 
and being their top priority, whereas 34 patients reported a different area affected. This was 
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interpreted as undergoing a reprioritisation in the areas of QoL that were currently most 
important to the patient. However, as illustrated by the areas of QoL reported in Table 8.19, 
reprioritisation could not necessarily be considered as adaptive, but reflective of changing 
functional problems as a result of treatment. Despite this, the null hypothesis that there 
would be no evidence of reprioritisation in QoL domains between baseline and post 
treatment assessment was rejected. 
There was no evidence for any association between the occurrence of reprioritisation and 
either a negative or positive change in overall PGI score over time (r=-0.04; n=32; p>0.05). 
However, exploratory analysis of clinical, treatment and psychological factors found a 
significant positive association between a change in priority over time and depression at 6-8 
months (r=0.48; n=44; p<0.001), indicating that the occurrence of reprioritisation was 
associated with higher levels of depression at the same time point. There was no 
correlation between level of optimism and reprioritisation. 
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Table 8.19: Areas of top priority reported by patients in the PGI, pre-treatment and 
post treatment 
Patient Area of top priority before Area of top priority 6-8 Evidence of 
treatment months after treatment rcprioritisation 
Problems with speech Speech _ 
2 Social life Pain + 
3 Uncertainty Social life + 
4 Eating Loss of pre treatment levels of + 
energy 
5 Unable to go to work loss of earnings _ 
6 Communication Communication - 
7 No areas affected Fear of recurrence + 
8 Fear of recurrence Concern over recurrence - 
9 Ability to look after grandchildren Climbing stairs + 
10 Concern for family Tiredness + 
11 Family life Not able to work + 
12 Difficulty eating Fear of recurrence + 
13 Difficulty eating Not eating - 
14 Difficulty eating Can't be bothered with + 
anything 
15 leaving my husband alone to cope Difficulty eating some meats + 
16' Fear of recurrence Concern over future + 
17 1? ating some foods People looking at me + 
18 people staring bating more quickly + 
19 Cannot get support to move home Depression + 
20 Family life Family life - 
21 Concern for my two dogs I leanng - 
deafness on one side + 
22 Do not feel like sex Difficulty eating + 
23 Ability to work Interests + 
24 Nothing affected Nothing affected 
25 Difficulty eating Difficulty eating - 
26 'T'alking Feeling uncertain + 
27 Being depressed Social life + 
28 Feeling uncertain Difficulty eating + 
29 Nothing affected Can not eat at all now + 
30 Nothing affected Notable to work + 
31 Speech Speech _ 
32 Difficulty eating Difficulty eating _ 
33 letting people down Financial problems + 
34 Poor energy Singing -husky voice now + 
35 General day to day family life No areas affected - life is great! + 
36 Not able to do job Much less energy + 
37 Fear for family/children Social life + 
38 Feeling uncertain Social life + 
39 Concern about operation Fear of recurrence + 
40 Concern over future Family life + 
41 1 get on with life but feel depressed Fear of recurrence + 
at times 
42 Concern over recovery in hospital Concerns over time taken for - 
neck scars to fade 
43 Difficulty working Surprise at collarbone looking + 
prominent and ugly 
44 Tiredness Eating + 
45 Being dependent on others Difficulty with swallowing food + 
Alternatively, this could be interpreted as being the same constnict. 
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8.5.4 Predictors of study drop-out 
It was hypothesised that there would be no differences in baseline characteristics between 
patients who dropped out of the study by the last follow-up assessment and those that did 
not. This hypothesis was rejected. The only baseline psychological factors found to be 
significantly associated with study completion were illness and treatment beliefs. In 
particular, illness identity (z=-1.97; p=0.05), beliefs about the consequences of the illness 
(z=-2.40; p=0.02), emotional representations (z=-2.22; p=0.03) and beliefs about the 
necessity of treatment (z=-2.35, p=0.02) were associated with completion of measures at 8 
month follow-up. Examination of the mean values indicated that patients reporting more 
symptoms related to HNC, strong beliefs about the negative consequences, strong 
emotional representations, and strong beliefs in the necessity for treatment to their health, 
were more likely to drop-out of the study. There were no differences evidenced for coping 
strategies used, levels of optimism, anxiety or depression, satisfaction with information or 
any differences in QoL or pain before treatment (p>0.05). 
Of the variables: stage of cancer, type of treatment, illness identity, consequences, 
emotional representations and necessity entered into the regression model, 49% of the 
variance in drop-out was predicted by factors of, emotional representation, perceptions of 
the necessity of treatment and tumour stage (x2=32.97; df=5; p<0.001). However, only 
perceptions of the necessity of treatment and stage of cancer were significant (Table 8.20), 
indicating that patients with strong beliefs about the necessity for treatment were 30% 
more likely to drop out of the study than those with weaker beliefs. Patients with stage 4 
tumours were 43 times more likely to drop out of the study compared to those with stage 1 
tumours. 
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'Table 8.20: Baseline factors predicting dropout of study 8 months after treatment 
B SE Wald Exp (B) 95% CIt 
Lower Upper 
Emotional representations 0.20 0.12 2. -11 1. ' 1.1) 1.5 
Necessity of treatment 0.27 0.14 3.9? 1.3 1.0 1.7' 
Stage lt - - - - - 
Stage 2 2.24 0.99 5.09 9.4 1.3 65.9' 
Stage 3 0.65 1.16 0.31 1» 0.2 18.4 
Stage 4 3.77 1.02 13.72 43.3 5.9 317.6' 
t reference groti 
* p<O. US; " p<0. I)01 
(I (osmcr & Lcºneshow'l'est: x' =5.75; cdf=8; p>O. ()5 
8.6 DISCUSSION 
I'hc main aims of this repeat measures design study were to establish key changes in variables 
over time and to investigate whether components of the SR M were predictive of long- term 
outcomes. 
8.6.1 Changes over time in key factors 
Generally, (. o1, worscncd one month post-treatment as compared to baseline lcvcls. I Ioowcvcr, 
6-8 months after the end of treatment, levels of global ( ol., were better than baseline levels. 
Althot gh levels of anxiety remained higher than levels of depression at all assessments, levels 
quickly diminished and plateaued after treatment. Conversely, levels of depression increased as 
physical functioning worsened but showed signs of gradually decreasing 6-8 months after 
treatment. These results are consistent with previous findings (Chawla ct al., 1999; dc Graeff et 
al., 1999b; I lammerlid ct al., 2001b; Kohda et al., 2005), whereby most treatment associated 
symptoms increase and are most likely to be responsible for the temporary deterioration of 
Qol, and increase in depressive symptoms. 
Although patients reported a better overall Qol, longer term than at baseline, when they may 
have been experiencing symptoms of their disease, general I IR-QoL scores as assessed by the 
SF-12 (in particular physical functioning) were still shown to be poorer at 6-8 months than 
general (US) population levels (not age or gender adjusted). The last measurement was taken 
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relatively soon after the end of treatment (6-8 months) and it is not known whether QoL 
continues to increase until it reaches levels shown by the general population and, if so, how 
long this takes to occur. It has previously been suggested that any improvements to HR-QoL 
occur in the first 12 months after treatment with very little change afterwards (de Graeff et al., 
2000b; Morton, 2003; Rogers et al., 1999). It is of interest to note that despite similar baseline 
levels between the two SF-12 component summary scores, and a worsening of physical 
functioning in particular, HR-QoL related to mental functioning increased significantly 
between one month and 6-8 months after treatment. This demonstrates that patients' QoL 
does not necessarily worsen in line with physical difficulties, depending on what aspects of 
QoL are being assessed. Patients demonstrated longer-term problems with specific symptoms 
related to their treatment, such as; trouble with eating due to sticky saliva and having a dry 
mouth, and loss of functioning of the shoulder and arm. However, the use of painkillers 
decreased and as mentioned previously, emotional /mental functioning improved. 
This study also highlighted the dynamic nature of illness and treatment representations, with 
significant changes over time shown in key patient beliefs. Perceptions of the necessity of 
treatment significantly increased over time and correspondingly, patients understanding of their 
illness significantly increased too. Interestingly, patients' beliefs about the personal 
controllability of their illness significantly decreased from baseline perceptions. In addition to 
these changes, patients' perceptions of the consequences of their illness were also less negative. 
These changes indicate that patient's beliefs may be modifiable and independent to illness 
identity (and levels of symptoms they are currently experiencing). Not much is known about 
how beliefs change over time and what motivates change. However, the significant changes 
highlighted in this study suggest that beliefs may be associated with positive adaptive processes. 
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8.6.2 Predictive factors of long-term QoL (6-8 months after the end of treatment) 
It was hypothesised that illness and treatment perceptions assessed at baseline would not 
explain a significant amount of variance in longitudinal outcomes. Illness and treatment 
perceptions were not found to be significant predictors of either: standardised HR-QoL (as 
assessed by SF-12 PCS and MCS scores and EORTC QLQ-C30 Global QoL/health status 
scores), individualised QoL, or levels of anxiety, and therefore null hypotheses relating to these 
outcomes were accepted. However, levels of depression 6-8 months after the end of treatment, 
were predicted by beliefs regarding the expected duration of the illness (Timeline beliefs) and 
therefore, hypothesis 1c was rejected. 
Coping strategy was found to be significantly associated with only two outcome measures; 
Global health status/QoL and depression. Levels of acceptance coping were negatively related 
to Global health status/QoL and positively related to depression indicating that lower levels of 
acceptance were reported by individuals experiencing high levels of QoL and low levels of 
depression. This may appear to be contrary to expectations but, it may be that acceptance is 
related to severity of symptoms and impairment resulting from the cancer, or indeed states of 
denial. Patients reporting low levels of depression and high QoL may be un-accepting of their 
cancer due to denial or because they have very little by way of signs and symptoms to remind 
them of their cancer diagnosis. The literature also demonstrates that patient beliefs may be 
more predictive of outcomes than coping mechanisms (Heijmans, 1998; Moss-Morris et al., 
1996; Orbell et al., 1998; Scharloo et al., 1998). However, previous studies have shown that 
coping is related to HR-QoL (when beliefs are not assessed) (Hassanein et al., 2001) and have 
suggested that pre-treatment coping strategies may be an important focus for intervention 
(Allison et al., 2004; Chaturvedi, Shenoy, Prasad, Senthilnathan, & Premlatha, 1996; List et al., 
2002). 
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Depression and outcome were not found to be related as other prospective studies assessing 
these relationships within 12 months of treatment have suggested (D'Antonio et al., 1998; de 
Graeff et al., 2000b). This indicates that when other psychological variables are taken into 
account, the relationship between depressive symptoms and QoL diminishes, and that QoL is 
not just a proxy indicator of depression. 
In a longitudinal study of fifty males undergoing surgery for HNC, the objective level of the 
threat (i. e. the extent of impairment resulting from surgery or the prognosis), was not 
correlated with subjective levels of anxiety. This indicated that it is the way individuals interpret 
the health threat that is influential to emotional outcomes such as anxiety or depression 
(Demaddalena & Zenner, 1991). It was also found that information about the outcome of 
treatment was not enough to reduce anxiety. It was suggested that it is also necessary to 
enhance a patient's feeling of personal control and this could be achieved through continual 
contact with the doctor. The idea that patient control is a precursor to reducing anxiety among 
HNC patients is also reinforced by work by Dropkin (2001), whose study of 75 HNC patients 
demonstrated that as patient's perception of control increases, dependence decreases (as shown 
by levels of self-care) and anxiety reduces (Dropkin, 2001). However, this was not supported 
by the present research whereby only pre-treatment levels of anxiety were predictive of 
longitudinal anxiety. However, the analysis demonstrated that only 27% of the variance in post- 
treatment anxiety was explained by pre-treatment levels and therefore, other unknown factors 
may have more of an influence. 
Gender and stage of cancer were found to be predictors of outcomes such as Global QoL, 
PCS scores, and individualised QoL. However, no other socio-demographic or clinical factors 
were found to be significant predictors. Other authors have reported the significance of alcohol 
abuse as predictive of QoL (Sehlen et al., 2002), and although we did not explicitly collect this 
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data and use it for analysis, the coping strategy of `using substances to cope' did not prove to 
be significantly associated. 
8.6.3 Factors predictive of the fulfilment of expectations after treatment 
Little has been published on expectations in HNC patients and as such the measures that were 
used in this study were novel. The results of this study demonstrated that the only pre- 
treatment factors associated with the fulfilment of expectations regarding the outcome of 
treatment (cosmetic and/or physical effects of treatment, not prognosis related) were 
perceptions about the negative consequences of the illness. Patients who believed, prior to 
treatment, that their illness would have strong negative consequences were 50% less likely to 
report that their expectations had been fulfilled 6-8 months after the end of treatment. 
Therefore, hypothesis 2 was rejected. Optimism or severity of cancer, were not significant 
factors. A gender difference was observed when examining the factors associated with 
expectations regarding the extent of recovery 6-8 months since treatment. Females and those 
with low mental component summary scores (MCS) at baseline were less likely to report having 
their expectations about recovery fulfilled. Most interestingly, a relationship between 
satisfaction with information at baseline and the fulfilment of expectations overall was 
demonstrated. 
8.6.4 Implications for intervention 
Patients' beliefs and perceptions about their illness have successfully been the focus for 
interventions in a variety of illnesses (Candy, Chalder, Cleare, Wessely, & Hotopf, 2004; Petrie 
et al., 2002). This chapter has demonstrated that illness perceptions prior to treatment, in 
particular, beliefs about how long the illness will last, the perceived negative consequences of 
the illness, and the emotional response, are related to outcomes after treatment. It is these 
beliefs that could be used as a basis for intervention in the time period between diagnosis and 
shortly after treatment in order to maximise longitudinal outcomes. 
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In addition, satisfaction with information was found to be associated with outcomes of 
depression, Mental Component Summary scores, and fulfilment of expectations overall. The 
information giving process could be developed to encourage more realistic (but positive) 
expectations through more contact with specialist nurses and `expert' patients. However, 
research has suggested that it is the inferences individuals make about the information that 
determines levels of distress rather than the meanings the information giver intends to convey. 
It has been documented that people are more likely to experience anxiety if the information is 
interpreted as threatening (Teasdale, 1993). This indicates that people interpret the information 
they have been given within their own framework of ideas and theories of their illness, which is 
why it is of importance to access patients' views about their illness and treatments in relation to 
their satisfaction with information prior to and during treatment. 
8.6.5 The usefulness of the PGI as a tool for eliciting 'response-shift' 
The concept of response shift has been found to be of potential importance when measuring 
changes in health state over time. It has previously been suggested that attitudes towards a 
particular construct such as QoL do not remain constant over time and individuals have been 
found to place differing emphasis on the importance of domains and this may change over 
time (McGee, O'Boyle, Hickey, O'Malley, & Joyce, 1991; O'Boyle, McGee, Hickey, O'Malley, 
& Joyce, 1992). One of the major difficulties with attempting to assess response shift is that it 
is essentially an abstract concept that is difficult to measure directly (see Chapter 3, part 3.4.2). 
The process of response shift in the current research was operationalised as a change in an 
individual's priorities over time, and the PGI was used to attempt to assess changes in values 
and priorities between diagnosis and 6-8 months after treatment. 
Previous research using the PGI has yielded mixed opinions as to its potential usefulness in 
clinical practice. Many studies, including the original developmental study, have reported that 
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not all respondents are able to complete the PGI correctly (Ruta, Garratt, & Russell, 1999; Ruta 
et al., 1994) and this was found to be associated with lower levels of education and lower levels 
of physical functioning (Ruta et al., 1999). Since the original version (Ruta et al., 1994), a 
simpler version incorporating a prompt list has been developed (used in the current study) in 
order to maximise response rates. However, in concordance with the current study, research 
using the revised version has shown no improvement in response rates (MacDuff et al., 1998) 
and thus the representativeness and reliability of the PGI is still under question. 
The current results from the PGI suggest that individuals list the areas of their lives that are 
most affected by their condition and not necessarily areas that are most important to them. 
This may be because respondents have difficulty understanding the instructions, or separating 
health related quality of life from other factors which compromise their overall life quality. In 
addition, it has been argued that patients may not realistically be able to isolate the effect of one 
medical condition on their lives, over and above other unrelated conditions they may have 
(MacDuff, 2000). Based on the present results, hypothesis 3 was rejected, however, the finding 
of a positive relationship between reprioritisation and depression in the current chapter 
suggests that `changes in priority' are more likely to be indicative of an increase in negative 
cognitions due to problems developing in different areas, rather than as a positive process of 
life reprioritisation. 
A more useful method for assessing response shift, in terms of reprioritisation, may be to 
examine changes in key illness perceptions over time. For example, perceptions of the negative 
consequences of the illness were found to significantly decrease after treatment. This may be 
indicative of individuals undergoing a period of self-actualisation and positive growth and may 
be more representative of the concept of reprioritisation than the PGI is able to achieve. 
Further research is needed to test whether changes in perceptions of consequences are related 
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to processes of reprioritisation and other related constructs such as `benefit finding' (see 
Chapter 3). 
8.6.6 Factors predictive of individuals dropping out of study 
It was hypothesised that there would be no differences in baseline characteristics between 
patients who completed measures 6-8 months after the end of treatment and those that did 
not. This was rejected as baseline illness and treatment beliefs and stage of cancer were found 
to significantly predict full study concordance amongst those recruited at baseline. Tumour 
stage, emotional representations and beliefs about the necessity of treatment predicted 49% of 
the variance in drop-out, although only factors of tumour size and necessity of treatment were 
found to be significant. It is intuitive that individuals with larger tumour stages are more likely 
to drop out for reasons such as entering a palliative phase or tumour recurrence, however, it is 
less easy to explain the reasons why people with stronger beliefs in the necessity of treatment 
should be more likely to drop-out. It may be that there is a strong but partially independent 
relationship between cancer severity (tumour stage) and need for treatment, thus those with 
larger tumours perceive more necessity for treatment. 
8.6.7 Limitations 
This study had a number of limitations, generic to QoL research and more specific to this 
study in particular. 
A problem with QoL data in general, is that there is an inherent bias towards those that are 
better off and indeed those that have survived. Follow-up data tends to be skewed towards 
those with earlier stage tumours and therefore less physical consequences of treatment. A 
comparison of those that were originally recruited into the study and those that remained at 
follow-up, demonstrated a significant difference in tumour stage, with those remaining in the 
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study being diagnosed with earlier stage tumours at the outset. Relatively large attrition rates for 
a number of reasons, limits the generalisability of the results. 
The removal of outliers as a process prior to analysis may have meant that data were more 
generalisable, however, outliers tended to be patients who were significantly worse off. It could 
be argued that these are perfectly valid scores, however their non-removal would mean that any 
subsequent models would not provide a good fit for the remaining data. 
A weakness of the study was that the follow-up period was relatively short (6-8 months after 
the end of treatment). This was due to time constraints and due to the varying and sometimes 
lengthy duration of the treatment. It would have been interesting to see whether relationships 
between psychological factors and outcomes remained stable over a longer time period. 
A limitation of the current operationalisation of the SRM, measured at specific time points is 
that people's models of their illness and their response to illness and treatment are probably 
dynamic. The complexities of how these beliefs interact with outcomes are lost with the type of 
study employed. The feedback system of the SRM may be better captured using interview 
methodology in order to examine the nature and effects of appraisal processes. The same 
applies to the assessment of the response shift phenomenon. 
A number of measures used in this study were unvalidated, such as the items assessing 
expectations, or preliminary validated, such as the satisfaction with information scales. As a 
result, analyses using these measures should be interpreted with caution. 
8.6.8 Conclusions 
The results from this chapter highlight the utility and limitations of the illness perceptions 
framework and the SRM as investigative tools to examine the potential relationships between 
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key psychological factors and outcomes. Although much of the variance in outcomes such as; 
individualised QoL, Physical Component Summary scores, and anxiety was explained by their 
respective baseline levels, Mental Component Summary scores, Global health status/QoL, 
depression and the fulfilment of expectations, were explained by the types of beliefs patients 
had and the method of coping employed. This is of potential importance in the planning stages 
of interventions based on factors other than un-modifiable clinical, treatment related, or socio- 
demographic factors. 
It would be of further interest to investigate whether baseline factors found to be predictive of 
outcomes at six to eight months after treatment, were predictive of longer-term outcomes or 
whether the relationships between beliefs and outcomes change over time as suggested by the 
results of chapters 7 and 8. Further research could extend the study for longer than was feasible 




STUDY OF POST-TREATMENT ADAPTATION AND SATISFACTION WITH 
LIFE AFTER CANCER: A CROSS-SECTIONAL COMPARISON STUDY USING 
THREE PATIENT SAMPLES AND A MATCHED NON-CLINICAL SAMPLE 
9.1 INTRODUCTION 
Despite the possibility of long-term functional consequences related to treatment of cancer of 
the head and neck, many studies have determined that cancer in general does not inevitably 
lead to long-term problems with psychological well-being and overall quality of life 
(Andrykowski et aL, 1996; De Haes & Knippenberg, 1985; Stiegelis et aL, 2003). The previous 
chapters have highlighted how size of tumour and physical functioning are not wholly 
responsible for patient's perceptions of their QoL pre- and post treatment, and in particular are 
not explanatory of ratings of depression and anxiety. 
Despite the longitudinal study design used in the previous study, little is known about the 
cognitive and emotional adaptive processes that occur over a longer time period, and whether 
any changes in physical, social, cognitive, or emotional functioning significantly impact on an 
individual's self-perception or subjective well-being (SWB). 
SWB is receiving increased attention as an important long-term outcome following illness or 
injury. SWB as a construct is thought to contain both an emotional component (which can be 
further divided into pleasant and unpleasant affect (Diener & Emmons, 1984)), and a 
cognitive-judgmental component, which is often referred to as life satisfaction (Andrews & 
Withey, 1976). The majority of research has focused on the assessment of affective well-being, 
with a plethora of measurement instruments that have been developed. For example, the 
Positive and Negative Affect Scale (PANAS) (Watson, Clark, & Tellegan, 1988) was developed 
to measure mood and affective well-being and there are many scales to measure unpleasant 
affect (e. g. depression). 
320 
9.1.1 The cognitive component of SWB: Life satisfaction 
Less researched, however, is the wider issue of how life satisfaction is affected by illness. Shin 
and Johnson (1978) defined life satisfaction as a judgemental process, in which individuals 
assess the quality of their lives on the basis of their own unique set of criteria (Shin & Johnson, 
1978). Based on this definition, life satisfaction can be considered a conscious cognitive 
judgement of one's life based on how well it matches up to their self-imposed standards. 
Life satisfaction can be assessed on a global level or can focus more narrowly on aspects of life 
such as work, recreation or relationships. The justification for studying it at a more global level 
is that the narrower aspects tend to co-occur and it is not likely that people will have the same 
criteria for a `good life'. The Satisfaction With We Scale (Diener et al., 1985), used in this 
chapter, aims to measure global judgements of life satisfaction. The primary advantage of 
measuring life satisfaction with this approach is that the individual, rather than outside 
agencies, uniquely determines the comparative standard upon which the judgment of life 
satisfaction is based. While this flexibility may limit a clear understanding of the relative 
importance of specific life domains across populations, life satisfaction scores allow for 
comparisons in overall life satisfaction across different populations. 
Due to time constraints with following-up a cohort of patients for longer in the main study, 
and the fact that no comparisons groups were used throughout the research, a cross-sectional 
comparison study involving longer term survivors was conducted. Comparisons between 
clinical and non-clinical samples can be problematic because of the use of specific quality of life 
measures, therefore, questions of a more general nature i. e. life satisfaction, were used to 
compare cancer survivors long-term satisfaction with life with other populations. 
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9.2 AIMS 
There have been few studies examining cognitive and emotional adaptation over time, 
specifically in head and neck cancer patients. This chapter focuses on the longitudinal positive 
outcome of HNC, i. e. subjective well-being, as opposed to the assessment of HR-QoL, which 
primarily focuses on deviation away from health and functioning. This study intends to give 
some insight into whether over time, patients who survive HNC are satisfied with their lives in 
a wider context, not just from the perspective of functional status. 
Therefore, the main aim of this chapter was to establish whether HNC patients in remission 
were at risk of long-term problems with adaptation, whilst establishing the factors that 
contribute to overall cognitive and emotional adaptation' 1. 
9.3 HYPOTHESES 
More specifically, this study will test the following null hypotheses regarding the long-term 
impact of HNC on patients' perceptions of overall life satisfaction and whether clinical, 
physical or psychological factors are associated with cognitive and emotional adaptation. 
1: Controlling for time since treatment, where appropriate, patients treated for cancer of the 
head region (excluding neck and throat cancer) will show cognitive adaptation by 
demonstrating similar levels of life satisfaction as: 
a) Patients treated with surgery for a benign condition of the head; 
b) Patients treated for early stage laryngeal cancer; 
c) An age and gender matched non-clinical sample. 
11 For the purposes of this study, cognitive adaptation was assessed by measuring levels of life satisfaction, 
and emotional adaptation was assessed using levels of anxiety and depression. 
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2. There will be no significant differences in levels of HR-QoL between patients treated for 
cancer of the head region and: 
a) Patients treated with surgery for a benign condition of the head; 
b) Patients treated for early stage laryngeal cancer; 
c) An age and gender matched non-clinical sample. 
This study will also test emotional adaptation issues in patients by assessing whether levels of 
psychiatric morbidity differed from the normal population. Depression and anxiety were 
assessed as markers of emotional adaptation. 
3. Patients treated for cancer of the head region will show emotional adaptation by 
demonstrating similar levels of depression and anxiety to that of a normal population. 
9.4 METHOD 
9.4.1 Design 
The study was a cross-sectional, postal questionnaire survey using three groups of patients and 
an age and gender matched non-clinical sample to represent a normative sample. 
9.4.2 Procedure 
All participants (excluding the age and gender matched non-clinical sample) were posted a 
patient information sheet (Appendix VIII), two consent forms, a reply paid envelope and the 
questionnaire consisting of the four measures detailed in section 9.3.4. Ten additional questions 
asked about socio-demographic factors, type of treatment (choice of four categories: surgery, 
radiotherapy, chemotherapy and other), time since last being treated, whether patients were still 
undergoing treatment, and whether any further illnesses or diseases had been diagnosed since 
being treated for the particular condition of interest. Participants recruited into the normative 
sample were asked whether they had suffered from any major illnesses / diseases in the last ten 
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years. Patients found to be still undergoing treatment for their condition were excluded from 
analysis. 
9.4.3 Measures 
The following measures were chosen to maintain continuity throughout the thesis. All the 
measures used were short in order to reduce responder burden and maximise response rates. 
" SWLS (Diener et aL, 1985) to measure satisfaction with life. 
" SF-12v2 (Ware et al., 2002) to measure HR-QoL. 
" LOT-R (Scheier et al., 1994) to measure personality in the form of life orientation/ 
optimism. 
0 HADS (Zigmond et al., 1983) to measure state depression and anxiety. 
Full descriptions of the content and scoring of these measures can be found in the methods 
section in chapter 5. 
9.4.4 Socio-demographic and clinical information 
Socio-demographic variables of. age, gender, socio-economic status, marital status and ethnicity 
were assessed as described in the methods section. Clinical factors such as site and stage of 
cancer were assessed from patient notes or databases. 
9.4.5 Participants 
Four distinct samples were collected in order to test the main hypotheses relating to the impact 
of cancer diagnosis, type of treatment and time since treatment on life satisfaction. So that the 
influence of time since treatment could be minimized, all patient samples were at least 6 
months post-treatment to allow for physical healing. The exact procedures for the 
identification and recruitment of each of the samples can be found in Chapter 5 part 5.1.2.2. A 
summary of each of these samples can be found in the following section. 
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9.4.5.1 Sample of patients treated for malignant tumours of the head 
Patients were eligible if they were at least 6 months post treatment and had been diagnosed and 
treated for carcinoma of the head region, with no active recurrences or further treatment 
planned. Patients were recruited from Guy's Hospital. 
9.4.5.2 Sample of patients treated for malignant tumours of the glottis/larynx (Throat 
cancer group) 
The original aim of this comparison group was to recruit patients diagnosed with an early stage 
malignant tumour of the neck (larynx or glottis), who had been treated with radiotherapy only. 
This was to provide a cancer comparison group for the effects of surgery. In addition, these 
patients could also have provided a comparison for the effects of cancer stage on adaptation. 
However, due to problems with recruitment and the accuracy of hospital records, this sample 
was used as a comparison group for the effect of treatment for cancer with less severe aesthetic 
consequences to the facial region than a head cancer. Patients were recruited from Guy's 
Hospital and The Royal Marsden Hospital. 
9.4.5.3 Sample of patients treated for benign salivary gland conditions 
Participants within this sample consisted of patients treated by one oral surgeon (consistent 
with the head cancer patients) for a benign condition of the salivary glands requiring surgery. 
Inclusion criteria were that all patients should have been treated surgically and that the final 
histological diagnosis was benign. 
9.4.5.4 Age and gender matched non-clinical sample 
Participants were recruited from the community in the UK using a reputable market research 
agency (Research Initiatives Ltd) to provide a normative sample. This sample was purposefully 
matched with the sample of recruited head cancer patients on factors of age and gender. 
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9.4.6 Statistical analysis 
The following clinical and socio-demographic variables were dichotomised: Stage of cancer 
(early (T1 /T2) vs. advanced (T3/T4), marital status (living with partner vs. living alone), 
ethnicity (white vs. non-white) and highest qualification (none/ O' levels vs. further education 
and above). Type of treatment was also dichotomised (dummy coded) into 3 mutually exclusive 
groups: Surgery (S) only (YIN); Radiotherapy (RT) +/- chemotherapy (CT) (YIN); and S& 
RT/ CT (Y/N). 
Sample group differences between measures were assessed with Kruskall Wallis tests with post- 
hoc comparisons for non-parametric data (see preliminary analysis section 9.5.4). As sample 
sizes were small, analyses between groups were conducted using non-parametric tests. 
Where regression models were constructed, correlational analyses were conducted first in order 
to reduce the number of factors entered into final models. Multiple linear regression analyses 
were conducted (using the stepwise method) to assess how much of the variance in satisfaction 
with life (or outcome variable of depression) was due to patient group or other explanatory 
factors. Method of entry and diagnostics were as described in previous chapters. 
9.5 RESULTS 
9.5.1 Response rates of the samples 
The survival status of non-responder patients in the salivary gland sample and the HC sample 
was probed with a phone call to the GP listed in the notes. Many patients were not contactable 
and many had died since treatment. Two patients did not provide consent, one of which could 
not read and currently felt too ill to respond. 
A more detailed breakdown regarding responders versus non-responders is presented in Table 
9.1. 
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There were no significant differences between responders and non-responders in gender 
(p>0.05) or age (p>0.05), however, note-responders tended to be older than responders in all 
samples (Table 9.1). A significant difference was found for stage of cancer at diagnosis in the 
main sample of patients with head cancer, whereby non-responders were more likely to have 
been diagnosed with more advanced stages of cancer (V=0.12; p=0.05). 
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9.5.2 Socio-demographic characteristics of study samples 
Table 9.2 presents the socio-demographic characteristics of each group. Age of the whole 
sample ranged from 17 years to 95 years old. The majority (97%) of the throat cancer sample 
were male, approximately half of the benign salivary gland condition group and two thirds of 
the head cancer and normative sample were male. The throat cancer and the normative sample 
reported similar levels of educational attainment, with only 24% and 29% respectively, 
reporting having qualifications at GCE/A'level or above. In contrast, 53% of the participants 
in the benign salivary gland sample reported an educational level of GCE/A' level or above. Of 
the salivary gland patients, 70% were married or cohabiting and only 6% were widowed, in 
contrast to the other samples, which may have been due to the younger age of the salivary 
gland patients in comparison to the other groups. The majority of participants from all of the 
groups were of white UK ethnic origin. 
9.5.3 Clinical characteristics of study samples 
The sample of patients treated for cancer of the head was fairly heterogeneous, with mixed 
sites and stages of cancer, and treatment schedules (Table 9.3). The majority were tongue 
cancers (410/6) and 60% were early stage (T1 /T2). Time since last treated ranged from 1 to 12 
years (mean=4.6 years). The majority of the sample (86%) had been treated with surgery (40% 
of these had been treated with surgery only). The throat cancer sample was more homogenous 
since all had been treated for early stage cancer of the glottis or larynx. Time since last 
treatment was similar to that of the other groups (mean=4.1 years, range from 1 to 10 years). 
The majority of the sample (97%) had been treated with radiotherapy (52% of these with 
radiotherapy alone). The sample treated for benign salivary gland conditions, was comprised of 
patients diagnosed with neoplasms of the parotid gland (83%) and other major salivary glands 
(17%). All had been treated with surgery and time since treatment ranged from 1 to 10 years 
(mean=4.2 years). 
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9.5.4 Preliminary analyses 
Transforming variables improved kurtosis and skewness, however the majority of these were 
still not within an acceptable range and in addition Kolmorogov-Smirnov (K-S) tests proved 
significant (p<0.05). The main outcome variable of satisfaction with life (SWL) and explanatory 
variables of optimism, anxiety and depression still proved non-normally distributed after 
transformation, however, values of skewness were within an acceptable range and K-S 
statistics, although significant, were low. Therefore, it was decided to proceed with subsequent 
multivariate analyses using SWL as the outcome variable. Indeed neither the dependent variable 
or the independent variables have to conform to the assumptions of normality if the number of 
cases included is large (i. e. over 40 cases per IV) (Tabachnik et al., 1996). 
The impact of negative kurtosis on estimates of the distribution is considered to be minor with 
samples of greater than 100, moreover, the impact of positive kurtosis is insignificant in sample 
sizes greater than 200 (l'abachnik et al., 1996). Therefore, the kurtosis of the variable 
distributions in this sample was not of importance given the main sample sizes used for 
regression purposes were of between n=195 to approximately n=300. Age was found to be 
normally distributed without the need for transformation. 
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'Table 9.2: Socio-demographic characteristics of study samples 
Head cancer Throat cancer Benign 
salivary gland 
conditions 
(n=115) (n=33) (n=47) 
Mean age 64.2 67.3 52.5 
(SD: range) (11.5: 37-95) (9.5; 53-86) (1.1.3; 17 82) 
n (%) n (%) n (%) 
Gender 
Male 73 (63) 32 (97) 25 (53) 
Female 42 (37) 1 (3) 22 (. 17) 22 
I lighest educational 
qualification 
None 50 (44) 21 (6.1) 11 (23) 
GCSE/ 0 levels 21 (18) 2 (6) 11 (23) 
GCE/ A levels/ similar il (1O) 1 (3) 10 (21) 
Higher Education/ 13 (11) 3 (9) I (2) 
similar 14 (12) 4 (12) 8 (17) 
Degree/ similar 3 (3) - 
Higher degree 6 (13) 
Marital status 
Single 7 (6) 3 (9) 6 (13) 
Married/ co-habiting 73 (64) 20 (61) 33 (70) 
Divorced/separated 17 (15) 4 (12) 5 (11) 
Widowed 17 (15) 6 (18) 3 (6) 
Ethnicity 
White 111 (97)1 32 (97) 10 (85) 
Black - Caribbean - 1 (3) 3 (G) 
Black - African - - I (2) 
Indian 2 (2) - I (2) 
Other Asian - - I (2) 
Other 1 (1) - 1 (2) 





(11.5: 37 85) 
n (%) 
7.1 (64) 
















Table 9.3: Clinical characteristics of study samples 
Head cancer Throat cancer 
patients patients 
(n=115) (n=33) 
n (°/0) n (n/, %) 
Specific site: 'l mguc: 47 (41) larynx/ glottis 
t OMN : 15 (13) 33 (100) 
Gum: 12 (10) 
I'll): 3 (3) 
Palate: 3 (3) 
Tonsil: 7 (G) 
Mandible: 4 (3) 
Parotid: 2 (2) 
Paranasal sinus: 
3 (3) 
Oro l)harynx: 1 (1) 
Other mouth: 17 (15) 
Fa r: 1 (1) 
Stage: Early T1/T2 
Advanced T3/T4 
Mean time since last treated 
in years 
(SD: range) 
Type of treatment 
Surgery only (S) 
Radiotherapy only (RT) 
RT & Chemotherapy (CT) 
S& RT 
S&RT&CT 




69 (60) 33 (100) 
41 (3G)ß - 
4.6 4.1 
(3.0; 1-12) (2.4: I-1U) 
46 (40) 1 (3) 
15 (13) 17 (52) 
2 (1) 1 (3) 
48 (42) 14 (42) 




" data from 1 person missing 























Benign N/; \ 
4.2 N/A 
(2.7; 1-IU) 






9.5.5 Differences between samples (uni-variate analysis) 
The socio-demographic and clinical characteristics of the samples are shown in Tables 9.2 and 
9.3 respectively. 
9.5.5.1 Socio-demographic variables 
Significant socio-demographic differences were found between the four groups. Age, 
(X2(3)=30.10, p<0.01), and gender (x2 (3)=17.89, p<0.01), were found to significantly differ 
between the samples. Post hoc comparisons showed that participants diagnosed with throat 
cancer (larynx/glottis) were significantly older and more likely to be male compared with the 
other three groups (p<0.01). Participants in the salivary gland conditions sample were 
significantly younger than the other three groups (p<0.01). Level of qualification differed 
between the normative sample and the salivary gland condition group, (x2 (3)=10.10, p<0.05), 
with participants in the normative sample being less qualified. The ethnic makeup of the 
samples also significantly differed, (x2 (3)=10.15, p<0.05), with the salivary gland group having 
significantly more non-white participants than the three others. There were no significant 
differences in marital status between groups. 
9.5.5.2 Clinical variables 
No significant group differences were found in terms of whether other major illnesses had 
been diagnosed since treatment for the condition of interest (x2 (3)=6.91, ns). However, 
between the three patient samples, significant clinical differences were evidenced. Significant 
differences in stage and treatment were found between the groups, with participants in the 
head cancer group being diagnosed with later stage cancers than those in the throat cancer 
group, x2 (1)=17.12, p<0.01 (as expected). Treatments significantly varied between the groups, 
as shown in Table 9.3. There were no group differences found for the amount of time (in 
years) since treatment. 
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9.5.5.3 Life Satisfaction 
There were no significant differences in levels of life satisfaction between the four groups, (x2 
(3)=1.23, ns) (Table 9.4). However, all three patient samples scored higher than the normative 
sample. 
9.5.5.4 HR-QoL 
Highly significant group differences were shown for levels of physical functioning, with 
differences in Physical Component Summary (PCS) scores, (x2 (3)=13.61, p<0.01). Post hoc 
comparisons demonstrated that differences were between patients having had salivary gland 
conditions (high PCS scores) and participants in the head cancer and normative samples 
(lowest PCS scores). Similarly, significant group differences were found between SF-12 
subscales of. level of Physical Functioning (x2 (3)=10.53, p<0.05); Role Physical scores, 
(x2(3)=12.47, p<0.01); and Bodily Pain, (x2 (3)=12.94, p<0.01). In each case, the normative 
sample scored significantly lower, i. e. had worse functioning for each of the significant 
subscales compared to either the salivary gland condition group or the throat cancer patients 
(see Table 9.4 for means and medians). Patients with cancer of the head region also scored 
significantly worse than the salivary gland patients on subscales of Physical and Role 
Functioning. In contrast to these findings, significant differences in Mental Health functioning 
were found between the sample of salivary gland patients and those treated for head cancer, 
(x2(3)=10.34, p<0.05), however, in this case, post hoc tests revealed that the salivary gland 
condition sample scored significantly 
lower (i. e. reported worse functioning) than the head 
cancer patient sample. 
No significant group differences were shown in Mental Component Summary (MCS) scores, 
(x2 (3)=6.71, ns), or in subscales of General Health, (x2 (3)=7.10, ns); Vitality, (x2 (3)=4.34, ns), 
Social Functioning, (x2 (3)=4.38, ns), and Role Emotional, (x2 (3)=2.63, ns). 
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9.5.5.5 Optimism 
There were no significant differences in levels of optimism between the four groups, 
(X2(3)=4.31, ns). 
9.5.5.6 Anxiety and depression 
Differences in levels of depression were shown (x2 (3)=8.45, p<0.05), with differences 
evidenced between the normative sample and the salivary gland condition groups only. 
Participants in the normative sample demonstrated significantly higher levels of depression 
than those in the salivary gland conditions sample. 
There were no significant differences in levels of anxiety between the four samples 
(x2(3)=2.95, ns). 
As it was revealed that there were no significant group differences between the main dependent 
measure of We Satisfaction, it was decided to explore possible reasons for variation whilst 
controlling for effect of patient sample. Significant group differences in socio-demographic 
factors and HR-QoL were established previously, therefore it was imperative to determine 
whether these had more impact on life satisfaction than patient group alone. Two linear 
regression models were conducted on the whole sample, controlling for the effect of patient 
group (dichotomised into four dummy variables) and socio-demographic factors. 
Although Satisfaction With Life Scale scores were found to be non-normally distributed, the 
amount of skew was within an acceptable range and the K-S statistic showed a trend towards 
non-significance. The score distribution 













Satisfaction With Life Scale scores 
' td Dev = 7.58 
'. Ioan = 21.9 
306.00 
Figure 9.1: Histogram of Satisfaction With Life Scale (SWLS) scores for combined 
sample (n=306) 
9.5.6 Determinants of Satisfaction with Life (SWL) 
9.5.6.1 Model 1: Using SF-12 PCS and NICS scores 
All variables were entered into the first model using a stepwise method (i. e. age, gender, marital 
status, qualifications, ethnicity, sample group, time since treatment, diagnosis of major illness 
since treatment, optimism, anxiety, 
depression and f IR-Qol,. I IR-QoL was represented by the 
component summary scores of MCS and PCS. All variables could be entered without reducing 
the power of the study as the overall sample size was large (approx. 300). 
335 
5.0 10.0 15.0 20.0 25.0 30.0 350 
7.5 12.5 17.5 22.5 27.5 32.5 
v 




















































o .nocoC ö 'nr ýriöýnöýri ~ 
r 
oo- ý] r\ r In r r 00 "1- ri (Pi C, I 
o 06 M GO rn kn ^ - ^ ) .n 0 
r-ý 06 C 1 
0 0 t in . V' 
C 1 C'l Cli - rrý en C11 C, I en o6 
444 
-t Mr G1 MMin O 
M 00 inl1 
(11 r- 
'Crr'I nrtn' 't 
r 
C, I 
CD ri 1nCD CD oooCZ o ('i Ooo Ir) CD Ir) o rl o , 
(`I - 00 r-. - "n n ni ýri c-1 
Crý "*^" 
^O 1j 
p^p rn V' VM o0 
"Z '? or- cCD CD o In tern ýi cý !t ch c" C, -t 
00 00 00 Z 00 ,n 00 
C' 
-t n 
it f (1 
Op p( nOO 
C) C: ) r- C-1 tei ýri 
-t CN 
oo r- r t- 'n 








in Cl! "0 oo . -. - 00 oo In e) 
ci MC1iCl lri. *ry, ri 1i 06 "i -f ö N r 00 00 r 00 in t- cal 
O OpOOpOO M O 
tr) o O 'O n cl, Op (`l 




`tom '. n 
''t M- -'r O -`? M Cl 00 V O "t 
N 
M oo r- ýt t- t- 
00 öö ö OCC cn cn en 
II 
M en CII) en 
ý c II II II 
CC C\ C\\\ 
IC rCCC 
CCCCCC S- 
cc Vý C\ 
G 
Oý o0 o0 00 
OOÖOÖOCC 
"- m r. -Q 
c0 
QÖy +'i uuvCCv O+ v, a pp 
iý ý, " O ýý cä [3" 
Op Ci 
WCvQ 
u ýa v"f 
es 
37xnx 
Cý cý 1s~ ý. ý CQOo 
M 
M 
Analysis revealed that optimism explained the largest amount ofvarl ianrc in hic satisfy ti (m, 
along with levels of depression, levels of Mental sind Physical IIR Oc)l. (P( a and N1( a), martial 
status and age (ad/: R-'=0.47; V_44.05; d/=6,286, p<0.05). I liglicr levels of optimism, better 
physical and mental functioning, being married (or living with a partner) older age, and lower 
levels of depression were associated with higher levels cat life satisfaction (Table 9. F) and 
altogether could explain 47°' of the variance in S\V'l, se )re. 
Table 9.5: Explanatory factors of Satisfaction with Life in whole sample using SF-12 
component summary scores (n=293) 
Explanatory factor Std (3 
Optimism (1 .O[ -R) 2 0.3 
Mental Component Summary' (SF-12) 0.23 
1)cpression -0.19' 
. \gc (). 14+; 
Marital status 0.13** 
Physical Component Summary (SF- 12) 0.13* 
Overall Model: R' =0.48; adl. R2 =O. 47; F=44.05; Lit =6,286 
, p<0.05,1p<0.005 
9.5.6.2 Model 2: Using SF-12 subscales 
The second multiple regression model was again conducted with tiWI as the outcome variable, 
and including explanatory factors as described previously, however the eight subscales of the 
SF-12 were entered instead of the two summary component scores. This was to explore in 
more detail whether particular elements of I IR-Qol, were important when remaking judgements 
of life satisfaction. 
Using more specific measures of I IR-Qol,, it was found that higher levels of optimism, lower 
levels of depression, better Role I,. motional functioning, older age and being married (or living 
with a partner), were associated with higher levels of S\W'I. (fable 9.6) and could explain 
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apIroximatcly 48"o of the variance in life satisfaction scores (U- =0.. 19; , id/. U- =U. -/X; I, '= 57.65; 
d/=5,? 97; p<0.0I). 
Table 9.6: Explanatory factors of Satisfaction with Life in whole sample using SF-12 
subscales (n=303) 
Explanatory factor Std P 
Optimism (1 X Y1-R) 0.34 
Depression -(). 3()'* 
1Zolc FmOtional I unctioning (SF- 12) 0.17* * 
: Agc 0.1511 
Marital Status 0.1 1 
Overall Model: R2 =0.49; adj. R2 0.48; F=57.65; df= 5,29,. 
[)<(). O1; "p<O. 005 
Tests for normality, linearity, homo>sceclasticity, multicollincarity and independence of residuals 
For each of the models I and 2, plots of standardised residuals against standardised predicted 
values were fairly random and evenly dispersed, therefore, data were probably within the limits 
for meeting assumptions of hotnoscedasticity and linearity. Assumptions were met for 
normally distributed errors. 'Ehe P-P plots of normally distributed residuals represented normal 
distributions and histograms of standardised residuals also demonstrated normal distributions. 
The assumption of independent errors was met with Durbin-Watson statistics of 
approximately 1.9. Collinearity statistics of tolerance and variance inflation factors (VIF) were 
well within acceptable ranges (>0.2 and <10 respectively) indicating that the assumptions of no 
multicollinearity were met. 
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9.5.7 Relationships between cognitive adaptation (represented by SWL), time since 
treatment and clinical factors 
In order to explore whether time since treatment and type of treatment impacted on adaptation 
and to further test the hypothesis 1: `Controlling for time since treatment, patients orated for cancer of the 
head will show cognitive adaptation by demonstrating similar levels of life satisfaction as: 
a) Patients treated with . surgery for a benign condition of the head, 
b) Patients treated for early stage laryngeal cancer. 
Further analyses were conducted using the three patient samples only (head cancer, throat 
cancer and salivary gland patients). 
9.5.7.1 Correlational analysis 
Correlation analysis with all explanatory variables and SWL were conducted. Socio- 
demographic variables of age (r=0.15; p<0.05) and marital status (r=0.18; p<0.05), clinical 
variables of stage of cancer (r=-0.19; p<0.05), and treatment group of surgery only 
(r=0.15; p<0.05), depression (r=-0.60; p<0.01), anxiety (r=-0.44; p<0.01), optimism 
(r=0.54; p<0.01) and all HR-QoL sub-scales (p<0.01) were significantly associated with 
satisfaction with life. Time since treatment was not significantly associated with satisfaction 
with life (r=-0.03; p>0.05) or depression (r=-0.04; p>0.05). 
9.5.7.2 Regressional analysis 
As there were only 195 patients included in this analysis, stepwise regression analysis was 
conducted using only variables which proved significantly associated with SWL in univariate 
analysis. 
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Table 9.7: Explanatory factors of Satisfaction with Life in patient groups only (n=195) 
Explanatory factor Std ß 
Optimism (IA 1 R) 0.33 
1)cpression -U. 31 ** 
Role F, motional Functioning (SF- 12) 0.19'« 
Agc (). 19 
Overall Model: R2 =0.49; adj. R2 =0.48; 1'=44.19; df=4,186' 
'p<0.01; "p<0.005 
None of the clinical factors such as treatment type, or stage of cancer could significantly 
explain satisfaction with life, and again, optimism and levels of depression cc>ntrihutcd the most 
('fable 9.7). "Together with age and role emotional functioning, this model could explain 
approximately 48"io of the variance in life satisfaction amongst this mixed patient sample (R 
=0.49; adj. R2 =0.48; 11=44.19; d1=4,186; p<0.01). 
"Pests for normality, linearity, homoscedasticity, MUlticollincarity and indcpcndcncc of residuals 
Plots demonstrated that there may have been heteroscedasticity in the data from the regression 
model. Assumptions were met for normally distributed errors. The p-p plot of residuals 
appeared slightly deviated from the normal distribution and the histogram of standardised 
residuals demonstrated a slightly positively skewed distribution. The assumption of 
independent errors was met with a Durbin-Watson statistic of 2.0. Collinearity statistics of 
Tolerance and VII were well within acceptable ranges indicating that the assumptions of no 
multicollinearity were met. In conclusion, the results presented in 't'able 9., 7 should be 
interpreted with a certain amount of caution. 
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9.5.8 Sample differences in health status (HR-QoL) 
The results of uni-variate analyses (and Table 9.4) indicated that there were noticeable 
differences in HR-QoL between the samples. Two regression models were constructed for 
each of the HR-QoL summary component scales of PCS and MCS, to assess how much of the 
variance was due to patient group or socio-demographic differences between the samples. The 
second null hypothesis was tested: 
There will be no significant d jerences in levels of HR- QoL between patients with head cancer and, a) Patients 
treated with surgery for a benign condition of the head, b) Patients treated for early stage laryngeal cancer; c) An 
age and gender matched non-clinical sample. 
Previous uni-variate analysis demonstrated no group differences in Mental Component 
Summary scores (MCS) and thus regression analysis failed to find any variance due to sample 
group. The only socio-demographic factor to significantly contribute to MCS score was gender 
(R2 =0.05; ad R2 =0.04; F=14.7; df=1,295; n=297; p<0.001). The association was negative 
indicating that being female was associated with reporting lower MCS scores. Although found 
to be significant, gender only contributed 4% of the variance in MCS. 
Regarding physical health status, analysis revealed that age and being in a particular sample 
group significantly contributed to the variance in Physical Component Summary (PCS) scores 
(R2 =0.14; ad: R2 =0.13; F=23.4; df=2,299; n=302; p<0.001). Both factors were negatively 
associated with PCS score indicating that increasing age, and being in the normal sample group 
were associated with lower physical HR-QoL. 
Tests of the models revealed that there might have been heteroscedasticity in the data. 
Assumptions were met for normally distributed errors. The p-p plots of residuals looked 
slightly deviated from the normal distribution and the histograms of standardised residuals 
demonstrated slightly positively skewed distributions for both models. The assumption of 
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independent errors was met for both models. Collinearity statistics of Tolerance and VIF were 
well within acceptable ranges indicating that the assumptions of no multicollinearity were met. 
In conclusion, the results from the two models examining the explanatory factors for MMCS and 
PCS scores should be interpreted with a certain amount of caution. 
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9.5.9 Adaptation in patients treated for cancer of the head region 
This study also sought to investigate adaptation issues in the main sample of patients only, by 
firstly assessing whether time since treatment affected perceptions of life satisfaction, and 
secondly, whether levels of depression and anxiety differed from the age and gender matched 
non-clinical sample. The following null hypotheses were tested: 
Time since treatment will not be associated with levels of /i% satic/nction in head cancer patients'' 
`Patients treated for cancer of the head will show emotional adaptation Gy demonstrating . rigni/icrmtly similar 
levels of depression and anxiety to that of the age and gender matched non-clinical sample. ' 
Although there were no statistically significant differences in life satisfaction scores between 
the samples, the mean score for the head cancer sample was higher than that for the age and 
gender matched non-clinical sample (Table 9.4). 








satisfaction with life scale scores 
d Dev = 7.70 
'. 1oan = 21.9 
. =114.00 
Figure 9.2: Histogram of Satisfaction With Life Scale (SWLS) scores for patients treated 
for head cancer (n=114) 
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9.5.9.1 Correlational analysis 
Correlation analysis with explanatory variables and satisfaction with life were conducted using 
head cancer patients only. The socio-demographic variable of age (r=0.19; p<0.05), clinical 
variables of stage of cancer (r=-0.22; p<0.05), and treatment group of surgery only 
(r=0.26; p<0.01), depression (r=-0.57; p<0.01), anxiety (r=-0.42; p<0.01), optimism 
(r=0.59; p<0.01) and all HR-QoL sub-scales (p<0.01) were significantly associated with 
satisfaction with life. Time since treatment was not significantly associated with satisfaction 
with life (r=0.03; p>0.05) or depression (r=-0.08; p>0.05). 
9.5.9.2 Regressional analysis 
Multivariate analysis revealed that only four factors significantly contributed to variation in 
S%VL scores in the head cancer patients (Table 9.8). Similar to previous results, optimism was 
positively associated with SWL, along with aspects of HR-QoL and type of treatment (R2 
=0.55, ad j. R2 =0.54; F=32.87, df=4,107, p<0.005). Results indicated that patients who had high 
levels of trait optimism, high levels of role emotional and social functioning and who had only 
been treated surgically, were more likely to be more satisfied with their lives. Neither stage of 
cancer or socio-demographic factors added significantly to the variance. 
Tests demonstrated that there might have been heteroscedasticity in the data from the 
regression model. Assumptions were met for normally distributed errors. The p-p plot of 
residuals looked slightly deviated from the normal distribution and the histogram of 
standardised residuals demonstrated a slightly positively skewed distribution. The assumption 
of independent errors was met with a Durbin-Watson statistic of 2.2. Collinearity statistics of 
Tolerance and VIF were well within acceptable ranges indicating that the assumptions of no 
multicollinearity were met. In conclusion, the results from the analysis presented in Table 9.8 
should be interpreted with some caution. 
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Table 9.8: Explanatory factors of Satisfaction with Life in patients with cancer of the 
head only (n=114) 
Explanatory factor Std 
OE)tlmism (l X) l -R) (). 1(, ' 
Role Fmotimial Functioniog (SF-12) 0.2611 
Surgery only 0.201 « 
Social Functioning 0.19' 
Ovcnall Model: R-'=0.55; adj. R2 Ü. 54; F=32.87; elf=4,1(17" 
, p<0.05; * rp<0.005 
In contrast to the previous models, depression (lid not significantly c<mtril>utc to life 
satisfaction in this patient sample, and as S\V1, is intended t() assess the c<gnitivc rather than 
affective components of satisfaction, a further (Iucstion was asked, rc1atini i() what factors 
could explain affective aspects of S\\], (i. c. depression). 
9.5.9.3 What factors contribute to emotional adaptation (i. e. levels of depression and anxictv)? 
Further regression analyses were conducted using depression and anxiety as outcome variables. 
It was further hypothesised that Icvels of functioning (i. e. I IR-Q01') would he associated with 
both depression and anxiety. 
Depression 
The overall model consisting of five variables, presented in "['able 9.9, accounted for 7O" of 
the variance in depression (a(/j. R2 =0.70; 1; =52.37; d/ 5,107, p<0.005). lour subscales of II R- 
QoL, and optimism were negatively associated with depression scores. The model indicated 
that as I IR-Qol, and levels of optimism lowered, depressive symptoms increased. 
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Table 9.9: Explanatory factors of depression in Patients with cancer of the head only 
(n=113) 
Explanatory factor Std 
Role 1)11\", Icll 
Mental I lcalth -(>? H 1+ 




General I Icalth -U. 17 
Overall Model: R2=0.71; adj. R2=U. 70; F=52.37; ddf= 5,107" 
I1, <0. i5; `. p<O. I)O5 
Anxiety 
; Anxiety was accounted for (59°/(, of the variance) by levels of optimism and mental health 
R2 =0.59; I'=77.96; (11--, 2,110 p<0.001). The model ('Table 9.10) indicated that high levels ()1 
anxiety were related to low levels of optimism and low levels of mental health. 
Table 9.10: Explanatory factors of anxiety in patients with cancer of the head only 
(n=112) 
Explanatory factor 





Overall Mlodel: R2 =0.59; adj. R2 =0.58; F=77.96; cif=?, 110 
*p<0.05; *"p<O. 001 
Tests demonstrated that there might have been heteroscedasticity in the data from each of the 
regression models. Assumptions were met for normally distributed errors. The p-}) plots of 
residuals looked slightly deviated from the normal distribution and histograms of standardised 
residuals demonstrated slightly negatively skewed distributions. The assumption of 
independent errors was met with Durbin-Watson statistics of approximately 2.0. Collinearity 
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statistics of Tolerance and VIF were well within acceptable ranges indicating that the 
assumptions of no multicollinearity were met. In conclusion, the results from multi-variate 
analyses examining the explanatory factors of depression and anxiety should be interpreted 
with a certain amount of caution. 
9.5.9.4 Comparison of levels of anxiety and depression between patients with cancer of the 
head, the age and gender matched non-clinical sample and a normative sample 
There was some concern over whether our age and gender matched non-clinical sample was 
representative of a normal population, as scores of physical functioning and pain were found to 
be significantly worse for this sample than our patient samples. Moreover, levels of depression 
and anxiety appeared to be higher than all three patient samples and significantly higher than 
the benign salivary gland patients. 
Unfortunately there are no widely used population data for the HADS, with which to compare 
our normative sample, however, recent data have been published for a large non-clinical adult 
UK sample (Crawford, Henry, Crombie, & Taylor, 2001). In order to ascertain whether the 
patients treated for head cancer had comparable levels of depression and anxiety to the normal 
population (i. e. demonstrating emotional adaptation post-treatment), a comparison was made 
between our main head cancer sample, the age and gender matched non-clinical sample and the 
normative data set. Table 9.11 presents descriptive data for the three data sets. 
The RADS raw scores were positively skewed for all samples. The head cancer sample 
displayed lower levels of anxiety than both of the normative samples. Similarly, lower 
percentages of the sample, compared to the normative data sets, could be classed as having 
moderate or severe levels of clinical anxiety. The two normal samples demonstrated similar 
mean values, however, our matched sample had a slightly lower median value. Similar 
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proportions of both samples had scores of 8 or more, which signified clinical caseness (32% 
and 33%), although the distribution of scores across the three clinical divisions varied. 
Regarding scores on the depression subscale, all three samples displayed the same median value 
of 3, which was lower than the anxiety scores. The use of mean and SD values are limited with 
skewed data, however, scores across the samples were similar, albeit lowest in the adult UK 
normative sample and highest in our age and gender matched non-clinical sample. This may 
have been due to the differences in sample size. Examining the proportions of participants 
falling within the limits for clinical depression, the matched non-clinical sample had the highest 
proportion (21%), followed by the head cancer sample (17%) and then the adult UK normative 
sample (11%). 
Due to the fact that a substantial proportion of the general adult population endorsed a 
number of anxiety and depression items, Crawford and colleagues (2001) argue for the use of a 
cut-off of 10/11 to signify a clinical case instead of the recommended 8 (Zigmond et al., 1983). 
Data for gender is not available for the adult UK normative sample, however, the authors 
report that females scored significantly higher than males on both scales. The results from the 
comparisons between the two normative data sets demonstrate that the age and gender 
matched community sample collected from the market research agency was not representative 
of the normal population, particularly in terms of levels of depression. This may have been due 
to the relatively small sample size or data collection methods. Any comparisons based on this 
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The primary aims of this chapter were to assess the extent to which patients diagnosed with 
cancer of the head region showed cognitive and emotional adaptation after treatment. In order 
to do this, levels of life satisfaction and anxiety and depression were examined, in relation to an 
age and gender matched non-clinical sample and two additional patient groups. 
9.6.1 Cognitive adaptation 
Preliminary results showed that levels of satisfaction with life (SVUL) reported by the head 
cancer patients were not significantly different from the non-clinical sample or patients who 
had been treated for an early stage throat cancer or a benign salivary gland condition. 
Therefore, the first hypotheses were accepted. Moreover, mean values demonstrated that all 
patient samples reported higher levels of life satisfaction than the non-patient sample (although 
this did not reach statistical significance). This finding is comparable to previous studies of 
SWL in which no differences in life satisfaction have been demonstrated between different 
patient groups and healthy controls (Kreitler, Chaitchik, Rapoport, Kreider, & Algor, 1993). 
However, a Norwegian study of 204 long term HNC survivors (7-11 years since diagnosis) and 
766 matched controls, reported significantly worse levels of life satisfaction and physical health 
between their patient sample and a matched healthy sample (Bjordal, Mastekaasa, & Kaasa, 
1995). The authors explain the lack of consistency between these results and that of the cancer 
literature (Danoff, Kramer, Irwin, & Gottlieb, 1983; Kaasa, Aass, Mastekaasa, Lund, & Fossa, 
1991; Kreider et al., 1993; Olweny, Juttner, & Rofe, 1993) by hypothesising that re-appraisal 
and other processes of adaptation `may not be applicable for a population with considerable side-effects, 
including ph, sical limitations and changes of appearance after treatment, which are constant reminders of their 
disease'(Bjordal et al., 1995). Other research has indicated that life satisfaction in HNC patients 
is related to pain, speech difficulties and dysphagia (Morton, 1995). Our results suggest, 
however, that despite worse physical HR-QoL reported by the head cancer sample, compared 
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to patients in the non-cancer patient group (salivary gland conditions), levels of life satisfaction 
were similar. This demonstrates that physical limitations do not necessarily lead to worse 
perceptions of life satisfaction. 
Despite finding no significant differences in HR-QoL between the head cancer sample and the 
non-clinical matched sample, examination of mean values indicated that the head cancer 
sample scored lower than all other patient samples on six of the eight HR-QoL domains 
(including the PCS score). Thus, hypothesis 2a was rejected and hypotheses 2b and c were 
accepted as no significant differences in physical HR-QoL were found between the head cancer 
patients and the normative sample or throat cancer sample. 
Multivariate analysis demonstrated that SF-12 domains, in particular Role Emotional 
Functioning were contributory factors to SWL in all of the samples combined, and in the head 
cancer sample only. In the whole sample combined (n=303), approximately half of the variance 
in SWL (adjusted R2 of 0.48) could be accounted for by levels of optimism, depression, role 
emotional functioning, age and marital status. Interestingly, low levels of depression and high 
levels of optimism were both independent explanatory factors of high life satisfaction 
indicating that these are distinct and independent factors not just opposite ends of the same 
spectrum. Being married was also associated with high levels of life satisfaction which is also 
robustly demonstrated in the literature (Waite, 1995). The relationship between marital status 
and SWB has been hypothesised in two ways. Firstly, the `selection' hypothesis, that satisfaction 
with life leads to more success with marrying (Mastekaasa, 1992), and secondly, the `social role' 
explanation that marriage itself predisposes to more opportunity for social support which leads 
to higher levels of life satisfaction (Johnson & Wu, 2002). 
Few studies have been published reporting the levels of life satisfaction in HNC patients, 
indeed fewer still have assessed the patterns of life satisfaction over a longer period of time. It 
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was hypothesised that time would have an effect on levels of cognitive and emotional 
adaptation for many reasons, not least in terms of healing after treatment and diminishing 
levels of pain, however, we failed to find any effect of time on levels of life satisfaction or 
emotional adaptation, and therefore, hypothesis 3 was accepted. 
Treatment modality aside, no other clinical or treatment related factors were related to SWL. 
Having had `surgery only' was found to be protective of SWL which may have been due to the 
length of time taken to heal, as opposed to the long term effects of radiotherapy. Alternatively, 
`surgery only' may have been acting as a surrogate marker for tumour size or tumour severity as 
larger tumours are more likely to be treated with multiple modes of treatment. However, 
analysis with stage data was not found to be significant. No other stage related data was 
available. 
Although our study data were only cross-sectional, and thus can not indicate whether life 
satisfaction had changed over time, previous studies have reported that life satisfaction (as 
measured by the We Satisfaction (LS) Scale (Warr et al., 1979)) undergoes significant 
improvement between diagnosis and 12 months later (Morton, 1995; Morton, 2003). It is 
plausible to assume that life satisfaction decreases around the time of diagnosis and treatment 
and therefore any subsequent increase could be taken as an indicator of cognitive adaptation. 
9.6.2 Emotional adaptation 
Levels of depression and anxiety in all of the samples were low (although lowest for 
depression) and well under boundaries for possible clinical disorders (Zigmond et al., 1983). 
There were no significant differences in anxiety and depression levels between the head cancer 
sample and the comparison samples, and therefore null hypothesis four was accepted. 
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HR-QoL and optimism, explained 70% of the variance in depression and 58% of the variance 
in anxiety in the head cancer sample only. As levels of HR-QoL and optimism lowered, 
depression and anxiety increased. These data indicate that patients that are at risk of long term 
depression and anxiety are those that have worse HR-QoL and lower levels of dispositional 
optimism. Both of these factors could be assessed at baseline and shortly after treatment 
which potentially has implications for early intervention. Although longitudinal assessment did 
not involve the same patient sample as previous chapters, mean values for both anxiety and 
depression in the current study indicate that levels may continue to decrease over time. 
Time since treatment, and the majority of the clinical and treatment related factors (surgery 
aside) had no influence on either cognitive or emotional adaptation, thereby providing further 
support for the premise that adaptation is a stable, personality based trait. 
The cognitive and affective components of SWB have been reported as highly interrelated 
(Diener, Suh, & Oishi, 1997), and depression was consistently found in the present study to be 
an explanatory factor of life-satisfaction, however, anxiety was not. 
9.6.3 The role of optimism in adaptation 
Research has shown that demographic factors such as health, income, educational background 
and marital status only account for a small amount of variance in SWB. Instead, studies have 
shown that SWB is fairly stable over time, that it may rebound with major life-events and that it 
is often correlated with personality traits (Diener, Oishi, & Lucas, 2003). 
Several meta-analyses have been conducted of the many personality traits that have been 
researched in association with aspects of SWB (DeNeve & Cooper, 1998; Lucas & Fujita, 
2000), however, much of this research has focused on the correlations between SWB and 
extraversion and neuroticism (Costa & McCrae, 1980; Watson & Clark, 1992). The strong 
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correlations found between negative affect and neuroticism, extraversion and pleasant affect, 
have lead many researchers to suggest that these traits provide the primary links between 
personality and SWB. However, as the review by DeNeve & Cooper (1998) demonstrated, 
other personality dimensions and traits, such as self-esteem and dispositional optimism, are 
also consistently related to SWB (Lucas, Diener, & Suh, 1996). Little is known as to whether 
these traits remain predictive once extraversion and neuroticism are controlled for. 
As previously highlighted, the head cancer sample in this study demonstrated similar levels of 
life satisfaction as the other samples, despite reporting worse HR-QoL. Personality traits such 
as dispositional optimism could potentially confound the interpretation of these results. At first 
glance, it could be considered that cognitive adaptation has occurred despite long lasting 
physical difficulties. However, levels of optimism were found to be highest in the head cancer 
sample (although not significantly), which may suggest that elevated life satisfaction scores 
could be a result of an optimistic outlook. 
Indeed multivariate analyses demonstrated that the most important determinant of cognitive 
adaptation throughout the analyses was level of optimism and this also held true with analyses 
with the head cancer sample alone. A previous similar study involving 55 HNC patients, and 
comparison samples comprising orthopaedic patients and healthy controls, found that SWL 
was not correlated with optimism (or health) in the HNC sample but was strongly associated 
with optimism in the other two samples (Kreider et al., 1993). The authors speculate that life 
satisfaction in cancer patients is denoted by satisfaction with other areas apart from health and 
optimism and this may be a function of seeking support from a wide variety of other sources, 
such as work, family and social life. The present study, demonstrates that cancer patients 
maintain similar levels of SWL and that optimism is a large explanatory factor. 
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9.6.4 Theories of adaptation 
The current study did not attempt to examine the underlying processes of adaptation and 
subjective well-being, however, several theoretical approaches aside from Leventhal's self- 
regulatory theory (1980) have been posited. 
Telic theorists hypothesize that SWB is gained when goals and needs are achieved (Diener, 
1984). Therefore, the determinants of SWB are not global but differ according to people's 
values and goals. According to goal theory, if people perceive themselves to have made 
progress towards their goals, in accordance to their values, then they are likely to be satisfied. 
For example, studies have demonstrated that individuals high in S\VB (and low in negative 
affect) perceived their goals to be more important and the probability of success higher than 
those low in SWB (Emmons, 1986), whereas those low in SWB (and high in negative affect) 
perceived more conflict between their goals (Emmons & King, 1988). In addition, Carver and 
Scheier (1990) proposed that perceptions of progression towards goals at a faster rate than 
standard leads to positive affect, whereas progress at a slower rate leads to negative affect. 
Consistent with this hypothesis, research by Brunstein (1993) found that perceived progress 
towards goals caused positive changes in SWB rather than vice versa (Brunstein, 1993). Thus, 
SWB, in particular life-satisfaction, is likely to reflect the individual's fulfilment of their values 
and goals, which also involves the search for meaningfulness in one's life, especially after a life- 
threatening illness. In this way, SWB could be considered a more robust measure of QoL, 
because it reflects deeper values beyond hedonistic pleasure and transient emotion. 
Another theoretical explanation as to why people who are confronted with a serious health 
threat demonstrate levels of well-being comparable to the normal population, is provided by 
theories of cognitive adaptation. For example, Taylor's theory of cognitive adaptation suggests 
that people may use a number of cognitive strategies to counteract the negative impact of 
distress on well-being. Taylor argues that when an individual experiences a personally 
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threatening event, the readjustment process focuses around three themes: a search for meaning 
in the experience, an attempt to regain mastery over the particular event and life in general, and 
an effort to restore one's self-esteem (Taylor, 1983). Research has demonstrated that patients 
who were successful across these three themes, were emotionally better adjusted than those 
who were unable to form and maintain this set of illusions or perceptions (Taylor, Lichtman, & 
Wood, 1984). The majority of research based on Taylor's theory of cognitive adaptation has 
focused on the assessment of optimism, control and self-esteem to represent the theory's three 
components. These aspects have been positively related to adaptation in a number of different 
patient groups, including coronary heart disease and cancer (Helgeson, 1999; Stiegelis et aL, 
2003). 
Studies involving healthy reference groups provide additional support for this theory. Patients 
have been found to demonstrate similar levels of optimism, control and self-esteem as healthy 
samples, which would indicate success in maintaining positive cognitions and thus adaptation 
to a health threat (Carpenter, 1997; Stiegelis et ad, 2003). It is also equally plausible that in order 
to adapt to the health threat, some form of `response-shift' (see chapter 3) has occurred over 
time, leading to reprioritisation of goals. 
9.6.5 Limitations 
A major limitation with this study was with the age and gender matched non-clinical sample. 
This sample was collected for use as a comparison sample and was intended to represent a 
sample derived from the normal population. However, it was quite apparent from the data that 
it was not representative of a `normative' sample. Standardised scores on the HR-QoL 
measures demonstrated that scores were lower than all of the patient groups for, role emotional 
functioning; general health; bodily pain; vitality and physical functioning which could not be 
explained by differences in age or gender. MCS and PCS scores were also demonstrably lower 
than the patient samples, and standardised levels (which may be explained by age related 
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factors, as summary scores are not age and gender standardised). In addition, the non-clinical 
sample displayed more elevated levels of depression than the adult UK normative data set 
(although depression scores were probably not significantly different). This lead to the 
unfortunate conclusion that the `normative sample' was not representative of the normal 
population and thus any comparisons using this group have to be treated with caution. This 
finding was surpising as a reputable research agency supplied the data, however it is not known 
from where they sampled. It is also equally plausible that the clinical samples were also highly 
selected, i. e. those that were worse off in terms of HR-QoL or anxiety and depression did not 
participate. This responder bias would have lead to an even larger discrepancy between the 
relatively well clinical samples and the unrepresentative normative sample. 
Despite the acknowledgment that adaptation is a dynamic process, few studies, including the 
present study, have attempted to examine the dynamic nature of its occurrence. Instead most 
of the evidence for adaptation is derived from cross-sectional studies (Frederick & 
Loewenstein, 1999). The main limitation of not using longitudinal data is that it prevents the 
comparison of post-event levels of SWL with their pre-treatment (or pre-diagnosis) levels, 
thereby limiting the evidence it can give for adaptation occurring. The use of comparison 
groups, using a mixture of benign and malignant tumour patient samples and a normative 
sample were justified in order to provide information on other peoples levels of life SWB, with 
and without having undergone a life-threatening event. In addition, the cross-sectional design 
does not provide information on the direction of causation, which may be more pertinent to 
relationships with factors such as marital status and levels of depression. 
It may have been fruitful to collect more information on the possible underlying processes of 
adaptation by including a measure of illness perceptions in the patient samples. However, it 
was felt that at this preliminary stage in the research into SWB, it would be more appropriate to 
keep the questionnaire pack as minimal as possible to increase the response rates. Further 
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research could utilise the knowledge gained from the previous studies presented in chapters 4 
and 6-8, to study in more depth possible underlying factors in addition to personality traits. 
Scores of the Satisfaction With Life Scale (SWLS) can be interpreted in terms of absolute life 
satisfaction as well as relative life satisfaction. A score of 20 represents the neutral point on the 
scale, the point at which the respondent is about equally satisfied and dissatisfied. The authors 
suggest that scores between 21 and 25 represent slightly satisfied, with 26 and over representing 
satisfied. Scores between 15 and 19 represent slightly dissatisfied with life and scores lower 
than 15 represent the spectrum from very to extremely dissatisfied. The samples in the present 
study, demonstrate satisfaction levels that would be deemed by the authors as `slightly satisfied'. 
Compared to the mean values presented as `normative data' in a review of studies using the 
SWLS (Pavot et al., 1993), twenty-one of thirty-five of the mean values presented were higher 
than our highest mean value of SWL (benign salivary gland condition patients). Although it 
appears that our patient samples have relatively high levels of satisfaction, populations 
reporting lower levels of satisfaction with life than our samples were; male prison inmates, 
hospital inpatients treated for alcohol abuse and abused women (Pavot et al., 1993). It is not 
known why all our samples, in particular the `normative sample' did not score higher with 
respect to life satisfaction and HR-QoL, it would be interesting to compare these data with UK 
standardised data. 
9.6.6 Implications for further research 
Assessing SWB (cognitive and emotional adaptation) appears to be promising for use in clinical 
practice and may provide additional information to standard HR-QoL measures. Our mixed 
samples demonstrated that positive cognitions may be reported in patients irrespective of 
severity of illness. To understand which individuals are able to cognitively and emotionally 
adapt after a threatening event such as cancer, further research should examine individual 
differences in positive cognitions. Intervening in those patients who do not show signs of 
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adapting could be valuable in enhancing their satisfaction with life and reducing psychological 
distress. Possible interventions could include one to one counselling or cognitive behavioural 
therapy to decrease levels of depression and increase opportunity for seeking social support. 
As previously mentioned, another avenue of research would be to build on this study by 
examining the process variables underlying adaptation. This could be achieved using a 
longitudinal study design guided by either Taylor's theory of cognitive adaptation (Taylor, 
1983) or Leventhal's SRM (Leventhal et al., 1984). This would provide data on the dynamic 
process of adaptation and would provide more information on the relationship between 
cognitive and emotional adaptation and whether they occur in parallel. 
9.6.7 Conclusions 
Similar to the majority of other cross-sectional studies of life satisfaction and long term 
emotional outcomes, the present study found that objective circumstances accounted for little 
variance in reports of subjective well-being (SWB). 
Survivors of cancer of the head region reported similar levels of satisfaction with life as the 
normal population, therefore there is evidence that patients with HNC cognitively and 
emotionally adapt over time. This lends support to the premise that people's well-being is 
relatively stable and, over time, people adapt to even the most extreme of life experiences. 
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CHAPTER 10 
GENERAL SUMMARY, DISCUSSION AND CONCLUSIONS 
10.1 Summary of rationale and main aims 
Recent developments in reconstructive techniques and more sophisticated treatment regimes 
for HNC have not automatically lead to an increase in survival rate. Therefore, conservation 
and reconstruction procedures, speech therapy and prostheses have been directed towards 
lessening the impact of the disease and its treatment in terms of quality of life. A critical review 
of the literature (see Chapter 2) highlighted that HR-QoL is considered an important patient 
centred outcome following treatment for HNC. This has been demonstrated by the vast 
number of studies incorporating assessments of HR-QoL. The review highlighted that the 
majority of studies have been aimed at comparing the effects of different treatment modalities 
and tumour characteristics, and have therefore only provided information about the effects of 
treatment and disease related factors on HR-QoL. This has resulted in valuable information 
about the effects of disease sites and treatments on HR-QoL, however few studies have 
attempted to account for other reasons why variation in QoL (both between patients and over 
time) occurs. 
This thesis explored the role of psychological factors in predicting QoL in patients diagnosed 
and undergoing treatment for HNC using a self-regulatory framework (Leventhal et al., 1980; 
Leventhal et al., 1992). The primary aim of the thesis was to investigate the relationship 
between illness and treatment beliefs and both standardised HR-QoL and individualised QoL. 
There were seven key objectives for the research: 
There were seven key objectives for the research: 
" To explore the informational needs of HNC patients and the relationship between 
satisfaction with information and key outcomes (Chapters 4,5: Part 2& 6). 
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" To assess the impact of HNC on QoL using two distinct measures: a) standardised 
measures of HR-QoL (generic and cancer specific) and b) an individualised (patient 
centred) measure of QoL (Chapters 7 &8). 
" To assess the degree of concordance between the two main types of outcome measures 
(Chapter 7). 
" To apply Leventhal's Self-regulatory model (SRM) to guide understanding of the processes 
by which HNC patients understand and react to their illness and to assess how these 
change over time (Chapters 7& 8). 
" To investigate how particular variables specified within the SRhi (e. g. illness 
representations and coping responses) are related to outcomes (Chapters 7& 8). 
" To explore whether additional factors such as the extent to which patients are satisfied with 
information, can partially explain outcomes (Chapters 6& 8). 
" To explore whether psychological factors (illness and treatment beliefs) or clinical and 
treatment related variables are better predictors of adaptation over time (Chapters 8& 9). 
10.2 Summary of main results 
10.2.1 The role of information in QoL 
Literature from other clinical areas (chapter 3) highlighted that pre-treatment expectations were 
influential on outcomes such as; QoL (Koller et al., 2000), HR-QoL (Staniszewska, 1999; Wan 
et al., 1997) and functioning (Iversen et al., 1998; Mahomed et al., 2002) in a wide range of 
illness groups such as cancer, cardiac and arthritis patients. Based on Calman's contention that 
QoL assesses the `difference, or the gap, at a particular period of time between the hopes and 
expectations of the individual and that individual's present experience (Calman, 1984a; 
Calman, 1984b), a pilot study was conducted in order to examine the relationship between the 
fulfilment of expectations, the role of information and subsequent QoL. 
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The qualitative study produced in-depth data about the types of expectations individuals with 
HNC had at various stages of their treatment and recovery (chapter 4). Large variations were 
revealed between patient expectations and the actual experiences that were described. 
Expectations seemed to be derived in part from the information received. The study also 
highlighted the individual nature of the information giving process, whereby many patients did 
not want too much detailed information about their illness and treatment, especially at the early 
stages between diagnosis and treatment, yet many respondents required a detailed breakdown 
of all the possible complications and variables associated with the recovery process. These 
differences in requirements may have been due to differences in personality and/or coping 
strategies between patients although these relationships could not be determined in the present 
study. Previous research has indicated that stable individual differences exist between patients' 
tendencies either to seek or to avoid potentially stressful information about cancer and other 
threatening medical procedures (Miller, 1992). 
Analyses of data from the prospective study demonstrated that satisfaction with information 
before treatment was predictive of outcomes 6-8 months after treatment (chapter 8). 
Satisfaction with the amount and content of information was negatively associated with 
depression scores (Table 8.14) and positively related to MCS scores (Table 8.12), indicating that 
higher levels of satisfaction prior to treatment were predictive of better QoL and lower levels 
of depression. Satisfaction with the form and timing of the information was predictive of 
overall expectations being fulfilled 6-8 months after treatment. 
10.2.2 The impact of HNC on QoL 
Literature reviews (chapter 2) highlighted the morbidity and depression resulting from 
treatment for HNC, although these outcomes were shown to improve within one year. In the 
long-term, despite an initially high level of depression, a gradual improvement in psychological 
functioning and global QoL follows over the next few years. However, a subgroup of patients 
362 
who continue to experience high levels of psychological morbidity years after treatment has 
frequently been reported and it is important to note that this has not been shown to be related 
to physical functioning. 
To date there has been little attempt to explain variations in QoL and although factors such as 
stage, site of disease and type of treatment, have some impact on HR-QoL, it is unclear what 
additional factors account for the large variation evidenced in patient outcomes. Authors in the 
field are beginning to acknowledge that an individual's QoL is probably determined more by 
their perceptions of the disease than the disease itself (Sehlen et al, 2002). 
Of the psycho-social and behavioural factors identified from a systematic review of the 
literature (chapter 2, part 2), a number of important relationships were reported. The 
relationship between personality traits (extraversion/neuroticism, and dispositional optimism) 
and outcome in HNC was established in several studies (Aarstad et al., 2003; Allison et al., 
2000; Yu et al., 2001; Yu et al., 2003). The role of social support was less clear, although 
satisfaction with physician support was found to account for a significant proportion of 
variance in outcome (Mathieson et al., 1996). Satisfaction with information was also found to 
be related to outcome over time (Yu et al., 2001). The relationship between depression and 
QoL was also unclear with mixed study findings. The literature reviews highlighted the relative 
lack of research exploring the influence of psycho-social factors on HR-QoL in HNC and 
demonstrated the need for more robust and theoretically based studies in this area. 
10.2.3 The relationship between variables specified within the SRM (e. g. illness 
representations and coping responses) and outcomes 
Research on lay experiences of illness has found that coming to terms with an illness event 
involves patients interpreting why the event has happened, how it can be further prevented and 
how its effects can be overcome (Bury, 1991). This process may be better understood by 
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applying a framework such as Leventhal's Self Regulatory Model (SRM) (Leventhal et al., 
1980). The Self-Regulation Model proposes that in response to a health threat, such as the 
diagnosis of cancer, individuals develop their own beliefs and emotional responses about their 
illness and treatment, which then influence the coping procedures they adopt. These beliefs, 
emotional responses and coping strategies then influence the outcome, which, in this study, 
were perceptions of QoL. As this is a constant process of reappraisal, patient beliefs and 
coping strategies may be expected to change over time. 
10.2.3.1 Individualised QoL versus HR-QoL 
Although standardised (or traditional) HR-QoL measures are often used with HNC patients 
within a clinical setting, it has been suggested that they fail to capture the individual's sense of 
`quality of life'. This is because they focus on the individual's perception of QoL but only 
related to pre-selected domains. In contrast, patient generated outcome (individualised QoL) 
attempts to capture aspects of QoL that are most important to the individual at that particular 
time point. Given the interest in the use of individualised measures in clinical trials (Campbell 
et al., 2000; Patel et al., 2003) and with cancer patients in general (Camilleri-Brennan et al., 
2002; Lindblad et al., 2002; Waldron et al., 1999), an individualised measure of outcome was 
applied in comparison to HR-QoL in this thesis (chapters 7 and 8). Moreover, suggestions 
made by Leventhal and Colman (1997), indicated that individualised measures may provide 
better outcomes for predictive studies based on SRM components than HR-QoL, as `the 
judgement of quality is aproduct of both the individual's assessment of his or herpersonal experience within a 
variety of domains and the integration of these observations into an overall judgement... ' (Leventhal and 
Colman, 1997). 
It was hypothesised that there would be no relationship between pre-treatment standardised 
assessments of HR-QoL and the individualised measure of QoL due to their conceptual 
differences. The results of our study (chapter 7) suggested that there was partial overlap 
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between these measures pre-treatment and that the main overlap appeared to exist between 
individualised QoL and the cognitive, emotional and mental health HR-QoL domains of the 
standardised measures (Table 7.5). These results suggest that the individualised measure was 
tapping into the emotional and cognitive impact of being diagnosed with HNC. 
10.2.3.2 The relationship between illness perceptions and QoL 
In the present study, a significant amount of variation in pre-treatment HR-QoL could be 
explained by patient's perceptions of their illness (chapter 7). In particular, patients' Illness 
Identity (the amount of symptoms attributed to their HNC) and beliefs about the likely 
Timeline (perceptions about the length of time the illness would last) explained a significant 
amount of variance in HR-QoL and Global QoL (Tables 7.7 & 7.9). However, surprisingly, it 
was found that components of the SRM could not explain any of the variance in individualised 
QoL. Individualised QoL was only associated with the emotional response to the illness in the 
form of anxiety levels (Table 7.10). 
The literature demonstrated that patient beliefs and outcomes change over time (chapters 2 and 
3). Therefore, a longitudinal study was essential in order to determine whether the relationships 
between key components of the SRM and outcomes found at baseline were similar to those 
shown over time. 
Chapter 8 highlighted the dynamic nature of illness and treatment representations, with 
significant changes over time shown in key patient beliefs. Perceptions of the necessity of 
treatment significantly increased over time and correspondingly, patients' understanding of 
their illness significantly increased (Figure 8.2). Interestingly, patients' beliefs about the personal 
controllability of their illness significantly decreased over time from baseline perceptions. In 
addition to these changes, patients' perceptions of the consequences of their illness were also 
less negative. These changes indicate that as patient's beliefs change over time, they may also be 
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modifiable and are independent to illness identity (i. e. levels of symptoms they are currently 
experiencing). Not much is known about how beliefs change over time and what brings about 
these changes. However, the significant changes highlighted in this chapter suggested that 
beliefs may be associated with positive adaptive processes as other outcomes also generally 
improved over time (Figure 8.1). 
Pre-treatment illness and treatment perceptions were not found to be significant predictors of 
any of the QoL outcomes assessed 6-8 months after the end of treatment (PCS and MCS 
scores, Global QoL/health status and individualised QoL). This was a surprising finding and is 
discussed in more detail in section 10.3.1. Perceptions of the extent to which expectations had 
been fulfilled were predicted by beliefs about the consequences of the illness and the emotional 
response to the illness (Tables 8.16 & 8.18). 
10.2.3.3 The relationship between coping strategies and QoL 
The literature supports the notion that patient beliefs may be more predictive of outcomes than 
coping mechanisms (chapter 3); however, the SRM and the present data do not maintain this 
view. 
Pre-treatment coping strategies were related to pre-treatment QoL in the present study (chapter 
7). In particular, the use of more adaptive strategies, such as positive reframing, were associated 
with better QoL, and maladaptive strategies such as substance use and self-blame were 
associated with worse QoL. For example, higher levels of self-blame were associated with 
lower levels of global QoL (Table 7.9) and higher levels of reported substance use were 
associated with poorer mental QoL (MCS score) (Table 7.8). The direction of causation is not 
known, but it is feasible that less adaptive coping leads to poorer QoL. It is equally as plausible, 
however, that perceptions of poor QoL lead to difficulties coping effectively. 
366 
It is also worth reiterating that more maladaptive coping styles were also positively associated 
with more negative illness and treatment perceptions (Table 7.11). For example, higher levels 
of denial, substance use and venting were associated with perceptions of more negative 
consequences, greater concerns regarding treatment, and a greater emotional response to the 
illness. High levels of denial were also associated with lower levels of understanding 
(coherence) regarding their illness. 
Coping strategy was found to be significantly predictive of only one longitudinal QoL outcome 
measure; Global health status/QoL (chapter 8). Levels of acceptance coping were negatively 
related to Global health status/QoL indicating that lower levels of acceptance were reported by 
individuals experiencing high levels of QoL (Table 8.10). This may appear to be contrary to 
expectations but, it may be that acceptance is related to severity of symptoms and impairment 
resulting from the cancer, or indeed states of denial. Patients reporting high QoL may be un- 
accepting of their cancer due to denial or because they have very little by way of signs and 
symptoms to remind them of their cancer diagnosis. 
10.2.4 The relationship between optimism and QoL 
In contrast to previous research (Aarstad et al., 2003; Allison et al., 2000), dispositional 
optimism was not found to be an important explanatory variable of QoL in the prospective 
study. At baseline, optimism was not associated with any of the outcome measures (chapter 7), 
and was only predictive of Mental Component Summary (MCS) scores 6-8 months after 
treatment when higher levels of optimism were associated with higher MCS scores (chapter 8). 
In contrast, the cross-sectional study assessing the subjective well-being of HNC patients 
demonstrated that the most important determinant of cognitive adaptation throughout the 
analyses was level of optimism (chapter 9). The disparity between the results from the 
prospective study and the cross-sectional study may be explained by several factors. Firstly, 
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different outcome measures were used in the studies and additional explanatory factors such as 
illness and treatment perceptions were not present in the cross-sectional study. Personality may 
exert an indirect influence through the types of beliefs held, which disappears when illness 
perceptions are included in the analysis. Alternatively, the inconsistent pattern of associations 
found between optimism and outcomes is consistent with ideas of Segerstrom and colleagues 
who maintain that a more flexible model of optimism should be considered, whereby the 
context of the stressor is taken into account along with the degree of `disappointment' the 
individual experiences as a result (Segerstrom, 2005). 
10.2.5 Depression 
Levels of depression in the literature have been shown to vary considerably in HNC (see 
Chapter 2). However, levels in the present sample were found to be similar to pre-treatment 
levels reported in both cross-sectional and prospective designed studies (DAntonio et al., 1998; 
de Graeff et al., 2000b). It is possible, however, as higher levels have been reported in the 
literature (Birkhaug et al., 2002; Duffy et al., 2002) that the present sample is not representative 
of all patients with HNC and that patients with higher levels of depression did not take part. 
As expected, depression explained some of the variance in HR-QoL at baseline (Tables 7.7 & 
7.8), which is consistent with previous research (de Graeff et al., 2000b; Hammerlid et al., 
2001b). Surprisingly, baseline depression and longitudinal outcome were not found to be 
related as other prospective studies have suggested (D'Antonio et al., 1998; de Graeff et al., 
2000b). This reveals that when other psychological variables are taken into account, the 
relationship between depressive symptoms and QoL diminishes, and that QoL is not just a 
proxy indicator of depression. It was also interesting to note that variance in patient generated 
QoL was not explained by depressive symptoms at either time point. 
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Regarding depression as an outcome variable, half of the variance in baseline scores was 
explained by illness identity, anxiety and feelings of self-blame (Table 7.13). Associations were 
positive, indicating that higher scores on these three measures were related to higher 
depression. Longitudinal levels of depression were predicted by baseline beliefs regarding the 
expected duration of the illness (timeline beliefs), self-blame, levels of acceptance coping, and 
satisfaction with information (just after treatment). 
10.2.6 Were treatment and clinical related factors better predictors of adaptation over 
time than patient related factors? 
The results presented in chapter 8 indicated that only tumour stage was related to outcomes 
(Global health status/QoL, individualised QoL, and expectations regarding the extent of 
recovery). The relationship was inverse indicating larger tumours were associated with worse 
outcomes. None of the other clinical and treatment related factors proved significant. Similarly, 
findings from chapter 9 indicated that only treatment modality was related to cognitive 
adaptation (satisfaction with life). 
Having had `surgery only' was found to be protective of satisfaction with life which may have 
been due to less time taken to heal, as opposed to the long term effects of radiotherapy (Table 
9.8). Alternatively, `surgery only' may have been acting as a surrogate marker for tumour size 
or tumour severity as larger tumours are more likely to be treated with multiple modes of 
treatment. Analysis with stage data was not found to be significant, however. From these 
results it appears that patient related factors such as patient perceptions, coping strategies and 
levels of satisfaction with information were better explanatory factors of outcome than any 
clinical or treatment related factors. 
10.3 Theoretical implications 
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A key aim of this thesis was to examine the utility of the SRM in predicting outcomes in IINC. 
Furthermore, if this model proved constructive in the understanding of adaptive processes in 
this patient group, factors found to be predictive of outcomes and potentially modifiable may 
be used to inform future intervention studies to enhance patient outcomes after treatment. 
10.3.1 The application of the SRM to guide understanding of the processes by which 
HNC patients understand and react to their illness 
Chapter 3 highlighted the wealth of evidence linking components of the SRM to outcomes 
such as QoL or depression in various illness groups (Moss-Morris et al., 2003; Rutter et al., 
2002; Vaughan et al., 2003). However, a criticism of these studies was that the majority were 
based on cross-sectional data and thus the direction of causation cannot be established. 
Literature searches highlighted that there had been no previously published work examining 
this relationship in HNC patients. 
The SRM framework was useful in guiding the original selection of factors to be included in 
the current research. The IPQ and BMQ instruments had not frequently been applied to the 
area of cancer and thus not much was known about their suitability for use with FINC patients. 
Components of the SRM such as illness perceptions and coping strategies were found to be 
better explanatory factors of dependent variables such as HR-QoL and depression at baseline 
than longitudinally. In particular, beliefs relating to illness identity, timeline, and emotional 
representations were significantly related to outcome, in addition to coping strategies such as 
substance use, self-blame, self-distraction, venting and use of instrumental support. Particular 
outcomes were more successfully explained by components of the SRbi than others. For 
example, approximately half of the variance in pre-treatment Global health status/QoL was 
explained by coping strategies and illness beliefs alone. Likewise, a large proportion of anxiety 
and depression at baseline were explained by SRM components. 
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However, baseline illness and treatment perceptions and coping strategies were not found to be 
predictive of the majority of outcomes at longitudinal follow-up. Depression was an exception 
to this rule, with 67% of the variance predicted by psychological factors of; timeline beliefs, 
self-blame, acceptance coping and satisfaction with information. This finding is, however, 
consistent with the SRM which maintains that a person's cognitions and behaviour influence 
outcomes at that time and cognitions and behaviour at one point of time would not necessarily 
be expected to influence outcomes at another time point in the future. 
The results have indicated that the SRM was valuable in providing information about the 
underlying psychological determinants of a variety of outcomes at baseline. It was also useful 
for examining the extent to which patient's beliefs and coping strategies at the time of 
diagnosis affected levels of depression over time. The SRM proved limited for predicting other 
longitudinal outcomes, however, the SRNI does not actually specify direct relationships 
between illness beliefs and outcomes or relationships over time (as mentioned previously). The 
model stipulates that illness beliefs guide coping, and the model proved successful in 
establishing a link between these two components. 
In terms of the utility of the SRM for the design of interventions, findings from the current 
research indicate that any positive effects of intervention would be limited if solely based on 
illness representations and coping strategies. However, these psychological factors were more 
successful in explaining outcomes than any demographic or clinical factors, which provides 
promising data for intervening in the case of vulnerable patients. 
10.3.2 Alternative theories on which to base research into adaptation in HNC patients 
An alternative theory on which to base studies examining adaptation in people who are 
confronted with a serious health threat is Taylor's theory of cognitive adaptation (Taylor, 
1983). As applied in chapter 9, Taylor's theory of cognitive adaptation suggests that people may 
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use a number of cognitive strategies to counteract the negative impact of distress on well-being. 
Taylor argues that when an individual experiences a personally threatening event, the 
readjustment process focuses around three themes: a search for meaning in the experience, an 
attempt to regain mastery over the particular event and life in general, and an effort to restore 
one's self-esteem (Taylor, 1983). Research has demonstrated that patients who were successful 
across these three themes, were emotionally better adjusted than those who were unable to 
form and maintain this set of illusions or perceptions (Taylor et al., 1984). The majority of 
research based on Taylor's theory of cognitive adaptation has focused on the assessment of 
optimism, control and self-esteem to represent the theory's three components. It may be 
fruitful to examine adaptation from the perspective of this theory and use the three themes 
outline above as a basis for intervention in individuals who do not show adaptation over time. 
Further work may determine whether this theory is more appropriate to the study of IINC 
patients than the SRM. 
10.4 General critique/limitations of the research 
The specific limitations of each study have been addressed in some detail in each chapter, 
however, a discussion of a number of more general limitations and criticisms can be found in 
this section. 
10.4.1 Theoretical issues 
The majority of the research in this thesis was based on the SRM, however, it was not possible 
to fully test this model due to its complexity. In particular, it proved difficult to capture the 
dynamics of when and how changes to outcome occurred and what factors in particular caused 
the change. The problem with using formulaic measurement times to assess process factors 
and outcome i. e. at 1 month and 6 months etc, is that changes can not be captured exactly 
when they occur, and the variability between people in terms of when changes occur can not 
be observed. A key component of the SRM is the appraisal process, and similar to the majority 
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of studies applying the SRM, this part of the model was not tested. The appraisal stage of the 
model is critical in understanding outcomes as it accounts for the two-way process between the 
beliefs people have and the coping strategy they employ. This then has repercussions for 
outcome. The appraisal mechanism is rarely assessed as it is difficult to capture when it occurs 
and how it manifests. Attempts could be made to assess this process through interviewing, 
although the full extent of this process may be obscured in patients who are less aware of it 
occurring. Until we fully understand the mechanism of appraisal and its relationship between 
coping and beliefs, it is impossible to establish how important this process is in influencing 
outcome. 
10.4.2 Measurement and analytical issues 
The QoL questionnaires used in the thesis may have substantial overlap with the attributes of 
illness representations assessed by the IPQ (e. g. illness identity overlaps with symptom 
experience, emotional representations may tap into emotional functioning, etc). This may 
partially explain associations between illness representations and outcomes. However, this 
would not explain why timeline beliefs were key explanatory factors, and existing outcome 
measures typically neglect the effect of time-line and control on QoL and do not address 
beliefs relating to treatment. 
Many of the measurement tools used in this research were not validated, for example the SCIP 
and the three items to assess expectations (pages 183-185). The decision to use non-validated 
measures was taken as no other suitable validated measures existed. Preliminary work 
supported the usefulness and psychometric properties of these measures, however, further 
research is needed with additional patient samples in order to comment on the absolute 
reliability and validity of these particular measures. 
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A problem with QoL data in general, is that there is an inherent bias towards those that are 
better off and indeed those that have survived. Follow-up data tends to be skewed towards 
those with earlier stage tumours and therefore less physical consequences of treatment. A 
comparison of those that were originally recruited into the study and those that remained at 
follow-up, demonstrated a significant difference in tumour stage, with those remaining in the 
study being diagnosed with earlier stage tumours at the outset. Relatively large attrition rates for 
a number of reasons, limits the generalisability of the results. A recent paper attempted to 
clarify whether there was a more appropriate way to statistically analyse longitudinal QoL data 
due to issues of dropout (Curran, Molenberghs, Aaronson, Fossa, & Sylvester, 2002). The 
authors suggest that modelling approaches such as selection models and pattern-mixture 
models may be useful when considering the effects of drop-out on the data. However, these 
methods may be more pertinent to examining treatment effects across a large group rather than 
individual patterns. 
Alternatively, cluster analysis may be a more appropriate method of analysis for small data sets 
such as those generated from HNC samples. Cluster analysis is a tool of discovery which is 
useful for revealing associations in data which may not be previously evident. For example, it 
may be useful to know whether there is a pattern between illness representations or indeed 
relationships between illness representations and outcomes. Cluster analysis could also be used 
to create individual patient profiles of factors of interest such as beliefs and coping strategies 
which could then be used as a basis for one-to-one interventions (Clatworthy, Buick, Hankins, 
Weinman, & Horne, 2005; Hobro, Weinman, & Hankins, 2004). Indeed, a limitation of much 
of the work using the SRM, the present work included, is the assessment and reporting of 
beliefs on an individual basis. The SRM was intended to examine obvious dusters of beliefs in 
order to provide a schematic model, and therefore not necessarily providing an assessment of 
individual illness representations. 
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Regarding the power of the study, many of the models may not have been adequately powered 
due to low sample sizes. This was due to the fact that HNC is a relatively rare disease, made 
worse by problems with recruitment. A larger multi-centred site is required to harness 
sufficient cases in the time period and understand any regional variations. In addition, to this, 
large numbers of statistical tests applied to the data meant an increased possibility of a resultant 
Type I error. The significance level of the tests could have been lowered; however, this 
inevitably would have increased the Type II error rate. 
10.4.3 Length of follow-up 
The follow-up time of the longitudinal study was limited to six to eight months post treatment 
due to time and funding. Time taken to complete treatment varied considerably between 
patients and some patients had not finished treatment up to four to five months after 
diagnosis. This meant that some of the patients had a shorter follow-up period than others. 
Important changes may occur between six and eight months into recovery, especially in the 
case of late toxicities of radiotherapy treatment, and using an arbitrary cut-off such as this may 
have meant that factors and beliefs that might impact outcomes over a longer term were 
obscured. 
It would be of further interest to investigate whether baseline factors found to be predictive of 
outcomes at six to eight months after treatment, were predictive of longer-term outcomes or 
whether the relationships between beliefs and outcomes change over time as suggested by the 
results of chapters 7 and 8. Further research could extend the study for longer than was feasible 
in the present study. This would have further implications for the utility of intervention at 
different time-points. 
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It is also acknowledged that other factors may have had an influence on outcomes for several 
reasons. Firstly, from the literature reviews presented here and wider reading, additional 
psychological variables, such as social support, may affect QoL and depression. 
Secondly, a substantial amount of variance was unaccounted for in the models presented in this 
thesis, thereby suggesting that other factors are exerting an influence on outcome. Social 
support has shown to buffer the negative consequences of illness (Kornblith et al., 2001) under 
the right circumstances, and it is reasonable to assume that access to appropriate social support 
may impact on QoL, either directly or via perceptions or coping strategies. Further research 
could investigate this aspect in more detail. 
10.5. Clinical implications and recommendations based on research findings 
10.5.1 Early recognition of vulnerable individuals 
The findings from the studies in this thesis indicate that there may be scope to provide both 
general and individualised interventions. Results have suggested that individuals who may have 
problems adapting over time could be identified by assessing dispositional factors such as low 
levels of optimism. Head and neck nurses trained to identify patients at risk early on could 
provide additional support or rehabilitation on an individual basis. 
Head and neck cancer services require additional specialist HN nurses trained to provide 
advice, tailored information provision and appropriate counselling to patients in need. Better 
access to specialist counselling or psychological support services within the hospital (and not 
via the GP) would be recommended in cases where the patient's level of distress is not 
diminishing and depression levels not improving over time. 
10.5.2 Tailoring information to meet an individual's need 
Chapters 4 and 6 highlighted that HNC patients have differing needs for information and vary 
in their levels of satisfaction. Written materials provided for HNC patients typically consist of 
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generic information, often in the form of pamphlets or booklets and were designed for generic 
use amongst all patients with HNC. Although these materials are a cost-effective method for 
providing valuable generic information, it could be argued that their one-size fits all approach is 
not sensitive to the variation that exists between people in their desire for and understanding of 
information (Kreuter et al., 1999). Satisfaction with information has been shown to be 
associated with particular patient beliefs (although the direction of causation is unclear) and has 
been shown to influence whether patient's expectations have been met after treatment. With 
this in mind and, as recommended by other authors (Newell et al., 2004; Semple et al., 2002), it 
would seem judicious to assess HNC patients needs for information on an individual basis. 
Technological advances mean that highly customised materials could feasibly be designed on an 
individual basis. Materials could be tailored to multiple aspects of the individual, providing 
information that fits their lives better than generic materials currently used (Holt et al., 2000). 
Although this is a new area for providing health education messages, it could feasibly be 
applied for understanding patient's individual requirements for information instead of the 
professional providing information they consider valuable. Further research could investigate 
the feasibility and design of tailored information and messages for HNC patients and cancer 
patients in general. 
An association between satisfaction with information and outcomes such as global QoL and 
depression was found. Consequently, satisfaction with information could be an important 
target for intervention in order to improve short-term and long-term patient well-being. 
Targeting unmet informational needs could prove a cost-effective and relatively simple 
intervention. 
An additional positive aspect of enhancing patient satisfaction with information, by providing a 
good match between the provision of information and patients' requirements, is the promotion 
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of partnership between the patient and the health care professional. The need for good 
communication between health professionals and patients is emphasised in current MIS policy 
(NHS Centre for Reviews and Dissemination, 2000) and also serves to aid the decision making 
process by empowering the patient (Grahn, 1996). 
10.5.3 Access and advertisement of specialist support groups 
Another key area to emerge from this thesis was the scope for improving the provision of 
information about support groups. Over half of the current sample had not received any 
information about support groups prior to their treatment and a third reported the same one 
month after treatment. A report by The King's Fund (1997) found that many fINC patients 
did not know of the existence of support groups and that some professionals did not advertise 
support groups as patients did not ask for them (Edwards, 1997). It appears that not much has 
changed since this report. Local support groups known specifically for HNC patients and 
partners existed at many of the recruiting sites, and information about these could be supplied 
regardless of whether patients explicitly ask or appear to have difficulties coping. Patients' 
perceptions of these groups could also be challenged through better advertising of the activities 
available at the groups and through actively inviting patients and supporters as part of routine 
practice. 
10.5.4 Teaching patients coping strategies 
Our findings suggested that coping strategies may be better predictors of outcome than patient 
beliefs. Better levels of QoL were associated with `adaptive' coping strategies such as positive 
reframing. Worse outcomes were associated with higher levels of substance use and self-blame. 
Over the longer term, higher levels of acceptance coping were predictive of better Global QoL. 
Previous attempts have been made to teach HNC patients coping strategies using psycho- 
educational interventions in order to improve QoL (Allison et al., 2004). Their intervention 
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focused on enhancing a sense of personal control and learning emotional and instrumental 
coping responses. Although modest benefits were reported, the intervention was not tailored 
to the individual and did not necessarily address the patient's requirements or deficits. In terms 
of providing a clinic based intervention, patients' individual coping styles could easily be 
assessed at different time points and addressed in a more personal and meaningful way. 
Reducing maladaptive coping, such as high alcohol and substance use could be addressed 
through counselling alongside teaching alternative (and less harmful) ways of coping. 
10.5.5 The utility of assessing individualised QoL as part of clinical practice 
With regard to generating specific information about patients, individual QoL assessment has 
value. However, for large scale clinical studies examining changes in QoL after treatment etc, it 
would not be appropriate to use highly individualised QoL statements. Patient generated 
measures such as the PGI can be difficult to interpret and use in a meaningful way. Due to this, 
patient generated outcome measures may be appealing for use in clinical practice, however, 
they are probably best used as an adjunct to traditional HR-QoL measures. 
10.6 Implications for further research 
Several key areas emerged as important areas for further study. Firstly, the SCIP gave 
promising results when used in the present studies, however, further validation of its 
psychometric properties is needed as the instrument has essentially only undergone preliminary 
testing. If the instrument was found to be valid and acceptable in further research, it may prove 
a useful tool both clinically and to further understand relations with outcomes in research 
settings. 
Satisfaction with information was predictive of beliefs regarding the necessity of treatment and 
how important the treatment was in controlling their disease. One explanation for this could be 
that patients are getting the information too late and the importance of the treatment has not 
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been fully recognised. Although all the patients in this sample underwent some form of 
treatment, this finding is noteworthy and it would be valuable to further investigate whether 
beliefs about treatment and control after undergoing primary treatment arc predictive of 
adherence to further treatment, or are influential in the decision making process prior to 
primary treatment. 
The preliminary work presented in this thesis on patient expectations provided some 
interesting findings and the present research could be extended to examine the relationship 
between informational needs, expectations and patient outcomes in more detail. The literature 
suggests that pre-treatment expectations can influence post-treatment outcomes (Iversen et al., 
1998) and it would be interesting to further validate the items used to tap into expectations in 
this thesis and explore these and other relationships more robustly. 
The next stage in this work would be to design and implement interventions with the aim of 
improving post-treatment QoL and psychological adaptation. Tailored interventions could 
therefore address particular beliefs such as treatment concerns and the time scale of the illness, 
and focus on fostering more adaptive coping strategies such as acceptance and the use of 
emotional and instrumental support, whilst avoiding maladaptive coping strategies, such as self- 
blame and substance use. One avenue could be through the use of cognitive-behavioural 
approaches aimed at altering the negative beliefs about the treatment and course of the illness 
whilst encouraging a sense of control over the illness. Other methods of coping such as seeking 
social support and accepting the situation could be offered as alternatives to avoidance coping 
such as self-blame and using substances such as drugs and alcohol. It may be feasible to 
implement more simple interventions through support groups with the aid of specialist nurse- 
counsellors. 
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Assessing subjective well-being (cognitive and emotional adaptation) appears to be promising 
for use in clinical practice and may provide additional information to standard I-IR-QoL 
measures. The patient samples used in chapter 9 demonstrated that positive cognitions may be 
reported in patients irrespective of severity of illness. To understand which individuals are able 
to cognitively and emotionally adapt after a threatening event such as cancer, further research 
should examine individual differences in positive cognitions. Intervening in those patients who 
do not show signs of adapting could be valuable in enhancing their satisfaction with life and 
reducing psychological distress. Possible interventions could include one to one counselling or 
cognitive behavioural therapy to decrease levels of depression. 
Another area of research could be to build on the cross-sectional study presented in chapter 9 
by examining the process variables underlying adaptation. This could be achieved using a 
longitudinal study design guided by either Taylor's theory of cognitive adaptation (Taylor, 
1983) or Leventhal's SRM (Leventhal et al., 1984). This would provide data on the dynamic 
process of adaptation and would provide more information on the relationship between 
cognitive and emotional adaptation and whether change occurs in parallel. 
10.7 Conclusions 
The cross-sectional and prospective studies contained in this thesis have increased our 
understanding of the predictors of QoL in HNC patients. 
Important relationships were found between components of the SRM such as illness beliefs 
and coping, and outcomes. Psychological factors such as these were found to be better 
predictors of outcome and adaptation than either clinical/treatment related factors or socio- 
demographic factors. 
If the findings of this thesis can be replicated in other samples of HNC patients, this has 
important implications for the design of evidence based interventions in order to facilitate 
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adaptive coping strategies and improve patient outcomes (both cognitive and emotional). 
Eliciting and addressing negative perceptions of the consequences of the disease and treatment, 
whilst maintaining strong perceptions of the necessity of treatment and helping patients cope in 
more adaptive ways could be feasible targets. 
More generic interventions could also be devised such as the early recognition of vulnerable 
people due to dispositional and situational factors. These individuals could be provided access 
to specialist rehabilitation services, or cognitive behavioural counselling for those that need 
help with adapting after treatment. Other important targets for intervention could include the 
provision of individualised information and the promotion of awareness of support groups. 
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APPENDIX II: Preliminary data extraction sheet 
Ref no: 
Reviewer: 
A DETAILS OF PUBLICATION 
Author ........................................................................................... ...................................... Title ..................................................................................................................................... 
Reference ............................................................................................................................ 
Country study sample derived 
from ....................................................................................... 
B RESEARCH Q/HYPOTHESES 
a) Aim 
b) Outcome 
C STUDY DESIGN 
a) Recruitment procedures reported? 
b) Cross-sectional, 
Prospective/ longitudinal 
c) Time since diagnosis/treatment 
d) Control patients / comparison group reported? 
D i. PARTICIPANTS 
no. of patients 
patient characteristics in study 
i. e. cancer type (SCC etc) 
site of cancer, 
stage of cancer 
treatment 
or whether mixed sample reported 
recurrent cancer? 
complications reported? 
neck dissections reported? 
age, sex, class, ethnicity, geographic location, other info 
Is sample representative of study population? 
i. e. recruitment rate 
response rate 
inclusion/exclusion criteria? 
ii. CONTROL PATIENTS / COMPARISON GROUP (if applicable) 
no. of patients 
patient characteristics in study 
i. e. cancer / no cancer 
site of cancer 
stage of cancer 
treatment 
or whether mixed sample reported 
recurrent cancer? 
complications /neck dissections? 
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age, sex, class, ethnicity, geographic location, other info 
Is sample representative of intended population? 
i. e. recruitment rate 
response rate 
inclusion/exclusion criteria 
E OUTCOME MEASURES 
Who carried out measurement? 
What was the measurement tool? 
Was the reliability and validity reported: 
- in literature? 
- for particular study sample? 
What was measured at baseline? 
Time interval between measurements? 
Other sources of information used 
F ANALYSIS 
Statistical techniques used? 
What factors were adjusted for? 




Particular HR-QoL subscales found to be impaired? 
H AUTHOR COMMENTS 
Conclusions from study 
Inferences from study 
I OTHER CONSIDERATIONS/ REVIEWER COMMENTS 
Strengths/weaknesses of study 
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APPENDIX III: Critical appraisal form 
Factor Weighting 
Study aims/ Good (2) Aims clear, research Q or hypotheses 
research Q stated. Adequate (1) Aims stated, no specific research Q 
or hypotheses. 
Poor (0) Aims not clear or not stated. 
Study design Good (2) Prospective or case/ control 
Adequate (1) Cross-sectional 
Poor (0) Not clear 
Sample Good (2) Large, representative, well described 
characteristics: Adequate (1) Limited info on sample 
Poor (0) Unable to determine characteristics and 
representativeness of sample or poor 
representativeness. 
Analysis Good (2) Appropriate multivariate analyses, 
controlling for confounding factors 
Adequate (1) appropriate but limited/simplistic 
analyses. 
Poor (0) analyses inappropriate/ inadequate, likely 
to give misleading results. 
Statistical Good (2) power calculation included or 
power appropriately powered study. 
Adequate (1) adequately powered going by 
sample size/analyses 
Poor (0) v. underpowered going by sample size/ 
analyses 
Validity of Good (2) Accurate and derived from good 
conclusions statistical analyses/design. 
Adequate (1) Generally supported by results. 
Poor (0) bear no resemblance to results presented 
Overall score (0 - 12) 
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APPENDIX IV 
Semi-structured interview schedule 
Patient's retrospective accounts of experiences of head and neck cancer: 
expectations and informational needs 
I would like to ask you about the experiences and thoughts you 'vc' had in the tine sire e 
you were first diagnosed. I wait to get a better understanding o/ the sorts of 
expectations and perceptions people have not onh, about their illne. ý. c and stchsecluc'nt 
treatment but also regarding the impact to their li/i' i» geirc'ral. 
Reassure of confidentiality and anon i'mih' and gain irrfin-mecl c"ofr. ('ft to use tupc 
recorder. 
Opening Q 
1. I'd like to start by asking you to tell nie a little bit about when you were First 
diagnosed and the kind of treatment you've had since. 
A Expectations: 
Now, I'd like you to think about whether you had any cypectatio, Is rcgardingi, omr 
treatment and recovery. 
1. Can you tell me whether you had any expectations regarding your treatment'' 
do you iliunk you didn't 1L1' ý : iýýv') 
2. Can you tell me whether you had any expectations regarding the recovery process'? 
(Prompt ýcý arding how you would fccl, look, function in, n;,,, I ; jtcly <ýftýr ; inýl it 
tiiric Point alter rccoýý. ýry. ) 
3. [If applicable] This is a difficult question, but, could you tell me whether your 
expectations have been met? (Prompt: In %ti hat sorts ()I- vý av s ýv hy 
4. Looking back, do you think now that you had realistic expectations? 
(Prompt: In what ways 'v crc they realistic; not realistic? ) 
5. Did you have any worries or concerns over any aspect of the treatment or recovery'? 
(Prompt: What would happen, procedures, outcome, vvakinýL UP III hospital, hovv y'ooii'(l 
feel or look, how long the recovery process would take, impact on life, coping etc) 
6. Prior to treatment, did you have any expectations regarding what you thought your 
health would be like now? (Prompt: Better vVorse the sannt collij) uICd to hovv vOu I'M 
now? ) 
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7. Prior to treatment, did you have any expectations regarding what you thought your 
quality of life would be like now? (Prompt: Better /worse / the same compared to how 
you feel it is now? ) 
8. Do you think there have been any changes to your life due to the cancer and 
treatment? (Prompt: e. g. the consequences of treatment, life priorities, feelings, day to 
day activities/ work/ functioning.... In what way have things changed, why have they 
occurred, how do you feel about this? ) 
B Informational needs Irole in preparation: 
I'd now like to ask you some questions regarding the information you received about 
your illness and treatment and how satisfied you were with it. 
1. Thinking back, were you satisfied with the amount and type of information you were 
given about your illness and the types of treatment suitable for you? (Prompt: amount, 
type of info. when given, by whom, info about illness, info about treatment, in what 
ways satisfied/ not satisfied, what aspects were you most happy/least happy with. ) 
2. [If not covered] What sorts of information were you given? (Prompt: verbal, reading 
materials, mixture of both, did you read it all, how well did you understand/ remember 
what was said/ read. ) 
3. Were you told in advance about all the procedures you underwent? 
(Prompt: anything that happened that was unexpected - in hospital or afterwards. ) 
4. Were you given information or told about any impact the treatment may have on how 
you would physically feel? (Prompt: pain, functioning, aesthetically, energy etc) 
5. Were you given information or told about any impact the treatment may have on your 
lifestyle or quality of life? (Prompt: ability to work, housework, daily activities, family 
functioning, social life etc) 
6. Is there anything you wish that you had been told? 
7. Were there any side-effects or aspects of the treatment that you wish you'd been 
warned of? 
8. How do you think the information you received helped you to prepare for what 
happened? 
9. Do you think there would be any way of improving how well prepared you felt? 
10. Thinking back to when you were first diagnosed and then undergoing treatment, was 
there anything that you remember feeling uncertain about? (Prompt: Any aspects of 
treatment or recovery you weren't sure about and why. Any aspects of your life as a 
whole - financial, family, job? ) 
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APPENDIX IVb: SUMMARY OF QUESTIONNAIRES USED IN THE RESEARCH 




APPENDIX IV (b) 
Summary of questionnaires used in the research and reported in different 
chapters of the thesis 
CHAPTER 
56789 
Page number 190 216 254 279 320 











EORTC QLQ C30 X - X X - SFI2v2 - - X X - PGI - - X X - SWLS - - - - X HADS - - X X X 
Expectations - X _ 
Predictors/ explanatory 
factors 
IPQ-R X X X X _ BIPQ X 
BMQ - Specific X X X X - HADS X X X X X 
LOT-R X X X X X 
Brief COPE - X 1 X X 
SCIP X X 
_ X _ Expectations 
SF12v2 X 
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Guys, King's and 5th Floor Thomas Guy House 
St Thomas' Guys Campus 
School of Medicine London SE19RT 
Psychology Unit Direct line tel: +44 (0) 20 7955 5000 ext Departmental tel: +44 (0) 20 7955 4965 
Departmental fax: +44 (0) 20 7955 2727 
APPENDIX V 
PATIENT INFORMATION SHEET Version 2 
Study of quality of fife in patients with head and neck cancer 
17ING'S. 
NCollege LODON 
University of London 
We are a research team at Guy's Hospital, London who are carrying out a study examining the quality 
of life in patients with head and neck cancer. We would like to invite you to help us with our research. 
Before you decide it is important for you to understand why the research is being done and what it will 
involve. Please-take time to read the following information carefully and discuss it with friends, 
relatives and your GP if you wish. Ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
Thank you for reading this. 
What is the purpose of the study? 
We would like to find out what factors affect the quality of life of people with head and neck cancer 
both before and after treatment. We are interested in each individual's expectations and perceptions 
about their illness and treatment over the eight mouth period since diagnosis. If you participate, this 
may help us to find out what factors are important to people at different stages of their illness and 
treatment and why some people experience difficulty adjusting after their cancer diagnosis. 
If you participate, -a questionnaire pack will be used to assess your quality of life, anxiety and 
depression four times during the next twelve months. In addition, your views and expectations 
regarding your diagnosis and treatment will also be assessed by questionnaire. 
Do I have to -take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. If you decide to take part you are still 
free to withdraw at any time and without giving a reason. This will not affect the standard of care you 
receive. 
What will happen to me ifI take part? 
The study will last for 8 months from your consent to take-part, and your participation will be required 
at 4 time periods during this period. 1) After diagnosis, but before treatment, 2) 1 month after treatment 
3) at 4 months-and 4) at 8 months following treatment. In order to help you fill in the questionnaire, a 
researcher will arrange to meet you at a time when you will be visiting the hospital for an appointment 
and at a time convenient to you. We would like you to complete a questionnaire pack asking about 
how you currently feel relating to your illness and your treatment. If at any time you change your mind 
and would like to withdraw from the study, you do not have to give us a reason. 
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What are the possible benefits of taking part? 
The information we get from this study will help us to understand the issues that are important to 
newly diagnosed cancer patients and whether these issues change over time. This will enable us to be 
aware of any difficulties you are having throughout your treatment and follow-up at Guy's Hospital. 
We also hope that this information can be used to design appropriate interventions for individuals who 
have difficulty adjusting after cancer treatment. This should benefit patients in the future. 
Will my taking part in this study be kept confidential? 
All information which is- collected about you during the course of the research will be kept strictly 
confidential. Any information about you which leaves the hospital will have your name and address 
removed so that you cannot be recognised from it. Your identity will not be revealed in any 
report/publication. 
Who is organising and funding the research? 
This study is being funded by the Guy's & St. Thomas' Charitable Foundation and has been reviewed 
and approved by the Guy's Research Ethics Committee. 
Contact for Further Information 
Consumers for Ethics in Research (CERES) publish a leaflet entitled `Medical Research and You : 
This leaflet gives more information about medical research and looks at some questions you may want 
to ask Please ask us for a copy, or if you wish, a copy may be obtained from CERES, PO Box 1365, 
London N16 OBW. 





5th Floor; Thomas Guy House, 
Guy's Hospital, 
London SEI 9RT 
Tel: 020 7848 6790 
Email: carrie. d. Ilewellyn@kcl. ac. uk 
Professor Mark McGurk 




Tel: 020 7955 4342 
Please keep this information sheet and a signed consent form for further reference. 
Patient Information sheet Version 2 04/04/02 
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APPENDIX VI: CONSENT FORM FOR PROSPECTIVE STUDY 
398 
Guy's, King's 
and St Thomas' 
Dental Institute 
Department of Oral 
and Maxillofacial 
Surgery 
Professor Mark Mcßurk Mo FRCS ow Fos acs Floor 23 Guy's Tower 
Secretary Guy's Hospital 
Tel 020 7955 4342 London Bridge 
London SE19RT 
Tel 020 T955 4342 




LREC Study Number. 02/03/07 APPE NDIX 
University of London 
Patient Identification Number for this trial: 
CONSENT FORM 
Title of Project: Study of quality of life in patients treated for head and neck 
cancer 
Name of Researchers: CD Llewellyn, Professor M McGurk, Professor J Weinman 
Please Initial box 
1. I confirm that I have read and understand the information sheet (Version 3. dated 07/01/04) 17 
for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, .Q 
without giving any reason, without my medical care or legal rights being affected. 
3. I understand that sections of any of my medical notes may be looked at by 'responsible Q 
individuals from the research team or from regulatory authorities where it is relevant to my 
taking part in research. I give permission for these Individuals to have access to my 
records. 
4.1 agree to take part in the above study. 






1 for patient; 1 for researcher; 1 to be kept with hospital notes 
II 
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APPENDIX VII: QUESTIONNAIRE PACK FOR PROSPECTIVE STUDY 
400 
TEXT BOUND INTO 
THE SPINE 
APPENDIX 
VII patients' views 
about cancer, treatment and 
informational requirements 
Thank you for agreeing to take part in this study. 
By taking part you will be contributing to 
research which may be useful in improving the 
quality of life for patients in the future. 
All of the information you provide will be 
completely confidential. None of the medical 
staff looking after you will see your answers. 
Ref. No. 
401 
ABOUT THE QUESTIONNAIRE 
Thank you for agreeing to take part in this study. 
" The aim of this questionnaire is to find out what factors affect the quality 
of life of people who have been diagnosed with head and neck cancer. 
We are interested in the views you may have about your illness and its 
treatment over the next twelve months. 
" The questionnaire starts with a section on your views about your illness 
and the treatment that has been recommended for you. The next section 
asks about your quality of life now and general health /activities, There are 
also questions asking about the way you are currently feeling. We would 
also like to find out your views regarding the information you have been 
given about your illness and treatment and finally there are some 
background questions about yourself 
" Don't spend too long on any question - the first answer that comes to 
you is usually the best. 
" Try to answer all the questions. 
" If you cannot answer a question, don't worry, just go on to the next and 
return to it after. 
" If you have difficulty answering these questions please contact the 
researcher contact details on the back of this questionnaire, 
" All the information you give will be treated in the strictest 
confidence. Your name will not be identified on this questionnaire 
and treating staff will not have access to your answers. 
" Once you have completed this questionnaire please return it in the 
enclosed freepost envelope or hand it directly to the researcher, 
Please remember - there are no right or wrong answers. 
We are interested in your personal views only. 
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ILLNESS PERCEPTIONS QUESTIONNAIRE - REVISED (IPQ-R) & 
BELIEFS ABOUT MEDICINES QUESTIONNAIRE (BMQ) - SPECIFIC SCALE 
YOUR VIEWS ABOUT YOUR ILLNESS 
listed below are a number of symptoms that you may or may not have 
experienced since your illness. Please indicate by circling Yes or No, whether 
you have experienced any of these symptoms since your illness, and 
secondly, whether you believe that these symptoms are related to your illness. 
Please fill in both sections 
I have experienced this 
symptom since my illness 
s' Pain Yes No 
Sore Throat' Yes No 
Nausea Yes No 
Breathlessness Yes No 
Weight Loss Yes NO 
Fatigue Yes No 
Stiff Joints Yes No 
Sore Eyes Yes No 
Difficulties eating Yes No 
s'o Headaches Yes No 
Upset Stomach Yes No 
S12 Sleep Difficulties Yes No 
Dizziness Yes No 
1" Loss of Strength Yes No 
s'5 Difficulties speaking Yes No 
This symptom is related 































We are interested in your own personal views of how you now see your 
cancer. Please indicate how much you agree or disagree with the following 




p' My Illness is likely to be permanent El 
rather than temporary 
F-1 
My illness will last for a long time F-I El F-I 7 F1 
P' I expect to have this illness for the 7 EJ 77 
rest of my life 
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P4 My illness has major consequences 
on my life 
My illness strongly affects the way 
others see me 
'P6 My illness causes difficulties for those 
who are close to me 
IP7R Nothing I do will. affect my illness 
'Pa I have the power to influence my illness 
My actions will have no affect on the 
outcome of my illness 
1P10RMy illness is a mystery to me 
""RI don't understand my illness 
P'2RMy illness doesn't make any sense to me 
1P13 My symptoms come and go In cycles 
p" My illness is very unpredictable 
P15 I go through cycles In which my 
illness gets better and worse. 
1 
1116 i get depressed when I think about 
my illness 
'ý" When I think about my illness I get upset 
I'18 Having this illness makes me feel anxious 
ýJ 00 ýJ 
Cho X00 00 
QQQQQ 
QQQQQ 
1: 1 El El El El 
El El El El 1: 1 
F-I F-I F-I F-I* F-I 
El 1: 1 El El El 
El El 1: 1 1: 1 1: 1 
El F-I F-I F-1 Fý 
F-I F-I F-I F-I F71 
F. -I F-I F-I F71 F-I 
F-I El El 1: 1 El 
F 0 F-I F-1 El 
El El El El El 
7 El F-I F-I 7 
El El El 0 El 
404 
CAUSES OF YOUR ILLNESS' 
In the space below, *please list in rank-order the three most important factors 
that you believe caused YOUR illness. 




BELIEFS ABOUT TREATMENT 
Please indicate how much you agree or disagree with the following 
statements about your treatment by ticking the appropriate box. 
My health in the future will depend 
on my treatment 
My health at present depends 
on -my treatment 
N' My life would be -impossible without 
this treatment 
I" Without this treatment I would be very III 
''6 My treatment protects me from 
becoming worse 
I Having to undergo treatment worries me 
I sometimes worry about the long-term 
effects of the treatment 
a My treatment is a mystery to me 
G My treatment disrupts my life 
505 e(>(, e? 
EI EI n r-ý ' 
El 1: 1 El El El 
. 1: 1 El 1: 1 1: 1 El 
El El P El El 
El El El El El 
1: 1 El El El 1: 1 
1: 1 El El El El 
F-I F-I F-I F-I Fý 
El 1: 1 El El El 
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THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF 
CANCER (EORTC) QLQ - C30 (version 3) 
We are interested in some things about you and your health. Please answer 
all of the questions yourself by circling the number that best applies to you. 
There are no "right" or "wrong" answers. The information that you provide will 
remain strictly confidential. 
QLQ1 Do you have any trouble doing strenuous 
activities, like carrying a heavy shopping 
bag or a suitcase? 
QIQ2 Do you have any trouble taking a Iona walk? 
°LQ' Do you have any trouble taking a short walk 
outside of the house? 
°LQ" Do you need to stay in bed or a chair during the day? 
L°5 Do you need help with eating, dressing, washing 
yourself or using the toilet? 
During the past week: 
QLQ5 Were you limited in doing either your work or other 
daily activities? 
QLQ7 Were you limited in pursuing your hobbies or other 
leisure time activities? 
QLQI Were you short of breath? 
°LQ9 Have you had pain? 
°La10 Did you need to rest? 
Q(Q1 Have you had trouble sleeping? 
QLQ12 Have you felt weak? 
QLQ13 Have you lacked appetite? 
QLQ14 Have you felt nauseated? 
QLQ15Have you vomited? 
Not at A Quite Very 
All Little a Bit Much 
12 3 4 




1 2 3 4 
1 2 3 4 
1234 
12 3 4 
12 3 4 
12 3 4 
l2 3 4 
12 3 4 
12 3 4 
12 3 4 
12 3 4 
12 3 4 
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Not at A Quite Very 
All Little a Bit Much 
buring the past week: 
01°16Have you been constipated? 1 2 3 4 
'111 Have you had diarrhoea? 1 2 3 4 
°1°18 Were you tired? 1 2 3 4 
""Did pain interfere with your daily activities? 1 2 3 4 
°1220Have you had difficulty In concentrating on things, 
like reading a newspaper or watching television? 1 2 3 4 
°1021 Did you feel tense? "1 2 3 4 
Did you worry? 1 2 3 4 
°L023 Did you feel irritable? 1 2 3 4 
°1Q24 Did you feel depressed? 1 2 3 4 
QL021 Have you had difficulty remembering things? 1 2 3' 4 
Has your physical condition or medical treatment 
interfered with your family life? 1 2 3 4 
°CQ27Has your physical condition or medical treatment 
interfered with your social activities? 1 2 3 4 
Has your physical condition or medical treatment 
caused you financial difficulties? 1 2 3 4 
for the following questions please circle the number between 1 and 7 that 
best applies to you 
How would you rate your overall health during the past week? 
123456 7 
Very poor Excellent 
x°30 How would you rate your overall quality of life during the past week? 
1234.5 6 .7 
Very poor Excellent 
407 
© Copyright 1995 EORTC study group on Quality of Ufa. All rights reserved. Version 3.0 
THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF 
CANCER HEAD AND NECK MODULE (EORTC QLQ - H&N35) 
Patients sometimes report that they have the following symptoms * or 
problems. Please indicate the extent to which you have experienced these 
symptoms or problems during the past week. Please answer by circling the 
number that best applies to you. 
Not at A Quite Very 
During the past week: All Uttle a Bit Much 
HN31 Have you had pain In your mouth? 12 3 4 
HN32 Have you had pain In your jaw? 12 3 4 
H" Have you had soreness In your mouth? 12 3 4 
W34 Have you had a painful throat? 12 3 4 
""-15 Have you had problems swallowing liquids? 12 3 4 
HN36 Have you had problems swallowing pureed food? 12 3 4 
HN37 Have you had problems swallowing solid food? 12 3 4 
"" Have you choked when swallowing? 12 3 4 
HN39 Have you had problems with your teeth? 12 3 4 
H"ý0 Have you. had problems opening your mouth wide? 12 3 4 
HN41 Have you had a dry mouth? 12 3 4 
Have you had sticky saliva? 12 3 4 
H"43 Have you had problems with your sense of smell? 12 3 4 
HN44 Have you had problems with your sense of taste? 12 3 4 
HN45 Have you coughed? 12 3 4 
H" Have you been hoarse? 12 3 4 
HN47 Have you felt ill? 
HN4B Has your appearance bothered you? 
HN48' Have you had any problems in the area of your 








Not at A 
Du All ring the past week: 
little 
w49 Have you had trouble eating?. 1 2 
1N50 Have you had trouble eating in front of your family? 1 2 
'ß'S1 Have you had trouble eating in front of other people? 1 2 
11,152 Have you had trouble enjoying your meals? 1 2 
Have you had trouble talking to other people? 1 2 
'`' Have you had. trouble talking on the telephone? 1 2 
Have you had trouble having social contact with 
your family? 1 2 
N'S6 Have you had. trouble having social contact 
with friends? 1 2 
" Have you had trouble going out in public? 
Have you had trouble having physical 
contact with family or friends? 
F"59 Have you felt less interest in sex? 
'' Have you felt less sexual enjoyment? 
During the, past. week: 
"I Have you used pain-killers? 
" Have you taken any nutritional supplements 
(excluding vitamins)? 
MO Have You Osed a feeding tube? 
"1 Have you lost weight? 
I" Have you gained weight? 
12 
Quite Very 










12 3 4 
12 3 4 
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SF-12 HEALTH SURVEY (SF-12v2) 
ý. 
YOUR HEALTH AND WELL-BEING 
This survey asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual 
activities. 
For each of the following questions please mark an ZJ in the box that best 
describes your answer. 
' In general would you say your health is: 
Excellent Very good Good Fair Poor 
QQQQQ 
The following questions are about activities you might do during a typical day. 




a. Moderate activities, such as moving a table, Li 
pushing a vacuum cleaner, bowling or playing golf 






sF3 - During the past 4 weeks how much time have you had any of the 
following problems with your work or regular daily activities as a result of 






All Most Some A little None 
of the of the of the of the of the 
time time time time time 
a. Accomplished less than you would like U U U U 




' During the past 4 weeks how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 




ca. Accomplished less than you would like Li 
b. Did work or other activities less carefully Li 
than usual. 
Most Some A little None 
of the of the of the of the 
time time time time 
Q Q Q Q 
Q Q Q Q 
During the past -4 weeks how much did p-Q-ni Interfere with your normal work 
(including both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
QQQ-QQ 
SF6 These questions are about how you feel and how things have been with you 
du_rinqthe past 4 weeks. For each question, please give one answer that comes 
closest to the way you have been feeling. How much of the time during the last 
4 weeks... 
All Most Some A little None 
of the of the of the of the of the 
time " time time time time 
a. Have you felt calm and peaceful C1 C) Li Li Li 
b. Did you have a lot of energy Li U U Li Li 
c. Have you felt downhearted and depressed Li U. .U Li Li 
If 
07 During the past 4 weeks how much of the time has your physical health or emotional 
r Lem interfered with your social activities (like visiting friends, relative, etc. )? 
All of Most of Some of A little of None of 
the time . 'the 
time the time the time the time 
Q Q Q Q Q 
411 
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SATISFACTION WITH CANCER INFORMATION PROFILE (SCIP) 
ii 
TEXT BOUND INTO 
THE SPINE 
Satisfaction with information 
We would like to ask you about the information you have received about 
you diagnosis and treatment for cancer. Firstly, please answer whether you 
have received any information about the following aspects of your illness 
and secondly, rate the amount you have received (if Applicable). If you are 
having or have had more than one type of treatment please give your 
overall feeling about the information you have received. 
Y. Rýeýso tick one box oar tb 
Did you receive any Do you feel as if you have 
y ß'eä hs coon ý'ý, 4 `; > 
tý s ,c 
information about: received enough information 
Yes No 
What your diagnosis means to you Q 
The types of treatment suitable. for you Q 
The expected benefit of treatment Q 
What procedures your treatment 
will involve Q 
Whether the treatment has any 
unwanted side effects 
Q 
What the risks of you experiencing 
side effects are 
Q 
What the risks of you experiencing 
complications are 
Q 
What you should do if you 
experience unwanted side effects 
Q 
Whether your treatment interferes with 
other medicines you may be taking 
Q 
How you may expect to feel 
mmediately after treatment 
Q 
The effects of treatment on your 
ability to work 
J 
2 Who to ask/where to go for possible 
financial support Li 
Whether you may need further 














Too About Too None 
much right little wanted 
Q Q Q Q 
Q Q Q Q 
Q Q Q Q 











. Piepse tick Qng.; box yin a ,. Did you receive any 
iý each se Ction '7 information about: , Y 
Yes No 
The effect of treatment on your 
appearance QQ 
The long term impact of treatment 
on functioning (daily activities) QQ 
How long you expect recovery to take QQ 
How your treatment may impact on 
your quality of life over the next year 
QQ 
Patient support groups for you and 
your partner 
QQ 
Do you feel as if you have 
received enough information 
Too About Too None 
much right little wanted 
Q Q Q Q 
Q Q Q Q 
Q Q Q Q 
Q Q Q Q 
QQ QQ 
Overall, how would you rate the following: 
Very Satisfied Neither 
satisfied 
The usefulness of the information to you QQQ 
The usefulness of the information to 
your partner/family 
Q 
`'The amount of written information supplied Q 
"ý The amount of verbal information supplied Q 
The timing at which you received information Q 
The detail of the information given to you Q 
How understandable the information 
was to YOU 
Q 
Dis- Very dis- 
satisfied satisfied 
Q Q 
Q Q Q Q 
Q Q Q Q 
Q Q Q Q 
Q Q Q Q 
Q Q Q Q 
QQQQ 
"- is there any further information you wish you had received? 
Is there anything else you would like to add regarding the information you 
'? ceived? 
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THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
This section will help you to let us know how you are. Read each item and 
tick the box of the response which comes closest to how you have felt in the 
lost few days. *Don't take too long over your replies, your immediate reaction 
will probably be more accurate than a long thought out response. 
AD' I feel tense or `wound up' AD, ' I have lost interest in my appearance 
Most of the time Q Definitely Q 
A lot of the time Q I don't take so much care as I should Q 
From time to time, occasionally Q I may not take quite as much care Q 
Not at all Q I take just as much care as ever Q 
^D2 I still enjoy the things I used to enjoy AD6 I can laugh and see the funny side 
Definitely as much Q 
of things 
Not quite so much Q 
As much as I always could Q 
Only a little 
Q Not quite so much now Q 
Hardly at all 
Definitely not so much now, Q 
Not at all Q 
AD3 I get a sort of frightened feeling 
like `butterflys' in my stomach AD' I feel restless as if I have to be on 
Q 
the move 
Not at all 
Occasionally Q 
Very much Indeed Q 
Quite often 
Q Quite a lot Q 
Very offen 
Q Not very much Q 
Not at all . 
Q 
A1 $ get a sort of frightened feeling as if 
something awful is about to happen AD' Worrying thoughts go through my mind 
Very definitely and quite badly Q 
Yes; but not too badly 
Q 
A little, but it doesn't worry me 
Q 
Not at all 
Q 
-A great deal of the time 
Q 
A lot of the time Q 
From time to time but not too offen Q 
Only occasionally Q 
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I look forward with enjoyment to things AD13I can enjoy a good book or radio 
Q As much as i ever did 
or TV programme 
Rather less than I used to 
Often Ei 
Definitely less than I used to 
Sometimes Ei 
Hardly ever Ei 
Not often Ei 
'I'll feel cheerful 
Not at all 
Not often 
Sometimes 
Most of the time 
'' I get sudden feeling of panic 
Very often Indeed 
Quite often 
Not very often 
Not at all 
Very seldom El 
AD14 I feel as if I am slowed down 
Nearly all the time Q 
Very often Q 
Sometimes Q 





FOR Over the past month, how often have 
you worried about the possibility that 
cancer might come back? 
(3 
\12l can sit at ease and feel relaxed 
Definitely Q 
Usually Q 
Not often Q 
Not at all Q 








THE BRIEF COPE 
These next items deal with ways you've been coping-with the* stress in your 
life since you were diagnosed with cancer. There are many ways to try to 
deal with problems. Different people deal with things in different ways, but 
I'm interested in how you've tried to deal with it. Each item says something 
about a particular way of-coping. I want to know to what extent you have 
been doing what the item says. How much or how frequently. Don't answer 
on the basis of whether it seems to be working or not-just whether or not 
you're doing it. Use these response choices. Try ' to rate each item 
separately in your mind from the others. 
YOU as you can. 
col I've been turning to work or other 
activities to take my mind off things. 




\o QA ýyo 
F-I Fý F71 F-I 
CO2 I've been concentrating my efforts on 
doing something about the situation I'm in. 
QQQQ 
CO3 I've been saying to myself "this Isn't real, " 
QQQQ 
c I've been using alcohol or other drugs 
to make myself feel better. 
QQQQ 
Q CO5 I've been getting emotional support 
from others. 
Q El 
C I've been giving up trying to deal with It. 
QQQQ 
C07 I've been taking action to try to make Q El QQ 
the situation better. 
Coll I've been refusing to believe that it QQQQ 
has happened. 
CO9 I've been saying things to let my QQ 
unpleasant feelings escape, 
El F-1 
co"I've been getting help and advice 
from other people. 
QQQQ 
CO1I've been using alcohol or other drugs QQQQ 
to help me get through it. 
417 
CO12I've been trying to see it in a different 
light, to make it seem more positive. 
COl31've been criticising myself. 
CO14I've been trying to come up with a 
strategy about what to do. 
KA 1,10q 
00 4Pb 
El El El 1: 1 
El El El El 
El El El El 
CO15I've been getting comfort and 
understanding from someone, 
Q Q Q Q 
cO'bl've been giving up the attempt to cope. 
Q Q Q Q 
co"I've been looking for something good 
in what is happening. 
Q Q Q 
cO BI've been making jokes about it. 
Q Q Q Q 
cp19I've been doing something to think QQ 
about it less, such as going to movies, F-I El 
watching TV, reading, daydreaming, 
sleeping, or shopping. 
CO20I've been accepting the reality of QQQQ 
the fact that it has happened. 
c02' I've been expressing my negative feelings. 
QQQQ 
C029've been trying to find comfort in 
my religion or spiritual beliefs. El El El El 
I've been trying to get advice or help 
from other people about what to do. 
cc)241've been learning to live with it. 
co251've been thinking hard about 
what steps to take. 
c0261've been blaming myself for things 
that happened. 
CD27 been praying or meditating. 
CO2 i've been making fun of the situation. 
El El El El 
El El El 1: 1 
El El El El 
El El El 1: 1 
El El El 0 
El E] 1: 1 1: 1 418 
LIFE ORIENTATION TEST - REVISED (LOT-R) 
Please be as honest and accurate as you can throughout. Try not to let your 
response to one statement influence your responses to other statements. 
There are no "correct" or "incorrect" answers. Answer according to your 
own feelings, rather than how you think "most people" would answer. 
ß`e Oß`00 
0 






LO"If something can go wrong for me, it will. 
Q Q Q Q Q 
=I'm always optimistic about my future, 
Q. Q Q Q Q 
'41 hardly ever expect things to go my way. 
Q Q Q Q Q 
°I rarely count on good things happening Q Q Q Q Q 
to me. 
LcIT6Overall, I expect more good things to 
happen to me than bad. 
Q Q Q Q Q 
BACKGROUND QUESTIONS ABOUT YOU 
We would like to ask you a few questions about yourself. 
Your date of birth 
Are you: MALE Q 
FEMALE Q 
Please tick the box that best describes your highest educational qualification: 
No qualifications Q Degree or similar Q 
GCSE /0 levels Q Higher degree Q 
GCE /A levels or similar Q Other, please specify 
Higher Education or similar Q 
419 
Are you...? 
Single Q Married/living together Q 
Divorced Q Widowed ' Q 
Separated. Q 
How would you describe your ethnic group? 
White Q Indian Q 
Black -'Caribbean Q Pakistani Q 
Black - African Q Bangladeshi* Q 
Black - Other Q Chinese 
Q 
Other Q Other Asian* Q 
Thank you for your time and effort. 
Please check that you have answered 
all the questions on each page. 
Return in the pre-paid envelope. 
420 
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Tel 020 7955 4342 
Fax 020 7955 4165 
IN's KG College 
LONDON 
University of London 
PATIENT INFORMATION SHEET Version 1 
Study of quality of He in patients treated for conditions of the salivary gland 
Dear 
We are a research team at Guy's Hospital, London who are carrying out a study examining the quality 
of life of patients who have been 'treated for conditions of the salivarygland. We would like to invite 
you to help us with our research. Before you decide it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following information 
carefully and discuss it with friends, relatives and your GP if you wish. Ask us if there is anything that 
is not clear or if you would like more information. Take time to decide whether or not you wish to 
take part. 
Thank you for reading this. 
What is the purpose of the study? 
We would like to find out what factors affect the post-treatment quality of life of people with 
conditions of the salivary gland. We are interested in each individual's experience and satisfaction 
with their life since treatment. If you participate, this may help us to find out what factors are 
important to- people after being treated for their illness and why some people experience difficulty 
adjusting after treatment. 
If you participate, the enclosed questionnaire pack will be used to assess. your current quality of life 
and other related factors. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. If you decide to take part you are still 
free to withdraw at any time and without giving a reason. This will not affect the standard of care you 
receive. 
What will happen to me if I take part? 
This study will require you to complete the questionnaire pack once. If you require any help 
completing the questionnaire, please let us know and a researcher will arrange to meet you at a time 
when you will be visiting the hospital for an appointment or at home at a time convenient to you. If at 
any time you change your mind and would like to withdraw from the study, you do not have to give us 
a reason. 
Patient Information sheet: Version 1 07/01/04 422 
What are the possible benefits of taking part? 
The information we get from this study will help us to understand the issues that are important to 
patients who have undergone treatment for cancer and whether these issues change over time. We also 
hope that this information can be used to design appropriate interventions for individuals who have 
difficulty adjusting after cancer treatment. This should benefit patients in the future. 
Will my taking part in this study be kept confidential? 
All information which is collected about you during this study will be kept strictly confidential. Any 
information about you which leaves the hospital will have your name and address removed so that you 
cannot be recognised from it. Your identity will not be revealed in any report/publication. If you do 
not wish to complete the questionnaire please return it in the reply-paid envelope and this- will ensure 
we do not inadvertently ask you again. 
Who is organising and funding the research? 
This study is being funded by the Guy's & St. Thomas' Charitable Foundation and has been reviewed 
and approved by South East London NHS Research Ethics Committee. 
Contact for Further Information 
Consumers for Ethics in Research (CERES) publish a leaflet entitled `Medical Research and You 
This leaflet gives more information about medical research and looks at some questions you may want 
to ask Please ask us for a copy, or if you wish, a copy may be obtained from CERES, PO Box 1365, 
London N16 OB W. 
Yours sincerely, 
Professor Mark McGurk 
If you have any queries, please do not hesitate to contact either myself (Tel: 020 7955 4342) or Carrie 
Llewellyn (020 7848 6790). 
Please keep this information sheet and a signed consent form for further reference. 
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Guy's, King's Professor Mark McCurk MD FRCS DLO Fos RCS Floor 23 Guys Tower 
and St Thomas' 
Secretary Guy's Hospital IN( "S 
Dental Institute Tel 029 7955 4342 London Bridge 
London SE1 9RT 
KCullege 
Department of Oral 
and Maxillofaclal 
Tel 020 7955 4342 LONDON Fax 02079554165 
Surgery 
University of London LREC Study Number. 02/03/07 APPENDIX IX Patient Identification Number for this trial: 
CONSENT FORM 
Title of Project: Study of quality of life in patients treated for conditions of the 
salivary glands 
Name of Researchers: CD Llewellyn, Professor M McGurk, Professor J Weinman 
Please Initial box 
1. I confirm that I have read and understand the information sheet (Version 1. dated 07/01/04) 
for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
Q 
without giving any reason, without my medical care or legal rights being affected. 
3. I understand that sections of any of my medical notes may be looked at by *responsible Q 
individuals from the research team or from regulatory authorities where it is relevant to my 
taking part In research. I give permission for these individuals to have access to my 
records. 
J 
4.1 agree to take part in the above study. 
Name of Patient Date Signature 
Researcher Date Signature 
1 for patient; 1 for researcher; 1 to be kept with hospital notes 
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Yd February 2003 
King's College Hospital 
Denmark Hill 
London SE5 9R5 
Tel: 020 7737 4000 
Fax: 020 7346 3445 
www. kingsch. nhs. uk 
Dear Carrie Llewellyn 
s 
Re.: King's College Hospital LREC Protocol No. 02-03-053 
Guy's LREC Protocol No. 02/03/07 
Assessing the role of psychological factors in predicting subjective quality of life in 
patients with head and neck cancer 
Thank you for submitting the above application. This is suitable for approval under the reciprocal 
arrangement of the Ethics Committees within Southeast London Strategic Health Authority. The 
following documents have been reviewed: 
9 Health Authority Locality Form signed 17.01.03 
" Guy's LREC application form signed 22.02.02 
" Guy's LREC approval letter dated 18.04.02 
" Guy's and St Thomas' R&D registration confirmation letter dated 25.04.02 
" Consent Form referring to information sheet version 2 dated 04.04.02 
" Patient Information Sheet version 2 dated 04.04.02 
" Research Protocol version 1* (* version number allocated by KCH LREC as none given) 
" CV for Andrew John Lyons 
I have no `local' ethical objections to this study and therefore I am happy to give approval on 
the understanding that you will follow the conditions of approval set out below. 
" You do not undertake this research until approval has been given by 'the relevant NHS 
Trust. 
" You do not deviate from, or make changes to, the protocol without prior written approval 
from this Research Ethics Committee, except where necessary to eliminate immediate 
hazards to research participants or when the change involves only logistical or 
administrative aspects of the research. In such cases the REC should be informed within 
seven days of the implementation of the change. 
" You complete and return the standard progress report form to the REC one-year from the 
date on this letter and thereafter on an annual basis. This form should also be used to 
notify the REC when you research is completed and in this case should be sent to this 
REC within three months of completion. 
" If you decide to terminate this research prematurely you send a report to this REC within 15 days, indicating the reason for early termination. 
King's College Hospital ý 
NHS Trust 
ýýý \ýýABOGr ý y"i 
o4ý' 
f ýýSABýýý 
INVESTOR IN PEOPLE 
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" You advise the REC of any unusual or unexpected results that raise questions about the 
safety of the research 
King's College Hospital LREC complies with the ICH GCP requirements. 
Yours sincerely 
LCJ ? hthlhHV 
Dr D Jewitt 
r. , Chairman, Research Ethics Committee 
King's College Hospital 
Contact: Lisa Strittmatter 
Tel: 020 7346 3923 
Fax: 020 7346 4245 
Email: lisa. strittmatter(@kingsch. nhs. uk 
428 
Guy's & St Thomas' 
HOSPITAL TRUST 
Guy's Research Ethics Committee 
Chairman: ," Professor Steven Sacks 
Administrator: Mrs Valerie Heard 
valerie. heard@gstt. sthames. nhs. uk 
12 March 2003 
Ref: 02/03/07 
Ms Carrie Llewellyn 
Unit of Psychology 
5th Floor Thomas. Guy House 
Guy's Hospital 
Dear Ms Llewellyn 
Guy's Research Ethics Committee 
3rd Floor Nuffield Annexe 
Henriette Raphael House 
Guys Hospital 
London SEI9RT 
Tel: 020 7955 4559 or 020 7955 5000 Ext. 5181 
Fax: 020 7955 4303 
Please always quote reference number in correspondence 
Re: 02103107 Assessing the role of psychological factors in predicting subjective quality of life 
in patients with head and neck cancer 
Amendments I and II (Version 1) detailed in form dated 3 March 2003 
Life Orientation Test (undated) 
Appendix 2. The satisfaction with information about medicines scale (SIMS) (undated) 
An Executive Sub-Committee of the Guy's Research Ethics Committee met on 10 March 2003 
to consider the above amendment(s) and' gave approval on behalf of the Committee. This will be 
reported in the minutes for the meeting held on 26 March 2003 
This Committee functions in accordance with the guidelines of ICH GCP. A list of the full 
membership of the Guy's Research Ethics Committee is given below. 
Yours sincerely 
Mrs Valerie Heard 
LREC Administrator 
Full membership of the Guy's Research Ethics Committee 
Professor 
Miss Sara Arenas-Lopez - Pharmacist 
Miss Usa Bumapp Nursing Representative, Guys 
Dr Michael Fenlon Prosthetic Dentistry. Guy's 
Mr John Fowler Lay Representative, non-Guy's 
Anna McKay Legal/Lay Member 
Dr David Miles Consultant Oncologist, Guy's 
Dr Jacques Mizan Academic Assistant GP Member, non-Guy's 
Professor Costantino Pitzalis Consultant Rheumatologist, Guy's 
lVl, a [Wut , JGl IUOl owlI 
Dr M. K. Sharief 
VGy 
Consultant Neurologist 
Professor Emily Simonoff Professor of Child & Adolescent 
Psychiatry, Guy's 
Jin-Jin Tang Pharmacist 
Dr Shane Tibby Paediatric Intensive Care Unit, Guy's 
Dr Val Wass Senior Lecturer in General Practice 
& Primary Care 
DrAdrfan Williams and DrAdrian Hopper, Co-Chairs St Thomas' 
Hospital LREC, ex officio members 
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Guy's & St Thomas' 
HOSPITAL TRUST 
Guy's Research Ethics Committee 
Chairman: Professor Steven Sacks 
Administrator: Mrs Valerie Heard 
18 April 2002 
02/03/07 
Ms Carrie Llewellyn 
Department of Oral Medicine 
King's College Dental Institute 
Denmark Hill Campus 
Caldecot Road 
London 5E5 9RW 
Dear Ms Llewellyn 
Guy's Research Ethics Committee 
Guy's Hospital 
London SEI 9RT 
Tel: 020 7955 5000 Extension 5181 
"FäX 020 7955 4303 
valerie. heard@kcl. ac. uk 
Re: 02103/07 Assessing'the role of psychological factors in predicting subjective quality of life in patients 
with head and neck cancer 
Patient information sheet and consent form Version 2 dated 04/04/02 
Questionnaire EORTC QLQ-C30 (version 3) 
PROFESSOR JOHN WEINMAN, PROFESSOR MARK McGuRK (SUPERVISORS) 
Thank you for your letter of 4th April 2002 enclosing an amended information sheet and consent 
form listed above. This meets the committee's concerns and the study has Guy's Research Ethics 
Committee approval. 
All information sheets and consent forms in this study need to carry. the Ethics Committee reference 
number and version number/date. 
Permission is granted on the understanding that: 
i) Any ethical problem arising in the course of the project will be reported to the Committee; 
ii) Any change in the protocol or subsequent protocol amendments will be forwarded to the Committee using the 
enclosed form (available in electronic format). The principal investigator should see and approve any such 
changes and this needs to be indicated in the forwarding letter to the Committee. 
iii) A brief report will be submitted one year after commencement, thereafter annually, and after completion of 
the study. Continuing approval is dependent upon this report. 
iv) Approval is given for research to start within 12 months of the date of application. If the start is delayed 
beyond this time, applicants are required to consult the Chairman of the Committee. If the study does not 
start within 3 months of date of this letter, please notify the Committee of the date of commencement 
for record purposes. 
A list of members in attendance at the 27 March 2002 meeting is enclosed. 
Yours sincerely 
Steven H Sacks 
Chairman of the Guy's Hospital Research Ethics Committee 
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Primary Care Trust 











New England Road 
Brighton 
BN1 4GW 
Direct Line: 01273 296437 
2 keny. Ionghurst@bhcpct. nhs. uk 
Ref: (B) 03/10 
From the Brighton LREC 
Study title: Assessing the Role of Psychological Factors in Predicting Subjective 
Quality of Life (QoL) in Patients with Head and Neck Cancer 
" Patient information sheet (version 4- dated 1318/03) 
" Consent form (version 3- dated 117103) 
" Research Protocol (dated 1315/03) 
Thank you for your letter and enclosure of 13 August 2003. 
can confirm that the amended patient information sheet is now satisfactory and I am 
writing to inform you that Chairman's Action has been given to approve this study. 
Approval is granted on the understanding that: 
1) Any ethical problem arising in the course of the project will be reported to the Committee. 
ii) Any change in the protocol or subsequent protocol amendments will be forwarded to the 
LREC. The principal investigator should see and approve any such changes and this needs to 
be indicated in the forwarding letter to the Committee. 
iii) All serious adverse events must be reported within one week to the Ethics Committee, at the 
same time indicating that the principal investigator has seen the report and whether or not 
they feel it poses any new ethical or safety issues. 
iv) A brief report will be submitted one year after commencement, thereafter annually, and after 
completion of the study. 
v) Approval is given for research to start within 12 months of the date of application. If the start 
is delayed beyond this time, applicants are required to consult the Chairman of the 
Committee. 
Brighton & Sussex University Hospitals NHS Trust now operates a research & development approvals process. 
If you are an employee of the Trust, or wish to undertake research using either Trust patients or facilities you will 
need to apply for trust approval before the project can commence. In order to do this you will need to complete 
and sign a Trust approval project record. To obtain a copy, please contact Scott Hayfield, R&D Manager on 
01273 696955 ext 7497 or email scott. harfielda-bsuh. nhs. uk. 
Yours sincerely 
Kerry Longhurst (Mrs) 
Senior Research Ethics Committee Administrator 
C. lProgram WeslQualcommlEudoral(b)0310ddoc 
Switchboard: 01273 295490 General Fax 01273 295461/62 
Minicom: 01273 296205 431 
South East London il/ 
Strategic Health Authority 
University Hospital Lewisham 
Research Ethics Committee 
1st Floor Research Centre 
Lewisham High Street 
London, SE13 6LH 
Chair: Annette Jeanes 
Administrator: Pat Martin 
Direct line: 020 8333 3135 
Fax: 020 8314 0626 
Email: pat. martine-uhl. nhs. uk 
Website: www. corec. org. uk 
Ms Carrie Llewellyn 29th July 2003 
Psychology Unit 
Giy's, King's & St Thomas' School of 'Medicine 




Dear Ms Llewellyn, 
Protocol: Assessing the role of psychological factors in predicting 
subjective quality of life in patients with head and neck 
cancer 
Ref No: 03/08101 (please quote in all correspondence) 
Thank you for your application. This study has been approved under 
reciprocal agreements made with the Guys' & St Thomas' Hospital Ethics 
Committee. 
Yours sincerely, 
cc Annette Jeanes 
Chair, Lewisham REC 
T 
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Patron Her Majesty The Queen 
THE ROYAL MARSDEN NHS TRUST 
LONDON AND SURREY 
Ref: CF/Ethics/ PROTOCOL No. 2300 
27 August 2003 
Ms Carrie Llewellyn 
-Research Psychologist 
Psychology Unit 
5' Floor, Thomas Guy House 
Guy's Hospital . 
LONDON SEI 9RT 
Dear Carrie 
Re: Protocol No. 2300 Assessing the role of psychosocial factors In predicting 
subjective quality of life (QoL)*in patients with head and neck cancer 
Dr Christopher Nutting, Ms Carrie Llewellyn, Ms Joanna Coetzer) 
Thank you for sending me the revised patient information sheet (Version 2) for the above 
study incorporating the changes requested by the Research Ethics Committee at their 
meeting on 20th August 2003. I confirm that this now meets the Committee's requirements 
and that final approval is given for the study to go ahead. 
Please note the following: 
1. Ethical approval is granted subject to commencement within one year of the date of this 
letter. If for any reason it is not possible to start within one year, ethical approval will be 
deemed to have lapsed at the end of the period and it will be necessary to resubmit the 
proposal to the Committee for approval. 
2. The REC is required by its Constitution and Terms of Reference to monitor the progress 
of approved research and requires you to meet the following ongoing obligations: 
(a) to submit to the - REC any proposed amendments to the research protocol for 
consideration and approval prior to any implementation 
(b) to inform the REC of any adverse events (or any other relevant information notified to 
the Consultant in charge or of which he/she becomes aware) relating to the original 
application or amendments submitted to the REC and/or which would raise questions about 
the ethical acceptability of the continued conduct of the research 
(c) to provide for the REC an annual report on the progress of research projects 
(d) to supply to the REC copies of any papers published as a result of research 
(e) to inform the REC before publishing any unanticipated and/or sensitive research 
results 
Fulham Road LONDON SW3 3JJ Telephone: 020 7808 2958 
The Royal Marsden Hospital Charity Registered Number 1050537 
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Patron Her Majesty The Queen 
THE ROYAL MARSDEN NHS TRUST 
LONDON AND SURREY 
(f) to inform the REC of any anticipated/actual adverse media reports, wherever 
possible prior to their publication/transmission. 
The Royal Marsden NHS Trust Research Ethics Committee is compliant with the 
International Committee on Harmonisation/Good Clinical . Practice (ICH/GCP) 
Guidelines for 
the Conduct of Trials involving the Participation of Human Subjects as they relate to the 
responsibilities, , 
composition, function, operations and records of an Independent 
Committee/Independent Review Board. To this end it undertakes to adhere as far as is 
consistent with its Constitution, to the relevant clauses of the ICH Harmonised Tripartite 
Guideline for Good Clinical Practice, adopted by the Commission of the European Union on 
17 January 1997. 
Yours sincerely 
Christine A Ferguson 
Secretary to the REC 
cc R& D Office 
Dr Christopher Nutting, Consultant Clinical Oncologist, Head of Head and Neck Unit 
RIM Chelsea 
Fulham Road LONDON SW3 3JJ Telephone: 020 7808 2958 
The Royal Marsden Hospital Charity Registered Number. 1050537 
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Out Ref PO/WW103AL190 
21 November 2003 
Mr Laurence Newman 





The Joint UCWCLH Ethics Committee 
Committee Alpha 
Research & Development 
1`t Floor, Vezey Strong Wing 
112 Hampstead Road 
London NW12LT 
Tel: 020 7380 9579 
Fax 020 7380 9937 
Website: WWw. Uclh. or 
Dear Mr Newman 
REC Ref No: 03/0263 (please quote in all correspondence) 
REC Name: Committee Alpha (please quote in all correspondence) 
Study Title: Assessing the role of psychological factors in predicting subjective quality of life (QoL) In patients with head and neck cancer 
The Joint UCVUCLH Committees on the Ethics for Human Research: Committee Alpha reviewed 
your application on 6 November 2003. The documents reviewed were as follows: 
" REC application form 




The members of the committee present approved your application in principle, however, before final 
approval can be granted, the committee would like you to respond to the following concerns, which' 
are detailed below: 
How would the information be kept anonymous, as all staff would be able to have sight of the 
answers? 
page 2 of the patient information sheet under sub-heading Who is organising and funding the 
research? " remove the word "approved° from the second line of the paragraph. 
The Committee has delegated authority to the Chair and Vice-Chair to give you approval when it is 
felt a satisfactory response to the above issues has been received, 
An advisory committee to North Central London Strategic Health Authority 435 
When submitting the response to the committee, please . send revised 
documentation where 
appropriate highlighting the changes that you have made and give revised version numbers and 
dates. 
Your application has b on given a uniquer rence number please use it on all 
correspondence witthe REC 
Yours sincere /. 
Ars Patricia Orwell J Dr Steve Pereira 
Chair / Vice-Chair 
Email: wendy. walker@uclh. org 
ýý' 
I. 
An advisory committee to North Central London Strategic Health Authority 
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Patron Her Majesty The Queen 
THE ROYAL MARSDEN NHS TRUST 
Research Ethics Committee 
020 86613893 
28t" May 2004 
Ms Carrie Llewellyn 
Research Psychologist 
Psychology Unit 
5th Floor, Thomas Guy House 
Guy's Hospital 
LONDON SEI 9RT. 
Dear Ms Llewellyn 
RE: Protocol 2300 Assessing the role* of psychosocial factors In predicting 
subjective quality of life (QOL) in patients with head and neck 
cancer 
Amendment date: 27/04/2004 
The above amendment was reviewed by the Research Ethics Committee at the meeting 
held on 19th May 2004. 
Ethical opinion 
The members of the Committee present gave a favourable ethical opinion of the amendment 
on the basis described in the notice of amendment form and supporting documentation. 
Approved documents 
The documents reviewed and approved at the meeting were: 
Protocol Amendment 3 (ver. 1 27/04/2004) 
Patient Information Sheet and Consent Form (Version 3 07/01104) 
Membership of the Committee 
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
Management approval 
Before implementing the amendment, you should check with the host organisation whether it 
affects their approval of the research. 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
Downs Road SUTTON SW2 5PT Telephone: 020 8661 3893 




Patron Her Majesty The Queen 
THE ROYAL MARSDEN NHS TRUST 
LONDON AND SURREY 




Copy to: Dr Chris Nutting, Head & Neck Unit, Royal Marsden 
Enclosures List of names and professions of members who were present at the meeting 
and those who submitted written comments 
Downs Road SUTTON SM2 5PT Telephone: 020 8661 3893 
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APPENDIX XI: Satisfaction with Life Scale (SWLS) 
This section is to find out how satisfied you are. with your life at present. . 
Below- are five statements that you may agree or disagree with. 
Please tick the -box that best applies and be open and honest in your responses. 
Neither 
Strongly Slightly agree nor Slightly Strongly 
Disagree Disagree Disigree disagree Agree Agree Agree 
1. In most ways my life is Q Q Q Q Q Q Q 
close to my ideal. 
2. The conditions of my life Q Q Q Q Q Q Q 
are excellent. 
3. I am satisfied with'my life. 
Q Q Q Q Q Q Q 
4. So far I have gäined the Q Q QM Q Q Q Q 
important things I want in life. 
5. If I could live my life over, Q Q Q Q Q Q Q 
I would change almost nothing. 
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TEXT BOUND INTO 
THE SPINE 
APPENDIX XII: Brief IPQ (BIPQ) 
YOUR VIEWS ABOUT YOUR ILLNESS 
We are interested in your views now about your illness and treatment. 
Please circle the number on the scale that best indicates your response. 
P°' How much does your illness still affect your life in general? 
012345678.9 10 
no affect severely 
at all affects my life 
How long do you think your illness will continue? 
0123456.7.89 10 
a very forever 
short time 
V' How much control do you feel you have over your Illness? 





How much do you think your treatment has helped your illness? 
01234567 8 9 10 
no effect extremely helpful 
at all 
Are you still experiencing symptoms as a result of your illness? 
Yes Q No Q 
Pw if yes, how severe are your symptoms? 





'IQ' How concerned are you about your illness? 
01234567 8 9 10 





'IQ" How well do you understand your illness now? 
01234567 
not at all 
How much does your illness still affect you emotionally? 
(e. g. does it make you angry, scared, upset or depressed) 
01234567 









APPENDIX XIII: BELIEFS ABOUT MEDICINES QUESTIONNAIRE (BMQ) ITEMS 
USED FOR FOLLOW-UP STUDY 
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BELIEFS ABOUT TREATMENT 
Please indicate how much you agree or disagree with the following 




N4 Without the treatment I would be very ill 
N5 My treatment has protected me from 
becoming worse 
0mc 
CI still sometimes worry about the El 
long term effects of the treatment 
cA My treatment has disrupted my life 1: 1 171 1-1 F71 Fý 
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APPENDIX XIV: Expectations items 
EXPECTATIONS REGARDING YOUR TREATMENT AND RECOVERY 
We would like to ask you about the kinds of -expectations you may have 
had regarding your treatment- and recovery., For each of the following 
questions please circle the response that best describes your answer. 
D' To what degree have'your expectations regarding the outcome of treatment been met? 
(Le, cosmetic and/or physical effects of treatment) 
better than about the same 
expected as expected 
worse than no expectations 
expected at all 
At present, to what degree have your expectations regarding the extent of recovery 
currently been met? 
no expectations worse than about the some better than 
at all expected as expected expected 
To what extent have your expectatl6ns regarding the whole treatment and recovery 
period to date been fulfilled by your experiences? 
not at all somewhat as mainly as completely 
as I expected I expected I expected as I expected 
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CANCER PROFILE (SCIP) SCORES 
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APPENDIX XV 
Pre-treatment SCIP Scores - Satisfaction with amount & content of Information 
RELIABILITY ANALYSIS - SCALE (ALPHA) 
Mean Std Dev Cases 
1. TOSI1 B 
_ . 
9020 . 3003 51.0 2. SI2B TO . 9412 . 2376 51.0 3. TOSI3B 
_ . 
8824 . 3254 51.0 4. 
_SI4B 
T0 . 8824 . 3254 51.0 5. TOSI5B 
_ . 
7843 . 4154 51.0 6. 
_SI6B 
TO . 7647 . 4284 51.0 7. T0_SI7B . 6078 . 4931 51.0 8. T0_SI8B . 5686 . 5002 51.0 9. T0_SI9B . 7059 . 4602 51.0 10. TOSI10B . 8039 . 4010 51.0 11. TO7_SI11 B . 8039 . 4010 51.0 12. T0_S 112 B . 6078 . 4931 51.0 13. T0SI13B 
_ . 
7843 . 4154 51.0 14. T0 
_S114B . 
8431 . 3673 51.0 15. T0_SI15B . 7843 . 4154 51.0 16. T0_SI16B . 6667 . 4761 51.0 17. T0_SI17B . 6275 . 4883 51.0 18. T0_SI18B . 6863 . 4686 51.0 
RELIABILITY ANALYSIS - SCALE (ALPHA) 
N of Cases = 51.0 
N of 
Statistics for Mean Variance Std Dev Variables 
Scale 13.6471 19.3129 4.3946 18 
Item-total Statistics 
Scale Scale Corrected 
Mean Varia nce Item- Squared Alpha 
if Item if Item Total Multiple if Ite m 
De leted Deleted Correlation Correlation Deleted 
TOSI1 B 
_ 
12.7451 18.6337 . 2272 . 8881 SI2B TO 
_ 
12.7059 18.6518 . 2946 . 8863 
_SI3B 
TO 12.7647 18.5035 . 2513 . 8878 TOS I4 B 
_ 
12.7647 17.8235 . 5036 . 8811 
_SI513 
TO 12.8627 17.0008 . 6246 . 8765 TO_SI6B 12.8824 16.5859 . 7289 . 8725 TO_SI7B 13.0392 16.5184 . 6366 . 8756 TOS18B 
_ 
13.0784 16.5937 . 6059 . 8769 S198 T0 12.9412 17.4165 . 4386 . 8833 TO_S 110 B 12.8431 17.0149 . 6461 . 8759 TOSI11 B 
_ 
12.8431 17.2949 . 5569 . 8789 SI 12B T6 13.0392 17.5184 . 3758 . 8863 TOSI13B 
_ 
12.8627 16.9608 . 6370 . 8760 
_SI 
1413 TO 12.8039 17.4808 . 5526 . 8793 TO_SI 15B 12.8627 17.7208 . 4059 . 8840 TO_SI16B 12.9804 17.0196 . 5261 . 8801 TO_SI17B 13.0196 16.6596 . 6058 . 8769 TO_S 118 B 12.9608 16.7584 . 6086 . 8768 
Reliability Coefficients 18 items 
Alpha = . 8862 Standardized item alpha = . 8838 
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Pre-treatment SCIP Scores - Satisfaction with form and timing of Information 
RELIABILITY ANALYSIS -SCALE (ALPHA) 
Mean Std Dev Cases 
1. SIHNC19 4.1429 . 6206 70.0 2. SIHNC20 4.0143 . 7121 70.0 3. SIHNC21 3.6714 1.0032 70.0 
4. SIHNC22 4.2143 . 6570 70.0 5. SIHNC23 3.9571 . 7882 70.0 6. SIHNC24 4.0571 . 6786 70.0 7. SIHNC25 4.1714 . 4495 70.0 
N of Cases = 70.0 
N of 
Statistics for Mean Variance Std Dev Variables 
Scale 28.2286 14.0919 3.7539 7 
RELIABILITY ANALYSIS -SCALE (ALPHA) 
Item-total Statistics 
Scale Scale Corrected 
Mean Variance Item- Squared Alpha 
if Item if Item Total Multiple if Ite m 
Deleted Deleted Correlation Correlation Deleted 
SIHNC 19 24.0857 10.6882 . 7440 . 6865 . 8375 SIHNC20 24.2143 10.4317 . 6855 . 6069 . 8426 SIHN C21 24.5571 9.8155 . 5202 . 3398 . 8812 SIHNC22 24.0143 10.4491 . 7560 . 5929 . 8345 SIHN C23 24.2714 10.2876 . 6295 . 4128 . 8509 SIHNC24 24.1714 10.5789 . 6916 . 5041 . 8423 SIHN C25 24.0571 11.8228 . 6687 . 5522 . 8537 
Reliability Coefficients 7 items 
Alpha = . 8675 Standardized item alpha = . 8872 
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Striking the right balance: A qualitative pilot study 
examining the role of information on the development of 
expectations in patients treated for head and neck cancer 
C. D. LLEWELLYN, M. McGURK, & J. WEINMAN 
Institute of Psychiatry, London, UK 
Abstract 
The a priori aims of this study were, firstly, to investigate the types of expectations patients treated for 
head and neck cancer had prior to treatment and the extent to which these had been met post- 
treatment. Secondly, to investigate the role information played on the development of expectations. 
Semi-structured interviews were conducted with 15 patients. Data were analysed and classified using a 
Framework Analysis Approach. Expectations were subcategorized as either 'Specific' or 'Global'. 
'Specific' expectations centred around: side effects of treatment, post-treatment aesthetics and the 
recovery process. 'Global' expectations centred around the whole cancer experience. A large 
proportion of patients described the whole experience as being much worse than they had anticipated. 
'The role of information on expectations' was subcategorized into: 'too much' information, 'too little' 
information and the 'timing' of information. In conclusion, there were large variations in the types of 
expectations patients had, and between patients expectations and their actual experiences. 
Expectations appeared to be influenced by the information received and retained. Respondents 
emphasized the fine line between being given 'too much' information at the wrong time and 'not 
enough' information at the right time. This study has clear implications for reducing pre- and post- 
treatment uncertainty by supplying verbal and written information on a timely and individual basis, in 
order to reduce the mismatch between patient expectations and experiences. 
Keywords: Qualitative, head and neck, cancer, information, expectations 
Introduction 
The incidence of cancer of the mouth and pharynx ranks sixth in the world and ranks third in 
developing countries (Parkin et al., 1999). Striking differences in incidence rates exist 
between different geographical (and therefore cultural, ethnic and socio-economic) regions. 
Cancer of the mouth and throat (ICD-10: C00-C14 & C32), is the fifth most common 
anatomical site for cancer in the world, with half a million incident cases of oral, pharyngeal 
and laryngeal cancer in 1990 (Ferlay et al., 1998; Parkin et al., 1999). Altogether, the figures 
for head and neck cancer (HNC) represent a substantial disease burden, with high mortality 
rates of 54% overall: death to registration ratios range from 0.47 to 0.65 according to site 
(Johnson, 2002). 
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Treating HNC patients for cure involves either surgery, radiotherapy and/or chemother- 
apy in varying combinations. Each treatment has its own toxicities and adverse late effects, 
which are often intensified when used in combination. Small primary tumours can be 
eradicated by either surgery or radiotherapy. In cases involving less accessible lesions (e. g. 
the vocal cords, tonsil and hypopharynx), radical radiotherapy can enable good function and 
cosmesis to be retained and this is generally the treatment of choice. Salvage surgery may be 
required in those patients with residual or recurrent disease after radiotherapy (Bloom, 
1987). 
The high doses of radiotherapy required to gain loco-regional control of HNC are 
associated with an increased risk to normal tissue with significant impacts on quality of life 
(Hammerlid et al., 1997). Acute skin and mucosal reactions are common during irradiation 
and generally subside after treatment. Late irradiation-induced changes can lead to fibrosis 
and may lead to permanent and serious problems with regard to function, comfort and 
cosmesis. The most frequent effects following treatment with radiotherapy are due to the 
reduction of saliva following direct or incidental irradiation of the salivary glands. The 
resulting mouth dryness (Xerostomia) may lead to rapid and severe widespread dental caries 
(Bloom, 1987), difficulties eating with a decreased or lack of taste and smell, or problems 
speaking. 
During the last 20 years, advances in intra-oral soft tissue reconstruction by revascularized 
tissue transfer (e. g. from pectoral or forearm donor sites) have lead to more extensive 
tumour ablation in patients, as even large defects can be repaired in one step procedures. 
However, the size of the tumour and reconstruction technique will have an effect on the 
short- and long-term function of the organ, frequently leading to problems eating, drinking, 
speaking or even breathing. Even minor surgery can lead to significant facial disfigurement. 
The traditional gold standard for regional disease control has been radical resection of all 
lymph bearing tissues in the neck. Despite modifications to the `classic' dissection, neck 
dissection is still responsible for permanent and significant change in shoulder function as 
well as increased postoperative pain. Although curative or palliative in intent, all the 
procedures outlined above have their own associated morbidities 'and consequences which 
the patient should be informed of. 
Cancer of the head and neck not only poses a threat to life but, in patients who survive, 
consequences of the disease and treatment can be far-reaching and especially traumatic if 
unanticipated. These unexpected consequences may, in turn, lead to long-term difficulties 
with adjustment. Evidence from the literature has shown that pre-treatment expectations 
influence recovery from surgery (McCarthy et al., 2003) and health related quality of life 
(HR-QoL) after radiotherapy (Koller et al., 2000) and HR-QoL during in-patient stays 
(Staniszewska, 1999) in a wide range of illness groups. 
Although unforeseen complications can arise, some of the uncertainty and trauma could 
be lessened with accurate and timely information at a level that patients can understand. For 
example, Leydon et al. (2000) demonstrated that not all patients want extensive information 
about their condition and treatment at all stages of their illness. However, patients 
undergoing surgery often experience considerable anxiety as a result of receiving too little 
information or information that they cannot understand (Krupat et al., 2000). Studies have 
shown that the majority of written pre-operative instructions are not understood by patients 
(Livingston, 1989) and in another study, that only 60% of cancer patients could correctly 
describe their treatment (Cassileth et al., 1980). 
In addition to the timing and format of the information supplied, another key issue is the 
mechanism by which information benefits the patient. Janis (1958) argued that pre-operative 
information allows patients to engage in `work of worrying'. He proposed that information is 
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useful because it allows patients to anticipate and rehearse the stressful events they are about 
to encounter and therefore cope more successfully with them. However, it has also been 
recognized that the benefits of information may vary considerably according to the timing of 
the information (Pinder, 1990) and the personality and demographics of the patient (Mahler 
& Kulik, 1991; Miller & Mangan, 1983). 
Despite the growing volume of research into the informational needs of patients with 
cancer in general, little is known specifically about the informational requirements of 
patients with highly traumatic diseases such as HNC. It is also not known whether the 
information received by patients plays a role in the development of expectations. 
'Therefore, this study sought to examine in depth: 
(1) The types of expectations patients had prior to treatment and the extent to which 
patients considered that these expectations had been met post treatment. 
(2) The role of information on the development of expectations. 
Method 
Recruitment of participants 
Patients were recruited from head and neck cancer clinics run at two London Hospital 
NHS Trusts and were based on a convenience sample. This was to minimize any bias 
that may have been created by pre-selecting patients into the study. Patients may have 
been more likely to talk about their experiences in the context of a clinical review visit 
than returning on a separate occasion. Recruitment criteria were any post-treatment 
patient up to 18 months post-diagnosis and free of disease. This 18 months post- 
diagnosis cut off point was for several reasons. Most importantly to ensure that 
experiences were relatively recent to avoid problems with recall, secondly, to explore a 
spectrum of opinions at different stages of treatment and recovery and, thirdly, for more 
practical reasons of increasing the sample eligible for recruitment. Patients were recruited 
during the period from 10th January 2003 to 5th March 2003. Ethical approval for this 
study was granted by the local research ethics committee and consent was obtained from 
all participants. 
Data collection 
Semi-structured interviews were conducted in quiet rooms in the clinics. The interviews 
were iterative from the beginning, meaning that the first interview schedule was transformed 
over the first few interviews according to the usefulness and responsiveness to certain 
questions. Interviews typically began with a short discussion about why they were in the 
clinic on that day and how long it had been since they had first been diagnosed, in order to 
establish rapport. A broad opening question such as; `could you describe forme some of the 
experiences you have gone through since your diagnosis? then followed and participants 
were prompted to think back over their experiences and expectations if required. Questions 
were presented in as neutral a way as possible to minimize potential bias. The interviewer 
encouraged the participant to elaborate on stories and situations to illustrate important 
points. All interviews were tape-recorded and lasted between approximately 15 to 55 
minutes, the average being about thirty minutes in duration. Transcripts were produced 
shortly after each interview. Demographic and medical data were collected from hospital 
medical records. 
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Data analysis 
Data were analysed using a Framework Analysis Approach (Ritchie & Spencer, 1994). This is 
a matrix-based approach to qualitative data analysis, which, is based on transcripts produced 
verbatim from the taped interviews. This technique involves identifying recurring and 
important themes based on a combination of a priori issues, emergent themes and recurring 
attitudes or experiences. Major themes in the data arising in these transcripts (determined by 
an initial read through of all the transcripts and then in-depth analyses of the first seven 
transcripts) were then used as headings/themes under which the systematic charting of the 
content of all the transcripts was carried out. This ensured that the themes could be refined. 
Any new themes that subsequently arose were added to the framework. This method ensured 
that the diversity of the participants' experiences were encapsulated. Analysis was carried out 
after all the participants had been interviewed and this was to minimize the potential bias of 
one interview influencing the next based on any framework that subsequently emerged. 
Reliability of the data 
In order to comment on the reliability of the data, a second rater (CK) was given the 
framework of emergent themes/headings and the verbatim transcripts and asked to appraise 
them according to their content. Any discrepancies that arose were discussed until inter- 
rater satisfaction was achieved. 
Results 
Profile of participants 
Participants were 15 patients treated for head and neck cancer and under the care of two 
maxillo-facial/oral surgery consultants, attending clinics at two south London hospitals. One 
male patient refused to take part and one taped interview (also a male patient) had to be 
discarded due to extraneous background noise. This gave a response rate of 88%. 
Table I provides a breakdown of the demographic and treatment profiles of the 
participants. Ten participants (67%) were female. Ages ranged from 38 to 75 (mean = 54; 
median = 51; SD = 10.5). All patients except 2 classified themselves as white UK ethnic 
origin, one patient was Asian and one patient was Iranian. The time since diagnosis ranged 
from 11 to 18 months (median = 9; mean = 9.7; SD = 4.8). All tumours except one 
(adenocarcinoma) were squamous cell carcinomas (SCC). Three patients had carcinoma of 
the tongue, three of the mandible, four of the maxillary region, three floor of mouth and one 
each of the tonsil and palate. All patients except one had surgical treatment and the majority 
also had radiation therapy. All patients were free of disease at the time of interview. Figures 
after quotes refer to the interview no., sex and age of the participant. 
Two main themes of `patient expectations' and `the role of information' were explored 
and which resulted in a number of sub-themes (Table II). The results have been presented 
in two parts, according to each main theme. 
Part 1. Patient expectations 
Respondents described expectations reflecting two central themes: `Global' expectations 
regarding the whole cancer experience and more 'specific-expectations, centred around side 
effects, aesthetic aspects and the recovery process. 
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Table II. Structure of main themes, sub-themes and examples of issues to emerge from interviews. 
Main Theme Sub-theme Example of issues to emerge 
1. Patient expectations: Global Unexpected enormity of treatment / recovery 
Expectations being surpassed by reality 
Specific Side-effects of treatment 
Aesthetical outcome 
Recovery as a process 
2. Information influencing Too much information Limits to how much info can be 'taken in' 
expectations through: Repercussions on ability to cope 
Too little information 'Missing' information 
Lack of clarity 
Timing of information Knowledge gap 
Uncertainty 
Global expectations 
A large proportion of respondents described the whole experience as being worse than they 
had imagined. A few patients expressed a sense of unexpected `enormity' about the surgical 
treatment and the subsequent physical recovery process, particularly those who had also 
received radiotherapy, as emphasized by: 
`I didn't realize how big it was all going to be ... Even had I been told, I don't think 
I 
would have expected what happened'. [2, F, 42] 
' ... 
he (the surgeon) tells me it's not dangerous - it's not a big operation. But when I 
come here I was surprised - it was a big operation'. [4, M, 51] 
`I'll be quite honest, I didn't realize the operation at the time would pull me down as 
regards health so much. I think because I lost so much weight,, I felt so weak. It affected 
me more than I thought it was going to at the time. ' [9, F, 70] 
Similarly, patients reported feeling surprise (post-treatment) at the extent of the operation 
due to the relatively small part of the lesion visible to the patient. The fact the tumour was 
extensive but not visible had obviously not been explained to the patient: 
`I wasn't expecting such a large area (affected) from what seemed such a small, well, not a 
small operation, but such a large affected area from a small area that was involved in the 
surgery'. [12, F, 59] 
A few respondents reported that the whole cancer experience had been better than they 
had been expecting. One woman described how she felt physically better now than she had 
thought she would: 
`Well, I did think that I may feel worse actually. Everybody says you'll feel tired and you 
won't be able to do this or won't be able to do that but I'm doing everything so... 
[10, F, 48] 
Similarly, another woman reflected on her ability to cope, despite not having any concrete 
expectations: 
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`I think I've actually done better than what I thought I might. Because you don't know. 
You just don't really know, well, I didn't know what to expect. Perhaps I didn't ask 
enough questions but then I didn't want to know... I think I've coped a lot better than I 
thought I would'. [1, F, 47] 
Specific expectations 
Side effects. Expectations regarding specific outcomes of treatment and recovery reflected 
both positive and negative aspects. Respondents were able to describe their experiences of 
specific side effects that had exceeded their expectations, for example, 
`There was a lot less pain than I expected. I was able to eat quite quickly and I was able to 
talk better than I thought I would'. [12, F, 59] 
`I was also told that they didn't think that I would speak for six months, but I did. As soon 
as they took me off tracheostomy, they could understand me basically, so that was a 
bonus'. [14, F, 38] 
Conversely, a few respondents recalled their surprise at experiencing arm and shoulder 
mobility problems (due to the neck dissection): 
`I had mobility problems for quite some time which I hadn't expected. I couldn't raise my 
left arm very much ... I wasn't expecting as much numbness... ' 
(12, F, 59] 
One patient, at a relatively early stage since diagnosis (5 months) described his current 
situation after undergoing radiotherapy: 
`It's all a lot worse than I thought it would be. I can't eat because I have no saliva both 
sides, it's very dry'. [4, M, 5 1] 
Aesthetics. Aside from functional aspects, disfigurement immediately after the operation was 
a particularly emotive issue due to the uncertainty surrounding the extent of surgery. Many 
respondents chose not to look at themselves immediately afterwards due to the large amount 
of swelling, however, one woman's expectations were surpassed when she finally looked at 
herself a week later: 
`I actually looked a hell of a lot better than I thought I would... `cos I thought I might lose 
a cheek or outer skin whereas all mine is internal'. [1, F, 47) 
Respondents tentatively expressed expectations and hopes regarding future aesthetic 
improvement, either for further cosmetic procedures or healing with time. 
The recovery process. Expectations regarding the recovery process seemed realistic in some 
people who recognized that recovery would take place over an extended period of time 
and would be challenging. For some people, pre-treatment expectations had been less 
realistic in hindsight, with expectations that after a couple of months they would be feeling 
the same or better than they had at diagnosis. For example, expectations regarding current 
health status, were mentioned by a couple of respondents. One woman struggled to 
conceal her disappointment at not recovering as quickly as she was expecting and 
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attempted to put it in perspective by suggesting her expectations may have been 
unrealistically optimistic: 
`I had expected it to be a little better. Maybe I was just being overly optimistic, you know 
(pause) but I don't expect (pause) I mean, the important thing is that the cancer is gone 
but I had some major setbacks on the ward'. [15, F, 43] 
Additionally, one woman described how she was expecting physical changes but was 
uncertain how they would manifest. She also recalled not expecting any psychological 
problems. However, she was currently experiencing panic attacks related to her loss of 
confidence and altered appearance: 
`Well, I did expect that there might be some big changes, perhaps physically. I didn't 
expect any psychological problems but I did expect to be physically different and I wasn't 
sure what that would mean'. [12, F, 59]. 
Expectations regarding recovery were also revealed through expectations of returning to 
work. Expectations appeared to be related to prior advice from the consultant and 
comparison with other patients who had undergone similar procedures. These proved to be 
exceeded in some. For example: 
`Mr X said it would be minimum 6-7 months up to a year, 2 years depending on 
individuals. I was actually back at work in November, the November after the April (7 
months)'. [1, F, 47] 
Prior expectations had not been met in others: 
`It had been my expectation to go back to work at the end of this month, having finished . 
the radiotherapy at the end of October. I thought 4-5 weeks recovery, back to work. But 
no'. [5, M, 49] 
Patients' expectations were reported to change over time. Many post-treatment patients 
confided how shocked they were at the extent to which life in general had actually changed 
afterwards, despite expecting some alteration. A few respondents mentioned that their 
expectations changed throughout the recovery and the post-treatment period, lowering with 
experience of complications or problems. One respondent reported that she had learnt to be 
more patient regarding the speed of recovery after her expectations had not been met. This 
appeared to suggest that many people were optimistic in the early stages of the recovery 
process, but, with time and experience, people later developed more realistic expectations, 
suggestive of adaptive processes taking place. 
Part 2. The role of information on the development of expectations 
Many respondents presented a conflicting picture of needs and requirements, between 
not wanting too much information on the possible complications and side effects 
associated with treatment but feeling in hindsight that they were `missing' information 
regarding specific events. Explanations for this variation were forwarded by respondents, 
mainly relating to pre-treatment fear and perceived ability to cope with too much 
knowledge. 
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Too much information 
Many respondents reflected that they hadn't wanted `too much' information pre-operatively. 
This appeared to be related to fear and a perceived lack of ability to cope. This was 
illustrated by statements such as: 
`I only needed to know what was needed to be known. Because if I'd had too much 
information you would have found me in the corner with a vodka bottle'. [1, F, 47] 
and; 
`there's a limit to how much one can take in actually on something like this and how much 
you can actually cope with. Sometimes if you knew, like, any challenging thing you have to 
go through - if you knew all the horrible things that were going to happen you'd be like, 
`no way! Thanks a lot'. [13, F, 47] 
Too little information 
Although the general level of satisfaction with information was reported to be high, a few 
respondents reflected that there had been a distinct lack of information on the long-term 
impact on life and information on financial benefits available. For many respondents who 
reported `missing' information pre-treatment, psychological consequences (such as anxiety 
and depression) were revealed post-treatment. A few respondents reported unexpected 
long-term side effects which they related to `missing information'. 
For example: 
`One thing I was very shocked by was that I couldn't speak after the operation ... It took a 
couple of weeks until I was sure I was going to be able to talk. 'Iahe other thing I was very 
numb ... No, I hadn't known about that. So it was quite missing information. I was quite 
shocked by that because I really had been expecting that the numbness would be 
temporary'. [13, F, 47] 
Expectations were clearly related to the information given by the treating staff and the risks 
associated with the particular treatment recommended. Many respondents reported some 
aspect of treatment or recovery that they were not told of (or couldn't recall being told). 
There was a common lack of clarity regarding the effects of radiotherapy, from hardening 
of the scar tissue from surgery or developing bald patches on the head, to major 
complications of failure of facial skin grafts. Many respondents reported a lack of 
understanding regarding how the effects of radiotherapy would make them feel `setback' 
after recovery from surgery. 
The variance between what to expect derived from detailed information and the actual 
experience was dramatically highlighted by one respondent: 
`Nearly all that's happened, the doctors told me beforehand. I was given a massive 
amount of literature, booklets which I studiously read, so I could almost foretell what 
was going to happen. The only thing that has changed, that was quite significant, was 
that after the radiotherapy (pause) I didn't expect the radiotherapy to burn holes in my 
face'. [5, M, 49] 
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A few of the patients contracted post-surgical Methicillin-Resistant Staphylococcus Aureus 
(MRSA) and felt particularly anxious and uninformed. This was emphasized by one woman 
who described her distress at the lack of information: 
`It was a nightmare in that nobody could tell you it, would tell you anything. And 
everybody was embarrassed about it... Somebody had forgotten to tell the anaesthetist 
that I had MRSA and there was all this kerifufle whilst they sorted that out'. [11, F, 63] 
Timing of information 
The lack of specific information or `missing' information appeared to be related to the 
timing of information. Previous quotes have demonstrated that not all patients wanted 
detailed information at all stages of the illness, however, one respondent suggested that 
patients should have full knowledge of all possible side effects and outcomes of treatment, 
prior to treatment, regardless of the anxiety this may provoke. The same respondent later 
mentioned that not knowing the full facts when complications arose was a major source of 
anxiety for him: 
'... the times when things were going wrong and nobody was telling me were the times 
that I became anxious, agitated and concerned... ' [5, M, 49] 
This was further emphasized by a couple of respondents who considered that the lack of 
information or clarity stemmed from a `knowledge gap' `between a full understanding of 
what's going to happen to you and what information can convey'. [12, F, 59] . This was 
perceived to be caused by two factors, namely, the lack of time between diagnosis and 
treatment and the fact that traumatic experiences are indescribable until they've been 
experienced (likened to childbirth by a couple of women). The shock of diagnosis and the 
lack of time to assimilate the information were highlighted thus; 
`At that time, when they've just told you, you have cancer and you're just about to have 
major surgery, you're not really listening... your mind's not on it'. [3, M, 56] 
and; 
`It was all carefully explained but it doesn't really register in the short time you have to 
think about it. You're trying to cope with a lot of information and you're not feeling very 
well'. [12, F, 59] 
Discussion 
The findings from this qualitative study give increased insight into how pre- and post- 
treatment expectations in a sample of head and neck cancer patients are derived in part from 
information received. Respondents described expectations reflecting two sub-themes: 
relating to `specific' expectations centred around side effects; aesthetic aspects of treatment 
and the recovery process; and `global' expectations regarding the whole cancer experience. 
Favourable experiences were underpinned by expectations being surpassed. 
This pilot study also highlighted the individual nature of the information giving process, 
whereby many patients did not want too much detailed information about their illness and 
treatment, especially at the early stages between diagnosis and treatment, yet many 
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respondents required a detailed breakdown of all the possible complications and variables 
associated with the recovery process. These differences in requirements may have been due 
to differences in personality and/or coping strategies between patients. Research has 
indicated that stable individual differences exist between patients' tendencies either to seek 
or to avoid potentially stressful information about cancer and other threatening medical 
procedures. Miller (1992,1997) proposed that people react to health threats by coping in 
one of two ways. Either by trying to avoid or minimize obtaining stressful information and by 
distracting themselves from threatening information (blunting coping style) or by attending 
and scanning for threat relevant information about aversive medical events and rehearsing 
and amplifying them cognitively (monitoring coping style) (Miller, 1992 and 1997). 
Tentative support for these coping styles was evidenced in the present study whereby some 
patients explicitly stated that they hadn't wanted to know pre-operatively what was going to 
happen to them in detail versus some respondents who had sought out detailed information. 
The data from the interviews also indicated that there was probably a dynamic relationship 
between a patient's need for information, expectations and coping. Modifying this cycle by 
intervention either at the informational level or through targeting specific coping strategies 
may influence patients expectations. 
The role of information has previously been investigated in relation to a range of 
outcomes after treatment for head and neck cancer. Perceptions of adequate information 
from specialists were found to be predictors of positive rehabilitation outcomes in 
laryngectomy patients treated 2-6 years previously (De Boer et al., 1995). Similarly, 
satisfaction with information provided shortly before the end of radiotherapy was found to 
be a significant predictor of quality of life (QoL) in nasopharyngeal cancer patients 4 months 
later (Yu et al., 2001). The relationship between information and QoL has not been found 
to be straightforward. Kreider et al. (1995) concluded from a study of 55 head and neck 
cancer patients that 'the psychosocial effects of the information the patient has at his or her 
disposal about the disease and its prognosis are greater than the effects of the severity of 
disease per se'. This suggests that the psycho-social effects of the disease and treatment are 
not necessarily direct functions of disease severity but are mediated by the meanings the 
patient assigns to the disease and the total situation. Information is a major determinant of 
the meanings assigned along with the cognitive representation of a health threat. However, 
Kreider et al. (1995) found that the effects of providing information were in some respects 
beneficial and in others detrimental from a psychological point of view (Kreitler et al., 
1995). Our study also found that for some people, too much information meant that they 
were unable to cope with the health threat due to high feelings of anxiety and fear. Although 
we did not seek to investigate the role of information on subsequent QoL or mood in our 
study, the evidence suggests that pre-treatment information is relevant to post-treatment 
adaptational processes/rehabilitation and these could be mediated by the individual's 
expectations. Indeed, as Calman proposed in 1984, QoL should be considered 'the extent to 
which our hopes and ambitions are matched by experience'. He argued that to improve 
QoL, health care should 'narrow the gap between a patient's hopes and expectations and 
what actually happens' (Calman, 1984). Through tailoring information to the individual, the 
mismatch between unrealistic expectations and experience could be narrowed thus 
potentially improving outcome. 
This study highlighted that patients' needs were frequently not being met. This is 
consistent with a report by The National Cancer Alliance (2002), who highlighted through 
discussions with a focus group that although some patients had received written 
information, this was inadequate for their needs. A study by Edwards (1998), also 
highlighted the lack of satisfaction regarding information giving. It was suggested that 
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patients wanted to have more information about the impact of their treatment and about 
different treatment options rather than details of the operation. In addition, Mesters et al. 
(2001) found that more supportive information about access to help and solutions was 
required. 
Many extraneous factors contribute to the information giving process (such as: the time 
available to the patient, the presence of a multidisciplinary team, patient factors ... etc. ). However, the majority of patients would like to be provided with written information and 
explanations about their treatment, advice on how to manage the effects of the treatment on 
their daily lives and adequate preparation prior to discharge from hospital. Written 
information is especially pertinent in cases where the patient is being subjected to `too much 
information' around the time of diagnosis. It may even be feasible to provide the patient with 
a tape recording of early consultations to listen to at a time appropriate to them. Information 
about the late onset of symptoms (particularly with radiotherapy) should be provided on a 
written basis as contact with the relevant health care professional may not be feasible after 
treatment has ended. 
Evidence, involving patients with other illnesses, suggests that pre-treatment expectations 
can have an influence on post-treatment outcomes in both a negative and positive way. For 
example, Iversen et al. (1998) found that patients having surgery for lumbar spinal stenosis 
who had ambitious pre-surgery expectations for physical functioning were more likely to 
have improved function and satisfaction 6 months later. Conversely, having unmet 
expectations regarding outcome (e. g. high expectations regarding pain relief) resulted in 
worse perceptions of outcome, such as more pain and less satisfaction with pain relief post- 
surgery. This highlights the importance of patients to have an optimistic stance regarding 
outcomes but without expectations being unduly unrealistic. 
Regarding the potential limitations, the data gained from the present study may be 
biased towards patients who have coped relatively well since diagnosis and who return for 
review visits. The majority of the patients had speech impediments to various degrees. 
This provided difficulties with transcribing, however, with careful listening and 
transcribing the interviews shortly afterward conducting them, this was not a problem, 
excluding one male case which combined with extraneous background noise, had to be 
discarded. The sample of patients interviewed were not representative of a typical sex ratio 
expected with HNC and this has to be acknowledged as a limitation of using a 
convenience sample. Although the nature of qualitative research is not to provide 
generalizable data, and the aim of the study was to explore patient expectations regarding 
recovery and outcome, in an area such as HNC where there are clear gender implications 
of having a disease that impacts aesthetically, a more representative sample may have 
provided different results. 
The patients interviewed were at different periods of recovery, which may have had 
implications for memory biases. Patients were generally more upset when in the first stages 
of adjustment and patients having a longer period of recovery may have forgotten the pre- 
treatment expectations they had. 
More pertinent to qualitative research is the issue of introducing biases into the data. This 
can occur at the time of the interviewer due to the person interviewing, whilst interpreting 
the data or even due to variables such as the time of interview, the interview room and 
interruptions by other staff. A more linear approach to data analysis was adopted in terms of 
analysing the data after all the interviews had been conducted which could be considered a 
limitation of the study. However, the intention was to elicit the patient's perspective before 
forming a framework and therefore any potential biases and assumptions, before all the 
interviews had been conducted. 
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In conclusion, this pilot study produced a rich amount of material about the types of 
expectations individuals with HNC had at various stages of their treatment and recovery. 
Large variations between patient expectations and the actual experiences that were 
described were revealed. Expectations, both global and specific, seemed to be derived in 
part from the information received. Satisfying patients' needs for information has important 
implications for patient outcome. Reducing the uncertainty pre-treatment and narrowing 
the gap between expectation and actual experience may reduce feelings of depression and 
anxiety, as a result of experiencing unexpected negative events. This could easily be achieved 
by providing more written information on topics of importance to patients on a timely basis. 
Further research would be needed to explore the relationship between the fulfilment of pre- 
treatment patient expectations and patient outcomes, such as QoL or depressive symptoms, 
post-treatment. 
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KEYWORDS Summary The survival rate in advanced cancer of the head and neck has remained 
Review; at approximately 50%, and efforts are now directed towards reducing the impact of 
Head and neck cancer; the disease and its treatment in terms of functioning and health related-quality of 
Health related quality life (HR-QoL). Factors such as stage, site of disease and type of treatment all impact 
of life; on HR-QoL, but it is unclear what additional factors influence HR-QoL. 
Psychology A systematic review was undertaken of studies that have investigated psycho- 
social or behavioural factors associated with HR-QoL in this patient group. 
Literature was systematically searched using electronic databases and hand- 
searching relevant journals. Data were sought on HR-QoL and studies were only 
included if the measurement instrument was recognised as a reliable and valid mea- 
sure of HR-QoL. Studies had to include at least one psycho-social or behavioural pre- 
dictor variable. 
Sixteen studies fulfilling the inclusion criteria were identified and reviewed. Five 
main factors were associated with varying degrees with HR-QoL, personality, social 
support, satisfaction with consultation and information, behavioural factors, such as 
consuming alcohol and smoking, and depressive symptoms. 
The major difficulty with synthesising the findings was the amount of different 
indices of QoL that have been used. However, a number of psycho-social factors 
have been investigated in relation to HR-QoL in head and neck cancer patients, 
some of which are potentially modifiable, such as those related to informational 
needs. Further research is needed to investigate other psychological factors 
which may influence aspects of HR-QoL. By understanding the relationship between 
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HR-QoL and potentially modifiable variables, interventions can be designed with the 
aim of improving a patient's tong-term well-being. 
© 2005 Elsevier Ltd. All rights reserved. 
Introduction 
In 1998, there were 6500 incident cases in the UK of 
lip and mouth (including tongue), pharynx and lar- 
ynx cancers, and 2700 deaths, equivalent to be- 
tween seven and eight deaths per day. ' Despite 
recent developments in reconstructive techniques 
and more sophisticated treatment regimes involv- 
ing specialist multi-disciplinary teams, the survival 
rate in advanced disease has remained at approxi- 
mately 50%. Continuing efforts such as conserva- 
tion and reconstruction procedures, speech 
therapy and prostheses have been directed towards 
lessening the impact of the disease and its treat- 
ment in terms of disability and functioning. 
Comprehensive assessment of the impact of 
head and neck cancer encompasses more than 
clinical outcomes such as survival and disease pro- 
gression and even goes beyond level of function- 
ing, to include patient well-being. The interest 
in quality of life (QoL) has increased in recent 
years and much has been published examining 
QoL issues in HNC patients. 2'3 There is wide varia- 
tion in what is meant by QoL. The World Health 
Organisation has defined a high QoL as a 'state 
of complete physical, mental and social well- 
being and not merely the absence of disease or 
infirmity. ' Using the WHO's definition, global 
QoL could feasibly include a patient's psychologi- 
cal and emotional status and perceptions of satis- 
faction found in work, home life, religion, family, 
education or income. Assessing global QoL gener- 
ally provides a broader picture of the impact of 
disease on an individual's life. In clinical practice, 
however, QoL generally refers to health-related 
quality-of-life (HR-QoL) which seeks to examine 
aspects of QoL thought to be impacted by a health 
or medical concern. Assessment of HR-QoL typi- 
cally includes physical, psychological and social 
domains. Each domain may include measures that 
assess the patient's perception of symptoms, abil- 
ity to function and disability. 4 
As it is accepted that 'HR-QoL' is a broad, multi- 
dimensional concept, a number of questionnaires 
have been developed that reflect this complex con- 
ceptual framework. There are three main catego- 
ries of questionnaire that are commonly applied 
to assess the HR-QoL of HNC patients, performance 
questionnaires aside: global HR-QoL, general can- 
cer HR-QoL and HNC specific HR-QoL. Global or 
generic questionnaires can be applied to patients 
with any disease or a 'normal' population and as- 
sess physical, psychological and social functioning 
(e. g., Short form Health Survey (SF-12); 5 General 
Health Questionnaire (GHQ)6). General cancer 
questionnaires focus on common symptoms and 
side-effects of cancer treatments (e. g., The Euro- 
pean Organisation for Research and Treatment of 
Cancer (EORTC) core questionnaire; 7 The Func- 
tional Assessment of Cancer Therapy Scale (FACT- 
G); 8 Functional Living Index-Cancer Scale (FLIC)9). 
HNC specific HR-QoL questionnaires are intended 
to assess the specific impact of HNC and its treat- 
ment on an individuals HR-QoL in terms of oral 
function, which includes aspects of communica- 
tion, swallowing, chewing, nutrition and cosmesis 
(e. g., The EORTC QLQ H&N3510). 
HR-QoL has been found to vary over time and 
with treatment modality in head and neck cancer 
patients. " 12 However, there is a poor understand- 
ing of the reasons why people at similar stages 
of the disease who have also received similar treat- 
ments experience different levels of quality of 
life. Accumulating research evidence has revealed 
that there is enormous variation in the ways pa- 
tients adjust to illness and the nature of this 
adjustment is crucial in determining both psycho- 
logical and physical health outcomes. There is 
also consistent evidence that this variation is not 
primarily due to clinical factors such as illness 
severity. 
The primary value of understanding individual 
variation in HR-QoL is to minimise the impact of 
HNC on a patient's life. By understanding the rela- 
tionship between HR-QoL and potentially modifi- 
able psychological factors interventions can be 
designed with the aim of maximising a patient's 
long-term HR-QoL. To gain a better understanding 
of what additional factors have been assessed in 
relation to HR-QoL in HNC a systematic review 
was undertaken. 
The systematic review sought to answer the fol- 
lowing research questions: 
(1) What psycho-social or behavioural factors are 
associated with HR-QoL? 
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(2) What is the relationship between depressive 
symptoms and HR-QoL? 
Methods 
Search techniques and terms 
Databases 
An electronic search was undertaken of 10 data- 
bases: MEDLINE, CANCERLIT, CINAHL, EMBASE, 
PsycINFO, the Institute for Scientific Information 
(151) databases of Science Citation Index Expanded 
(SCI-EXPANDED) and Social Sciences Citation Index 
(SSCI) via the Web of Knowledge (WOK). Recent 
journals that may not have entered the electronic 
system were also hand-searched (Cancer, Head 
and Neck; Journal of Clinical Oncology; Laryngo- 
scope; International Journal of Oral and Maxillofa- 
cial Surgery; British Journal of Oral and 
Maxillofacial Surgery; Otolaryngology Head and 
Neck Surgery; Quality of Life Research, Psycho- 
Oncology). An attempt was also made to identify 
any peer-reviewed but unpublished work by asking 
leading researchers /clinicians in the field. 
Search terms 
Two search strategies were conducted on each 
database separately, based on searching subject 
headings (i) and a free-text search (ii), these were 
then combined using the Boolean operator 'OR'. 
(Specific search terms are listed in Appendix A. ) 
The searches were limited by including only Litera- 
ture published in the English language between the 
years 1980 to present and only involving human 
participants. The year of 1980 was considered a 
good cut-off point due to the relative recency of 
literature on quality of life. All commentaries, edi- 
torials, case-reports and review articles were 
excluded. 
Study inclusion criteria 
Outcome measures 
Data were sought on HR-QoL and studies were only 
included if the measurement instrument was either 
recognised as a reliable and valid measure of QoL. 
Assessment of HR-QoL typically includes physical, 
psychological and social domains, therefore, mea- 
sures of purely functional status were not included. 
Instruments such as the Hospital Anxiety and 
Depression Scale (HADS) and measures of disfigure- 
ment were also not considered measures of HR-QoL 
for the purposes of this review. 
Data extraction and synthesis 
Data were extracted from full-version articles 
using pre-designed tables to ensure that data 
extraction was standardised. Disease characteris- 
tics of the patient, (i. e., site and type of cancer, 
treatment type and outcomes) were too heteroge- 
neous to apply formal meta-analytical pooling. 
Individual studies were reported separately, with 
their specific design features and results, in accor- 
dance with accepted guidelines from the NHS Cen- 
tre for Reviews and Dissemination. 13 
Critical appraisal of study quality 
Each of the studies was scored for quality on six cri- 
teria. These included the study aims or research 
question, study design, sample characteristics, sta- 
tistical analysis, statistical power and validity of 
conclusions. Each factor was valued on a three- 
point scale with 0 indicating poor, I for adequate 
and 2 for good and an overall score for the study 
was thus calculated by summing these out of a pos- 
sible total score of 12 points (see Appendix B for 
definitions). 
Results 
A total of 16 studies fulfilling the inclusion criteria 
were identified and reviewed. The final selection of 
studies showed wide variation in terms of the as- 
pects of QoL that were assessed, patient sample 
and study design. Key data are summarized in 
Tables I and 2. Four main factors were identified 
in relation to HR-QoL in HNC patients. The results 
are discussed below under the main headings of 
Personality, Social support, Satisfaction with con- 
sultation and information, and Behavioural factors. 
The relationship between depression and HR-QoL 
has been considered separately due to the debate 
that depression may simply reflect a dimension of 
QoL, and includes studies that have analysed the 
extent to which depressive symptoms affect HR- 
QoL as well as vice versa. 
Personality 
Personality may be defined as a person's character- 
istics that are responsible for relatively stable pat- 
terns of feeling, thinking and behaviour. 14 There 
are many ways of conceptualising and measuring 
personality 'traits' however but few have been 
investigated as potential influences on HR-QoL in 
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Table 1 Summary of variables studied in relation to HR-QoL 
Variable Specific component Study 
Personality . Neuroticism and extraversion 15 
. Dispositionat optimism 18,19,21 
Social support . Satisfaction with family physician support 23 
. Extent of social contact with family, friends, neighbours 17 
Information . Satisfaction with information and consultation 21 
Risk behaviour . Alcohol 27-29 
0 Smoking 29,34 
Mood . Depression 
HNC. Four studies were identified that attempted 
to examine this relationship. 
Neuroticism and extraversion 
A recent cross-sectional study by Aarstad et al. 's 
demonstrated an association between personality, 
as measured by The Eysenck Personality Question- 
naire16 and HR-QoL (EORTC QLQ-C30 + HN35) in 
two different samples of successfully treated pri- 
mary HNC patients. The patients consisted of one 
sample of 96 HNC patients and another sample of 
104 laryngectomised patients, also discussed later 
in the review, in a study by Birkhaug et al. " 
Aarstad et al. 15 found that high neuroticism was 
associated with a lower HR-QoL in both patient 
samples. Specifically, neuroticism was negatively 
correlated with cancer specific HR-QoL, 7 and posi- 
tively correlated with the majority of general can- 
cer symptom scales in both samples, and with the 
majority of head and neck cancer specific scores1° 
in the laryngectomised sample only. These associa- 
tions were reported as stable after adjustments 
were made for gender, age, marital status, educa- 
tional level, number of children and level of treat- 
ment. Significant positive associations were found 
between extraversion scores and general health/ 
QoL, demonstrating that higher extraversion scores 
were associated with better QoL functioning. 
Dispositional optimism 
The rote of dispositional optimism on HR-QoL in 
HNC patients was assessed in three papers, but 
was the primary focus of only two. 18''9 
In a prospective study by Allison et al., 18 dispo- 
sitional optimism was associated with better 
HR-QoL in a consecutive sample of 101 French 
HNC patients. The sample consisted of oral, pha- 
ryngeal and laryngeal cancer patients and mea- 
sures were taken at baseline and three months 
following treatment. The dependent variable of 
17,29,34,38,41,42,44,46,53 
HR-QoL was measured using a cancer specific HR- 
QoL measure only (EORTC QLQ-C30) and optimism 
was evaluated using a French version of the Life 
Orientation Test (LOT). 20 Optimism scores were 
dichotomised around the median, and in multivar- 
iate analyses of the pre-treatment data, the 
dichotomised LOT rating significantly predicted 
HR-QoL domains of role, cognitive and emotional 
functioning; global HR-QoL; pain and fatigue, 
whilst adding treatment as another independent 
variable and controlling for disease site and stage. 
A similar result was gained from multi-variate ana- 
lyses conducted on three-month follow-up HR-QoL 
data. Bivariate analyses indicated that 'optimistic' 
patients were more likely to report better HR-QoL 
than 'pessimists', however, specific results from 
the multi-variate analyses were not reported. 
In a repeated measures design study by Yu 
et al., 21 the association between satisfaction with 
information and QoL in 211 nasopharyngeal cancer 
patients was examined. In addition to these main 
variables of interest, trait optimism was included 
as part of a battery of psychosocial variables. Opti- 
mism was measured using a single visual analogue 
line. HR-QoL was measured with the Chinese ver- 
sion of the Functional Assessment of Cancer Ther- 
apy-General Scale: FACT-G (Ch). 22 Optimism at 
follow-up Time 1 (at the completion of radiother- 
apy but 4 months post-baseline) was initially found 
to be a significant predictor of HR-QoL 4 months 
later (8 months post-baseline), in addition to 
variables of 'satisfaction with the information 
provided', 'worry about family', treatment and 
recurrence after baseline. However, after adjust- 
ing for baseline QoL scores, optimism became 
insignificant. 
In the same patient group, 19 the mediating role 
of optimism between eating ability and post-radia- 
tion QoL was investigated with a series of regres- 
sion analyses, and adjusting for baseline HR-QoL 
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- status) and cancer stage at 
baseline. The results 
cký 
v 0N 
Q) MUb indicated that eating ability at the completion of 
r 0Uü -' radiotherapy was independently predictive of both 
L dQ optimism and QoL 4 months later. However, this 
`°U relationship was no longer significant when opti- 
° mism was controlled for. These data suggest that -p C '^ CNC mn ü (a C: M v optimism was exerting a mediating effect between ö 








EL-ä, Two cross-sectional studies analysed the impact of 






social support on HR-QoL. In the earlier study 
" v 
UQy 
vvE 23 social support of 45 patients by Mathieson et al. 
a , was measured using the Social Support Question- WON°O 
vao "E naire (SSQ). 24 The results of a regression analysis 
=v 
°r with HR-QoL as the dependent variable (derived aO 
10 *E U from the Functional Living Index-Cancer scale 
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that QoL at Time 2 (8 months after referral) was 
predicted by the five-item cognitive subscale of 
the MISS. This suggested that NPC patients report- 
ing more satisfaction with the information pro- 
vided approximately 1 month after the end of 
radiotherapy, had a better QoL 4 months later. 
Optimism and worry at time 1, treatment and 
recurrence after baseline, were also found to sig- 
nificantly predict QoL at Time 2. However, when 
baseline QoL and stage of disease at time of diag- 
nosis were adjusted for, the most significant pre- 
dictor remained the patient's satisfaction with 
information. Worry, treatment and recurrence 
after baseline also remained significant and all 
other variables, including optimism, were found 
to be insignificant. 
Behavioural factors associated with HR-QoL: 
alcohol consumption and smoking 
Three recent studies have investigated the rela- 
tionship between alcohol intake and HR-QoL in 
HNC patients, with differing results. Allison27 con- 
ducted a cross-sectional survey of 191 patients 
with either carcinoma of the oral cavity, pharynx 
or larynx. Alcohol intake was measured with a sin- 
gle item question, 'during the past month have you 
drunk alcohol on one or more occasions? ' The re- 
sults from multi-variate regression analyses 
showed that alcohol consumption was significantly 
associated with EORTC QLQ-C30 + HN35 domains 
of physical functioning, role functioning, global 
HR-QoL, fatigue, pain, swallowing, dry mouth and 
feeling ill, whilst controlling for age, gender, 
employment status, disease site and stage, time 
since treatment and treatment modality. Data indi- 
cated that patients consuming at least one alco- 
holic drink in the past month had better HR-QoL 
functional scores and lower levels of symptoms 
than participants reporting no alcohol intake. How- 
ever, the results presented in the paper lack the 
detail to make any more assumptions regarding 
these relationships. 
In contrast, in a prospective study by Sehten 
et al., Z$ excess alcohol consumption was found to 
be associated with worse HR-QoL. A sample of 83 
patients with HNC were assessed with the FACT-G 
questionnaire prior to radiotherapy, at the end of 
radiotherapy and six weeks after. Socio-demo- 
graphic variables were measured with the Current 
Situation in Personal Life questionnaire, which 
was developed by the authors. Patients with a 
Karnofsky performance status score of <50 were 
excluded from recruitment. Binary logistic regres- 
sion models were used with the FACT-G sum score 
dichotomised into low (<70) and high HR-QoL (>70). 
After testing various models based on medical and 
socio-demographic variables, having children, cur- 
rent employment, alcohol abuse, level of second- 
ary education and gender were found to account 
for a quarter of the variance in HR-QoL six weeks 
after radiotherapy. On examination of the odds ra- 
tios, patients with no or low secondary education 
had a four-fold higher risk of having a low HR-QoL 
than patients with medium secondary education 
and an eight to nine-fold higher risk than patients 
with a high education. Male patients were at a 
higher risk of low HR-QoL, as were patients without 
children and unemployed. However, it was found 
that those at highest risk of low HR-QoL were pa- 
tients reporting alcohol abuse. The confidence 
intervals were not reported which, again, makes 
it difficult to ascertain their significance. 
In contrast to both of the above studies, Duffy 
et al., 29 failed to find any relationship be- 
tween alcohol intake and HR-QoL (SF-36V and 
HNQoL, 30'31) although a significant relationship be- 
tween smoking and HR-QoL was found. Alcohol was 
measured with the Alcohol Use Disorder Identifica- 
tion Test (AUDIT)32 which is a 10-item screening 
instrument that assesses both level of alcohol in- 
take and related problems, including hazardous 
drinking, alcohol abuse and dependence. Smoking 
was measured with the Fagerstrom Test for Nico- 
tine Dependence (FTND)33 which is a six-item ques- 
tionnaire. Smoking was found to be negatively 
associated with five scales of the SF-36V3° physical 
functioning, general health, vitality, social func- 
tioning and role-emotional health, however, alco- 
hol was not associated with any of the HR-QoL 
scales. However, a 12-month prospective study 
involving 105 HNC patients by Gritz et al., 34 failed 
to find any relationship between current smoking 
(smokers vs. quitters) and global HR-QoL. Patients 
were originally recruited as part of a larger ran- 
domised controlled trial comparing two differently 
delivered smoking cessation programmes and as 
such the paper only included patients who had re- 
ported tobacco use within the last year prior to 
diagnosis. HR-QoL was measured using the Cancer 
Rehabilitation Evaluation System-Short Form 
(CARES-SF)35 which is a generic cancer measure 
that yields a global score and five summary scores 
(physical, psychosocial, marital, sexual and medi- 
cal interaction). 
Depressive symptoms 
Nine papers examined the relationship between 
depressive symptoms and HR-QoL. Three of these 
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used cross-sectional designs and the others were 
prospective studies with short and longer-term 
outcome assessments. In addition, two further pro- 
spective studies examined the relationship be- 
tween depression and HR-QoL using depression as 
the outcome (dependent) measure. These three 
groups have been presented separately below. 
Cross-sectional studies 
Significant relationships between depressive symp- 
toms and HR-QoL were found in all three of the 
cross-sectional studies. Duffy et al., 29 used the 
Geriatric Depression Scale-Short Form (GDS-SF)36 
to assess levels of depression in a mixed sample 
of 81 HNC patients and found that nearly half had 
significant depressive symptoms. HR-QoL was mea- 
sured using the SF-36V3° and the HNQoL. 31 All 12 
multiple regression analyses indicated strong nega- 
tive associations between significant depressive 
symptoms and HR-QoL, when controlling for age, 
tumour site and stage, nicotine and alcohol 
problems. 
Similarly, Birkhaug et al., " found that 35% of 
patients, on average 10 years since treatment, re- 
ported either possible or probable depression using 
the Beck Depression Inventory (BDI). 37 Significant 
negative correlations existed between all HR-QoL 
functional scales, global health/QoL score and 
depression, indicating that the lower the HR-QoL, 
the higher the depression. 
An earlier study by D'Antonio et al., 38 of 50 pa- 
tients evaluated from 6 months to 6 years post-sur- 
gery, also found an inverse relationship between 
HR-QoL, as measured by the FACT-G, FACT-HNS 
and the UW-QoL scales, and depression (BDI). Using 
the full version of the BDI, 22% of the sample dem- 
onstrated moderate to severe levels of depression. 
There were no relationships reported between the 
clinician evaluation of a patient's emotional well- 
being and the patient's score of emotional well- 
being (derived from the FACT-G) or depression. 
All analyses were uni-variate, therefore, no adjust- 
ments for other factors were made. 
Prospective studies 
The relationship between depression and HR-QoL 
during the first year post-treatment was reported 
in two papers. 
De Graeff et al., 39 revealed a predictive rela- 
tionship between depression and HR-QoL (EORTC 
QLQ-C30 + HN35) in a sample of 153 HNC patients. 
The total amount of variance explained by depres- 
sion was slightly greater for the prediction of head 
and neck specific scales than for the general cancer 
scales. Overall, depression, tumour stage and Kar- 
nofsky performance status were the most impor- 
tant predictors of HR-QoL. 
However, another 12-month prospective study 
involving 105 HNC patients by Gritz et al., 34 failed 
to find any relationship between depressive mood 
and HR-QoL (CARES-SF). Depressive mood was mea- 
sured as part of the Profile of Mood States (POMS) 
scale. 40 The Depression-Dejection factor from 
the POMS reflects sadness, guilt, emotional isola- 
tion, worthlessness and futility. The results of 
multi-variate analyses showed that only treatment 
type, and HR-QoL at one month, were predictive of 
HR-QoL at 12 months. 
The prospective relationship between depres- 
sive symptoms and HR-QoL, as an outcome mea- 
sure, over a longer period, has been investigated 
in only two studies. 41 '42 Hammerlid et al., " re- 
ported significant relationships between depressive 
symptoms (HADS43) and HR-QoL (EORTC QLQ-C30 
scales of Global QoL, emotional functioning and 
an HEtN35 item of pain) in 133 patients (57% of 
the original sample) at 3 years post-treatment. It 
is unclear what percentage of total eligible pa- 
tients the recruited sample represented. 
In contrast, Nordgren et al., 42 failed to find any 
relationship between baseline depression (HADS) 
and HR-QoL (EORTC QLQ-C30 + HN35) 5 years after 
diagnosis, in a sample of patients with cancer of 
the larynx. 
Depression as an outcome variable 
The role of HR-QoL in predicting depression was 
examined in two papers based on the same data- 
set. De Leeuw et al., 44 collected data on 155 HNC 
patients at 6 and 12 months following treatment, 
in order to assess whether pre-treatment factors, 
including HR-QoL, could be used to predict depres- 
sion at these time points. HR-QoL was represented 
by three scales of general cancer related physical 
symptoms derived from 12 items from the EORTC 
QLQ-C30 + 3, the Physical Functioning scale and 
head and neck tumour specific and treatment re- 
lated physical symptoms derived from the 21 items 
of the EORTC QLQ-H&N37.45 Social support, coping 
and locus of control were also measured as pre- 
dictive variables. Stepwise multiple regressions 
were conducted to predict depression at 6 and 
12 months post-treatment, entering tumour stage, 
age, gender, depressive symptoms at baseline, 
coping, cancer locus of control, support, the ex- 
tent of social network, openness to discuss cancer 
in family, current HR-QoL (as represented by, gen- 
eral cancer related physical symptoms, tumour 
and treatment related physical symptoms and 
Physical Functioning). Two-thirds of the variance 
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in depressive symptoms was explained by these 
factors at 6 months and a half at 12 months. In 
addition to tumour stage and gender, current HR- 
QoL explained half of the variance at 6 months. 
Psychosocial variables measured prior to treatment 
explained an additional 12% of the variance 
(depressive symptoms, avoidance coping and the 
extent of formal social network). However, it is 
clear that most of this variance was from levels 
of depression prior to treatment. 
Unsurprisingly, a similar relationship also 
emerged from another study by de Leeuw et al., 46 
reporting a slightly higher recruitment rate of 197 
patients with 6 months post-treatment data and 
171 patients with 12 months post-treatment data. 
Again, it was demonstrated that depressive symp- 
toms prior to treatment were the best predictor 
of depressive symptoms at each time point. Data 
from 139 patients 2 years post treatment and 123 
patients 3 years post-treatment, indicated that 
depression at those time points was mostly ex- 
plained by baseline (pre-treatment) depression. 
HR-QoL could explain a further 20% approximately. 
Patients who had a recurrence during this time- 
period were not excluded from analyses. 
Limitations 
Study design and quality 
The majority of studies included in this review 
are limited by methodological and statistical prob- 
lems or missing data. However, seven of the 
studies included in this report attracted the highest 
'quality' score of 'good' (scores of at least 9 out 
of 12) when critically appraised according to the 
criteria (Table 2). Three studies were deemed 
to be of a 'poor' quality (scores of between 0 
and 4). The majority of studies did not forward 
any specific hypotheses for testing and all of the 
studies lacked any hypothetical or theoretical 
framework on which to base their research 
questions. 
The studies varied in sample sizes and response 
rates, ranging from sample sizes of 4523 to 232.41 
Response rates for the studies ranged from 45% of 
the original number of patients eligible for inclu- 
sion19'21 to 99%, 18 however, many of these were 
based on convenience samples and recurrent can- 
cer patients and in many studies the exact number 
of patients eligible for inclusion at the time of the 
study has not been reported, therefore, the re- 
sponse rates cannot be ascertained. This limits 
the ability to generalise from these studies. 
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Health-related quality of life as an outcome 
measure 
The majority of the studies used the EORTC 
QLQ-C30EtHN35 to assess HR-QoL. However, many 
different dependent (or outcome) variables were 
selected to measure relationships between vari- 
ables. The lack of concordance between results 
may have been due in part to using different mea- 
sures of HR-QoL or using different subscales of the 
same measure. For example Mathieson et al., 23 
used a composite score from a general mea- 
sure of HR-QoL in cancer patients and Birkhaug 
et al., " used both general cancer and head and 
neck cancer specific scales in their assessment of 
the relationship between HR-QoL and social sup- 
port. In addition, studies used different methods 
of data collection. 
Statistical limitations 
In many studies it was difficult to ascertain how 
results had been statistically derived from the 
data. Many of the studies relied on uni-variate 
analyses and did not control for variables already 
known to be potentially confounding (e. g., various 
socio-demographic and medical/treatment fac- 
tors). HR-QoL at baseline was not always ade- 
quately controlled for when analysing data from 
prospective studies. 
It was unclear whether much of the data pub- 
lished met assumptions for parametric testing and 
the general lack of detail made it difficult to deter- 
mine whether variables entered into regression 
models were statistically appropriate. Authors 
rarely mentioned whether skewed data had been 
transformed before analyses. Similarly, there was 
a general lack of detail regarding missing data 
and how this was dealt with before analyses. De- 
spite the small sample sizes generally recruited in 
the field of head and neck cancer, few of the stud- 
ies reported actual power calculations or provided 
comment about the power of study based on their 
method of analyses. 
Discussion 
Health related quality of life is now considered an 
important patient centred outcome variable fol- 
lowing treatment for head and neck cancer. This 
has lead to a dramatic increase in the number of 
studies incorporating assessments of HR-QoL. De- 
spite this increase in interest, the majority of stud- 
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ies investigating HR-QoL in this population have 
mainly been aimed at comparing the impact of dif- 
ferent treatment modalities and have therefore 
only commented upon the effects of treatment 
and disease related variables. This has resulted in 
knowledge about the effects of disease site and 
treatment on HR-QoL, however, few studies have 
attempted to explore the impact of non-clinical 
variables on HR-QoL. 
The limited data regarding the role of personal- 
ity traits on reported HR-QoL indicated significant 
predictive and associative relationships. All four 
studies examining trait characteristics of either 
neuroticism/extraversion or optimism were consid- 
ered 'adequate' or 'good' in quality. 15,18,19,21 
Results demonstrated that the higher the extraver- 
sion or optimism score of the patient, the higher 
they rated their HR-QoL. In contrast, patients scor- 
ing highly for neuroticism were more likely to have 
a low HR-QoL. Personality is thought to influence 
health outcomes either directly or indirectly 
through a number of mechanisms, including symp- 
tom reporting47°48 and coping styles. Dispositional 
optimism has been found to correlate positively 
with problem-focused coping, the positive reinter- 
pretation of a problem and the attempt to accept 
the reality of situations that are perceived to be 
uncontrollable. 20 Coping may be an important 
mediator between personality and outcome and 
thus may be more open to psychological interven- 
tion than directly targeting relatively stable per- 
sonality traits. 49 
The role of social support on HR-QoL is less 
clear. Of the two 'adequately' rated cross-sec- 
tional studies, one study failed to find any relation- 
ship between the 'extent of social support from 
family, friends and neighbours' and HR-QoL, 17 
whereas, another study demonstrated that 'satis- 
faction with physician support' accounted for 45% 
of the variance in HR-QoL. 23 The 'support' assessed 
in these two instances illustrates not only the wide 
differences in underlying construct between differ- 
ent types of social support measure but of the sub- 
sequent implications that arise from employing 
different types of support measure. Interestingly, 
the study finding no relationship between level of 
support and HR-QoL involved laryngectomy pa- 
tients who may have more complex issues involving 
communication, social support needs and subse- 
quent HR-QoL. Social support is a complex interac- 
tive construct, which may only be effective when 
matched with the patients needs. Studies also con- 
firm that it is the perceived quality of the social 
support that affect outcomes such as well-being 
and depression. 50 It is these components of support 
which need to be explored in more detail in future 
work in order to have a clearer understanding of 
their possible effects on QoL. 
Alcohol and nicotine usage were found to be 
associated with HR-QoL in two ways. An 'ade- 
quately' rated cross-sectional study by Allison, 
found having had at least one alcoholic drink in 
the past month (post-treatment) was associated 
with higher levels of HR-QoL. This may have been 
due to better functional ability in swallowing and 
drinking rather than alcohol per se influencing 
HR-QoL. In a 'poorly' rated study by Sehlen 
et at., 28 excess alcohol was associated with a worse 
HR-QoL, which may have been representative of 
worse disease and an addiction to alcohol. Simi- 
larly, Duffy et al., 29 found a negative relationship 
between nicotine dependence and HR-QoL, demon- 
strating that those with a high dependence to nic- 
otine reported worse HR-QoL. The scope for 
providing support and intervention in treating 
addictions such as these for particular at risk 
patients would be beneficial not only in terms of 
an individual's QoL but also to limit the chance 
of cancer recurrence in the future, as alcohol 
and tobacco are well known aetiological agents of 
HNC. 
A fairly consistent picture emerges from the lit- 
erature regarding the relationship between depres- 
sive symptoms and HR-QoL. Of the nine studies 
included in this review, seven reported signifi- 
cant relationships between depression and HR- 
QoL, "'", 29,38 41,44'46 despite the range in quality 
ratings of the studies and the wide range of depres- 
sion measures applied. For example, the BDI in- 
cludes vegetative symptoms (loss of appetite, 
fatigue, lack of motivation etc. ), which are attrib- 
utable to depression, however, these symptoms 
can also be indicative of treatment side-effects 
or disease progress. This makes any relationship 
less easy to interpret. The HADS, on the other 
hand, does not contain any items that are related 
to physical conditions. Three of the studies report- 
ing associations were cross-sectional in design and 
analyses were uni-variate, therefore direction of 
causation is unknown. Regarding depression as a 
predictor of HR-QoL, the results appear inconclu- 
sive as 2 out of 4 of the studies failed to find a sig- 
nificant relationship in either the short-term or the 
longer term. Of the two studies examining the role 
of HR-QoL on depression, it was found that 
although significant relationships existed, depres- 
sion at baseline was a far better predictor of 
depression than current HR-QoL. These last two 
studies were rated highly as 'good', but were actu- 
ally based on the same data set and similar analy- 
ses and, therefore, should not be taken as 
providing 'double' the support. 
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It is unsurprising that depression is related to 
HR-QoL, however, it is difficult to ascertain which 
has the overriding influence on the other, as the 
relationship between depression and HR-QoL is 
complex, dynamic and somewhat overlapping. 
The lack of consistency regarding the relationship 
between depression and other outcomes, not just 
HR-QoL, reflects a fundamental problem in all 
area's of the literature and not just HNC. This dis- 
crepancy also illustrates that lower HR-QoL may 
not necessarily lead to depressive symptoms or 
conversely that those who are depressed may have 
a relatively good HR-QoL compared to others. The 
underlying mechanism for this inconsistency may 
be due to adaptive or non-adaptive processes, such 
as 'burnout' as a result of long periods of stress51 or 
adjustment to the illness and threat'39 both of 
which may be related to mediational factors such 
as coping or effectiveness of support networks as 
mentioned previously. The relationship between 
physical symptoms/ impairment and depression is 
far from understood. Further research is needed 
to unravel these relationships. 
Recommendations 
A number of key points emerge from this review. 
Arguably, there is a great need for more robust 
and theoretically-driven studies in this area. The 
main differences in HR-QoL between treatments 
and between cancer sites have now been defined 
and longitudinal patterns have been established, 
therefore, it is time to turn our attention to the 
predictors of HR-QoL and adaptation in order to de- 
velop appropriate interventions for change. Many 
interventions are now proceeding and failing with- 
out the robust empirical evidence or theoretical 
basis on which to base their content. 52 The need 
for reliable study designs and clear research 
questions based on theories which can be put into 
practice, are now of paramount importance if pro- 
gression is to be made in this field. If potentially 
modifiable psycho-social factors are related to as- 
pects of HR-QoL then these can be targeted with 
psychological intervention. Further research may 
elucidate which psychological factors would be 
best targeted, either for at risk groups or individu- 
als at risk of poor outcome. 
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Appendix A. Search terms 
(i) For the subject heading search, the term 
'head and neck cancer' was exploded to 
include the following subject index terms: 
neoplasms of head and neck, hypopharyngeal, 
laryngeal, nasopharyngeal, oropharyngeal, 
pharyngeal, tongue, tonsillar, esophageal, 
mouth, oral cavity, salivary gland, tracheal, 
submandibular gland and otorhinolaryngolic. 
This was combined with the subject heading 
'Quality of life', which would also serve to 
include health related quality of life (HR- 
QoL) as a subject heading. 
(ii) For the free text search, terms of Cancer$, 
carcino$, neoplas$, tumo? r$, 'head and 
neck', oral, mouth$, hypopharyn$, tongue, 
laryn$, naso$, oropharyn$, pharyn$, tonsil, 
esophag$, oesophag$, salivary, tracheal$, 
submandibular$, otorhinolaryn$, quality of 
life, QoL, health state$, as text words (in title 
and abstract) were combined. 
Appendix B. Critical appraisal of study 
quality 
Factor Score 
Study aims/ Good (2): Aims clear, 
Research research Q or hypotheses 
question stated 
Adequate (1): Aims stated, no 
specific research Q or 
hypotheses 
Poor (0): Aims not clear or not 
stated 
Study design Good (2): Prospective or case/ 
control 
Adequate (1): Cross-sectional 
Poor (0): Not clear 
Sample Good (2): Large, 
charac- representative, 
teristics well described 
Adequate (1): Limited info on 
sample or small and 
unrepresentative sample 
Poor (0): Unable to determine 
characteristics and representa- 
tiveness of sample 
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Factor Score 
Analysis Good (2): Appropriate multi- 
variate analyses, controlling 
for confounding factors 
(esp. site/ treatment if hetero 
sample) 
Adequate (1): Appropriate 
but limited /simplistic 
analyses 
Poor (0): Analyses 
inappropriate/ 
inadequate, likely to give 
misleading results 
Statistical power Good (2): Power calculation 
included or appropriately 
powered study 
Adequate (1): Adequately 
powered going by sample 
size/analyses 
Poor (0): v. Underpowered 
going by sample size/ 
analyses 
Validity of Good (2): Accurate and 
conclusions derived from good statistical 
analyses/design 
Adequate (1): Generally 
supported by results 
Poor (0): Bear no 
resemblance to 
results presented 
Total score: Those scoring between 0 and 4= poor, 5 and 
8= adequate, 9 and 12 = good. 
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Abstract 
Aims: To assess the extent to which individualised quality of life (QoL) was 
and to assess how much of the variation in each of these measures could be ( 
Methods: Fifty-five patients with newly diagnosed head and neck cancer coi 
Index (PGI), the European Organisation for Research and Treatment ofCancei 
Explanatory factors were measured with the following: the Illness Perceptio 
Questionnaire (BMQ), the Hospital Anxiety and Depression Scale (HADS), 
Main findings: Standardised and individualised QoL measures were correlat 
domains of emotional and cognitive functioning and SF- 12 domains of menta 
psychological factors explaining each of the three outcome measures were d 
related to standardised health-related quality of life (HR-QoL), 
xplained by psychological variables. 
ipleted the following outcome measures: the Patient Generated 
(I: ORI'C) QLQ-C30 and the Short Form 12 version 2 (SF- 12v2). 
is Questionnaire-Revised (IPQ-R), the Beliefs about Medicines 
and the Brief COPE (a shortened version of the COPE). 
d only partly. The PGI correlated only with EORTC QI. Q-C30 
health, emotional role, social, and physical role. The underlying 
Conclusions: Respondent-generated measures such as the PGI could be used as an adjunct to more standardised measures of HR-QoL 
clinically. This has implications for assessing the impact of head and neck cancer on individualised QoL and also for improving patients' 
outcome through interventions aimed at targeting underlying psychological factors. 
© 2005 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved. 
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Introduction 
In 1998, there were 6500 new cases of i 
cancer in the UK, and 2700 deaths, be 
eight deaths a day. Despite developments 
reconstructive techniques the survival aft 
ease has remained at about 50%, and tho 
incur considerable morbidity. Support ser 
of speech therapists, dieticians, and pros 
ers have lessened the impact of disability and impaired 
functioning. 
and throat Assessment of the impact of head and neck cancer should 
seven and encompass more than survival, and extends beyond function- 
atment and ing to include patient well-being. Recently, much has been 
mnced dis- published on QoL issues in patients with head and neck can- 
o are cured cer, but there is wide variation in what is meant by quality 
in the form of life. The World Health Organisation has defined a high 
practition- QoL as a `state of complete physical, mental, and social 
well-being and not merely the absence of disease or infir- 
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' Using WHO's definition, global QoL should include a 
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income. Assessing global QoL generally provides a broader 
picture of the impact of disease on a person's life. In clin- 
ical practice, however, QoL usually refers to health-related 
quality of life (HR-QoL) which examines aspects of QoL 
affected by a health or medical concern. Assessment of HR- 
QoL typically includes physical, psychological, and social 
domains, and tends to make the assumption that a standard 
set of circumstances is required for optimal well-being. 
However, most assessments of HR-QoL do not take into 
account the fact that many patients have come to terms with 
their limitations and consequently these areas of measure- 
ment may have little impact on their extent of satisfaction. 
Within this context, there has been little published on the 
assessment of individualised QoL (how patients perceive 
their QoL with respect to areas most important to them) and 
how it compares with more standard measures. 
64 The use of a theoretical framework: the 
65 self-regulation model 
resentation of a disease will affect the prominence, meaning, 
and importance of the domains involved in making judge- 
ments of QoL. 4 Specification of variables within this frame- 
work has led to the development of hypotheses to test and 
further our understanding of QoL in patients with head and 
neck cancer. 
The aims of this study were two-fold: firstly, to assess 
the extent to which standardised and individualised measures 
of QoL were related to each other; and secondly, to assess 
the extent to which standardised and individual QoL before 
treatment can be explained by psychological variables, par- 
ticularly those factors guided by the self-regulation model. 
Three null hypotheses were tested: 
There is no correlation between standardised assessments 
of I IR-QoL and the individualised measure of QoL; 
patients' beliefs about their illness and treatment will not 
explain a significant amount of variation in standardised 
HR-QoL; and 
patients' beliefs about their illness and treatment will not 
explain a significant amount of variation in individualised 
QoL. 
66 Standardised HR-QoL varies with time and treatment, but 
67 why those with similar stages of disease and treatment should 
68 experience different levels of quality of life is not clear. How- Methods 
69 ever, there is enormous variation in the way patients adjust 
'o to illness and the nature of this adjustment is crucial to psy- During the period July 2003 to March 
2004,55 patients who 
71 chological and physical outcomes. In addition, this variation had recently been diagnosed with confirmed squamous cell 
72 is not primarily the result of clinical factors such as severity carcinoma of the head and neck were recruited 
from four hos- 
73 illness. To gain a better understanding of how treatment pitals in the south-east of England, after obtaining approval 
 of head and neck cancer influences QoL, a theoretical frame- from the Local Regional Ethics 
Committee and gaining 
75 work is required. The self-regulation modelt-3 (Fig. 1) shows patients' informed consent. 
Data were obtained during the 
76 how patients understand and adapt to a threat to their health. period between confirmation of the 
diagnosis but before treat- 
 The framework suggests that four broad classes of factors ment, by self-completed questionnaires and medical records. 
78 influence patients' judgements and behaviour: the cognitive Patients were recruited into an 8-month repeat measures 
79 representation of the threat of the disease (the beliefs that study, but only (cross-sectional) data obtained 
before treat- 
eo patients have about their illnesses and treatment); the affec- ment are presented in this paper. Inclusion criteria were any 
81 tive reaction (the emotional reaction to the illness); the coping patient over 18 years old with a newly 
diagnosed primary 
82 mechanisms to deal with the threat and the emotions elicited head and neck cancer. 
83 by the threat; and contextual factors such as social roles and Standard data that we recorded in this study were: age, sex, 




of health threat 
Health threat 
head and neck 
cancer 
=º Emotional representation f Coping procedure Appraisal 
of health threat 
Fig. 1. The self-regulation model. 
YBJOM 2292 1-7 







































L)TD 5! o wä' 
T 
C. D. Llewellyn et al. / British Journal of Oral and Maxillofacial Surgery xxx (2005) xxx--xxx 
variables that were recorded were site, stage of disease, and 
type of treatment planned. 
The details of the outcome instruments that we used are 
given in the appendix. They were: the European Organisation 
for the Research and Treatment of Cancer (EORTC) QLQ- 
C30, ' The General Health Survey Questionnaire, Short Form 
12 (SF-12v2)6 and the Patient Generated Index (PGI). 7 
The following measures were used to assess psychological 
factors: 
The Illness Perception Questionnaire-Revised (IPQ-R), 8 
The Beliefs about Medicines Questionnaire-Specific Scale 
(BMQ-Specific), ' The Hospital Anxiety and Depression 
Scale (HADS), 9 and the Brief COPE. 10 
Statistical analysis 
Characteristics of responders and non-responders were 
assessed for differences using chi square tests for sex and 
stage of cancer, and an independent Student's 1-test for age at 
diagnosis. Data on the three outcome measures were scored 
and standardised as per recommendations. Pearson's corre- 
lations were calculated among all the three outcome mea- 
sures to assess any associations. Pearson's correlations were 
also calculated among all variables and each of the three 
outcome variables to establish correlations. Point biserial 
correlations were calculated for dichotomous variables (sex, 
marital status, and ethnicity) where significant correlations 
existed (p < 0.01), variables were then entered into multiple 
linear regression models using a stepwise entry method, to 
assess how much of the variation in each of the QoL measures 
















The sample comprised 55 patients with newly diagnosed head 
and neck cancer, three quarters of those who had been invited 
to take part. There were 36 men (65%), which is typical 
of the disease, and the American Joint Committee on Can- 
cer (AJCC) stages of disease were fairly evenly distributed 
(Table 1). Those who declined to take part tended to be older 
and there were more men, but the differences were not sig- 
nificant. There was also no significant difference in stage of 
cancer between responders and non-responders. The domains 
within the different QoL measures were internally reliable 
(Table 2). 
The correlation between standardised HR-QoL and 
individualised QoL 
.6 Standardised 
HR-QoL and individualised QoL measures 
67 were correlated only partly 
(Table 3). The PGI correlated 







63.4 (20.9) 0-100 0.8 
67.6 (25.0) 0-100 0.9 
77 (28.4) 0-100 0.8 
87.2 (17.7) 27-100 0.7 
75.1 (25.8) 0-100 0.7 
78.4 (29.4) 0-100 0.8 
SF-12 (n=55) 
Mental health 62.9 (21.2) 0-100 N/A 
Role emotional 74.1 (28.9) 0-100 0.9 
Social functioning'. b 74.5 (29.3) 0-100 N/A 
Role physical 69.8 (27.7) 0-100 0.86 
General healthy 62.7 (25.9) 0-100 N/A 
Bodily pains 75.4 (31.0) 0-100 N/A 
Vitalitya 47.3 (26.6) 0-100 N/A 
Physical functioningb 79.6 (29.2) 0-100 0.8 
a Cronbach's alpha cannot be computed as overall QoL consists of only 
I final score. 
b Data for I case missing. 
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Table I 
Characteristics of responders and non-responders 
3 
Characteristic Responders (n - 55) Non-responders' 
(n = 18) 
Sex 
Male 36 (65) 12(67) 
Female 19 (35) 6(33) 
Age (years) 
Mean (S. D. ) 59 (13.4) 61 (13.5) 
Range 23-89 29-81 
Ethnicity 
White 48 (87) - 
Other 7(13) 
Marital state 
Single/widowed 25 (45) 
Married/cohabiting 30 (55) 
Educationb 
<Secondary education 26 (47) - 
>Secondary education 26 (47) - 
AJCC Stage of cancer' 
Stage 1 11 (20) 3 (17) 
Stage 2 11 (20) 4 (22) 
Stage 3 9(16) 2(11) 
Stage 4a'` 13 (24) 4(22) 
Stage 4b 0 (l1) 3 (17) 
Stage 4c 1 (2) 2 (11) 
Treatment planned' 
Surgery only (S) 13 (24) - 
Radiotherapy only (RT) 16(29) - 
S&RT 13(24) - 
RT &C hcmo. (CT) 5 (9) - 
S&RL&CT 2(4) - 
Data are number (%) of patients. 
Data missing. 
h Some data from non-responders were not available 
Table 2 
Mean (S. D. ), range and Cronbach's alpha values for the QoL measures 
QoL domain Mean (S. D. ) Range Cronbach's cr 
l head PGI° (n=46) 4.2 (2.3) 0-10 N/A 
487 
























Correlations between individualised QoL and standardised HR-QoL 
measures 
HR-QoL Domain PGI (individualised QoL) n= 46 
Pearson's r p-value 
EORTC QLQ-C30 
Global QoL/health 0.46 <0.001 
Emotional functioning 0.32 <0.05 
Cognitive functioning 0.37 <0.01 
Physical functioning 0.04 >0.05 
Social functioning 0.15 >0.05 
Role functioning 0.22 >0.05 
SF-12 
Mental health 0.42 <0 005 
Role emotional 0.48 <0.001 
Social functioning 0.33 <0.05 
Role physical 0.30 <0.05 
fl n ralb 1ih n lc ýnnc 
Standardised HR-QoL: EORTC QLQ-C30 
The amount of variation in each of the five QoL domains 
ranged from 32 to 57% (Table 5). The only non-psychological 
factor to contribute significantly to Qol. was age, which partly 
explained Physical Functioning scores, in addition to Illness 
identity (IPQ-R) and beliefs about the Necessity of"Treatment 
(BMQ) (F= 12.63; d. f. = 3,49; p<0.01). A large variation in 
global QoL/health (43`%, ) was explained by levels of depres- 
sion (1lADS) and treatment concerns (BMQ) (F=20.8X; 
d. f. = 2,50; p<0.01). These correlations were inverse indicat- 
ing that fewer concerns regarding treatment and lower levels 
of depression were associated with better global QoL. 
Standardised HR-QoL: SF-12 
Bodily pain 0.19 >0.05 
The amount of variation explained in each of the 8 
Vitality 0.09 >0.05 QoL domains ranged from 20 to 49% (Table 6). Depres- 
Physical functioning -0.12 >0.05 sive symptoms contributed significantly to five of the 
eight Qol, domains. For example, variation in role physi- 
cal (F= 14.44; d. C= 1,53; p<0.01) and social functioning 
significantly only with EORTC QLQ-C30 domains of. emo- (F= 20.1; d. f. - 1,51; p<0.01) were explained by depression tional functioning (r=0.320, p<0.05); cognitive function- alone. Correlations were inverse, indicating that lower levels ing (r=0.368, p<0.01) and global QoLlhealth (r=0.464, of depression were associated with better QoL. 
p<0.001), and similarly with SF-12 domains of. men- About a third of the variation in general health (F= 11.32; 
tal health (r= 0.421, p<0.005); role emotional (r=0.476, d. f. "-2,47; p-0.01) could be explained by beliefs regard- 
p<0.001); social functioning (r=0.334, p<0.05) and role ing the illness timeline (IPQ-R) and the maladaptive coping 
physical (r= 0.304, p < 0.05). This suggests that, before treat- strategy of self-blame (Brief COPE). Stronger beliefs that the 
ment, patients' priorities were less concerned with physical illness would last a long time and high levels of self-blame functioning and more with emotional and cognitive well- were associated with lower QoL on this domain. Similarly, being. 
with the domain of vitality, stronger beliefs that the illness The two standardised I-iR-QoL measures were highly cor- would last a long time (timeline) and that the illness would 
related with each other. come and go (timeline--cyclical) were associated with lower Regression models examined the extent to which indepen- levels of vitality (F= 15.07; H. = 2,50; p<0.05). dent factors could explain variations in QoL (Tables 4-6). The Variation in role emotional (SF-12) was explained by 
main findings were: depression and the maladaptive coping strategy of substance 
use (Brief COPE) (F= 19.55; d. f. =2,47; p<0.01). Again, 
Individualised QoL rh; c rnrralat; nn .,, - , '., PrA fl -t h; oh IPVP1C of 
Only psychological factors significantly explained variation 
in PGI scores (Table 4). Illness identity from the IPQ-R 
and the adaptive coping strategies of acceptance and use 
of instrumental support (Brief COPE) together explained 
30% of the variation in PGI (F=7.39; d. f. = 3,41; p< 
0.01). 
Table 4 
Variation in individualised QoL (PGI) explained by independent variables 
(n=45) 
Explanatory factor ß 
Illness identity (IPQ-R) -0.30"" 
Acceptance (COPE) -0.38' 
Use of instrumental support (COPE) -0.38' 
Overall model: R2 - 0.35; adjusted R2 = 0.30; F= 7.39; d. f = 3,41 
p<0.05. 
xY p<0.01. 
depression and high levels of substance use could explain 
low levels of Role Emotional QoL. 
Sex, and treatment-related factors did not contribute sig- 
nificantly to any of the QoL domains in this sample. 
Discussion 
Although standardised HR-QoL measures are often used in 
patients with head and neck cancer within a clinical setting, 
it has been suggested that they fail to capture the individual's 
sense of `quality of life'. This is because they do not focus on 
the individual's perception of QoL over and above standard- 
ised QoL related to pre-selected domains. In contrast, patient- 
generated outcome (individualised QoL) attempts to capture 
aspects of QoL that are most important to the individual at 
that particular time. Given the interest in the use of individ- 
ualised measures in clinical trials' 1,12 and in patients with 
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Table 5 
Variation in HR-QoL (EORTC QLQ-C30) explained by independent variables 
HR-QoL domain Explanatory factor ß 
Global QoL/health (n = 53) 
Overall model: R2=0.46; adjusted R2=0.43; F=20.88; d. £ = 2,50` 
Physical functioning (n = 53) 
Overall model: R2 = 0.44; adj. R2 = 0.4; F=12.63; d. f = 3,49" 
Role functioning (n = 51) 
Overall model: R2 = 0.34; adj. R2 = 0.32; F= 24.99; d. f. =1,49" 
Emotional functioning (n = 53) 
Overall model: R2=0.58; adj. R2 = 0.57; F= 34.81; d. f = 2,50" 
Cognitive functioning (n = 53) 
Overall model: R2 = 0.39; adj. R2=0.36; F= 15.85; d. £ = 2,50" 
Social functioning (n = 51) 
Overall model: R2 = 0.35; adj. R2 = 0.32; F= 12.65; d. f = 2,48" 
Depression -3.73" 
Treatment concerns (13MQ) -1.33* 
Age 0.02" 
Illness identity (IPQ-R) 0.07" 
Necessity of treatment (BMQ) -0.07" 
Depression 0.15** 
Emotional representations (IPQ-R) 0.14" 
Substance use (COPE) 0.13" 
Anxiety 0.07" 
Illness identity (IPQ-R) 0.09" 
Positive reframing (COPE) 0.18" 
Timeline (IPQ-R) 0.14" 
p<0.05. 
ý" p<0.01. 
Table 6 cancer in general, 1 3- 15 the use of patient-reported outcomes 
Variation in HR-QoL (SF-12v2) explained by independent variables ,,,, t A I, t -A I ;I;., , t, o 'o., FI-, A-I -I, ranw r It uz c 
HR-QoL domain Explanatory factor 
Physical functioning (n = 52) Age 
Depression 
Model: R2 = 0.26; adj. R2 = 0.23; F= 8.42; d. f. = 2,49' 
Role physical (n = 55) Depression 
Model: R2 =0.21; adj. R2 =0.201 F= 14.44; d. f = 1,53" 
Bodily pain (n = 52) Depression 
Illness identity (IPQ-R) 
Model: R2 = 0.35; adj. R2 = 0.33; F= 13.44; d. f = 2,49** 
General health (n = 50) Timeline (IPQ-R) 
Self-blame (COPE) 
l Vülll LII l/l. I ll. l ll. l ül 111 ll ll. ül l. ü VI III. QU UI1U 114ý. 1ý lü11ýý1. t rr uu 
ß previously not known how standardised QoL measures and 
-0.96" individualised measures compared. In the present study we 
-2.79' hypothesised that there would be no correlation between the 
measures because of their conceptual differences. The results 
-3.83** 
of our study suggest that there is partial overlap between these 
measures and that the main overlap seems to exist between 
individualised QoL and domains assessing cognitive, emo- 
-4.16" tional, and mental functioning. We therefore rejected the first 
2.52', x null hypothesis. 
In contrast to our results, the PGI has been related to 
-5.25" physical aspects of 
HR-QoL in other groups of patients. For 
- 2.52" example, in a study of severely disabled patients with mul- 
Model: R2 =0.33; adj. R2 = 0.30; F= 11.32; d. f = 2,47** 
Vitality (n=53) Timeline (IPQ-R) -6.12"* 
Timeline cyclical (IPQ-R) -2.38* 
Model: R2 = 0.38; adj. R2 = 0.35; F= 15.07; d. f = 2,50' 
Social functioning (n = 53) Depression -4.4 
Model: R2 = 0.28; adj. R2 = 0.27; F= 20.1; d. f. = 1,51 
Role emotional (n = 50) Depression -4.89" 
Substance use (COPE) -4.82" 
Model: R2 =0.45; adj. R2 = 0.43; F= 19.55; d. f =2,47" 
Mental health (n= 50) Anxiety -2.41 
Illness identity (IPQ-R) -2.03" 
Model: R2 = 0.51; adj. R2 = 0.49; F= 24.29; d. f = 2,47" 
p<0.05. 
" p<0.01. 
tiple sclerosis, individualised QoL (as assessed oy the r(i) 
was related to a person's level of physical functioning, as 
opposed to a different patient-centred measure which seemed 
to be more related to feelings of health and vitality, 
16 similar 
to the PGI in our study. 
The PGI seems to be more responsive to change in health 
than the SF-36 and the EORTC-QLQ-C30 in other patients 
with cancer. 13 And may thus prove to be a more accurate tool 
for the assessment of the outcome of patients with cancer. 
The self-regulation model1-3 proposes that in response 
to a health threat, such as the diagnosis of cancer, people 
develop their own beliefs and emotional responses about their 
illness and treatment, which then influence the coping proce- 
dures that they adopt. These beliefs, emotional responses, and 
coping strategies then influence the outcome, which, in this 
study, were perceptions of QoL. As this is a constant process 
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of reappraisal, patients' beliefs and coping strategies may Appendix A 
change over time. In the present study, a significant amount 
of variation in pre-treatment QoL (both individualised and The European Organisation for Research and Treatment of 
standardised) could be explained by patients' perceptions of Cancer (EORTC) Quality of Life Questionnaire (QLQ)- 
their illness and treatment, and by the coping strategy that C30 is a well-known and validated questionnaire for self- 
they used. In particular patients' illness identity (the num- completion. The instrument has 15 multi-item and Single- 
ber of symptoms attributed to their head and neck cancer) item domains. For this study, only the five functional domains 
and beliefs about the likely timeline (perceptions about the (physical, role, emotional, cognitive, and social) and global 
length of time the illness would last) explained a significant QoL/health domain were used in analyses. I Iigher scores for 
amount of variation in QoL (both individualised and I IR- the functional and global domains of the core instrument sig- 
QoL). Treatment concerns and beliefs about the necessity for nified better functioning. 
treatment were also important in this group of patients. This The SF-12 is a multipurpose short-form consisting of 12 
therefore led us to reject the other two null hypotheses. In the items, all selected from the SF-36 I lealth Survey. `' Similar 
present study coping ability was related to QoL. In particular, to the SF-36, the SF-12 is a generic measure and version 2 
the use of more adaptive strategies such as positive reframing results in an eight-domain health profile (physical function- 
was associated with better QoL, and maladaptive strategies ing, physical role, bodily pain, general health, vitality, social 
such as substance use and self-blame were associated with a functioning, emotional role and mental health). I lighcr scores 
worse QoL. Previous research17 has highlighted this relation signified better functioning. 
between poor functioning and ineffective coping styles, such The Patient Generated Index is a global measure of QoL, 
as helplessness and hopelessness, anxious preoccupation, and based on the theoretical approach proposed by Calman22 who 
fatalism. Listet al. 18 found that maladaptive coping strategies defined QoL as `the extent to which our hopes and ambi- 
(cognitive escape-avoidance, sleeping more than usual, and tions are matched by experience'. The PGI is a three-stage 
behavioural escape avoidance, not seeking help or waiting self-completed measure. The first stage involves identifying 
before taking action) were related to poorer global QoL. a maximum of five areas of li fe that have been affected by the 
As reported by other authors, 19 19,20 depression explained a disease, plus 2 other boxes consisting of `areas affected by 
large amount of variation in HR-QoL. However, it is inter- other health problems' and `all other non-health areas of life'. 
esting to note that variation in patient-generated QoL was In the second stage, the respondent provides a rating of the 
not explained by depressive symptoms. However, HR-QoL degree to which reality meets expectations in each area listed 
instruments include depressive symptoms, and it is not sur- (on a scale of 0 to 10,0 indicating the area as the worst imag- 
prising that there is overlap with other scales that measure inable and 10 being exactly as wanted). In the third stage, the 
depression (for example, the HADS). The relation between respondent is asked to imagine that any of these areas of life 
physical symptoms, depression, and QoL is far from under- could he improved. The respondent is given 14 imaginary 
stood. Longitudinal research is needed to unravel these rela- points to be spent on whatever areas are deemed to be the 
tions. most important at that time. Finally an overall PGI score of 
The main limitation of this study is its cross-sectional between 0 and 10 is calculated, with higher scores indicating 
design. This means that no inferences can be made about better individualised QoL. 
which variables are exerting an influence on the others. The The Illness Perception Questionnaire-Revised is an exten- 
power of the study was low because of the few patients stud- sively used measure that assesses patient's beliefs and under- 
ied. This was overcome as much as possible by the selection standing of their illness in seven dimensions, and has con- 
of significant variables by univariate analysis before entering firmed validity and reliability across a range of illnesses. 
' It 
them into multivariate analyses. This reduced the number of provides a quantitative assessment of the nature and strength 
variables entered into multivariate analyses. Despite these of patients' beliefs about the following seven components: the 
potential limitations, the findings are potentially relevant to nature of the patients illness `identity', the number of symp- 
clinical practice. If the PGI and the IPQ-R are used, clinicians toms they perceive to be related to their illness, how long 
may gain a better understanding of their patients' views about the patient thinks their illness will last, and whether symp- 
their illness and treatment, which would promote a better toms are sustained or cyclical; the perceived consequences 
clinician-patient partnership. of the illness; how much personal control the patient feels 
they have over their illness; whether patients have a coher- 
ent understanding of their illness; and finally the emotional 
Acknowledgements picture the patient has of the illness. The higher the score on 
these dimensions the stronger the belief. 
CDL is supported by a grant from Guy's and St Thomas' The Beliefs about Medicine Questionnaire (BMQ) 
Charitable Foundation (no: R020216). Thanks to all the was originally designed to assess patients' beliefs about 
patients and staff from Guy's and St Thomas' Hospitals, The medicines prescribed for personal use. It is a well-known 
Royal Sussex County Hospital, and The Royal Marsden Hos- and validated measure and has been used in a wide range of 
pital who assisted with this project. illnesses. ' The BMQ-Specific was adapted to assess beliefs 
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about treatment in head and neck cancer and comprises two 
subscales assessing beliefs about the `necessity' for treat- 
ment to health and `concerns' about the possible side-effects 
and the disruptive effects of treatment. Higher scores reflect 
stronger beliefs about the necessity for treatment and stronger 
concerns. 
The Hospital Anxiety and Depressioin Score (HADS) is 
a widely used and validated scale and was used to provide a 
brief measure of state anxiety and depression. Higher scores 
indicate greater anxiety or depression. Scores can range from 
0 to 21 with scores of 11 or more indicating probable psy- 
chological morbidity. 
The Brief COPE 10 is a validated multidimensional coping 
inventory, which was used in this study to assess situational 
coping. This short form version of the full COPE23 assesses 
coping strategies on 14 conceptually different subscales-for 
example, coping by using self-distraction, using substances, 
using humour, positively reframing the situation, or self 
blame. Both adaptive and maladaptive coping strategies are 
therefore included. 
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